index	sentence	label
0	@PROTEIN$ enables Ca2+-activated @COMPOUND$-conductance in epithelia.	1
1	When Vitreoscilla were grown in medium containing 60mM @COMPOUND$ under both normal and limited aeration conditions, the levels of Vitreoscilla @PROTEIN$ (VHb) were decreased by greater than 90%, while the levels of the terminal respiratory oxidase, cytochrome bo, were increased 350% under normal aeration and 7-23% under limited aeration.	1
2	Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment (@PROTEIN$) to investigate the protection mechanism of epigallocatechin gallate (EGCG), the main constituent of @COMPOUND$.	0
3	Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment (@PROTEIN$) to investigate the protection mechanism of @COMPOUND$), the main constituent of green tea.	0
4	In addition, we demonstrated that Hsp20, @PROTEIN$ and HspB8 induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	0
5	In addition, we demonstrated that Hsp20, HspB2 and HspB8 induced @PROTEIN$ production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	1
6	In addition, we demonstrated that Hsp20, HspB2 and @PROTEIN$ induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	0
7	Furthermore, @COMPOUND$ was found to be capable of significantly preventing the inhibitory effect of @PROTEIN$ on Abeta oligomer formation.	1
8	The scavenger receptor, class B, type I (@PROTEIN$) is critical in maintaining the homeostasis of cholesterol and @COMPOUND$.	1
9	The scavenger receptor, class B, type I (@PROTEIN$) is critical in maintaining the homeostasis of @COMPOUND$ and alpha-tocopherol.	1
10	SR-BI binds @PROTEIN$ (HDL) and mediates the selective transfer of cholesteryl esters and @COMPOUND$ from circulating HDL to cells.	0
11	@PROTEIN$ binds high-density lipoproteins (HDL) and mediates the selective transfer of cholesteryl esters and @COMPOUND$ from circulating HDL to cells.	1
12	Thus, @PROTEIN$ influences neural and cognitive processes, a finding that highlights the contribution of @COMPOUND$ and alpha-tocopherol homeostasis in proper cognitive function.	0
13	Thus, @PROTEIN$ influences neural and cognitive processes, a finding that highlights the contribution of cholesterol and @COMPOUND$ homeostasis in proper cognitive function.	0
14	@COMPOUND$ is believed to confer its diabetogenic effect by inhibiting pancreatic @PROTEIN$ activity, leading to pancreatic beta-cell death.	1
15	@COMPOUND$ supplementation prevents the exercise-induced reduction of serum paraoxonase 1/@PROTEIN$ activities in healthy individuals.	1
16	@PROTEIN$ modified the association between cholesterol and cognitive decline, and the association between the ratio of @COMPOUND$ to cholesterol and cognitive functioning.	1
17	@PROTEIN$ modified the association between @COMPOUND$ and cognitive decline, and the association between the ratio of 27-hydroxycholesterol to cholesterol and cognitive functioning.	1
18	The mood stabilizers @COMPOUND$ and valproate selectively activate the promoter IV of @PROTEIN$ in neurons.	1
19	The mood stabilizers lithium and @COMPOUND$ selectively activate the promoter IV of @PROTEIN$ in neurons.	1
20	Treatment of cultured rat cortical neurons with therapeutic concentrations of @COMPOUND$ or VPA selectively increased the levels of exon IV (formerly rat exon III)-containing @PROTEIN$ mRNA, and the activity of BDNF promoter IV.	1
21	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of @PROTEIN$ or GSK-3beta isoforms.	1
22	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or @PROTEIN$ isoforms.	1
23	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of @PROTEIN$ or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or GSK-3beta isoforms.	1
24	Furthermore, treatment with other HDAC inhibitors, @COMPOUND$ and trichostatin A, or transfection with an HDAC1-specific siRNA also activated @PROTEIN$ promoter IV.	1
25	Furthermore, treatment with other HDAC inhibitors, sodium butyrate and @COMPOUND$, or transfection with an HDAC1-specific siRNA also activated @PROTEIN$ promoter IV.	1
26	Our study demonstrates for the first time that @PROTEIN$ and HDAC are respective initial targets for @COMPOUND$ and VPA to activate BDNF promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene.	1
27	Our study demonstrates for the first time that GSK-3 and HDAC are respective initial targets for @COMPOUND$ and VPA to activate @PROTEIN$ promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene.	0
28	Addition of biphasic @PROTEIN$ aspart 30 to optimized metformin and @COMPOUND$ treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).	0
29	Addition of biphasic @PROTEIN$ aspart 30 to optimized @COMPOUND$ and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).	0
30	Addition of biphasic insulin aspart 30 to optimized metformin and @COMPOUND$ treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through @PROTEIN$ plus Oral ageNts).	0
31	Addition of biphasic insulin aspart 30 to optimized @COMPOUND$ and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through @PROTEIN$ plus Oral ageNts).	0
32	In addition, treatment with @COMPOUND$ increased interleukin-4 (@PROTEIN$) mRNA and reversed the age-related decrease in hippocampal IL-4 concentration.	1
33	Based on these validities we identified alterations in the @PROTEIN$ gene in the CA1 and amygdala regions, specifically in exposed PTSD-like rats, which were normalized after treatment with @COMPOUND$.	1
34	@COMPOUND$ inhalation induced: (1) a transient bronchial inflammation, dominated by neutrophils; (2) a neutrophilia of the blood that persisted for up to 4 weeks; (3) a transient increased bronchial reactivity, and (4) a significant increase in @PROTEIN$ activity in the BALF.	1
35	To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of GCLC, @PROTEIN$ and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
36	To assess whether follicle-stimulating hormone (FSH) and @PROTEIN$ (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of GCLC, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
37	To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of @PROTEIN$, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
38	In conclusion, our results show that FSH and bFGF increase @COMPOUND$ levels in Sertoli cells through stimulation of the de novo synthesis and recycling by upregulating @PROTEIN$ and GR expression respectively.	0
39	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and @PROTEIN$ (POD) activities, and LPO.	0
40	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and @PROTEIN$ (POD) activities, and LPO.	0
41	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (@PROTEIN$) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0
42	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, @PROTEIN$ (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0
43	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (@PROTEIN$) and peroxidase (POD) activities, and LPO.	0
44	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (@PROTEIN$) activities, and LPO.	0
45	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (@PROTEIN$) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0
46	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (@PROTEIN$) and peroxidase (POD) activities, and LPO.	0
47	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and @PROTEIN$.	0
48	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, @PROTEIN$ (SOD) and peroxidase (POD) activities, and LPO.	0
49	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (@PROTEIN$) activities, and LPO.	0
50	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, @PROTEIN$ (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0
51	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and @PROTEIN$.	0
52	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, @PROTEIN$ (SOD) and peroxidase (POD) activities, and LPO.	0
53	Selenium and @COMPOUND$ levels were not associated to @PROTEIN$ Abeta42.	0
54	In vitro, the degradation of synthetic Abeta substrate added to @PROTEIN$ was markedly accelerated by low levels (2microM) of exogenous zinc and @COMPOUND$.	1
55	@PROTEIN$ mutation impairs cholinergic modulation of synaptic plasticity and suppresses @COMPOUND$ currents in hippocampus slices.	1
56	Similarly, mutant @PROTEIN$ impairs the ability of the cholinesterase inhibitor @COMPOUND$ to enhance LTP.	1
57	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of spermidine and @COMPOUND$ were significantly decreased, while putrescine concentration was significantly increased.	1
58	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while @COMPOUND$ concentration was significantly increased.	1
59	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of spermidine and @COMPOUND$ were significantly decreased, while putrescine concentration was significantly increased.	1
60	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while @COMPOUND$ concentration was significantly increased.	1
61	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of @COMPOUND$ and spermine were significantly decreased, while putrescine concentration was significantly increased.	1
62	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of @COMPOUND$ and spermine were significantly decreased, while putrescine concentration was significantly increased.	1
63	@COMPOUND$ also decreased brain Abeta peptides, beta-secretase activity and expression, and the level of @PROTEIN$ (an APP C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.	1
64	@COMPOUND$ also decreased brain Abeta peptides, beta-secretase activity and expression, and the level of C99 (an @PROTEIN$ C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.	1
65	@COMPOUND$ rapidly phosphorylated Akt and endothelial @PROTEIN$ (eNOS) in human endothelial cells.	1
66	@COMPOUND$ rapidly phosphorylated Akt and endothelial nitric oxide synthase (@PROTEIN$) in human endothelial cells.	1
67	@COMPOUND$ rapidly phosphorylated @PROTEIN$ and endothelial nitric oxide synthase (eNOS) in human endothelial cells.	1
68	Our findings indicate that @COMPOUND$ protects endothelial cells from death with phosphorylation of Akt and @PROTEIN$.	1
69	Our findings indicate that @COMPOUND$ protects endothelial cells from death with phosphorylation of @PROTEIN$ and eNOS.	1
70	@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, @COMPOUND$, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
71	@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, @COMPOUND$, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
72	Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and @COMPOUND$ levels were found to be increased; however, beta-carotene, retinol, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
73	@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, vitamin C, vitamin E, @COMPOUND$, and albumin levels were observed to be significantly decreased.	0
74	Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, vitamin C, @COMPOUND$, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
75	@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, vitamin C, @COMPOUND$, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
76	Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, @COMPOUND$, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
77	Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, @COMPOUND$, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
78	Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, vitamin C, vitamin E, @COMPOUND$, and albumin levels were observed to be significantly decreased.	0
79	@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and @COMPOUND$ levels were found to be increased; however, beta-carotene, retinol, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
80	@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, @COMPOUND$, retinol, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
81	Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, @COMPOUND$, retinol, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
82	@COMPOUND$ is an endogenous vasodilator gas produced by the enzyme @PROTEIN$ (HO).	1
83	The long pentraxin 3 (@PROTEIN$) is a multifunctional soluble pattern recognition receptor, involved in several processes ranging from innate resistance and inflammation to clearance of apoptotic cells and organization of @COMPOUND$-rich extracellular matrices.	1
84	The @PROTEIN$ gene product forms part of a complex with the glucocorticoid receptor and can modulate @COMPOUND$-binding affinity.	1
85	The FKBP5 gene product forms part of a complex with the @PROTEIN$ and can modulate @COMPOUND$-binding affinity.	1
86	Several studies have shown that epsilon 2 carriers have lower low-density lipoprotein and apo B levels and higher @PROTEIN$ @COMPOUND$ and apo A-I levels than epsilon 3 carriers.	1
87	Several studies have shown that @PROTEIN$ 2 carriers have lower low-density lipoprotein and apo B levels and higher high-density lipoprotein @COMPOUND$ and apo A-I levels than epsilon 3 carriers.	1
88	We report that peripheral administration of @COMPOUND$ (LPS) activates @PROTEIN$ and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests.	1
89	Administration of L-@COMPOUND$, a metabolite of tryptophan that is generated by @PROTEIN$, to naive mice dose dependently induces depressive-like behavior.	1
90	Administration of L-kynurenine, a metabolite of @COMPOUND$ that is generated by @PROTEIN$, to naive mice dose dependently induces depressive-like behavior.	1
91	FABP levels positively correlated with BMI, triglyceride levels, blood @COMPOUND$, glycated @PROTEIN$, atherogenic index and insulin levels.	0
92	@PROTEIN$ levels positively correlated with BMI, triglyceride levels, blood @COMPOUND$, glycated hemoglobin, atherogenic index and insulin levels.	1
93	FABP levels positively correlated with BMI, triglyceride levels, blood @COMPOUND$, glycated hemoglobin, atherogenic index and @PROTEIN$ levels.	0
94	We demonstrated that @COMPOUND$ stimulated the gene expression of both secreted (@PROTEIN$) and membrane-linked (Muc1, Muc3, Muc4) mucins.	1
95	We demonstrated that @COMPOUND$ stimulated the gene expression of both secreted (Muc2) and membrane-linked (@PROTEIN$, Muc3, Muc4) mucins.	1
96	However, @COMPOUND$ enemas did not modify the number of epithelial cells containing the protein @PROTEIN$, and caused a 2-fold decrease in the thickness of adherent mucus layer.	0
97	We examined the association of @PROTEIN$ C677T and A1298C, and changes in plasma @COMPOUND$ in 352 Tunisian patients with angiographically-demonstrated CAD, and 390 age and gender-matched healthy subjects.	0
98	However, we also observed that @COMPOUND$ (1alpha-hydroxylase inhibitor) enhanced 25(OH)D(3)-induced @PROTEIN$ expression in breast cancer cells.	1
99	Short-term withdrawal of @COMPOUND$ induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial @PROTEIN$.	1
100	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
101	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
102	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
103	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
104	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
105	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
106	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
107	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
108	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
109	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
110	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
111	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
112	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @COMPOUND$ peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
113	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
114	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
115	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
116	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
117	Abnormally high CSF 3-OMD occurs frequently for RLS patients indicating either increased @COMPOUND$ synthesis, limitations in l-dopa decarboxylation or increased @PROTEIN$/COMT activity, or some combination of these.	0
118	Abnormally high CSF 3-OMD occurs frequently for RLS patients indicating either increased @COMPOUND$ synthesis, limitations in l-dopa decarboxylation or increased MAT/@PROTEIN$ activity, or some combination of these.	0
119	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0
120	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0
121	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0
122	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0
123	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0
124	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0
125	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0
126	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0
127	The mood stabilizers @COMPOUND$ and valproate activate the @PROTEIN$ pathway in prefrontal cortex and hippocampus and potentiate ERK pathway-mediated neurite growth, neuronal survival and hippocampal neurogenesis.	1
128	The mood stabilizers lithium and @COMPOUND$ activate the @PROTEIN$ pathway in prefrontal cortex and hippocampus and potentiate ERK pathway-mediated neurite growth, neuronal survival and hippocampal neurogenesis.	1
129	In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of lysine decarboxylase and of ornithine decarboxylase to the same extent, but had no effect on @PROTEIN$ activity.	0
130	In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of lysine decarboxylase and of ornithine decarboxylase to the same extent, but had no effect on @PROTEIN$ activity.	0
131	In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of lysine decarboxylase and of @PROTEIN$ to the same extent, but had no effect on arginine decarboxylase activity.	1
132	In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of lysine decarboxylase and of @PROTEIN$ to the same extent, but had no effect on arginine decarboxylase activity.	1
133	In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of @PROTEIN$ and of ornithine decarboxylase to the same extent, but had no effect on arginine decarboxylase activity.	1
134	In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of @PROTEIN$ and of ornithine decarboxylase to the same extent, but had no effect on arginine decarboxylase activity.	1
135	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, P53 and @PROTEIN$ D1.	1
136	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, @PROTEIN$ and Cyclin D1.	1
137	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: @PROTEIN$, Bcl2, P53 and Cyclin D1.	1
138	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, @PROTEIN$, P53 and Cyclin D1.	1
139	The array and western blotting showed that Bcl2 and @PROTEIN$ D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1
140	The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; P53 expression was not affected while @PROTEIN$ was over expressed by combination of @COMPOUND$ with Dox.	1
141	The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; @PROTEIN$ expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	0
142	The array and western blotting showed that @PROTEIN$ and Cyclin D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1
143	In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of Bcl2 and @PROTEIN$ D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1
144	In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of @PROTEIN$ and Cyclin D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1
145	Randomised trials have demonstrated that the efficacy of anti-tumour necrosis factor (@PROTEIN$) agents is significantly increased by concomitant @COMPOUND$ (MTX) in rheumatoid arthritis (RA).	1
146	Neither @PROTEIN$ nor ATP altered production of reactive oxygen intermediates (ROI) or reactive @COMPOUND$ intermediates (RNI) by bovine monocytes.	0
147	Neither @PROTEIN$ nor ATP altered production of reactive @COMPOUND$ intermediates (ROI) or reactive nitrogen intermediates (RNI) by bovine monocytes.	0
148	Neither @PROTEIN$ nor @COMPOUND$ altered production of reactive oxygen intermediates (ROI) or reactive nitrogen intermediates (RNI) by bovine monocytes.	0
149	The @COMPOUND$ supplementation of the chronically immobile patients resulted in a smaller decrease in @PROTEIN$ 0.001).	1
150	Our results also suggest that @PROTEIN$ decreases quite linearly during @COMPOUND$ supplementation at any given 25-OHD level.	1
151	Common 677C--&gt;T mutation of the @PROTEIN$ gene affects follicular @COMPOUND$ synthesis.	1
152	Surprisingly, a deletion of the @PROTEIN$ gene affected not only insoluble @COMPOUND$) reduction, which requires pili, but also soluble Fe(III) reduction, which, in contrast, does not require pili.	1
153	Therapeutic @COMPOUND$/@PROTEIN$ activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.	1
154	However, when ERalpha negative MDA-MB-435 cells were treated with @COMPOUND$, they demonstrated increased expression of vascular endothelial growth factor (VEGF) in an @PROTEIN$ dependent manner; while the ERalpha positive MCF-7 cells did not.	1
155	However, when ERalpha negative MDA-MB-435 cells were treated with @COMPOUND$, they demonstrated increased expression of vascular endothelial growth factor (@PROTEIN$) in an AMPK dependent manner; while the ERalpha positive MCF-7 cells did not.	1
156	The @COMPOUND$-treated group showed increased @PROTEIN$ expression, intratumoral microvascular density and reduced necrosis.	1
157	@COMPOUND$ treatment was sufficient, however, to reduce systemic @PROTEIN$ and the proliferation rate of tumor cells in vascularized regions.	1
158	@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
159	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
160	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
161	TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
162	TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
163	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
164	@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
165	TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
166	TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
167	TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
168	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
169	TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
170	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
171	TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
172	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
173	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
174	TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
175	@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
176	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
177	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
178	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
179	TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
180	TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
181	TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
182	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
183	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
184	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
185	@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
186	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
187	TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
188	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
189	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
190	TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
191	TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
192	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
193	@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
194	TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
195	TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
196	TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
197	TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
198	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
199	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
200	TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
201	TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
202	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
203	Systemic administration of @PROTEIN$ vesicle elevates tumor tissue @COMPOUND$ tension and modifies tumor response to irradiation.	1
204	The participation of protein kinase A (PKA), protein kinase C (@PROTEIN$) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM @COMPOUND$, and 3 microM genistein, respectively).	0
205	The participation of @PROTEIN$ (PKA), protein kinase C (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM @COMPOUND$, and 3 microM genistein, respectively).	0
206	The participation of @PROTEIN$ (PKA), protein kinase C (PKC) and protein tyrosine kinase (PTK) in capacitation induced by @COMPOUND$ (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM genistein, respectively).	0
207	The participation of protein kinase A (PKA), @PROTEIN$ (PKC) and protein tyrosine kinase (PTK) in capacitation induced by @COMPOUND$ (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM genistein, respectively).	0
208	The participation of @PROTEIN$ (PKA), protein kinase C (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM @COMPOUND$, respectively).	0
209	The participation of protein kinase A (PKA), @PROTEIN$ (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM @COMPOUND$, respectively).	0
210	The participation of protein kinase A (PKA), protein kinase C (@PROTEIN$) and protein tyrosine kinase (PTK) in capacitation induced by @COMPOUND$ (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM genistein, respectively).	0
211	The participation of protein kinase A (PKA), protein kinase C (@PROTEIN$) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM @COMPOUND$, respectively).	0
212	The participation of protein kinase A (PKA), @PROTEIN$ (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM @COMPOUND$, and 3 microM genistein, respectively).	0
213	At the time, @PROTEIN$ activity was significantly inhibited and gamma-glutamyl @COMPOUND$ increased by ACA exposure.	0
214	The effect of the polymorphism is non-conservative and results in a glutamine to @COMPOUND$ change (Gln460Arg), which is likely to affect @PROTEIN$ dimerization and protein-protein interactions.	1
215	The effect of the polymorphism is non-conservative and results in a @COMPOUND$ to arginine change (Gln460Arg), which is likely to affect @PROTEIN$ dimerization and protein-protein interactions.	1
216	Increased @COMPOUND$ tone and decreased @PROTEIN$ concentrations may also contribute to reduced GH levels.	0
217	Inhibition of LTP by beta-amyloid is prevented by activation of @PROTEIN$ and stimulation of the @COMPOUND$/PKA signalling pathway.	0
218	A novel oligodeoxynuleotides containing 11 @COMPOUND$ motifs was synthesized and inserted into the VR1020 plasmid containing pig @PROTEIN$ (IL-6) gene (VPIL6) to construct recombinant plasmid, VPIL6C.	0
219	A novel oligodeoxynuleotides containing 11 @COMPOUND$ motifs was synthesized and inserted into the VR1020 plasmid containing pig interleukin-6 (@PROTEIN$) gene (VPIL6) to construct recombinant plasmid, VPIL6C.	0
220	Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the @COMPOUND$-dependent and-coupled transport of Na (+) and K(+) across the plasma membrane of a living cell in which such a process (@PROTEIN$) is detected.	1
221	Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the ATP-dependent and-coupled transport of @COMPOUND$ (+) and K(+) across the plasma membrane of a living cell in which such a process (@PROTEIN$) is detected.	1
222	Affinity electrophoresis analysis provided evidence that carboxymethylated dextran polymers grafted with high amounts of @COMPOUND$ groups (named DMCB) interact with @PROTEIN$.	1
223	Affinity electrophoresis analysis provided evidence that carboxymethylated @COMPOUND$ polymers grafted with high amounts of benzylamide groups (named DMCB) interact with @PROTEIN$.	1
224	Peripheral venous levels of @COMPOUND$, @PROTEIN$, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), malondialdehyde and glycosylated haemoglobin (HbA(1)c) were obtained in all subjects.	0
225	Peripheral venous levels of testosterone, @PROTEIN$, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), @COMPOUND$ and glycosylated haemoglobin (HbA(1)c) were obtained in all subjects.	0
226	Our results showed that @PROTEIN$ abolished the effect of the oxidant, protecting spermatozoa against reactive @COMPOUND$ species, and improving both sperm motility and chromatin status during incubation.	1
227	Intranasal and intravenous administration of live Cpn and Aa, respectively induced an accumulation of activated mast cells in the aortic sinus of apolipoprotein E-deficient mice, however, with varying responses in the systemic levels of @COMPOUND$ (LPS) and @PROTEIN$.	0
228	@PROTEIN$ and two additional catalase isozymes were induced by @COMPOUND$ or bensulfuron-methyl in S. maltophilia WZ2, but not in E. coli K12.	1
229	MnSOD and two additional @PROTEIN$ isozymes were induced by @COMPOUND$ or bensulfuron-methyl in S. maltophilia WZ2, but not in E. coli K12.	1
230	@PROTEIN$ and two additional catalase isozymes were induced by quinclorac or @COMPOUND$ in S. maltophilia WZ2, but not in E. coli K12.	1
231	MnSOD and two additional @PROTEIN$ isozymes were induced by quinclorac or @COMPOUND$ in S. maltophilia WZ2, but not in E. coli K12.	1
232	Results indicate that @PROTEIN$ has a much weakly role in the defense against @COMPOUND$ or bensulfuron-methyl induced oxidative stress, whereas SOD could be critical.	1
233	Results indicate that catalase has a much weakly role in the defense against quinclorac or @COMPOUND$ induced oxidative stress, whereas @PROTEIN$ could be critical.	1
234	Results indicate that @PROTEIN$ has a much weakly role in the defense against quinclorac or @COMPOUND$ induced oxidative stress, whereas SOD could be critical.	1
235	Results indicate that catalase has a much weakly role in the defense against @COMPOUND$ or bensulfuron-methyl induced oxidative stress, whereas @PROTEIN$ could be critical.	1
236	Moreover, @PROTEIN$ (except gamma4) reduce the ion channel block by the synthetic Joro spider toxin analog @COMPOUND$ (NASP).	1
237	Moreover, @PROTEIN$ (except gamma4) reduce the ion channel block by the synthetic @COMPOUND$ analog 1-naphthylacetyl spermine (NASP).	0
238	However, prewetting P(70/30) with a @COMPOUND$ buffer prior to aminolysis significantly improved cell numbers following immobilization of @PROTEIN$.	0
239	Our data suggest HumDN1 genotypes are related to total @COMPOUND$ levels in Han Chinese MI patients, but @PROTEIN$ gene polymorphisms are not associated with susceptibility to MI in Han Chinese.	0
240	Specifically, @COMPOUND$ was shown to alter S. mutans gene expression levels of gtfB, a known virulence factor, and yfiV, a putative @PROTEIN$ of cell-surface fatty acid genes.	1
241	Specifically, @COMPOUND$ was shown to alter S. mutans gene expression levels of @PROTEIN$, a known virulence factor, and yfiV, a putative transcriptional regulator of cell-surface fatty acid genes.	1
242	Degradation analysis over 8 weeks in the presence of 10 mg/L @PROTEIN$ showed a 50% decrease in total weight and an 80% decrease in @COMPOUND$ molecular weight.	1
243	Fluo-3 staining used in flow cytometry and video microscopy revealed an oxysterol-induced @COMPOUND$+) influx, varying according to the oxysterol studied, leading to the activation of the MEK/@PROTEIN$/2 pathway as demonstrated by Western blot analysis.	1
244	"To determine if response to endocrine therapy of breast cancer can be predicted by either a metabolic ""flare reaction"" detected by positron emission tomography (PET) with 2-((18)F)-fluoro-@COMPOUND$ (FDG), induced by an estradiol challenge, or by @PROTEIN$ (ER) status, determined by PET with the estrogen analog 16alpha-((18)F)fluoroestradiol-17beta (FES)."	0
245	"To determine if response to endocrine therapy of breast cancer can be predicted by either a metabolic ""flare reaction"" detected by positron emission tomography (PET) with 2-((18)F)-fluoro-2-deoxyglucose (FDG), induced by an @COMPOUND$ challenge, or by @PROTEIN$ (ER) status, determined by PET with the estrogen analog 16alpha-((18)F)fluoroestradiol-17beta (FES)."	0
246	Depletion of @COMPOUND$ levels was accompanied by the induction of @PROTEIN$ (GR) after 24h exposure with each of the four carbamates to CHO-K1 cells.	1
247	@COMPOUND$ and wortmannin inhibited the upregulation induced by @PROTEIN$ stimulation and amino acid deprivation but not that induced by osmotic shock.	1
248	Chloroquine and @COMPOUND$ inhibited the upregulation induced by @PROTEIN$ stimulation and amino acid deprivation but not that induced by osmotic shock.	1
249	Moreover, PD98059 and SP600125 inhibited only amino acid deprivation-induced upregulation and @COMPOUND$ inhibited only @PROTEIN$-induced upregulation.	1
250	Moreover, PD98059 and @COMPOUND$ inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only @PROTEIN$-induced upregulation.	0
251	Moreover, @COMPOUND$ and SP600125 inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only @PROTEIN$-induced upregulation.	0
252	The role of phosphorylated @PROTEIN$ (p-Akt) in oral carcinogenesis induced by @COMPOUND$ and alkaline environments was investigated.	0
253	Sera from a population sample of infants with cryptorchidism (n = 43), hypospadias (n = 41) and controls (n = 113) were analyzed for inhibin B, anti-Müllerian hormone (@PROTEIN$), @COMPOUND$, luteinizing hormone (LH), follicle stimulating hormone (FSH) and sex hormone binding globulin (SHBG).	0
254	Sera from a population sample of infants with cryptorchidism (n = 43), hypospadias (n = 41) and controls (n = 113) were analyzed for inhibin B, anti-Müllerian hormone (AMH), @COMPOUND$, luteinizing hormone (LH), follicle stimulating hormone (FSH) and sex hormone binding globulin (@PROTEIN$).	0
255	Myeloperoxidase (@PROTEIN$) is an endogenous oxidant enzyme that generates reactive @COMPOUND$ species (ROS).	1
256	In present study, we investigated the combined effect of @COMPOUND$ and baicalin on pancreatic damage and pancreatitis associated lung injury, as well as tissue @PROTEIN$ expression in the setting of AP.	0
257	In present study, we investigated the combined effect of emodin and @COMPOUND$ on pancreatic damage and pancreatitis associated lung injury, as well as tissue @PROTEIN$ expression in the setting of AP.	0
258	The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, tumor necrosis factor-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed @PROTEIN$ expression in pancreas and lung.	1
259	The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, tumor necrosis factor-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed @PROTEIN$ expression in pancreas and lung.	1
260	The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, @PROTEIN$-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
261	The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, tumor necrosis factor-alpha and @PROTEIN$, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
262	The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, tumor necrosis factor-alpha and @PROTEIN$, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
263	The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, @PROTEIN$-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
264	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (@PROTEIN$) and estrogen receptor-beta (ER-beta).	0
265	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and @PROTEIN$ (ER-beta).	0
266	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), @PROTEIN$ (LHR) and estrogen receptor-beta (ER-beta).	0
267	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and estrogen receptor-beta (@PROTEIN$).	0
268	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (@PROTEIN$), luteinizing hormone receptor (LHR) and estrogen receptor-beta (ER-beta).	0
269	Results showed that a moderate dose of @PROTEIN$ (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and estrogen receptor-beta (ER-beta).	1
270	In the current study, we knocked down @PROTEIN$ expression using cognate siRNA during low-dose @COMPOUND$ treatment to induce apoptosis in two human glioblastoma U138MG and U251MG cell lines.	1
271	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of glucose, albumin, Ca, @COMPOUND$, Na and FT4.	1
272	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of glucose, albumin, Ca, cholesterol, @COMPOUND$ and FT4.	1
273	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of @COMPOUND$, albumin, Ca, cholesterol, Na and FT4.	1
274	Comparison of 50 patients with the lowest @PROTEIN$ levels (mean of 3.4ng/ml) to 50 patients with highest leptin levels (mean of 34ng/ml), did not indicate differences in both @COMPOUND$ and ICTP between these two populations in spite of the highly significant difference in leptin levels.	0
275	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter @PROTEIN$ (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
276	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus @PROTEIN$ (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
277	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of @PROTEIN$.	0
278	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (@PROTEIN$) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
279	Resveratrol did not attenuate GA-induced generation of @COMPOUND$, but it did block GA-induced phosphorylation of connexin 43 (@PROTEIN$), a key modulator of GJIC.	0
280	@COMPOUND$ did not attenuate GA-induced generation of hydrogen peroxide, but it did block GA-induced phosphorylation of connexin 43 (@PROTEIN$), a key modulator of GJIC.	1
281	Resveratrol did not attenuate GA-induced generation of @COMPOUND$, but it did block GA-induced phosphorylation of @PROTEIN$ (Cx43), a key modulator of GJIC.	0
282	@COMPOUND$ did not attenuate GA-induced generation of hydrogen peroxide, but it did block GA-induced phosphorylation of @PROTEIN$ (Cx43), a key modulator of GJIC.	1
283	@COMPOUND$ accumulated cells in S phase of the cell cycle and reduced @PROTEIN$ expression.	1
284	Indeed, treatment of cells with 1 muM @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
285	Indeed, treatment of cells with 1 muM all-trans @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
286	Indeed, treatment of cells with 1 muM @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
287	Indeed, treatment of cells with 1 muM all-trans retinoic acid (@COMPOUND$) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
288	Indeed, treatment of cells with 1 muM all-trans @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
289	Indeed, treatment of cells with 1 muM all-trans retinoic acid (@COMPOUND$) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
290	Because @PROTEIN$ binds @COMPOUND$, this study is using this feature to select functional spermatozoa.	1
291	@COMPOUND$) promotes cytoprotection by activating @PROTEIN$-mediated up-regulation of antioxidant defence.	1
292	Here, we addressed this issue and found that @COMPOUND$) triggered nuclear accumulation of @PROTEIN$ (Nrf2), a transcription factor that up-regulates antioxidant-/electrophile-responsive element (ARE-EpRE)-related genes, in PC12 cells.	1
293	Here, we addressed this issue and found that @COMPOUND$) triggered nuclear accumulation of NF-E2-related factor-2 (@PROTEIN$), a transcription factor that up-regulates antioxidant-/electrophile-responsive element (ARE-EpRE)-related genes, in PC12 cells.	1
294	To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (@PROTEIN$) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
295	To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (IL6) and tumour necrosis factor alpha (@PROTEIN$) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
296	To investigate overnight variations in absolute values and patterns of cytokines including @PROTEIN$ (IL6) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
297	Using a cell culture model of synaptic NMDA receptor-dependent synaptic potentiation, we find that this is mediated exclusively by NR2B-containing @PROTEIN$, as implicated by NR2B-specific antagonists and the use of selective vs. non-selective doses of the NR2A-preferring antagonist @COMPOUND$-AAM077.	1
298	@COMPOUND$ protects against doxorubicin-induced cardiomyopathy: upregulation of @PROTEIN$ and Erk phosphorylation in a rat model.	1
299	A recently discussed cardiovascular risk factor, asymmetric dimethylarginine (@COMPOUND$), is known to act as an endogenous inhibitor of endothelial @PROTEIN$.	1
300	A recently discussed cardiovascular risk factor, @COMPOUND$ (ADMA), is known to act as an endogenous inhibitor of endothelial @PROTEIN$.	1
301	The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, IL-6 or @PROTEIN$ concentrations).	0
302	The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, @PROTEIN$ or TNF-alpha concentrations).	0
303	The net exercise-induced increase in 6-keto-@PROTEIN$ (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, IL-6 or TNF-alpha concentrations).	0
304	Significant elevation of numbers of GM-CFC evoked by the combinations of @COMPOUND$ with IL-3, @PROTEIN$, or GM-CSF as compared with these growth factors alone has been noted.	0
305	Significant elevation of numbers of GM-CFC evoked by the combinations of @COMPOUND$ with @PROTEIN$, SCF, or GM-CSF as compared with these growth factors alone has been noted.	0
306	Combination of @COMPOUND$ with @PROTEIN$ did not induce significantly higher numbers of GM-CFC in comparison with G-CSF alone.	0
307	Joint action of three drugs, namely of @COMPOUND$+ IL-3+ @PROTEIN$, produced significantly higher numbers of GM-CFC in comparison with the combinations of IB-MECA+ IL-3, IB-MECA+ GM-CSF, or IL-3+ GM-CSF.	0
308	Joint action of three drugs, namely of @COMPOUND$+ @PROTEIN$+ GM-CSF, produced significantly higher numbers of GM-CFC in comparison with the combinations of IB-MECA+ IL-3, IB-MECA+ GM-CSF, or IL-3+ GM-CSF.	0
309	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (IGF-1), transforming growth factor-beta1 (@PROTEIN$), or a combination of both growth factors were mixed with OPF, a poly(ethylene glycol)-diacrylate crosslinker and the radical initiators ammonium persulfate and @COMPOUND$, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
310	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (@PROTEIN$), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a poly(ethylene glycol)-diacrylate crosslinker and the radical initiators ammonium persulfate and @COMPOUND$, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
311	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (IGF-1), transforming growth factor-beta1 (@PROTEIN$), or a combination of both growth factors were mixed with OPF, a @COMPOUND$ crosslinker and the radical initiators ammonium persulfate and N,N,N',N'-tetramethylethylenediamine, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
312	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with @PROTEIN$-like growth factor-1 (IGF-1), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a poly(ethylene glycol)-diacrylate crosslinker and the radical initiators ammonium persulfate and @COMPOUND$, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
313	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (@PROTEIN$), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a @COMPOUND$ crosslinker and the radical initiators ammonium persulfate and N,N,N',N'-tetramethylethylenediamine, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
314	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with @PROTEIN$-like growth factor-1 (IGF-1), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a @COMPOUND$ crosslinker and the radical initiators ammonium persulfate and N,N,N',N'-tetramethylethylenediamine, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
315	@PROTEIN$ modulates osteoblast behavior on @COMPOUND$.	1
316	Treatment of H9c2 cell with low concentrations of Dox causes alterations in fibrous @PROTEIN$ including the nuclear lamina and sarcomeric cardiac myosin, as well as mitochondrial depolarization and fragmentation, membrane blebbing with cell shape changes, and @COMPOUND$ externalization.	0
317	The non-covalent interaction of @COMPOUND$ (BR) with @PROTEIN$ was investigated by the UV spectrometry, circular dichroism (CD) and isothermal titration calorimetry (ITC).	1
318	Recent studies suggest that crystals of monosodium urate (MSU), deposited in joints of patients with acute gouty arthritis, activate the NACHT domain, @COMPOUND$-rich repeat and @PROTEIN$ domain-containing protein (NALP)3 inflammasome.	0
319	Recent studies suggest that crystals of @COMPOUND$ (MSU), deposited in joints of patients with acute gouty arthritis, activate the NACHT domain, leucine-rich repeat and @PROTEIN$ domain-containing protein (NALP)3 inflammasome.	1
320	Nicotine, @COMPOUND$, and chlorpyrifos induced the phosphorylation of @PROTEIN$ and 2.	1
321	Nicotine, muscarine, and @COMPOUND$ induced the phosphorylation of @PROTEIN$ and 2.	1
322	@COMPOUND$, muscarine, and chlorpyrifos induced the phosphorylation of @PROTEIN$ and 2.	1
323	In conclusion, culturing blastocysts of cattle in a 5% @COMPOUND$ environment with M199 containing serum sustains embryo viability and permits constitutive and inducible @PROTEIN$ production.	1
324	Incubation in 20% @COMPOUND$ increases @PROTEIN$ production.	1
325	Histologic examination investigated deposition of extracellular matrix (ECM) including collagen, elastin, @COMPOUND$ (HA), @PROTEIN$, and decorin in the lamina propria of the scarred vocal folds.	0
326	Histologic examination investigated deposition of extracellular matrix (ECM) including collagen, @PROTEIN$, @COMPOUND$ (HA), fibronectin, and decorin in the lamina propria of the scarred vocal folds.	0
327	Histologic examination investigated deposition of extracellular matrix (@PROTEIN$) including collagen, elastin, @COMPOUND$ (HA), fibronectin, and decorin in the lamina propria of the scarred vocal folds.	0
328	A series of novel bis-pyridinium oximes connected by bis-@COMPOUND$, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and obidoxime.	0
329	A series of novel bis-pyridinium oximes connected by bis-@COMPOUND$, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and obidoxime.	0
330	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against @COMPOUND$ (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and obidoxime.	0
331	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and @COMPOUND$.	0
332	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and @COMPOUND$.	0
333	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against @COMPOUND$ (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and obidoxime.	0
334	In-vitro regeneration of @COMPOUND$ inhibited electric eel @PROTEIN$ by bis-pyridinium oximes bearing xylene linker.	1
335	In-vitro regeneration of sarin inhibited electric eel @PROTEIN$ by bis-pyridinium oximes bearing @COMPOUND$ linker.	1
336	A series of bis-pyridinium oximes connected by @COMPOUND$ linker were synthesized and their in-vitro reactivation potential was evaluated against @PROTEIN$ (AChE) inhibited by nerve agent, sarin.	0
337	A series of bis-pyridinium oximes connected by xylene linker were synthesized and their in-vitro reactivation potential was evaluated against @PROTEIN$ (AChE) inhibited by nerve agent, @COMPOUND$.	0
338	A series of bis-pyridinium oximes connected by @COMPOUND$ linker were synthesized and their in-vitro reactivation potential was evaluated against acetylcholinesterase (@PROTEIN$) inhibited by nerve agent, sarin.	0
339	A series of bis-pyridinium oximes connected by xylene linker were synthesized and their in-vitro reactivation potential was evaluated against acetylcholinesterase (@PROTEIN$) inhibited by nerve agent, @COMPOUND$.	0
340	Recent studies have focused on possible functional disorders of the enteric nervous system within the abomasal wall, since cattle with abomasal displacement have an increased activity of neuronal @PROTEIN$, as well as decreased @COMPOUND$ sensitivity.	0
341	Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite A771726 (@COMPOUND$).	1
342	Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as @COMPOUND$ and its metabolite A771726 (teriflunomide).	1
343	Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite @COMPOUND$ (teriflunomide).	1
344	Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as @COMPOUND$ and its metabolite A771726 (teriflunomide).	1
345	Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite A771726 (@COMPOUND$).	1
346	Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite @COMPOUND$ (teriflunomide).	1
347	Inhibition of @PROTEIN$ by zebularine enhances the antineoplastic action of @COMPOUND$.	0
348	Inhibition of @PROTEIN$ by @COMPOUND$ enhances the antineoplastic action of 5-aza-2'-deoxycytidine.	1
349	We hypothesise that @COMPOUND$ acts as a chemical or pharmacological chaperone, and suggest amino acid supplementation as a possible therapy in @PROTEIN$ mutations with mild phenotypes.	0
350	mRNA expressions of matrix metallopeptidase-9, inducible @PROTEIN$ and pro-inflammatory cytokines interleukin-1 beta and tumour necrosis factor-alpha in EAN sciatic nerves were greatly decreased by administration of @COMPOUND$ as well.	1
351	Then the review evaluates the involvement of @PROTEIN$ activated by the endogenous agonist @COMPOUND$ in the generation and propagation of epileptiform activity.	1
352	Glutamate @COMPOUND$ ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
353	Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (@COMPOUND$) biosynthesis.	1
354	@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from @COMPOUND$ and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
355	Glutamate cysteine ligase (@PROTEIN$), synthesizing @COMPOUND$ from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
356	@PROTEIN$ (GCL), synthesizing @COMPOUND$ from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
357	Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from @COMPOUND$ and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
358	@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in @COMPOUND$ (GSH) biosynthesis.	1
359	Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in @COMPOUND$ (GSH) biosynthesis.	1
360	@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (@COMPOUND$) biosynthesis.	1
361	We observed that @COMPOUND$ inhibited the proteasome activities and increased the level and insolubility of different @PROTEIN$ species, including phosphorylated tau.	1
362	Serine and cysteine @PROTEIN$ proved to be suitable tools for the production of amino acids and peptides conjugated to @COMPOUND$, whereas metalloproteases do not seem to be very qualified for accepting this nucleophile.	0
363	Role of serotonin @PROTEIN$ receptors in the antidepressant-like effect and the antinociceptive effect of @COMPOUND$ in mice.	1
364	The present study was undertaken to evaluate the potential role of @PROTEIN$ receptors in the antidepressant-like effect and antinociceptive effect of @COMPOUND$.	0
365	These findings show that @PROTEIN$ receptors play differing roles in modulating the antidepressant-like and antinociceptive effects of @COMPOUND$ in the models investigated.	1
366	In contrast, the antinociceptive effect of @COMPOUND$ is probably potentiated due to the blockade of somatodendritic @PROTEIN$ receptors in the same raphe nuclei, facilitating the descending monoaminergic pain control system.	1
367	Moreover, @PROTEIN$ hydrolysis of baicalin sequentially yielded glucuronic acid and @COMPOUND$ as confirmed by co-TLC with authentic samples.	1
368	Moreover, @PROTEIN$ hydrolysis of @COMPOUND$ sequentially yielded glucuronic acid and baicalein as confirmed by co-TLC with authentic samples.	1
369	The effect of this diet alone or after 2 weeks of treatment with @COMPOUND$ or glimepiride on glucose homeostasis, lipid profile, and levels of resistin and @PROTEIN$ was studied.	0
370	The effect of this diet alone or after 2 weeks of treatment with rosiglitazone or @COMPOUND$ on glucose homeostasis, lipid profile, and levels of resistin and @PROTEIN$ was studied.	0
371	Rosiglitazone corrected the altered parameters measured, except for liver TGs ; similarly, @COMPOUND$ reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	1
372	@COMPOUND$ corrected the altered parameters measured, except for liver TGs ; similarly, glimepiride reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	0
373	Rosiglitazone corrected the altered parameters measured, except for liver @COMPOUND$ ; similarly, glimepiride reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	0
374	Activation of ErbB3, @PROTEIN$ and Erk is essential for growth of human breast cancer cell lines with acquired resistance to @COMPOUND$.	0
375	Treatment with the EGFR inhibitor @COMPOUND$ preferentially inhibited growth and reduced the S phase fraction in the resistant cell lines concomitant with inhibition of Erk and unaltered @PROTEIN$ activation.	0
376	@COMPOUND$ protects from hepatic reperfusion injury through inhibition of IKK and @PROTEIN$ pathways and modification of cell proliferation.	1
377	@COMPOUND$ significantly improved animal survival and decreased transaminase levels, the indices for necrosis, liver damage, leukocyte infiltration, and @PROTEIN$ expression.	1
378	At the same time, @COMPOUND$ reduced the expression of both @PROTEIN$ 0.05).	1
379	@COMPOUND$ is hepatoprotective most likely via mechanisms including inhibition of IKK and @PROTEIN$ pathways and regulation of cell proliferation.	1
380	Here, we report that the citrus bioflavonoid @COMPOUND$ reduces amyloid-beta (Abeta) peptide generation in both human 'Swedish' mutant @PROTEIN$ transgene-bearing neuron-like cells and primary neurons.	1
381	Here, we report that the citrus @COMPOUND$ luteolin reduces amyloid-beta (Abeta) peptide generation in both human 'Swedish' mutant @PROTEIN$ transgene-bearing neuron-like cells and primary neurons.	1
382	We also find that @COMPOUND$ induces changes consistent with GSK-3 inhibition that (i) decrease amyloidogenic gamma-secretase @PROTEIN$ processing, and (ii) promote presenilin-1 (PS1) carboxyl-terminal fragment (CTF) phosphorylation.	1
383	We also find that @COMPOUND$ induces changes consistent with GSK-3 inhibition that (i) decrease amyloidogenic gamma-secretase APP processing, and (ii) promote @PROTEIN$ (PS1) carboxyl-terminal fragment (CTF) phosphorylation.	1
384	We also find that @COMPOUND$ induces changes consistent with GSK-3 inhibition that (i) decrease amyloidogenic gamma-secretase APP processing, and (ii) promote presenilin-1 (@PROTEIN$) carboxyl-terminal fragment (CTF) phosphorylation.	1
385	We also find that @COMPOUND$ induces changes consistent with @PROTEIN$ inhibition that (i) decrease amyloidogenic gamma-secretase APP processing, and (ii) promote presenilin-1 (PS1) carboxyl-terminal fragment (CTF) phosphorylation.	1
386	As validation of these findings in vivo, we find that @COMPOUND$, when applied to the Tg2576 mouse model of AD, decreases soluble Abeta levels, reduces GSK-3 activity, and disrupts PS1-@PROTEIN$ association.	1
387	As validation of these findings in vivo, we find that @COMPOUND$, when applied to the Tg2576 mouse model of AD, decreases soluble Abeta levels, reduces GSK-3 activity, and disrupts @PROTEIN$-APP association.	1
388	As validation of these findings in vivo, we find that @COMPOUND$, when applied to the Tg2576 mouse model of AD, decreases soluble Abeta levels, reduces @PROTEIN$ activity, and disrupts PS1-APP association.	1
389	Since biliverdin and @COMPOUND$ are downstream products of heme degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	1
390	Since biliverdin and bilirubin are downstream products of @COMPOUND$ degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	0
391	Since @COMPOUND$ and bilirubin are downstream products of heme degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	1
392	Here, we examine the effect of resistin on @COMPOUND$ uptake in human trophoblast cells and we demonstrate that transplacental glucose transport is mediated by @PROTEIN$ (GLUT)-1.	1
393	@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1
394	Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1
395	@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	1
396	Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	0
397	However, increased blood @COMPOUND$ (200 mg/dl) significantly impaired the inhibitory effect of ASA (84% for @PROTEIN$.005; 48% for P-selectin, P=NS).	0
398	The expressions of @PROTEIN$ mRNA in renal tissues were markedly up-regulated in untreated diabetic rats, and these could be notably reduced by @COMPOUND$ treatment.	1
399	In conclusion, @COMPOUND$ may have a potential therapeutic target in DN, which may be partly attributed to lowering of the expression of @PROTEIN$ in the local kidney and the urinary excretion of MCP-1.	1
400	The homomeric @PROTEIN$ (7) receptor is extraordinary in that in addition to distinctive localization and biological functions it exhibits several hallmark properties, for example, the receptor is potently inhibited by divalent cations such as calcium, magnesium, zinc and @COMPOUND$.	1
401	The homomeric @PROTEIN$ (7) receptor is extraordinary in that in addition to distinctive localization and biological functions it exhibits several hallmark properties, for example, the receptor is potently inhibited by divalent cations such as calcium, @COMPOUND$, zinc and copper.	1
402	This paper describes (1) the preparation of the intact oligosaccharides from @PROTEIN$ (II(3)NeuAcGgOse(4) Cer) and GbOse(4) Cer as examples to show the use of CGase to prepare intact @COMPOUND$ chains from GSLs, and (2) the specificity and detergent requirements of Rhodococcal EGCases for the release of glycan chains from different GSLs.	0
403	The discovery of the PLN/@PROTEIN$ interaction therefore unveils an important new link between @COMPOUND$+) homeostasis and cell survival, with significant therapeutic potential.	0
404	The discovery of the @PROTEIN$/HAX-1 interaction therefore unveils an important new link between @COMPOUND$+) homeostasis and cell survival, with significant therapeutic potential.	0
405	@COMPOUND$ alone evoked effects similar to low N/@PROTEIN$ doses, suggesting tonic inhibitory control over forelimb movement by endogenous N/OFQ.	0
406	Although previous studies indicated reduced levels of @COMPOUND$ residues during apoptosis, elevated Sambucus nigra agglutinin (SNA) reactivity might be due to the degradation of high molecular weight @PROTEIN$ (probably including cadherin) that masked the SNA-binding residues of the plasma membrane prior to apoptosis.	0
407	Although previous studies indicated reduced levels of @COMPOUND$ residues during apoptosis, elevated Sambucus nigra @PROTEIN$ (SNA) reactivity might be due to the degradation of high molecular weight glycoproteins (probably including cadherin) that masked the SNA-binding residues of the plasma membrane prior to apoptosis.	1
408	Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single whey acidic protein (@PROTEIN$) domain at the C-terminus.	0
409	Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single @PROTEIN$ (WAP) domain at the C-terminus.	0
410	Cross-linked @PROTEIN$ (1/2) heteromers showed strongly reduced or absent function that was selectively recovered upon treatment with @COMPOUND$.	1
411	Permeabilization of K. marxianus cells in relation to @PROTEIN$ activity was carried out using cetyltrimethyl ammonium bromide (@COMPOUND$) to avoid the problem of enzyme extraction.	1
412	Permeabilization of K. marxianus cells in relation to @PROTEIN$ activity was carried out using cetyltrimethyl @COMPOUND$ (CTAB) to avoid the problem of enzyme extraction.	1
413	Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of vinculin, beta-actin, osteopontin, and @PROTEIN$ in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0
414	Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of @PROTEIN$, beta-actin, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0
415	Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of @PROTEIN$, beta-actin, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0
416	Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of vinculin, @PROTEIN$, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0
417	Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of vinculin, beta-actin, osteopontin, and @PROTEIN$ in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0
418	Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of vinculin, @PROTEIN$, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0
419	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (@COMPOUND$, 5050) and a blend of PLGA and PHBV.	0
420	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, @COMPOUND$) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
421	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (@COMPOUND$, 5050) and a blend of PLGA and PHBV.	0
422	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), @COMPOUND$) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
423	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, @COMPOUND$) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
424	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), @COMPOUND$) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
425	Prediction of @PROTEIN$ receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-@COMPOUND$ amides and ureas based on the heuristic method, support vector machine and projection pursuit regression.	1
426	Quantitative structure-activity relationship (QSAR) models were developed to predict for @PROTEIN$ binding affinity of substituted 1-(3,3-diphenylpropyl)-@COMPOUND$ amides and ureas using linear free energy relationship (LFER).	1
427	It is suggested that @COMPOUND$ acting through the GABA(A) receptor mechanism on the expression of GnRH gene and @PROTEIN$ gene in the hypothalamus may be involved in two processes: the biosynthesis of GnRH and the release of this neurohormone in the hypothalamus.	1
428	It is suggested that @COMPOUND$ acting through the GABA(A) receptor mechanism on the expression of @PROTEIN$ gene and GnRH-R gene in the hypothalamus may be involved in two processes: the biosynthesis of GnRH and the release of this neurohormone in the hypothalamus.	1
429	It is suggested that @COMPOUND$ acting through the @PROTEIN$ mechanism on the expression of GnRH gene and GnRH-R gene in the hypothalamus may be involved in two processes: the biosynthesis of GnRH and the release of this neurohormone in the hypothalamus.	1
430	TT-induced increases in @COMPOUND$, adrenocorticotropic hormone and prolactin were reduced only after 3-h @PROTEIN$.	0
431	TT-induced increases in @COMPOUND$, @PROTEIN$ and prolactin were reduced only after 3-h REC.	0
432	TT-induced increases in @COMPOUND$, adrenocorticotropic hormone and @PROTEIN$ were reduced only after 3-h REC.	0
433	@COMPOUND$ inhibits vascular superoxide production induced by endothelin-1 : Role of NADPH oxidase, uncoupled eNOS and @PROTEIN$.	0
434	@COMPOUND$ inhibits vascular superoxide production induced by endothelin-1 : Role of NADPH oxidase, uncoupled @PROTEIN$ and PKC.	0
435	Quercetin inhibits vascular @COMPOUND$ production induced by endothelin-1 : Role of NADPH oxidase, uncoupled eNOS and @PROTEIN$.	0
436	Quercetin inhibits vascular @COMPOUND$ production induced by endothelin-1 : Role of NADPH oxidase, uncoupled @PROTEIN$ and PKC.	0
437	Quercetin inhibits vascular @COMPOUND$ production induced by @PROTEIN$ : Role of NADPH oxidase, uncoupled eNOS and PKC.	1
438	@COMPOUND$ inhibits vascular superoxide production induced by @PROTEIN$ : Role of NADPH oxidase, uncoupled eNOS and PKC.	1
439	Furthermore, ET-1 increased intracellular O(2*)(-) production in all layers of the vessel, protein expression of NADPH oxidase subunit @PROTEIN$ (phox) without affecting p22 (phox) expression and lucigenin-enhanced chemiluminescence signal stimulated by @COMPOUND$.	0
440	Furthermore, ET-1 increased intracellular O(2*)(-) production in all layers of the vessel, protein expression of NADPH oxidase subunit p47 (phox) without affecting @PROTEIN$ (phox) expression and lucigenin-enhanced chemiluminescence signal stimulated by @COMPOUND$.	0
441	Taken together these results indicate that ET-1-induced NADPH oxidase up-regulation and @PROTEIN$ uncoupling via PKC leading to endothelial dysfunction and these effects were prevented by quercetin and @COMPOUND$.	1
442	Taken together these results indicate that ET-1-induced NADPH oxidase up-regulation and eNOS uncoupling via @PROTEIN$ leading to endothelial dysfunction and these effects were prevented by quercetin and @COMPOUND$.	1
443	Taken together these results indicate that ET-1-induced NADPH oxidase up-regulation and @PROTEIN$ uncoupling via PKC leading to endothelial dysfunction and these effects were prevented by @COMPOUND$ and isorhamnetin.	1
444	Taken together these results indicate that ET-1-induced NADPH oxidase up-regulation and eNOS uncoupling via @PROTEIN$ leading to endothelial dysfunction and these effects were prevented by @COMPOUND$ and isorhamnetin.	1
445	We hypothesized that variants in @PROTEIN$ that lower LDL @COMPOUND$ levels are associated with reduced prevalence and incidence of peripheral artery disease (PAD).	1
446	A series of 2-aryl-naphtho(1,2-d) @COMPOUND$ derivatives have been synthesized and evaluated for @PROTEIN$ inhibitory activity.	0
447	@COMPOUND$ differentially alter @PROTEIN$ (2alpha) and PGE (2) release from bovine trophoblast and endometrial tissues during short-term culture.	1
448	@COMPOUND$ differentially alter PGF (2alpha) and @PROTEIN$ (2) release from bovine trophoblast and endometrial tissues during short-term culture.	1
449	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or linoleic acid (C18 :2omega6; @COMPOUND$) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
450	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or linoleic acid (C18 :2omega6; @COMPOUND$) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
451	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), @COMPOUND$ (22:6omega3; DHA) or linoleic acid (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
452	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or @COMPOUND$ (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
453	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or @COMPOUND$ (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
454	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), @COMPOUND$ (22:6omega3; DHA) or linoleic acid (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
455	@PROTEIN$ (DXS) catalyses the first committed step of the 2C-methyl-D-erythritol-4-phosphate (@COMPOUND$) pathway, which is an alternative isoprenoids biosynthetic route that has been recently discovered.	1
456	@PROTEIN$ (DXS) catalyses the first committed step of the 2C-methyl-@COMPOUND$ (MEP) pathway, which is an alternative isoprenoids biosynthetic route that has been recently discovered.	1
457	To get insight into the underlying mechanisms, we compared the ability of recombinant wild type and variant (D327N) @PROTEIN$ to influence @COMPOUND$ effects in MCF-7 breast cancer cells.	1
458	D327N @PROTEIN$ was more effective than wild type protein in inhibiting @COMPOUND$-induced cell proliferation and anti-apoptosis.	1
459	To test the hypothesis that increasing @COMPOUND$ levels is associated with improved @PROTEIN$ resistance in patients with polycystic ovary syndrome (PCOS).	1
460	Packed cell volume, total protein, creatinine, blood @COMPOUND$ nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0
461	Packed cell volume, total protein, creatinine, blood urea nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum @COMPOUND$ concentration increased.	0
462	Packed cell volume, total protein, creatinine, blood urea @COMPOUND$, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0
463	Packed cell volume, total protein, @COMPOUND$, blood urea nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0
464	The gene expressions of CYP1A1 and @PROTEIN$ in the placenta increased significantly in @COMPOUND$-treated groups on GD 15 and GD 18, but returned to the level similar to the corresponding control on GD 21.	1
465	The gene expressions of @PROTEIN$ and CYP2E1 in the placenta increased significantly in @COMPOUND$-treated groups on GD 15 and GD 18, but returned to the level similar to the corresponding control on GD 21.	1
466	The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (@PROTEIN$, alanin aminotransferase, alkaline phosphatase, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0
467	The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (aspartate aminotransferase, alanin aminotransferase, @PROTEIN$, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0
468	The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular @PROTEIN$, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (aspartate aminotransferase, alanin aminotransferase, alkaline phosphatase, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0
469	@PROTEIN$ was decreased with @COMPOUND$ and the coexposure, but not with arsenic, whereas GSH was decreased with arsenic and endosulfan, but not with the coexposure.	1
470	@PROTEIN$ was decreased with endosulfan and the coexposure, but not with arsenic, whereas @COMPOUND$ was decreased with arsenic and endosulfan, but not with the coexposure.	0
471	@PROTEIN$ activity was decreased in the @COMPOUND$-treated and the coexposed birds.	1
472	mRNA and protein levels of @PROTEIN$, Fas, and caspase-8, which are closely related to cell apoptosis by a death ligand/receptor-dependent apoptosis pathway, were increased by @COMPOUND$ treatment.	1
473	mRNA and protein levels of TNF-alpha, @PROTEIN$, and caspase-8, which are closely related to cell apoptosis by a death ligand/receptor-dependent apoptosis pathway, were increased by @COMPOUND$ treatment.	1
474	Taken together, the findings of this study have demonstrated that @COMPOUND$ could induce apoptosis in hepa1c1c7 cells by regulating @PROTEIN$ and inhibiting the expression of Bcl-2.	1
475	Taken together, the findings of this study have demonstrated that @COMPOUND$ could induce apoptosis in hepa1c1c7 cells by regulating Fas ligands and inhibiting the expression of @PROTEIN$.	1
476	@COMPOUND$ is known to bind @PROTEIN$, beta1 integrin and focal adhesion kinase, members of focal contacts, multi-protein complexes that mediate cell adhesion to the extracellular matrix.	1
477	Furthermore, supplementation of specific inhibitors of @PROTEIN$, C4H and 4CL in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
478	Furthermore, supplementation of specific inhibitors of PAL, C4H and @PROTEIN$ in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
479	Furthermore, supplementation of specific inhibitors of PAL, @PROTEIN$ and 4CL in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
480	In conclusion, P-gp and @PROTEIN$ have only a modest effect on the ADME of @COMPOUND$ in comparison to metabolic elimination.	1
481	The considerable drug-drug interaction observed with elacridar or @COMPOUND$ is only partly mediated by inhibition of P-gp and @PROTEIN$ and far more by the inhibition of other elimination pathways.	1
482	The considerable drug-drug interaction observed with @COMPOUND$ or pantoprazole is only partly mediated by inhibition of P-gp and @PROTEIN$ and far more by the inhibition of other elimination pathways.	1
483	There is clear evidence for TREK-1 and @PROTEIN$-1 in the heart and these channels are likely to regulate cardiac action potential duration through their regulation by stretch, @COMPOUND$, pH, and neurotransmitters.	1
484	There is clear evidence for @PROTEIN$-1 and TASK-1 in the heart and these channels are likely to regulate cardiac action potential duration through their regulation by stretch, @COMPOUND$, pH, and neurotransmitters.	1
485	@COMPOUND$-induced growth inhibition was associated with induction of Cdk inhibitor p21, inhibition of @PROTEIN$ D1 and activation of caspase-3.	1
486	Three proteins, porcine somatotropin, bovine @PROTEIN$, and immunoglobulin, as well as materials with a strong calorimetric glass transition (T(g)), that is, @COMPOUND$ and poly(vinypyrrolidone) (PVP), were studied by both TSC and differential scanning calorimetry (DSC).	0
487	Three proteins, porcine @PROTEIN$, bovine serum albumin, and immunoglobulin, as well as materials with a strong calorimetric glass transition (T(g)), that is, @COMPOUND$ and poly(vinypyrrolidone) (PVP), were studied by both TSC and differential scanning calorimetry (DSC).	0
488	The recombinant protein exhibited high @PROTEIN$ activity and could catalyze the conversion of L:-Phe to @COMPOUND$.	0
489	To investigate this relationship, we used actively growing young Sprague-Dawley rats and @COMPOUND$, one of the angiogenesis inhibitor (AI) to reveal the relationship of angiogenesis in the effect of @PROTEIN$.	0
490	Functional polymorphisms in the @PROTEIN$ and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and @COMPOUND$ treatment.	1
491	An alpha-numeric code for representing N-linked @COMPOUND$ structures in secreted @PROTEIN$.	1
492	Towards this end, we propose a fixed-length alpha-numeric code for representing N-linked @COMPOUND$ structures commonly found in secreted @PROTEIN$ from mammalian cell cultures.	1
493	There was a significant increase in @PROTEIN$ oxidase activity at 2.5 mg/L, which might indicate @COMPOUND$'s disruption of the mitochondrial membrane and subsequently ATP synthesis.	1
494	There was a significant increase in @PROTEIN$ oxidase activity at 2.5 mg/L, which might indicate irgarol's disruption of the mitochondrial membrane and subsequently @COMPOUND$ synthesis.	1
495	Treatment of A549, which express wild-type @PROTEIN$, and H1299, which are p53-deficient, human lung cancer cells with @COMPOUND$ resulted in inhibition of cell proliferation and an increase in apoptotic cell death ; however, A549 cells were more sensitive to the berberine-induced cytotoxic effects than H1299 cells.	1
496	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine @PROTEIN$.	1
497	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, IL-6 and @PROTEIN$, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
498	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, @PROTEIN$ and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
499	Furthermore @COMPOUND$ treatment markedly decreased the levels of @PROTEIN$, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
500	In addition, @COMPOUND$ treatment attenuated macrophage infiltration and inhibited urinary excretion of @PROTEIN$ (monocyte chemoattractant protein-1) and kidney cortex MCP-1 gene expression.	1
501	In addition, @COMPOUND$ treatment attenuated macrophage infiltration and inhibited urinary excretion of MCP-1 (@PROTEIN$) and kidney cortex MCP-1 gene expression.	1
502	Exogenous spermidine, arsenic and @COMPOUND$ modulate tobacco resistance to tobacco mosaic virus, and affect local and systemic glucosylsalicylic acid levels and @PROTEIN$ gene expression in tobacco leaves.	1
503	Exogenous @COMPOUND$, arsenic and beta-aminobutyric acid modulate tobacco resistance to tobacco mosaic virus, and affect local and systemic glucosylsalicylic acid levels and @PROTEIN$ gene expression in tobacco leaves.	1
504	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and PR-2 and @PROTEIN$ (ADC)).	1
505	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (@PROTEIN$ PR-1a and PR-2 and arginine decarboxylase (ADC)).	1
506	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and PR-2 and arginine decarboxylase (@PROTEIN$)).	1
507	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and @PROTEIN$ and arginine decarboxylase (ADC)).	1
508	She had a mutation in @PROTEIN$ gene consisting of an aminoacid change of Alanine to @COMPOUND$ in exon 5 (A382V).	1
509	She had a mutation in @PROTEIN$ gene consisting of an aminoacid change of @COMPOUND$ to Valine in exon 5 (A382V).	1
510	A series of @COMPOUND$-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles have been synthesized and evaluated for their @PROTEIN$ inhibitory activity in cell-based luciferase reporter assays.	1
511	However, @COMPOUND$ exhibited more potency in reducing @PROTEIN$ activity than methiocarb.	1
512	However, methomyl exhibited more potency in reducing @PROTEIN$ activity than @COMPOUND$.	1
513	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming @PROTEIN$ (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1
514	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming peroxidase (@PROTEIN$) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
515	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming @PROTEIN$ (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
516	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (@PROTEIN$) and lignin-forming peroxidase (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
517	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (@PROTEIN$) and lignin-forming peroxidase (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1
518	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) @PROTEIN$ (CAT) and lignin-forming peroxidase (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
519	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) @PROTEIN$ (CAT) and lignin-forming peroxidase (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1
520	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming peroxidase (@PROTEIN$) were found to be increased by proline and @COMPOUND$ under salt stress.	1
521	To decrease the level of androgen @COMPOUND$ in the prostate, we are interested in developing inhibitors of 17beta-hydroxysteroid dehydrogenase type 5 (@PROTEIN$).	0
522	To decrease the level of androgen @COMPOUND$ in the prostate, we are interested in developing inhibitors of @PROTEIN$ (17beta-HSD5).	0
523	A role for guanosine 3',5'-cyclic monophosphate (cGMP) and the @PROTEIN$ G (PKG) pathway in synaptic long-term depression (LTD) in the hippocampal CA1 region has been proposed, based on observations in vitro, where, for example, increases of (cGMP) result in short-term depression (STD) coupled with a reduction in presynaptic @COMPOUND$ release.	0
524	A role for @COMPOUND$ (cGMP) and the @PROTEIN$ G (PKG) pathway in synaptic long-term depression (LTD) in the hippocampal CA1 region has been proposed, based on observations in vitro, where, for example, increases of (cGMP) result in short-term depression (STD) coupled with a reduction in presynaptic glutamate release.	0
525	A role for guanosine 3',5'-cyclic monophosphate (@COMPOUND$) and the @PROTEIN$ G (PKG) pathway in synaptic long-term depression (LTD) in the hippocampal CA1 region has been proposed, based on observations in vitro, where, for example, increases of (cGMP) result in short-term depression (STD) coupled with a reduction in presynaptic glutamate release.	0
526	Application of an inhibitor of soluble guanylate @PROTEIN$ prevented LTD induced by low-frequency stimulation (LFS), and impaired LFS-STD elicited in the presence of @COMPOUND$.	0
527	Application of an inhibitor of soluble guanylate cyclase prevented LTD induced by low-frequency stimulation (LFS), and impaired LFS-@PROTEIN$ elicited in the presence of @COMPOUND$.	1
528	@COMPOUND$ induced apoptosis in androgen-dependent PWR-1E cells via a caspase-dependent and @PROTEIN$-independent mechanism.	1
529	In androgen-independent PC-3 cells, @COMPOUND$ also induced apoptosis by mechanisms that were partially inhibited by pan-caspase inhibition but were partially @PROTEIN$ dependent.	1
530	A differential regulation of the two @COMPOUND$ synthesizing enzymes (GAD65 and @PROTEIN$) parallels GABAergic neuron differentiation.	1
531	A differential regulation of the two @COMPOUND$ synthesizing enzymes (@PROTEIN$ and GAD67) parallels GABAergic neuron differentiation.	1
532	The increased levels of hepatic @COMPOUND$ and @PROTEIN$ activity and decreased levels of TBARS and nitrite were also observed in UDCA-treated BDL rats.	0
533	The production of rhG-@PROTEIN$ was induced by switching from growth on @COMPOUND$ to growth on methanol.	0
534	The production of rhG-@PROTEIN$ was induced by switching from growth on glycerol to growth on @COMPOUND$.	1
535	@COMPOUND$ potently reduces vascular inflammation and arteriosclerosis in @PROTEIN$-deficient ApoE ko mice.	1
536	Hypercholesterolemia is associated with decreased vascular @COMPOUND$ bioavailability and deletion of endothelial nitric oxide synthase (@PROTEIN$) markedly accelerates atherosclerosis development in apolipoprotein E knockout (apoE ko) mice.	0
537	Hypercholesterolemia is associated with decreased vascular @COMPOUND$ bioavailability and deletion of endothelial @PROTEIN$ (eNOS) markedly accelerates atherosclerosis development in apolipoprotein E knockout (apoE ko) mice.	0
538	@COMPOUND$ induces apoptosis in colorectal carcinoma cells by modulating the @PROTEIN$ and p38 MAPK pathways.	1
539	@COMPOUND$ induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and @PROTEIN$ pathways.	1
540	The protein inhibitors wortmannin (phosphoinositide 3 kinase inhibitor), PD 98059 (MEK inhibitor) and @COMPOUND$ (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
541	The protein inhibitors wortmannin (@COMPOUND$ 3 kinase inhibitor), PD 98059 (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
542	The protein inhibitors @COMPOUND$ (phosphoinositide 3 kinase inhibitor), PD 98059 (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
543	The protein inhibitors wortmannin (phosphoinositide 3 kinase inhibitor), @COMPOUND$ (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
544	Feeding long-chain n-3 polyunsaturated fatty acids during gestation increases intestinal @COMPOUND$ absorption potentially via the acute activation of @PROTEIN$.	0
545	Feeding long-chain n-3 @COMPOUND$ during gestation increases intestinal glucose absorption potentially via the acute activation of @PROTEIN$.	1
546	Furthermore, adding @COMPOUND$ (DHA) or an AMP-activated protein kinase (@PROTEIN$.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
547	Furthermore, adding @COMPOUND$ (DHA) or an AMP-activated @PROTEIN$ (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
548	Furthermore, adding @COMPOUND$ (DHA) or an @PROTEIN$-activated protein kinase (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
549	Prior to @COMPOUND$ supplementation, exercise induced a significant decrease in @PROTEIN$ activity, EMF, vitamin E concentration and a significant increase in MDA concentration at t+1d.	0
550	Prior to vitamin E supplementation, exercise induced a significant decrease in @PROTEIN$ activity, @COMPOUND$, vitamin E concentration and a significant increase in MDA concentration at t+1d.	0
551	After a 10 week vitamin E supplementation period, these exercise-induced changes in @PROTEIN$ activity, @COMPOUND$ and MDA concentration were still significant in the control group, but not in the supplemented group.	0
552	After a 10 week @COMPOUND$ supplementation period, these exercise-induced changes in @PROTEIN$ activity, EMF and MDA concentration were still significant in the control group, but not in the supplemented group.	1
553	In adulthood, @COMPOUND$ secreted by the testes is converted into estrogens by the preoptic @PROTEIN$.	1
554	@PROTEIN$ stimulated PGE (2) release mediated the reversible effect of @COMPOUND$ on tight junctions and, meanwhile, contributed to cell survival.	1
555	Cyclooxygenase-2 stimulated @PROTEIN$ (2) release mediated the reversible effect of @COMPOUND$ on tight junctions and, meanwhile, contributed to cell survival.	1
556	Interestingly, @COMPOUND$ inhibited the expression of ICAM and @PROTEIN$, followed by the suppression of macrophage recruitment into the aortic wall at 1 week after operation.	1
557	In addition, synthesis of collagen and @PROTEIN$ in the vascular wall were significantly increased by @COMPOUND$.	1
558	In a rat ARF model, induction of ARF by @COMPOUND$ (UN) treatment significantly decreased the levels of @PROTEIN$ (slc22a2) mRNA and protein in the kidney medulla.	1
559	Platelet reactivity and @COMPOUND$ resistance are associated with the H2 haplotype of the P2Y12-@PROTEIN$ receptor gene.	1
560	Platelet reactivity and @COMPOUND$ resistance are associated with the H2 haplotype of the @PROTEIN$-ADP receptor gene.	1
561	@COMPOUND$ up-regulates and activates @PROTEIN$-zeta in EBV-infected and EBV-transformed human B-cells.	1
562	We have proposed that @COMPOUND$ (CsA), despite being a @PROTEIN$, will activate PKC in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	1
563	We have proposed that @COMPOUND$ (CsA), despite being a calcineurin inhibitor, will activate @PROTEIN$ in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	1
564	Our results showed 2a, 2d and 2g as the most active compounds that inhibited the HIV-1 reverse @PROTEIN$ catalytic activity with cytotoxicity lower than @COMPOUND$ and SI higher than DDC and DDI.	1
565	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (COX-1), @PROTEIN$ (COX-2) and the transcription factor NF-kappaB.	1
566	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits @PROTEIN$ (COX-1), cyclooxygenase-2 (COX-2) and the transcription factor NF-kappaB.	1
567	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (@PROTEIN$), cyclooxygenase-2 (COX-2) and the transcription factor NF-kappaB.	1
568	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (COX-1), cyclooxygenase-2 (@PROTEIN$) and the transcription factor NF-kappaB.	1
569	After @COMPOUND$ stimulation of SV-FHAS and neoplastic astrocytes, real-time polymerase chain reaction showed an increase of the CPE, containing @PROTEIN$ splice variant only in astrocytoma cells.	0
570	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (@PROTEIN$).	0
571	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and @PROTEIN$ (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
572	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by @PROTEIN$-alpha (TNFalpha).	0
573	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (@PROTEIN$) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
574	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (@PROTEIN$) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
575	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (@PROTEIN$), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
576	@COMPOUND$ was able to reduce @PROTEIN$-induced upregulation of VCAM-1, ICAM-1 and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
577	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of VCAM-1, @PROTEIN$ and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
578	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of VCAM-1, ICAM-1 and @PROTEIN$ at both the protein and transcript (mRNA) level in HUASMC.	1
579	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of @PROTEIN$, ICAM-1 and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
580	However the quercetin metabolites, @COMPOUND$, quercetin 3-glucuronide and 3'-methylquercetin 3-glucuronide, had no effect on @PROTEIN$-induced up regulation of adhesion molecule or chemokine expression, at either concentration tested.	0
581	Coexpression pattern with @PROTEIN$ provides an indication that @COMPOUND$ could be the modulator of these adaptive responses to involution and dietary P restriction.	1
582	Dietary chia seed (Salvia hispanica L.) rich in @COMPOUND$ improves adiposity and normalises hypertriacylglycerolaemia and @PROTEIN$ resistance in dyslipaemic rats.	1
583	Pigs fed the high-@COMPOUND$ diet moreover had an increased concentration of trimethyllysine (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of gamma-butyrobetaine (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0
584	Pigs fed the high-lysine diet moreover had an increased concentration of @COMPOUND$ (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of gamma-butyrobetaine (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0
585	Pigs fed the high-lysine diet moreover had an increased concentration of trimethyllysine (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of @COMPOUND$ (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0
586	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and @PROTEIN$ (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
587	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of @PROTEIN$ ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
588	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (@PROTEIN$) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
589	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of @PROTEIN$ ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
590	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(@PROTEIN$-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
591	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, @PROTEIN$ release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
592	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of @PROTEIN$ and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
593	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of @PROTEIN$ and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
594	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and @PROTEIN$ (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
595	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(@PROTEIN$-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
596	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, @PROTEIN$ (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
597	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, @PROTEIN$ release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
598	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (@PROTEIN$) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
599	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, @PROTEIN$ (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
600	@COMPOUND$ inhibits vasa vasorum neovascularization in aortas of @PROTEIN$ (-/-)/LDL(-/-) double knockout mice.	0
601	@COMPOUND$ attenuates CD40-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced @PROTEIN$ activation.	1
602	@COMPOUND$ attenuates @PROTEIN$-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced MAPK activation.	1
603	Treatment of ECs with anthocyanins cyanidin-3-O-beta-glucoside (Cy-3-g) and @COMPOUND$ (Pn-3-g) prevents @PROTEIN$-induced endothelial activation by inhibiting production of proinflammatory cytokines and matrix metalloproteinases (MMPs).	1
604	Collectively, our findings suggested that the inhibition of JNK and @PROTEIN$ activation interrupts CD40 induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1
605	Collectively, our findings suggested that the inhibition of @PROTEIN$ and p38 activation interrupts CD40 induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1
606	Collectively, our findings suggested that the inhibition of JNK and p38 activation interrupts @PROTEIN$ induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1
607	Postsynaptic action of @COMPOUND$ is mediated through metabotropic P2Y and ionotropic @PROTEIN$ receptors abundantly expressed in neural cells.	1
608	However, the @PROTEIN$ C677T genotype, alone or together with a diet, influenced @COMPOUND$ (P=.03) and phosphatidylcholine (P=.03).	1
609	In addition, the @PROTEIN$ C677T genotype appears to influence the direction and use of @COMPOUND$ moieties in this group of women.	1
610	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (PKC)-alpha (30 min to 18 h), in concert with unaltered c-@PROTEIN$ N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
611	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (@PROTEIN$)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
612	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (PKC)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like @PROTEIN$ (5 min to 18 h).	1
613	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as @PROTEIN$ (PKC)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
614	Phospholipidosis and down-regulation of the @PROTEIN$-K/PDK-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
615	Phospholipidosis and down-regulation of the PI3-K/PDK-1/@PROTEIN$ signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
616	Phospholipidosis and down-regulation of the PI3-K/@PROTEIN$-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
617	"Lack of @COMPOUND$ significantly changed mucin (MUC) dynamics, as reflected by the enlarged goblet-cell ""cup"" area relative to controls; decreased @PROTEIN$ mRNA expression in the jejunum, ileum and colon of VAD rats and increased MUC3 mRNA expression in the ileum and colon of these rats."	1
618	"Lack of @COMPOUND$ significantly changed mucin (MUC) dynamics, as reflected by the enlarged goblet-cell ""cup"" area relative to controls; decreased MUC2 mRNA expression in the jejunum, ileum and colon of VAD rats and increased @PROTEIN$ mRNA expression in the ileum and colon of these rats."	1
619	In addition, @COMPOUND$ deficiency down-regulated @PROTEIN$ 6 mRNA expression while up-regulating toll-like receptors 2 and 5 mRNA expressions.	1
620	@COMPOUND$, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1
621	Curcumin, demethoxycurcumin and @COMPOUND$ differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1
622	Curcumin, @COMPOUND$ and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1
623	In contrast, chronic @COMPOUND$ markedly decreased 5-@PROTEIN$ levels in all regions.	1
624	This downregulation of 5-@PROTEIN$ by @COMPOUND$ and its enhancement by Org 34850 can explain our recent observation that GR antagonists augment the SSRI-induced increase in extracellular 5-HT.	1
625	Previous studies have showed that radio-frequency plasma deposited @COMPOUND$ coatings greatly reduced @PROTEIN$ adsorption (Gamma(Fg)) from highly diluted plasmas (0.1 and 1%) and subsequent platelet adhesion under static conditions.	1
626	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
627	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
628	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
629	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
630	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
631	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
632	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
633	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
634	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
635	Differential gene expression of @PROTEIN$ and interleukin-1 receptor associated kinase-M in peripheral blood mononuclear cells of young and aged rats following preconditioning with @COMPOUND$.	1
636	The IL-1 receptor-associated kinase 1 (IRAK-1) and @PROTEIN$ are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (TLRs).	1
637	The IL-1 receptor-associated kinase 1 (IRAK-1) and IRAK-M are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (@PROTEIN$).	1
638	The IL-1 receptor-associated kinase 1 (@PROTEIN$) and IRAK-M are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (TLRs).	1
639	The aim of this study was to evaluate the effect of age on the modulation of TLRs and IRAK-1 and @PROTEIN$ in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
640	The aim of this study was to evaluate the effect of age on the modulation of TLRs and @PROTEIN$ and IRAK-M in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
641	The aim of this study was to evaluate the effect of age on the modulation of @PROTEIN$ and IRAK-1 and IRAK-M in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
642	@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of @PROTEIN$ and Bcl-2.	1
643	@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of @PROTEIN$, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	1
644	Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of @PROTEIN$ and Bcl-2.	0
645	@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, @PROTEIN$, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	1
646	Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, @PROTEIN$, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	0
647	@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and @PROTEIN$.	1
648	Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and @PROTEIN$.	0
649	Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of @PROTEIN$, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	0
650	In this work, we identified a high affinity and potency metallocene-containing @COMPOUND$ peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its @PROTEIN$ and co-receptor binding sites.	1
651	In this work, we identified a high affinity and potency metallocene-containing @COMPOUND$ peptide conjugate that suppresses the interactions of HIV-1 envelope @PROTEIN$ at both its CD4 and co-receptor binding sites.	1
652	The ferrocene @COMPOUND$ conjugate bound to gp120 of both clade A (92UG037-08) and clade B (YU-2 and SF162) virus subtypes with nanomolar KD in direct binding and inhibited the binding of gp120 to soluble @PROTEIN$ and to antibodies that bind to HIV-1YU-2 gp120 at both the CD4 binding site and CD4-induced binding sites.	1
653	The ferrocene @COMPOUND$ conjugate bound to @PROTEIN$ of both clade A (92UG037-08) and clade B (YU-2 and SF162) virus subtypes with nanomolar KD in direct binding and inhibited the binding of gp120 to soluble CD4 and to antibodies that bind to HIV-1YU-2 gp120 at both the CD4 binding site and CD4-induced binding sites.	1
654	In the absence of exogenous Ca(2+) and Mg(2+) and in the presence of EGTA, which favours the release of endogenous Ca(2+), the polyamine @COMPOUND$ is able to stimulate the activity of pyruvate dehydrogenase complex (@PROTEIN$) of energized rat liver mitochondria (RLM).	1
655	In the absence of exogenous @COMPOUND$+) and Mg(2+) and in the presence of EGTA, which favours the release of endogenous Ca(2+), the polyamine spermine is able to stimulate the activity of pyruvate dehydrogenase complex (@PROTEIN$) of energized rat liver mitochondria (RLM).	0
656	In the absence of exogenous Ca(2+) and Mg(2+) and in the presence of @COMPOUND$, which favours the release of endogenous Ca(2+), the polyamine spermine is able to stimulate the activity of pyruvate dehydrogenase complex (@PROTEIN$) of energized rat liver mitochondria (RLM).	0
657	At concentrations higher than 0.5 mM, @COMPOUND$ still stimulates @PROTEIN$, when compared with the control, but shows a slight dose-dependent decrease.	1
658	Changes in @PROTEIN$ stimulation are very close to the phosphorylation level of the E(1alpha) subunit of PDC, which regulates the activity of the complex, but it is also the target of @COMPOUND$.	1
659	These results provide the first evidence that, when transported in RLM, @COMPOUND$ can interact in various ways with @PROTEIN$, showing dose-dependent behaviour.	1
660	Multiple metabolic and neuroendocrine mechanisms are responsible for the CR-mediated anti-inflammatory effects, including reduced adiposity and secretion of pro-inflammatory adipokines, enhanced glucocorticoid production, reduced plasma @COMPOUND$ and advanced glycation end-product concentrations, increased parasympathetic tone, and increased @PROTEIN$ production.	0
661	From the known regulatory mechanisms of Arc expression, HFD reduced N-methyl-D-aspartate receptor (NMDAR) activity, as seen by decreases in @COMPOUND$ phosphorylation of @PROTEIN$ and levels of NMDAR1.	1
662	From the known regulatory mechanisms of Arc expression, HFD reduced @PROTEIN$ (NMDAR) activity, as seen by decreases in @COMPOUND$ phosphorylation of NMDAR2A and levels of NMDAR1.	1
663	From the known regulatory mechanisms of Arc expression, HFD reduced N-methyl-D-aspartate receptor (NMDAR) activity, as seen by decreases in @COMPOUND$ phosphorylation of NMDAR2A and levels of @PROTEIN$.	0
664	Additionally, we demonstrated that 27-hydroxy@COMPOUND$, a cholesterol metabolite that enters the brain from the blood, decreases Arc levels as well as NMDAR and @PROTEIN$ kinase activities in rat primary hippocampal neurons.	1
665	Additionally, we demonstrated that @COMPOUND$, a cholesterol metabolite that enters the brain from the blood, decreases Arc levels as well as NMDAR and @PROTEIN$ kinase activities in rat primary hippocampal neurons.	1
666	@PROTEIN$, an inducible enzyme important in inflammation, catalyzes the production of prostanoids from @COMPOUND$.	1
667	cDNA probes have been developed for subsequent use in monitoring the @COMPOUND$ exposure of the clam Ruditapes decussatus and the cockle Cerastoderma glaucum using @PROTEIN$ (MT) gene expression in different tissues of these species.	0
668	Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, mimosine, L-Dopa, hydroquinone, xylidine, @COMPOUND$, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1
669	Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, mimosine, L-Dopa, @COMPOUND$, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1
670	Purified @PROTEIN$ was able to oxidize a variety of substrates including @COMPOUND$+, tryptophan, mimosine, L-Dopa, hydroquinone, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1
671	Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, @COMPOUND$, L-Dopa, hydroquinone, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1
672	Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, mimosine, @COMPOUND$, hydroquinone, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1
673	Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, mimosine, L-Dopa, hydroquinone, xylidine, n-propanol, @COMPOUND$, and ten textile dyes of various groups indicating as a versatile peroxidase.	1
674	Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, @COMPOUND$, mimosine, L-Dopa, hydroquinone, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1
675	@COMPOUND$ stabilizes the @PROTEIN$ activity during decolorization of dyes.	1
676	To achieve enzymatic production of calcium-stearate at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable @PROTEIN$ was selected and reaction conditions were optimized using calcium @COMPOUND$ and hydrogenated beef tallow as substrates.	1
677	To achieve enzymatic production of @COMPOUND$ at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable @PROTEIN$ was selected and reaction conditions were optimized using calcium hydroxide and hydrogenated beef tallow as substrates.	1
678	Under optimum conditions, 95% of beef tallow, in 2.5 h, was converted into @COMPOUND$ by using commercial @PROTEIN$ SDL 451.	1
679	@COMPOUND$ also inhibited p(473Ser) Akt, raf and p53 expression, and induced apoptosis by release of @PROTEIN$ and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
680	@COMPOUND$ also inhibited p(473Ser) @PROTEIN$, raf and p53 expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
681	@COMPOUND$ also inhibited p(473Ser) Akt, @PROTEIN$ and p53 expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
682	@COMPOUND$ also inhibited p(473Ser) Akt, raf and @PROTEIN$ expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
683	However, the simultaneous presence of the @PROTEIN$ *1B and CYP3A5 *1A alleles was associated with a 64% increase in @COMPOUND$ clearance (P = 0.0015), independent of both sex and CYP3A activity (as determined using the erythromycin breath test).	1
684	However, the simultaneous presence of the CYP3A4 *1B and @PROTEIN$ *1A alleles was associated with a 64% increase in @COMPOUND$ clearance (P = 0.0015), independent of both sex and CYP3A activity (as determined using the erythromycin breath test).	1
685	It was found that @COMPOUND$ administration produced lower levels of @PROTEIN$ and alkaline aminotransferase than that of the untreated group.	1
686	In addition, the levels of hepatic total protein, glutathione and @PROTEIN$ were higher in the @COMPOUND$ treated groups than those in the untreated control or the taurine depleted groups, while hepatic malondialdehyde content exhibited the negative effect.	1
687	In addition, the levels of hepatic total protein, glutathione and @PROTEIN$ were higher in the taurine treated groups than those in the untreated control or the taurine depleted groups, while hepatic @COMPOUND$ content exhibited the negative effect.	1
688	In addition, the levels of hepatic total protein, @COMPOUND$ and @PROTEIN$ were higher in the taurine treated groups than those in the untreated control or the taurine depleted groups, while hepatic malondialdehyde content exhibited the negative effect.	0
689	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and @COMPOUND$ were all decreased in the taurine treated groups.	0
690	Moreover, the concentrations of hepatic hydroxyproline, serum @COMPOUND$, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the taurine treated groups.	0
691	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the @COMPOUND$ treated groups.	1
692	Moreover, the concentrations of hepatic @COMPOUND$, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the taurine treated groups.	0
693	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the @COMPOUND$ treated groups.	1
694	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and @COMPOUND$ were all decreased in the taurine treated groups.	0
695	Moreover, the concentrations of hepatic @COMPOUND$, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the taurine treated groups.	0
696	Moreover, the concentrations of hepatic hydroxyproline, serum @COMPOUND$, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the taurine treated groups.	0
697	Pharmacological (@COMPOUND$) and molecular (shRNA) transcription inhibitor were used to impede formation of @PROTEIN$ transcripts.	1
698	Effect of small interference RNA targeting @PROTEIN$ mediated by rAAV combined @COMPOUND$ on pancreatic tumors in athymic mice.	0
699	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or @COMPOUND$.	1
700	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with @COMPOUND$, escitalopram, or venlafaxine.	1
701	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, @COMPOUND$, or venlafaxine.	1
702	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with sertraline, escitalopram, or @COMPOUND$ and 20 healthy controls.	1
703	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with @COMPOUND$, escitalopram, or venlafaxine and 20 healthy controls.	1
704	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with sertraline, @COMPOUND$, or venlafaxine and 20 healthy controls.	1
705	@COMPOUND$ increased @PROTEIN$ levels after 5 weeks and 6 months of treatment.	1
706	@COMPOUND$ increased @PROTEIN$ levels only after 6 months.	1
707	Taken together, a diet-induced increase of plasma and hepatic @COMPOUND$ levels leads to a posttranscriptional down-regulation of SR-BI in mouse liver via a mechanism likely involving @PROTEIN$.	0
708	Taken together, a diet-induced increase of plasma and hepatic @COMPOUND$ levels leads to a posttranscriptional down-regulation of @PROTEIN$ in mouse liver via a mechanism likely involving PDZK1.	1
709	A 5.5 kilobase-pair (kbp) @PROTEIN$-Kpn1 fragment containing gene(s) encoding for @COMPOUND$ degradation was cloned.	1
710	However, TXA(2) formation remains elevated in patients with cardiovascular disease on doses of @COMPOUND$ that fully suppress platelet @PROTEIN$, suggesting other tissue sources for TXA(2) formation.	1
711	However, @COMPOUND$) formation remains elevated in patients with cardiovascular disease on doses of aspirin that fully suppress platelet @PROTEIN$, suggesting other tissue sources for TXA(2) formation.	0
712	) production increased; metallothionein (MT) and @COMPOUND$ levels increased in most cases, and acetylcholinesterase (@PROTEIN$) activity decreased in summer.	0
713	) production increased; metallothionein (MT) and @COMPOUND$ levels increased in most cases, and @PROTEIN$ (AChE) activity decreased in summer.	0
714	From these findings, it is suggested that @COMPOUND$ may produce centrally mediated behavioural signs by increasing the ACh levels in the brain, resulting from its @PROTEIN$ and BuChE inhibitions.	1
715	Using DBA/2OlaHsd mice, we investigated the effects of chronic social defeat and concomitant treatment with @COMPOUND$/NBI 30775 on 1) the behavioural profile in the modified hole board test and 2) in-situ hybridization analysis-based expression of arginine vasopressin (AVP) and @PROTEIN$ mRNA in both the hypothalamic paraventricular nucleus and supraoptic nucleus.	0
716	Using DBA/2OlaHsd mice, we investigated the effects of chronic social defeat and concomitant treatment with @COMPOUND$/NBI 30775 on 1) the behavioural profile in the modified hole board test and 2) in-situ hybridization analysis-based expression of arginine vasopressin (@PROTEIN$) and CRH mRNA in both the hypothalamic paraventricular nucleus and supraoptic nucleus.	0
717	@PROTEIN$ release by @COMPOUND$, although significant, was not as remarkable as that induced by TNF-alpha.	1
718	IL-6 release by @COMPOUND$, although significant, was not as remarkable as that induced by @PROTEIN$.	0
719	These data suggest that @COMPOUND$ upregulates @PROTEIN$ via mechanisms distinct from TNF-alpha and contributes to the intra- and extracellular IL-6 deposits within the vasculature.	1
720	These data suggest that @COMPOUND$ upregulates IL-6 via mechanisms distinct from @PROTEIN$ and contributes to the intra- and extracellular IL-6 deposits within the vasculature.	0
721	@COMPOUND$ upregulates @PROTEIN$ via mechanisms that are distinct from those of tumor necrosis factor-alpha, in vascular smooth muscle cells.	1
722	@COMPOUND$ upregulates interleukin-6 via mechanisms that are distinct from those of @PROTEIN$-alpha, in vascular smooth muscle cells.	0
723	Among the 7 IL examined, only @PROTEIN$ transcript was increased by @COMPOUND$ treatment in human aorta smooth muscle cells.	1
724	Mechanisms of @PROTEIN$ induction by @COMPOUND$ were investigated in comparison with tumor necrosis factor (TNF)-alpha.	1
725	Mechanisms of IL-6 induction by @COMPOUND$ were investigated in comparison with tumor necrosis factor (@PROTEIN$)-alpha.	0
726	Mechanisms of IL-6 induction by @COMPOUND$ were investigated in comparison with @PROTEIN$ (TNF)-alpha.	0
727	Whereas @PROTEIN$ activated IL-6 promoter, which was impaired by p38 MAPK inhibitors or by mutation in the NF-kappaB-binding site within the promoter region, @COMPOUND$ did not affect IL-6 promoter activity.	0
728	Whereas TNF-alpha activated @PROTEIN$ promoter, which was impaired by p38 MAPK inhibitors or by mutation in the NF-kappaB-binding site within the promoter region, @COMPOUND$ did not affect IL-6 promoter activity.	0
729	@COMPOUND$ significantly increased the amount of intracellular @PROTEIN$ protein in the presence of brefeldin A.	1
730	7-ketocholesterol significantly increased the amount of intracellular @PROTEIN$ protein in the presence of @COMPOUND$.	1
731	@COMPOUND$ is a novel, phenolic antioxidant, and vascular protectant which dose-dependently inhibits @PROTEIN$ biomarkers in vitro.	1
732	@COMPOUND$ inhibits human cervical cancer cell growth in vitro in association with @PROTEIN$ demethylation and re-expression.	1
733	Clinically, it has been approved that DNA methylation inhibitors, such as @COMPOUND$ (5-Aza-dC), can reverse @PROTEIN$ promoter methylation, but widespread clinical use of these inhibitors is limited by their toxicity and instability in aqueous solution.	1
734	Clinically, it has been approved that DNA methylation inhibitors, such as 5-aza-2'-deoxycytidine (@COMPOUND$), can reverse @PROTEIN$ promoter methylation, but widespread clinical use of these inhibitors is limited by their toxicity and instability in aqueous solution.	1
735	Here, we constructed variants to test whether any of these motifs may explain why @PROTEIN$-DeltaN does not respond to stimulation with either ADP ribose or @COMPOUND$.	0
736	We found that @COMPOUND$ induced the activation of JNK, @PROTEIN$, and p38 MAPKs.	1
737	We found that @COMPOUND$ induced the activation of JNK, ERK, and @PROTEIN$.	1
738	We found that @COMPOUND$ induced the activation of @PROTEIN$, ERK, and p38 MAPKs.	1
739	Mechanistically, inhibition of @PROTEIN$ and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
740	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic @PROTEIN$ and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
741	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and @PROTEIN$ cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
742	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and @PROTEIN$, thereby preventing them from degradation during @COMPOUND$ treatment.	0
743	Mechanistically, inhibition of ERK and @PROTEIN$ activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
744	Accumulating evidence suggests that phosphatidylinositol (PI) pathways have been involved in the secretion of @COMPOUND$ (DA) and the regulation of @PROTEIN$, which is a target of methamphetamine (METH).	0
745	Accumulating evidence suggests that phosphatidylinositol (PI) pathways have been involved in the secretion of dopamine (DA) and the regulation of @PROTEIN$, which is a target of @COMPOUND$ (METH).	1
746	Accumulating evidence suggests that @COMPOUND$ (PI) pathways have been involved in the secretion of dopamine (DA) and the regulation of @PROTEIN$, which is a target of methamphetamine (METH).	1
747	@COMPOUND$ caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (PGE (2)) concentrations, accompanied by a compensatory increase in @PROTEIN$ mRNA expression.	1
748	@COMPOUND$ caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (@PROTEIN$ (2)) concentrations, accompanied by a compensatory increase in COX-2 mRNA expression.	1
749	These results indicate significant roles for products of the @PROTEIN$ pathway in testicular vascular control and steroidogenesis, which may have implications for men with marginal fertility taking @COMPOUND$ for extended periods, but also highlight the potential of this drug to ameliorate testicular damage caused by systemic or local inflammation.	1
750	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (GSH) and @COMPOUND$ (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (@PROTEIN$) were evaluated.	0
751	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of @COMPOUND$ (GSH) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (@PROTEIN$) were evaluated.	0
752	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of @PROTEIN$ (GR) and contents of @COMPOUND$ (GSH) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (TNF-alpha) were evaluated.	0
753	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (@COMPOUND$) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (@PROTEIN$) were evaluated.	0
754	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of @COMPOUND$ (GSH) and hydroxyproline (Hpr) in the lung as well as serum level of @PROTEIN$-alpha (TNF-alpha) were evaluated.	0
755	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of @PROTEIN$ (GR) and contents of reduced glutathione (@COMPOUND$) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (TNF-alpha) were evaluated.	0
756	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (GSH) and @COMPOUND$ (Hpr) in the lung as well as serum level of @PROTEIN$-alpha (TNF-alpha) were evaluated.	0
757	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of @PROTEIN$ (GR) and contents of reduced glutathione (GSH) and @COMPOUND$ (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (TNF-alpha) were evaluated.	0
758	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (@COMPOUND$) and hydroxyproline (Hpr) in the lung as well as serum level of @PROTEIN$-alpha (TNF-alpha) were evaluated.	0
759	The obtained data revealed that BCNU induced pathological changes and markedly increased lung collagen and level of @PROTEIN$ but decreased @COMPOUND$ content and GR activity and increased serum TNF-alpha compared to both control and MT-administered rats.	0
760	The obtained data revealed that @COMPOUND$ induced pathological changes and markedly increased lung collagen and level of @PROTEIN$ but decreased GSH content and GR activity and increased serum TNF-alpha compared to both control and MT-administered rats.	1
761	The obtained data revealed that @COMPOUND$ induced pathological changes and markedly increased lung collagen and level of Hpr but decreased GSH content and GR activity and increased serum @PROTEIN$ compared to both control and MT-administered rats.	1
762	The obtained data revealed that BCNU induced pathological changes and markedly increased lung collagen and level of Hpr but decreased @COMPOUND$ content and GR activity and increased serum @PROTEIN$ compared to both control and MT-administered rats.	0
763	Collectively, @PROTEIN$ supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, GLP-2R, and eNOS genes, and net portal absorption of AA.	1
764	Collectively, HMB supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, @PROTEIN$, and eNOS genes, and net portal absorption of AA.	0
765	Collectively, HMB supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, GLP-2R, and @PROTEIN$ genes, and net portal absorption of AA.	0
766	In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of RB-2, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, @COMPOUND$ esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in preparations of rat @PROTEIN$, 2, and 3 using a capillary electrophoresis assay.	0
767	In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of @COMPOUND$, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, 1-amino-4-bromoanthraquinone 2-sulfonic acid esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in preparations of rat @PROTEIN$, 2, and 3 using a capillary electrophoresis assay.	0
768	No significant differences were observed in plasma concentrations of @COMPOUND$, @PROTEIN$, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease beta hydroxybutyrate postpartum compared to CTL cows.	0
769	No significant differences were observed in plasma concentrations of glucose, @PROTEIN$, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease @COMPOUND$ postpartum compared to CTL cows.	0
770	The results showed that @COMPOUND$ augmented splenic-specific IgG1 and IL-4 as well as cell proliferation but suppressed specific IgG2a and @PROTEIN$ levels.	1
771	The results showed that @COMPOUND$ augmented splenic-specific IgG1 and @PROTEIN$ as well as cell proliferation but suppressed specific IgG2a and IFN-gamma levels.	1
772	@COMPOUND$ (Pfizer, Inc.) is a multitargeted kinase inhibitor that inhibits vascular endothelial growth factor (VEGF) receptor (R)-1, 2 and 3, platelet-derived growth factor receptors (PDGFR)-alpha and beta, Flt3, @PROTEIN$, and Kit.	1
773	@COMPOUND$ (Pfizer, Inc.) is a multitargeted kinase inhibitor that inhibits vascular endothelial growth factor (VEGF) receptor (R)-1, 2 and 3, platelet-derived growth factor receptors (PDGFR)-alpha and beta, @PROTEIN$, RET, and Kit.	1
774	@COMPOUND$ (Pfizer, Inc.) is a multitargeted kinase inhibitor that inhibits vascular endothelial growth factor (@PROTEIN$) receptor (R)-1, 2 and 3, platelet-derived growth factor receptors (PDGFR)-alpha and beta, Flt3, RET, and Kit.	1
775	@PROTEIN$ deletion blocks extinction of @COMPOUND$ place preference conditioning.	1
776	Decreased @PROTEIN$ expression increases extracellular @COMPOUND$ and alters its regulation in mouse striatum.	1
777	injection of @PROTEIN$ provoked a significant increase in plasma @COMPOUND$ level.	1
778	In 17 adults on a fixed metabolic diet, an 11-day course of @COMPOUND$ increased serum @PROTEIN$ and basal gastric acid output, but not maximal gastric acid output, compared with a placebo.	1
779	Since @COMPOUND$ was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on esterases, @PROTEIN$, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	0
780	Since @COMPOUND$ was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on @PROTEIN$, phenol sulfotransferases, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	0
781	We showed that after treatment of HCT116 cells with a low dose of @COMPOUND$ most of them stopped proliferation as documented by SA-@PROTEIN$ activity and the lack of Ki67 expression.	1
782	Tumor @PROTEIN$ differs from normal MUC1 by modified @COMPOUND$ side chains.	0
783	Mineralization and dehalogenation of @COMPOUND$ was evidenced by high @PROTEIN$ removal efficiencies (approximately 95%), and by the stoichiometric release of chloride ions from the halogenated compound (approximately 80%).	1
784	Mineralization and dehalogenation of 2,4,6-TCP was evidenced by high @PROTEIN$ removal efficiencies (approximately 95%), and by the stoichiometric release of @COMPOUND$ ions from the halogenated compound (approximately 80%).	0
785	Metabolism of @COMPOUND$ by @PROTEIN$ in different recombinantly expressed systems and its implications for the in vitro assessment of dextromethorphan metabolism.	1
786	Metabolism of dextrorphan by @PROTEIN$ in different recombinantly expressed systems and its implications for the in vitro assessment of @COMPOUND$ metabolism.	0
787	The sequential metabolism of @COMPOUND$ during in vitro studies, particularly using recombinant systems (rCYPs) expressing human @PROTEIN$, is assumed to be negligible.	0
788	The extent of metabolism was investigated for a range of DEX and @COMPOUND$ concentrations in microsomal preparations from three different rCYPs expressing human @PROTEIN$ (yeast, Supersomes and Bactosomes) containing 10 pmol of the enzyme.	0
789	Two novel @PROTEIN$ related metabolites were identified in Bactosomes, and assigned as single hydroxylations in the phenyl rings of @COMPOUND$ and HYM using ion-trap mass spectrometry.	1
790	Two novel @PROTEIN$ related metabolites were identified in Bactosomes, and assigned as single hydroxylations in the phenyl rings of DOR and @COMPOUND$ using ion-trap mass spectrometry.	1
791	Finally, the active site of @PROTEIN$ harbors an absolutely conserved @COMPOUND$ (Glu172), which is well positioned to act as a general acid-base residue.	1
792	In this study, we tested the hypothesis that the Angiopoietin 1 (Ang1)/@PROTEIN$ pathway mediates @COMPOUND$-induced vascular integrity and migration of neuroblasts after stroke.	0
793	In this study, we tested the hypothesis that the Angiopoietin 1 (@PROTEIN$)/Tie2 pathway mediates @COMPOUND$-induced vascular integrity and migration of neuroblasts after stroke.	0
794	@COMPOUND$ treatment significantly decreased blood-brain barrier (BBB) leakage and concomitantly, increased Ang1, @PROTEIN$ and Occludin expression in the ischaemic border (IBZ) compared to the MCAo control group.	1
795	@COMPOUND$ treatment significantly decreased blood-brain barrier (BBB) leakage and concomitantly, increased Ang1, Tie2 and @PROTEIN$ expression in the ischaemic border (IBZ) compared to the MCAo control group.	1
796	@COMPOUND$ treatment significantly decreased blood-brain barrier (BBB) leakage and concomitantly, increased @PROTEIN$, Tie2 and Occludin expression in the ischaemic border (IBZ) compared to the MCAo control group.	1
797	@COMPOUND$ also significantly increased doublecortin (@PROTEIN$, a marker of migrating neuroblasts) expression in the IBZ compared to control MCAo rats.	1
798	Ang1/@PROTEIN$ expression induced by @COMPOUND$ treatment promotes neuroblast micro-vascular coupling after stroke.	1
799	@PROTEIN$/Tie2 expression induced by @COMPOUND$ treatment promotes neuroblast micro-vascular coupling after stroke.	1
800	Suppressing the activity of @PROTEIN$ in 3T3-L1 adipocytes reduces mitochondrial biogenesis but enhances glycolysis and basal @COMPOUND$ uptake.	1
801	Therefore, @PROTEIN$ stands at the crossroad of glucose and fatty acid utilization and acts as a homeostatic switch to regulate the flux of TCA cycle, mitochondrial membrane potential and glycolysis to maintain a steady level of @COMPOUND$ production, particularly, when mitochondrial biogenesis is reduced.	1
802	Therefore, @PROTEIN$ stands at the crossroad of @COMPOUND$ and fatty acid utilization and acts as a homeostatic switch to regulate the flux of TCA cycle, mitochondrial membrane potential and glycolysis to maintain a steady level of ATP production, particularly, when mitochondrial biogenesis is reduced.	1
803	A significant decrease in mean total nitric oxide (NOx), nitrite, and @COMPOUND$ levels was also found after @PROTEIN$ plus dexamethasone administration.	1
804	A significant decrease in mean total nitric oxide (NOx), nitrite, and nitrate levels was also found after @PROTEIN$ plus @COMPOUND$ administration.	0
805	A significant decrease in mean total @COMPOUND$ (NOx), nitrite, and nitrate levels was also found after @PROTEIN$ plus dexamethasone administration.	1
806	Even if partially compensated with u-PA and @PROTEIN$, increased FVIII and vWF activity, and decreased nitric oxide levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus @COMPOUND$ administered healthy granulocyte donors.	0
807	Even if partially compensated with u-PA and protein C, increased FVIII and @PROTEIN$ activity, and decreased @COMPOUND$ levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus dexamethasone administered healthy granulocyte donors.	0
808	Even if partially compensated with u-PA and protein C, increased FVIII and @PROTEIN$ activity, and decreased nitric oxide levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus @COMPOUND$ administered healthy granulocyte donors.	0
809	Even if partially compensated with u-PA and @PROTEIN$, increased FVIII and vWF activity, and decreased @COMPOUND$ levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus dexamethasone administered healthy granulocyte donors.	0
810	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), @COMPOUND$ (vitamin B(1)) and riboflavin (vitamin B(2)).	1
811	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, @COMPOUND$, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
812	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, @COMPOUND$ (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
813	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, @COMPOUND$, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
814	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, @COMPOUND$, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
815	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), @COMPOUND$ (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
816	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (@COMPOUND$), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
817	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, @COMPOUND$, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
818	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of @COMPOUND$, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
819	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), @COMPOUND$ (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
820	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and @COMPOUND$ (vitamin B(2)).	1
821	@COMPOUND$ impairs @PROTEIN$-dependent gene expression in porcine kidney tubulus cells.	1
822	Therefore, in the present study, the effects of @COMPOUND$ on the nuclear translocation and transactivation of the transcription factor @PROTEIN$ as well as mRNA levels of Nrf2 target genes including glutathione-S-transferase and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	0
823	Therefore, in the present study, the effects of @COMPOUND$ on the nuclear translocation and transactivation of the transcription factor Nrf2 as well as mRNA levels of Nrf2 target genes including @PROTEIN$ and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	0
824	@PROTEIN$ was induced by @COMPOUND$, a well-known activator of this transcription factor.	1
825	Current data indicate that @COMPOUND$ nephrotoxicity may be, at least partly, mediated by an @PROTEIN$-dependent signal transduction pathway.	1
826	Parthenogenetic porcine blastocysts were generated by the following methods: (1) electroporation followed by blocking the activity of specific @PROTEIN$ with @COMPOUND$ ; (2) electroporation followed by inhibition of protein synthesis using cycloheximide ; and (3) electroporation only (control).	1
827	Parthenogenetic porcine blastocysts were generated by the following methods: (1) electroporation followed by blocking the activity of specific @PROTEIN$ with butyrolactone I ; (2) electroporation followed by inhibition of protein synthesis using @COMPOUND$ ; and (3) electroporation only (control).	0
828	Increased incorporation of dietary plant sterols and @COMPOUND$ correlates with decreased expression of hepatic and intestinal Abcg5 and @PROTEIN$ in diabetic BB rats.	1
829	Increased incorporation of dietary plant sterols and @COMPOUND$ correlates with decreased expression of hepatic and intestinal @PROTEIN$ and Abcg8 in diabetic BB rats.	1
830	Therefore, lower expression levels of Abcg5/@PROTEIN$ in diabetic rats may account for the increased accumulation of plant sterols and @COMPOUND$ in these rats.	1
831	Therefore, lower expression levels of @PROTEIN$/Abcg8 in diabetic rats may account for the increased accumulation of plant sterols and @COMPOUND$ in these rats.	1
832	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1
833	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1
834	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1
835	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1
836	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1
837	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1
838	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1
839	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1
840	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1
841	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1
842	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1
843	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1
844	These effects of @COMPOUND$ during the differentiation period were associated with down-regulation of @PROTEIN$ and ERbeta expression.	1
845	These effects of @COMPOUND$ during the differentiation period were associated with down-regulation of ERalpha and @PROTEIN$ expression.	1
846	Activities of microbial extracellular enzymes involved in carbon, @COMPOUND$, and phosphorus cycling declined appreciably with depth, the only exception being @PROTEIN$.	0
847	Activities of microbial extracellular enzymes involved in carbon, nitrogen, and @COMPOUND$ cycling declined appreciably with depth, the only exception being @PROTEIN$.	0
848	@COMPOUND$ (SU) treatment restores insulin secretion in patients with @PROTEIN$ mutations.	0
849	@COMPOUND$ (SU) treatment restores @PROTEIN$ secretion in patients with KCNJ11 mutations.	1
850	@PROTEIN$-alpha inhibition protects against @COMPOUND$-induced endothelial glycocalyx perturbation.	1
851	In the present study, we investigated whether @COMPOUND$-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether @PROTEIN$-alpha (TNFalpha) plays a role in this process.	0
852	In the present study, we investigated whether @COMPOUND$-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether tumor necrosis factor-alpha (@PROTEIN$) plays a role in this process.	0
853	The amino acid sequence deduced from the coding sequence encodes for @PROTEIN$ of 73 amino acids containing 21 @COMPOUND$ residues.	1
854	Transformation was achieved using a vector that targets genes to the rrn16/rps12 intergenic region of the sugar beet plastome, employing the @PROTEIN$ gene as a selectable marker against @COMPOUND$ and the gfp gene for visual screening of plastid transformants.	1
855	Transformation was achieved using a vector that targets genes to the rrn16/@PROTEIN$ intergenic region of the sugar beet plastome, employing the aadA gene as a selectable marker against @COMPOUND$ and the gfp gene for visual screening of plastid transformants.	0
856	@COMPOUND$ inhibits serum amyloid a-induced @PROTEIN$ expression in human endothelial cells.	1
857	This article investigated the effect of sulfite on total antioxidant capacity (TAC), total oxidant status, lipid @COMPOUND$ (LOOH), and total free sulfydryl groups (-SH) levels in normal and @PROTEIN$-deficient male albino rat plasma.	0
858	@PROTEIN$ deficiency was established by feeding rats a low molybdenum diet and adding to their drinking water 200 ppm @COMPOUND$.	1
859	@PROTEIN$ deficiency was established by feeding rats a low @COMPOUND$ diet and adding to their drinking water 200 ppm tungsten.	1
860	The differences in tissue distribution and protein levels of @PROTEIN$-B1 during the programmed cell death indicate that the receptor plays a major role in the modulation and function of @COMPOUND$ activity in Bombyx anterior silk glands.	1
861	Methylthioadenosine phosphorylase (@PROTEIN$) is involved in the metabolism of purines and converts methylthioadenosine (MTA) to @COMPOUND$.	1
862	Methylation-specific primers were used to analyze methylation of the @PROTEIN$ promoter, using DNA treated with @COMPOUND$.	0
863	Long-chain @COMPOUND$ also reduced @PROTEIN$-alpha and prostaglandin E(2) production, although the potency of inhibition for the latter was lower.	1
864	@PROTEIN$ deficiency is a novel cause of secretory diarrhea and may act via disrupting the supply of @COMPOUND$ (ATP) needed for the maintenance of ion gradients across membranes.	1
865	@PROTEIN$ deficiency is a novel cause of secretory diarrhea and may act via disrupting the supply of adenosine triphosphate (@COMPOUND$) needed for the maintenance of ion gradients across membranes.	1
866	@PROTEIN$ digestion, fluorescence anisotropy, and NMR experiments presented here were designed to resolve the issue and show that in arm-dimerization domain, the arms are structured, although differently, in the presence and absence of @COMPOUND$.	0
867	DNA array studies have revealed that @PROTEIN$ is strongly up-regulated by nitroso-glutathione (@COMPOUND$) and also displays a 12-fold increase in expression during biofilm growth of E. coli 83972 and VR50 in human urine.	1
868	We found that the third @COMPOUND$ in @PROTEIN$, Cys122, is oxidized to a sulfenic acid.	0
869	We found that the third cysteine in @PROTEIN$, Cys122, is oxidized to a @COMPOUND$.	0
870	In this report, we investigated the possible role of LA and vmPFC @PROTEIN$s in the consolidation of fear extinction using the NR2B-selective antagonist @COMPOUND$.	0
871	In this report, we investigated the possible role of LA and vmPFC @PROTEIN$ in the consolidation of fear extinction using the NR2B-selective antagonist @COMPOUND$.	0
872	Patients under clozapine-@COMPOUND$ therapy developed a rise of serum @PROTEIN$ levels.	1
873	Patients under @COMPOUND$-risperidone therapy developed a rise of serum @PROTEIN$ levels.	1
874	Western blots analysis showed that simvastatin increased the phosphorylation of @PROTEIN$ and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker @COMPOUND$.	1
875	Western blots analysis showed that simvastatin increased the phosphorylation of eNOS and @PROTEIN$, which can be blocked by the PI3K/AKT pathway blocker @COMPOUND$.	1
876	Western blots analysis showed that @COMPOUND$ increased the phosphorylation of @PROTEIN$ and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker LY294002.	1
877	Western blots analysis showed that @COMPOUND$ increased the phosphorylation of eNOS and @PROTEIN$, which can be blocked by the PI3K/AKT pathway blocker LY294002.	1
878	In in vitro study, @COMPOUND$ increases the phosphorylation of eNOS and of FKHRL1 through the @PROTEIN$/AKT signaling pathway.	1
879	In in vitro study, @COMPOUND$ increases the phosphorylation of @PROTEIN$ and of FKHRL1 through the PI3K/AKT signaling pathway.	1
880	In in vitro study, @COMPOUND$ increases the phosphorylation of eNOS and of @PROTEIN$ through the PI3K/AKT signaling pathway.	1
881	The elevation of @COMPOUND$ plasma levels by a perioperative intravenous infusion of L-alanyl-L-glutamine influenced the intracellular expression of @PROTEIN$ in the lower tertile only slightly.	1
882	Determination of bioactive matter by affinity adsorption solid substrate-room temperature phosphorimetry based on @PROTEIN$ labeled with self-ordered ring of @COMPOUND$.	0
883	In this paper we demonstrate that hedgehog signaling antagonists, including @COMPOUND$, and a second compound, CUR0199691, can inhibit growth of @PROTEIN$ (ER)-positive and ER-negative tumorigenic breast cancer cells at elevated doses.	0
884	The equality of K (D) of @COMPOUND$ binding to blood platelet membranes and to membranes from nerve endings appears to encourage the use of such membranes as a model for brain @PROTEIN$.	0
885	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and @PROTEIN$ while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
886	With supplementation of @COMPOUND$ in diet, lower expression of @PROTEIN$ and VEGF while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
887	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and VEGF while higher expression of GLAST, GS and @PROTEIN$ in retina of diabetic rats were determinated by RT-PCR 0.05).	1
888	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and VEGF while higher expression of @PROTEIN$, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
889	@PROTEIN$, VEGF, GLAST, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
890	GFAP, VEGF, @PROTEIN$, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
891	GFAP, VEGF, GLAST, GS and @PROTEIN$ expressions in normal controls were not altered by @COMPOUND$ treatment.	0
892	GFAP, @PROTEIN$, GLAST, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
893	@COMPOUND$ (NO), which is produced by nitric oxide synthase (@PROTEIN$), may play a role in the development of ASD.	1
894	@COMPOUND$ (NO), which is produced by @PROTEIN$ (NOS), may play a role in the development of ASD.	1
895	In conclusion, @COMPOUND$-A has sufficient bonding strength and comparatively low toxicity in clinical use of 0.3 mmol or less of TAD and 0.8 mL of 44 w/w % @PROTEIN$ solution.	0
896	@COMPOUND$ upregulates @PROTEIN$ activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway.	1
897	It has been reported that @COMPOUND$ may affect hepatoma cell growth in vitro by suppressing transforming growth factor beta-1 (@PROTEIN$) expression, suggesting that tamoxifen might also retard fibrogenesis.	1
898	We also explored the effect of @PROTEIN$ released by @COMPOUND$ because this neuropeptide is known to affect the microvasculature environment.	0
899	We also explored the effect of substance P released by @COMPOUND$ because this @PROTEIN$ is known to affect the microvasculature environment.	0
900	Whereas their toxicity is due to @PROTEIN$ inhibition, their secondary toxic effects have been related to free @COMPOUND$ radicals.	0
901	@COMPOUND$ diminished the plasma @PROTEIN$ activity on day 1 post-treatment, although testosterone levels remained unaffected.	1
902	Diazinon diminished the plasma @PROTEIN$ activity on day 1 post-treatment, although @COMPOUND$ levels remained unaffected.	0
903	Melatonin pretreatment prevented every alteration induced by @COMPOUND$, except the diminution of @PROTEIN$ plasmatic activity.	1
904	@COMPOUND$ pretreatment prevented every alteration induced by diazinon, except the diminution of @PROTEIN$ plasmatic activity.	0
905	Sialic acid-specific O-@PROTEIN$ and O-acetylesterases are responsible for the metabolism of esterified @COMPOUND$.	1
906	Sialic acid-specific O-acetyltransferases and O-@PROTEIN$ are responsible for the metabolism of esterified @COMPOUND$.	1
907	@COMPOUND$ vector injection also reduced spontaneous pain-related behaviors in the delayed phase of the formalin test and in both CFA and formalin models suppressed spinal c-@PROTEIN$ expression.	1
908	@COMPOUND$ vector injection also reduced spontaneous pain-related behaviors in the delayed phase of the formalin test and in both @PROTEIN$ and formalin models suppressed spinal c-fos expression.	0
909	Furthermore, 8-bromo-cGMP and @COMPOUND$ failed to reproduce the inhibitory effect of NO, indicating that NO acts directly on @PROTEIN$ rather than through classical NO signaling pathways.	0
910	Furthermore, @COMPOUND$ and peroxynitrite failed to reproduce the inhibitory effect of NO, indicating that NO acts directly on @PROTEIN$ rather than through classical NO signaling pathways.	0
911	@COMPOUND$ decreases expression of osmoprotective genes via direct inhibition of @PROTEIN$ transcriptional activity.	1
912	Because @COMPOUND$ (NO) is abundantly produced in the renal medulla, the present studies addressed the effect of NO on expression of osmoprotective genes and @PROTEIN$ activation in MDCK cells.	0
913	An RCC1 mutant in which all N-terminal serine and @COMPOUND$ residues were substituted with glutamate residues to mimic phosphorylation at these residues showed decreased binding to the karyopherin, @PROTEIN$, compared with wild type RCC1.	0
914	An RCC1 mutant in which all N-terminal @COMPOUND$ and threonine residues were substituted with glutamate residues to mimic phosphorylation at these residues showed decreased binding to the karyopherin, @PROTEIN$, compared with wild type RCC1.	0
915	An RCC1 mutant in which all N-terminal serine and threonine residues were substituted with @COMPOUND$ residues to mimic phosphorylation at these residues showed decreased binding to the karyopherin, @PROTEIN$, compared with wild type RCC1.	0
916	@COMPOUND$, acting on P2X (7) receptors, stimulates changes in intracellular calcium concentrations, maturation, and release of interleukin-1beta (@PROTEIN$), and following prolonged agonist exposure, cell death.	1
917	@COMPOUND$, acting on @PROTEIN$ (7) receptors, stimulates changes in intracellular calcium concentrations, maturation, and release of interleukin-1beta (IL-1beta), and following prolonged agonist exposure, cell death.	1
918	While the total @PROTEIN$ released during a 1 h @COMPOUND$ stimulation period was the same from islets in each sample, increasing hydrogel crosslinking density contributed to delays in insulin release from hydrogel samples within the 1 h stimulation period.	1
919	Ischaemia and @PROTEIN$, but not ischaemia and contraction, act synergistically in stimulating muscle @COMPOUND$ uptake in vivo in humans.	1
920	In summary, ischaemia and @PROTEIN$ independently stimulate skeletal muscle @COMPOUND$ uptake in vivo in humans, whereas ischaemia and contraction do not.	1
921	A comparison of the inhibitory effect of @COMPOUND$ on soluble and immobilized @PROTEIN$ showed that immobilization increased the linearity of the inhibition plot particularly in the range 0.1 nM-0.1 microM.	1
922	Extracellular lipase @PROTEIN$ prepared in our lab from the yeast Yarrowia lipolytica was used for the resolution of racemic @COMPOUND$.	1
923	Extracellular @PROTEIN$ LIP prepared in our lab from the yeast Yarrowia lipolytica was used for the resolution of racemic @COMPOUND$.	1
924	"The potential action of @COMPOUND$ as a ""chemical chaperone"": increase of @PROTEIN$ activity in fibroblasts from an adult GM1-gangliosidosis patient."	1
925	@COMPOUND$ perfusion marginally increased @PROTEIN$ levels to 7.3 fg/microg/ml on average in the upper arm and control axilla.	1
926	@COMPOUND$ induces PON1 expression through p44/42 mitogen-activated @PROTEIN$ signaling cascade in Huh7 cells.	1
927	@COMPOUND$ induces PON1 expression through @PROTEIN$/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.	1
928	@COMPOUND$ induces @PROTEIN$ expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.	1
929	Both @PROTEIN$ gene promoter activity and PON1 protein expression were elevated by @COMPOUND$ stimulation.	1
930	@COMPOUND$ phosphorylated @PROTEIN$/42 MAP kinase.	1
931	@COMPOUND$ increased the @PROTEIN$-PON1 DNA complex and this effect was attenuated by PD98059.	1
932	Pitavastatin increased the Sp1-@PROTEIN$ DNA complex and this effect was attenuated by @COMPOUND$.	1
933	Pitavastatin increased the @PROTEIN$-PON1 DNA complex and this effect was attenuated by @COMPOUND$.	1
934	@COMPOUND$ increased the Sp1-@PROTEIN$ DNA complex and this effect was attenuated by PD98059.	1
935	These observations suggest that @COMPOUND$ phosphorylates @PROTEIN$/42 MAP kinase and then activates the transcription of PON1 gene and increases the PON1 protein expression in Huh7 cells.	1
936	These observations suggest that @COMPOUND$ phosphorylates p44/42 MAP kinase and then activates the transcription of @PROTEIN$ gene and increases the PON1 protein expression in Huh7 cells.	1
937	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to PON1 DNA through the activation of @PROTEIN$/42 MAP kinase signaling cascade.	1
938	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of @PROTEIN$ and the Sp1 binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	0
939	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the @PROTEIN$ binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	1
940	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to @PROTEIN$ DNA through the activation of p44/42 MAP kinase signaling cascade.	1
941	Inhibition of cyclooxygenase 2 expression by @COMPOUND$ on joint inflammation induced by urate crystal and @PROTEIN$.	0
942	Inhibition of @PROTEIN$ expression by @COMPOUND$ on joint inflammation induced by urate crystal and IL-1beta.	1
943	Investigation of the effects of @COMPOUND$ (DAS), a garlic sulfur compound, on joint tissue inflammatory responses induced by monosodium urate (MSU) crystals and interleukin-1beta (@PROTEIN$).	0
944	Investigation of the effects of diallyl sulfide (DAS), a garlic sulfur compound, on joint tissue inflammatory responses induced by @COMPOUND$ (MSU) crystals and interleukin-1beta (@PROTEIN$).	0
945	Genetic variants of @PROTEIN$ (CYP2C9) and vitamin K epoxide reductase (VKORC1) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
946	Genetic variants of cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (@PROTEIN$) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
947	Genetic variants of cytochrome P450 2C9 (@PROTEIN$) and vitamin K epoxide reductase (VKORC1) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
948	In multivariate analysis, neither BMI, presence of obesity, nor baseline @COMPOUND$ was significantly associated with OS or @PROTEIN$ declines.	0
949	The interaction between PAF and the platelet agonists ADP, @PROTEIN$ and convulxin was analyzed in vitro in whole blood with the use of flow cytometry and was further characterized with the use of receptor antagonists to PAF (ABT-491), P2Y1 (MRS-2179), and P2Y12 (@COMPOUND$) as well as a monoclonal anti-PSGL-1 antibody (anti-CD162).	0
950	The interaction between PAF and the platelet agonists ADP, @PROTEIN$ and convulxin was analyzed in vitro in whole blood with the use of flow cytometry and was further characterized with the use of receptor antagonists to PAF (ABT-491), P2Y1 (@COMPOUND$), and P2Y12 (cangrelor) as well as a monoclonal anti-PSGL-1 antibody (anti-CD162).	0
951	Effects of @COMPOUND$ and fentanyl on spontaneous and endotoxin (lipopolysaccharide ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, TNF-alpha and @PROTEIN$ 0.01).	0
952	Effects of @COMPOUND$ and fentanyl on spontaneous and endotoxin (lipopolysaccharide ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, @PROTEIN$ and IL-10 0.01).	0
953	Effects of remifentanyl and fentanyl on spontaneous and @COMPOUND$ ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, @PROTEIN$ and IL-10 0.01).	0
954	Effects of remifentanyl and fentanyl on spontaneous and @COMPOUND$ ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results @PROTEIN$, TNF-alpha and IL-10 0.01).	0
955	Effects of remifentanyl and fentanyl on spontaneous and @COMPOUND$ ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, TNF-alpha and @PROTEIN$ 0.01).	0
956	Effects of @COMPOUND$ and fentanyl on spontaneous and endotoxin (lipopolysaccharide ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results @PROTEIN$, TNF-alpha and IL-10 0.01).	0
957	@COMPOUND$ and fentanyl could inhibit the expressions of IL-6, @PROTEIN$ and IL-10 induced by LPS.	1
958	@COMPOUND$ and fentanyl could inhibit the expressions of @PROTEIN$, TNF-alpha and IL-10 induced by LPS.	1
959	@COMPOUND$ and fentanyl could inhibit the expressions of IL-6, TNF-alpha and @PROTEIN$ induced by LPS.	1
960	Improved hepatic @PROTEIN$ signalling led to decreased phosphoenolpyruvate carboxykinase expression and reduced hepatic @COMPOUND$ output accordingly.	1
961	Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of @PROTEIN$/iNOS mRNA level is under the control of endogenous iNO/@COMPOUND$ signaling system.	1
962	Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of COX-2/@PROTEIN$ mRNA level is under the control of endogenous iNO/@COMPOUND$ signaling system.	1
963	Pre-synaptic @PROTEIN$s inhibit neurotransmitter release, suggesting that CB1R activation during extinction may decrease CCK peptide release as well as @COMPOUND$ release.	1
964	Pre-synaptic CB1Rs inhibit neurotransmitter release, suggesting that CB1R activation during extinction may decrease @PROTEIN$ peptide release as well as @COMPOUND$ release.	0
965	Pre-synaptic @PROTEIN$ inhibit neurotransmitter release, suggesting that CB1R activation during extinction may decrease CCK peptide release as well as @COMPOUND$ release.	1
966	Acute @COMPOUND$, through D(2) dopamine receptors, induced a dose-response increase in @PROTEIN$ in the cortex, with opposite effects over pFADD (Ser191/194), and no induction of apoptotic cell death (poly-(ADP-ribose) polymerase cleavage).	1
967	Acute @COMPOUND$, through @PROTEIN$, induced a dose-response increase in FADD protein in the cortex, with opposite effects over pFADD (Ser191/194), and no induction of apoptotic cell death (poly-(ADP-ribose) polymerase cleavage).	1
968	In a second experiment, possible @PROTEIN$ differences were investigated in rats selectively bred for differential responsiveness to novelty, propensity for drug-seeking and @COMPOUND$ sensitization.	0
969	Manganese @PROTEIN$ oxidize Mn(II) to @COMPOUND$), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.	1
970	Manganese @PROTEIN$ oxidize @COMPOUND$) to Mn(III), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.	1
971	@PROTEIN$ are multi-@COMPOUND$-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular oxygen to water.	1
972	@PROTEIN$ are multi-copper-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular @COMPOUND$ to water.	1
973	Hence, resistance to cancer in old Snell dwarf mice may be mediated by neuroendocrine factors that reduce @COMPOUND$ utilization besides elevated adiponectin, reduced IGF-I and a lack of GH, @PROTEIN$ and TSH, seen in both Snell and Ames dwarf mice.	0
974	Hence, resistance to cancer in old Snell dwarf mice may be mediated by neuroendocrine factors that reduce @COMPOUND$ utilization besides elevated adiponectin, reduced @PROTEIN$ and a lack of GH, PRL and TSH, seen in both Snell and Ames dwarf mice.	0
975	Therefore, @COMPOUND$, which inhibit the production of @PROTEIN$ by negative feedback, was considered a treatment option to control the evolution of calciphylaxis in a dialysed patient suffering from cholangiocarcinoma.	1
976	@COMPOUND$ levels and hormones (Peptide YY(3-36), @PROTEIN$ (GLP-1), leptin, ghrelin, insulin) that regulate EI were measured.	0
977	@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (GLP-1), leptin, ghrelin, @PROTEIN$) that regulate EI were measured.	0
978	@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (GLP-1), leptin, @PROTEIN$, insulin) that regulate EI were measured.	0
979	@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (GLP-1), @PROTEIN$, ghrelin, insulin) that regulate EI were measured.	0
980	@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (@PROTEIN$), leptin, ghrelin, insulin) that regulate EI were measured.	0
981	@COMPOUND$ levels and hormones (@PROTEIN$, glucagon-like peptide-1 (GLP-1), leptin, ghrelin, insulin) that regulate EI were measured.	0
982	@PROTEIN$ catalyze a calcium-dependent transamidation reaction that produces covalent cross-linking of available substrate @COMPOUND$ residues and modifies the extracellular matrix.	1
983	We fed rats @COMPOUND$ or valine deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, @PROTEIN$) and serine/threonine degrading enzymes (serine dehydratase, SDS) in the liver.	0
984	We fed rats lysine or @COMPOUND$ deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, @PROTEIN$) and serine/threonine degrading enzymes (serine dehydratase, SDS) in the liver.	0
985	We fed rats lysine or @COMPOUND$ deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, PHGDH) and serine/threonine degrading enzymes (serine dehydratase, @PROTEIN$) in the liver.	0
986	We fed rats @COMPOUND$ or valine deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, PHGDH) and serine/threonine degrading enzymes (serine dehydratase, @PROTEIN$) in the liver.	0
987	Dietary deficiency induced marked elevation of hepatic serine and @COMPOUND$ levels associated with enhancement of @PROTEIN$ mRNA expression and repression of SDS mRNA expression.	0
988	Dietary deficiency induced marked elevation of hepatic @COMPOUND$ and threonine levels associated with enhancement of @PROTEIN$ mRNA expression and repression of SDS mRNA expression.	0
989	Dietary deficiency induced marked elevation of hepatic serine and @COMPOUND$ levels associated with enhancement of PHGDH mRNA expression and repression of @PROTEIN$ mRNA expression.	0
990	Dietary deficiency induced marked elevation of hepatic @COMPOUND$ and threonine levels associated with enhancement of PHGDH mRNA expression and repression of @PROTEIN$ mRNA expression.	0
991	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor @COMPOUND$ (CHE), capsaicin (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (5HD).	0
992	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor chelerythrine (CHE), capsaicin (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (@COMPOUND$).	0
993	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor chelerythrine (CHE), @COMPOUND$ (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (5HD).	1
994	With the exception of specific genetic defects in purine metabolism, increased @COMPOUND$ is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, @PROTEIN$ resistance, the metabolic syndrome and renal failure.	1
995	With the exception of specific genetic defects in @COMPOUND$ metabolism, increased uric acid is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, @PROTEIN$ resistance, the metabolic syndrome and renal failure.	0
996	The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different @COMPOUND$ (FITC) conjugated @PROTEIN$.	0
997	The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different fluorescein isothiocyanate (@COMPOUND$) conjugated @PROTEIN$.	0
998	High @COMPOUND$ and @PROTEIN$ synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor STAT1 activity.	0
999	High @COMPOUND$ and interferon gamma synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor @PROTEIN$ activity.	1
1000	High @COMPOUND$ and interferon gamma synergistically stimulate @PROTEIN$ expression in U937 macrophages by increasing transcription factor STAT1 activity.	1
1001	To test our hypothesis that hyperglycemia interplays with @PROTEIN$ (IFN gamma), a key factor involved in atherosclerosis, to up-regulate the expression of genes such as matrix metalloproteinases (MMPs) and cytokines that are involved in plaque destabilization, U937 macrophages cultured in medium containing either normal or high @COMPOUND$ were challenged with IFN gamma and the expression of MMPs and cytokines were then quantified by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA).	0
1002	To test our hypothesis that hyperglycemia interplays with interferon gamma (@PROTEIN$), a key factor involved in atherosclerosis, to up-regulate the expression of genes such as matrix metalloproteinases (MMPs) and cytokines that are involved in plaque destabilization, U937 macrophages cultured in medium containing either normal or high @COMPOUND$ were challenged with IFN gamma and the expression of MMPs and cytokines were then quantified by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA).	0
1003	@COMPOUND$, a synthetic triterpenoid, inhibits expression of IL-6 and @PROTEIN$ phosphorylation in multi-drug resistant ovarian cancer cells.	1
1004	@COMPOUND$, a synthetic triterpenoid, inhibits expression of @PROTEIN$ and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.	1
1005	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0
1006	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0
1007	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0
1008	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0
1009	These studies demonstrated that @COMPOUND$ significantly inhibits IL-6 secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced @PROTEIN$ nuclear translocation.	1
1010	These studies demonstrated that @COMPOUND$ significantly inhibits @PROTEIN$ secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced Stat3 nuclear translocation.	1
1011	Treatment with @COMPOUND$ significantly decreases the levels of Stat3, @PROTEIN$, and Src phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	1
1012	Treatment with @COMPOUND$ significantly decreases the levels of Stat3, Jak2, and @PROTEIN$ phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	1
1013	On a molar basis, @COMPOUND$ yields a signal that is approximately 0.67 times that of @PROTEIN$.	0
1014	A 23.5-fold increase in @COMPOUND$ O-deethylation activity suggested that metabolic resistance through elevated levels of @PROTEIN$ dependent monooxygenase-activity is a possible resistance mechanism.However, synergism studies with different metabolic inhibitors revealed some contrasting resistance mechanisms between the METI-acaricides.	1
1015	The activities of Rho GTPases are predominantly controlled by guanine nucleotide exchange factors (@PROTEIN$), which activate GTPases by catalyzing the exchange of bound @COMPOUND$ for GTP.	1
1016	Parents (N = 19) of children with autism spectrum disorders (ASD) and adult controls (N = 17) underwent positron emission tomography (PET) using ((18)F) @COMPOUND$ to image cortical serotonin type-2 (@PROTEIN$) receptors.	1
1017	Natural @COMPOUND$ was enzymatically polymerized using soybean @PROTEIN$.	1
1018	Vesicle mobilization requires @COMPOUND$+)-induced Ca2+ release by presynaptic endoplasmic reticulum (ER) ryanodine receptors (@PROTEIN$) that in turn stimulates Ca2+/calmodulin-dependent kinase II (CamKII).	1
1019	These results highlight both the interactions between @PROTEIN$ and NMDA receptors in the determination of schizophreniform behaviours and the potential for the effects of @COMPOUND$ to be mediated by NMDA receptor regulation.	0
1020	Expression of @PROTEIN$ reduced the intracellular @COMPOUND$ concentration from 140 to 11 mM and resulted in maximal excretion rates of 11.2 nmol min(-1) mg(-1) as compared to 2.3 nmol min(-1) mg(-1) obtained without rhtC expression.	1
1021	In combination with an @PROTEIN$ mutation generated and introduced into the chromosome, an accumulation of up to 54 mM @COMPOUND$ was achieved as compared to 21 mM obtained with the ancestor strain.	1
1022	Furthermore, the CD3(+) T cells co-cultured with @COMPOUND$ treated U-87 and autologous GBM tumor cells showed a significant increase in expression in @PROTEIN$, a key cytokine produced by activated T cells, and accordingly enhanced tumor cytotoxicity.	1
1023	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (@COMPOUND$) and tyrosine kinase inhibitors (herbimycin A and tyrphostin 46).	1
1024	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (@COMPOUND$ and tyrphostin 46).	1
1025	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (herbimycin A and @COMPOUND$).	1
1026	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and actin reorganization via RhoA activation and @PROTEIN$ phosphorylation, thereby activating cell proliferation and migration in BAECs.	1
1027	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and actin reorganization via @PROTEIN$ activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.	1
1028	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and @PROTEIN$ reorganization via RhoA activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.	0
1029	Cell exposure to 250 microM @COMPOUND$ was able to induce @PROTEIN$ 2 up-regulation and increased in situ transglutaminase activity.	1
1030	Cell exposure to 250 microM @COMPOUND$ was able to induce @PROTEIN$ up-regulation and increased in situ transglutaminase activity.	1
1031	@COMPOUND$ can support the formation of membranous structures and an increase in @PROTEIN$ mRNA levels in differentiating oligodendrocytes.	1
1032	@PROTEIN$ elevates @COMPOUND$ levels in the hemolymph by stimulating glycogenolysis in target tissues.	1
1033	Here, we assessed the regulation of pancreatic @PROTEIN$ release by @COMPOUND$+), mitochondrial membrane potential (Delta Psi m), and reactive oxygen species (ROS), the signals involved in acute pancreatitis.	1
1034	Results showed that @COMPOUND$ treatment during early cocaine withdrawal attenuated increases in amygdalar CRF gene expression and cyclic adenosine monophosphate-dependent @PROTEIN$ regulatory and catalytic subunit (nuclear fraction) protein expression.	1
1035	Results showed that betaxolol treatment during early @COMPOUND$ withdrawal attenuated increases in amygdalar @PROTEIN$ gene expression and cyclic adenosine monophosphate-dependent protein kinase regulatory and catalytic subunit (nuclear fraction) protein expression.	0
1036	Results showed that @COMPOUND$ treatment during early cocaine withdrawal attenuated increases in amygdalar @PROTEIN$ gene expression and cyclic adenosine monophosphate-dependent protein kinase regulatory and catalytic subunit (nuclear fraction) protein expression.	1
1037	Results showed that betaxolol treatment during early @COMPOUND$ withdrawal attenuated increases in amygdalar CRF gene expression and cyclic adenosine monophosphate-dependent @PROTEIN$ regulatory and catalytic subunit (nuclear fraction) protein expression.	0
1038	The present findings suggest that the efficacy of betaxolol treatment on @COMPOUND$ withdrawal-induced anxiety may be related, in part, to its effect on amygdalar beta(1)-adrenergic receptor, modulation of its downstream cell-signaling elements and @PROTEIN$ gene expression.	0
1039	The present findings suggest that the efficacy of @COMPOUND$ treatment on cocaine withdrawal-induced anxiety may be related, in part, to its effect on amygdalar beta(1)-adrenergic receptor, modulation of its downstream cell-signaling elements and @PROTEIN$ gene expression.	1
1040	Furthermore, it is demonstrated that this strain has @PROTEIN$ activity, and the activity can be optimized under suitable growing conditions where wheat bran and @COMPOUND$ are the primary sources of carbon and nitrogen.	0
1041	Furthermore, it is demonstrated that this strain has @PROTEIN$ activity, and the activity can be optimized under suitable growing conditions where wheat bran and urea are the primary sources of carbon and @COMPOUND$.	0
1042	Glutathione S-transferase (@PROTEIN$) isozymes catalyze nucleophilic attack by reduced Glutathione (@COMPOUND$) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
1043	@PROTEIN$ (GST) isozymes catalyze nucleophilic attack by @COMPOUND$ (GSH) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
1044	Glutathione S-transferase (@PROTEIN$) isozymes catalyze nucleophilic attack by @COMPOUND$ (GSH) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
1045	@PROTEIN$ (GST) isozymes catalyze nucleophilic attack by reduced Glutathione (@COMPOUND$) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
1046	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent @PROTEIN$ phosphorylation.	1
1047	@COMPOUND$ inhibits @PROTEIN$-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	0
1048	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through @PROTEIN$-dependent AMPK phosphorylation.	1
1049	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, @PROTEIN$ degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
1050	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and @PROTEIN$ production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
1051	@COMPOUND$ inhibits TNF-alpha-induced @PROTEIN$ phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
1052	@COMPOUND$ also activated the @PROTEIN$ (c-Jun) transcription factor.	1
1053	Characterisation of @COMPOUND$ analogues to cross-link and label @PROTEIN$ receptors.	1
1054	In this study we determined whether the UV light-reactive @COMPOUND$ analogues 2-azido ATP, ATP azidoanilide (ATP-AA) and 2', 3'-O-(4-benzoylbenzoyl)-ATP (BzATP) can be used to label the ATP binding site of @PROTEIN$ receptors.	1
1055	In this study we determined whether the UV light-reactive ATP analogues @COMPOUND$, ATP azidoanilide (ATP-AA) and 2', 3'-O-(4-benzoylbenzoyl)-ATP (BzATP) can be used to label the ATP binding site of @PROTEIN$ receptors.	1
1056	In this study we determined whether the UV light-reactive ATP analogues 2-azido ATP, ATP azidoanilide (ATP-AA) and 2', 3'-O-(4-benzoylbenzoyl)-ATP (@COMPOUND$) can be used to label the ATP binding site of @PROTEIN$ receptors.	1
1057	In this study we determined whether the UV light-reactive ATP analogues 2-azido ATP, ATP azidoanilide (ATP-AA) and 2', @COMPOUND$ (BzATP) can be used to label the ATP binding site of @PROTEIN$ receptors.	1
1058	cross-linked to @PROTEIN$ receptors and this binding was reduced by co-incubation with @COMPOUND$.	1
1059	These studies demonstrate that photo-reactive @COMPOUND$ analogues can be used to label @PROTEIN$ receptor and may prove useful in elucidating the ATP binding site at this novel class of ATP binding proteins.	1
1060	@PROTEIN$ treatment for 72 h also induced EMT in the A549 cells and this transition led to resistance to @COMPOUND$.	1
1061	@PROTEIN$-antagonistic effects of hormones, cytokines and excess metabolic substrates such as @COMPOUND$ and fatty acids may be exerted via common mechanisms involving for example reactive oxygen species (ROS) accumulation and associated inflammatory responses.	1
1062	Optimization of decolorization of @COMPOUND$ (MB) dye by @PROTEIN$ (LiP) enzyme produced by white-rot fungus Phanerochaete chrysosporium using sewage treatment plant (STP) sludge as a major substrate was carried out in the laboratory.	1
1063	Glycine release was potentiated by the activation of @PROTEIN$ and diminished by increasing cyclic guanosine monophosphate levels with a phosphodiesterase inhibitor, @COMPOUND$.	0
1064	Glycine release was potentiated by the activation of @PROTEIN$ and diminished by increasing @COMPOUND$ levels with a phosphodiesterase inhibitor, zaprinast.	0
1065	@COMPOUND$ release was potentiated by the activation of @PROTEIN$ and diminished by increasing cyclic guanosine monophosphate levels with a phosphodiesterase inhibitor, zaprinast.	1
1066	Our study demonstrates that @COMPOUND$ causes evident damage to acinar cells, impairing both calcium homeostasis and secretory response to @PROTEIN$.	1
1067	Enteric neuronal dopamine (DA) inhibits @COMPOUND$ release and gastric motility; this has been thought to be mediated via neuronal dopamine-2 receptor (@PROTEIN$).	1
1068	As compared with parental B16 cells, the inhibitory effects of @PROTEIN$ and activin A on @COMPOUND$ content were relative smaller in B16 F10 cells, a subline of B16 cells that contain more pigment.	1
1069	However asynchronous EPSCs were increased following synaptic depression and a component of these appeared to be initiated by endogenously released @COMPOUND$ acting on presynaptic @PROTEIN$ receptors.	1
1070	Unexpectedly, the data suggest @PROTEIN$ receptor activation initiates a form of asynchronous @COMPOUND$ release, rather than detectably affecting the vesicles underlying action potential evoked release.	1
1071	The second enzyme of @COMPOUND$ synthesis, GSH synthase (GS) is also regulated in a coordinated manner as @PROTEIN$ subunits and its up-regulation can further enhance the capacity of the cell to synthesize GSH.	1
1072	In contrast, GH receptor-mediated increase in (@COMPOUND$+))(i) is @PROTEIN$-independent and is dissociated from insulin secretion.	1
1073	In contrast, GH receptor-mediated increase in (@COMPOUND$+))(i) is JAK2-independent and is dissociated from @PROTEIN$ secretion.	0
1074	In contrast, @PROTEIN$-mediated increase in (@COMPOUND$+))(i) is JAK2-independent and is dissociated from insulin secretion.	1
1075	SEMG I expression is upregulated by @PROTEIN$, IL-6 and @COMPOUND$.	0
1076	@PROTEIN$ I expression is upregulated by IL-4, IL-6 and @COMPOUND$.	1
1077	SEMG I expression is upregulated by IL-4, @PROTEIN$ and @COMPOUND$.	0
1078	@COMPOUND$ down-regulates @PROTEIN$ transcript and protein levels in MCF-7 breast cancer cells.	1
1079	Consumption of the trichothecene mycotoxin @COMPOUND$ (DON) induces @PROTEIN$ (IL-6)-dependent IgA nephropathy (IgAN) in mice.	1
1080	Consumption of the trichothecene mycotoxin @COMPOUND$ (DON) induces interleukin-6 (@PROTEIN$)-dependent IgA nephropathy (IgAN) in mice.	1
1081	The purpose of this study was to identify the signal transduction pathways by which DON up-regulates @PROTEIN$ in the peritoneal macrophage and how consumption of fish oil enriched with the n-3 PUFA @COMPOUND$ (DHA) suppresses these processes.	1
1082	The aim of the present study was to determine the effects of niacin and @COMPOUND$ on HDL formation by investigating the changes in @PROTEIN$ and ApoA-1 transcription in the human hepatoblastoma cell line (HepG2 cells).	0
1083	The aim of the present study was to determine the effects of @COMPOUND$ and chromium on HDL formation by investigating the changes in @PROTEIN$ and ApoA-1 transcription in the human hepatoblastoma cell line (HepG2 cells).	0
1084	Niacin and @COMPOUND$ cotreatment significantly induced the expression of @PROTEIN$ (PPARalpha) mRNA by approximately 1.3-1.8-fold.	1
1085	Niacin and @COMPOUND$ cotreatment significantly induced the expression of peroxisome proliferator-activated receptor-alpha (@PROTEIN$) mRNA by approximately 1.3-1.8-fold.	1
1086	@COMPOUND$ and chromium cotreatment significantly induced the expression of @PROTEIN$ (PPARalpha) mRNA by approximately 1.3-1.8-fold.	1
1087	@COMPOUND$ and chromium cotreatment significantly induced the expression of peroxisome proliferator-activated receptor-alpha (@PROTEIN$) mRNA by approximately 1.3-1.8-fold.	1
1088	A combination of @COMPOUND$ and chromium chloride did not significantly increase (3+1 mM) but instead reduced (1+3 mM) @PROTEIN$ gene expression.	1
1089	A combination of niacin and @COMPOUND$ did not significantly increase (3+1 mM) but instead reduced (1+3 mM) @PROTEIN$ gene expression.	1
1090	@COMPOUND$ inhibited cell proliferation with IC(50) values at 24 and 48 h of 12.5 and 7.5 muM doses, respectively, and decreased @PROTEIN$ protein expression at concentrations between 2.5 and 30 muM.	1
1091	30 muM, the SUL-induced suppression of @PROTEIN$ protein was reversed by preincubation with the proteasome inhibitor @COMPOUND$ and was accompanied by an increase in protein levels of the 20S catalytic core subunit PSMB5.	1
1092	30 muM, the SUL-induced suppression of ERalpha protein was reversed by preincubation with the proteasome inhibitor @COMPOUND$ and was accompanied by an increase in protein levels of the 20S catalytic core subunit @PROTEIN$.	0
1093	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial nitric oxide synthase (@PROTEIN$) mRNA in the aorta.	1
1094	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of @PROTEIN$ mRNA and an increase in endothelial nitric oxide synthase (eNOS) mRNA in the aorta.	0
1095	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial @PROTEIN$ (eNOS) mRNA in the aorta.	0
1096	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of @PROTEIN$ mRNA and an increase in endothelial nitric oxide synthase (eNOS) mRNA in the aorta.	1
1097	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial nitric oxide synthase (@PROTEIN$) mRNA in the aorta.	0
1098	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial @PROTEIN$ (eNOS) mRNA in the aorta.	1
1099	A series of @COMPOUND$ derivatives of thiazolyl-N-substituted amides were synthesized in a three-step reaction and tested for anti-inflammatory activity as well as @PROTEIN$ and cycloxygenase inhibitory actions.	0
1100	@PROTEIN$ involvement in the discriminative stimulus effects in rats of LSD, but not the @COMPOUND$ hallucinogen DOI.	0
1101	@PROTEIN$ involvement in the discriminative stimulus effects in rats of @COMPOUND$, but not the phenethylamine hallucinogen DOI.	1
1102	@PROTEIN$ involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen @COMPOUND$.	0
1103	Plasma levels of @COMPOUND$, zinc and carotenoids did not vary across quintiles, but weak negative correlations were observed with serum ferritin and @PROTEIN$ saturation.	1
1104	Plasma levels of @COMPOUND$, zinc and carotenoids did not vary across quintiles, but weak negative correlations were observed with serum @PROTEIN$ and transferrin saturation.	1
1105	@COMPOUND$ did not similarly affect @PROTEIN$ levels.	0
1106	Concurrently, the half-life of existing @PROTEIN$ protein was increased by @COMPOUND$, in association with a marked inhibition of chymotryptic activity in the 20S proteasome.	1
1107	To determine whether a regimen of @COMPOUND$ pretreatment, bivalirudin during the procedure and clopidogrel (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and platelet activating factor (10 nM).	0
1108	To determine whether a regimen of aspirin pretreatment, bivalirudin during the procedure and clopidogrel (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and @COMPOUND$ (10 nM).	0
1109	To determine whether a regimen of aspirin pretreatment, bivalirudin during the procedure and @COMPOUND$ (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and platelet activating factor (10 nM).	0
1110	To determine whether a regimen of aspirin pretreatment, @COMPOUND$ during the procedure and clopidogrel (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and platelet activating factor (10 nM).	0
1111	The @PROTEIN$ (LDLr) mediates the uptake of LDL particles enriched with @COMPOUND$, into several tissues.	1
1112	Under the condition of delayed intervention (30 days after deafening) following @COMPOUND$+ furosemide deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of @PROTEIN$ (BDNF) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
1113	Under the condition of delayed intervention (30 days after deafening) following @COMPOUND$+ furosemide deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of brain-derived neurotrophic factor (@PROTEIN$) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
1114	Under the condition of delayed intervention (30 days after deafening) following gentamicin+ @COMPOUND$ deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of @PROTEIN$ (BDNF) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
1115	Under the condition of delayed intervention (30 days after deafening) following gentamicin+ @COMPOUND$ deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of brain-derived neurotrophic factor (@PROTEIN$) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
1116	For this purpose, human erythrocyte @PROTEIN$ was initially purified 2139-fold in a yield of 29% by using 2', 5'-ADP @COMPOUND$ 4B affinity gel and Sephadex G-200 gel filtration chromatography.	0
1117	In the present study we perform a kinetic analysis of Campylobacter @PROTEIN$ using the continuous spectrophotometric method and show that the enzyme is highly specific for @COMPOUND$ nucleotides.	1
1118	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from L-tryptophan pyruvate, @COMPOUND$ and indole.	1
1119	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from @COMPOUND$ pyruvate, ammonia and indole.	1
1120	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from L-tryptophan @COMPOUND$, ammonia and indole.	1
1121	@PROTEIN$ allows soil microorganisms to use @COMPOUND$ as a source of nitrogen and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.	1
1122	@PROTEIN$ allows soil microorganisms to use urea as a source of @COMPOUND$ and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.	0
1123	Diastolic function and @PROTEIN$ changes during exercise predict @COMPOUND$ consumption in chronic heart failure patients.	1
1124	Although incubation with prolactin (PRL) and/or adrenocorticotrophic hormone (@PROTEIN$) resulted in a dose-dependent increase of @COMPOUND$ and progesterone release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
1125	Although incubation with @PROTEIN$ (PRL) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of @COMPOUND$ and progesterone release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
1126	Although incubation with prolactin (PRL) and/or adrenocorticotrophic hormone (@PROTEIN$) resulted in a dose-dependent increase of corticosterone and @COMPOUND$ release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
1127	Although incubation with prolactin (@PROTEIN$) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of @COMPOUND$ and progesterone release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
1128	Although incubation with prolactin (@PROTEIN$) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of corticosterone and @COMPOUND$ release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
1129	Although incubation with @PROTEIN$ (PRL) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of corticosterone and @COMPOUND$ release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
1130	@COMPOUND$, a SSRI, is mainly metabolized by cytochrome P450 (@PROTEIN$) 2D6 and 1A2.	1
1131	@COMPOUND$, a SSRI, is mainly metabolized by @PROTEIN$ (CYP) 2D6 and 1A2.	1
1132	@PROTEIN$ is expressed in the rat DVC, where mRNA is localized to neurons that exhibit electrophysiological sensitivity to @COMPOUND$ imbalance.	0
1133	Indoleamine 2,3-dioxygenase (@PROTEIN$) catalyzes the first and rate-limiting step of @COMPOUND$ pathway along the major route of Tryptophan catabolism.	1
1134	@PROTEIN$ (IDO) catalyzes the first and rate-limiting step of @COMPOUND$ pathway along the major route of Tryptophan catabolism.	1
1135	Type I @PROTEIN$ (TG1), an enzyme that catalyzes the formation of epsilon-(gamma-glutamyl) @COMPOUND$ bonds, is the key protein responsible for generation of the crosslinks.	1
1136	@PROTEIN$-oncogene inactivating effect by @COMPOUND$ rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.	1
1137	Like PSC, DSL6A cells secrete less @PROTEIN$ when cultured with @COMPOUND$.	1
1138	Caspase inhibition with z-@COMPOUND$ was unable to prevent @PROTEIN$ localization to the nucleus and subsequently unable to prevent cell death.	0
1139	Purinergic receptor agonists @COMPOUND$ and UTP selectively activate certain @PROTEIN$ family tyrosine kinases and stimulate Na,K-ATPase activity.	1
1140	Purinergic receptor agonists ATP and @COMPOUND$ selectively activate certain @PROTEIN$ family tyrosine kinases and stimulate Na,K-ATPase activity.	1
1141	@PROTEIN$ blockade resulted in significant increases in mean (+/-SD) ((11)C) @COMPOUND$-binding potential (BP(ND)) over baseline in brain regions representing the major functional domains of the cerebral cortex: association cortex+15.2+/-20.2% (p=0.05), sensory cortex+13.5+/-15.5% (p=0.03) and limbic (medial temporal lobe, MTL)+16.4+/-20.2% (p=0.03).	1
1142	@PROTEIN$ inhibitory activity of @COMPOUND$ and synergistic effect with acarbose.	1
1143	@PROTEIN$ inhibitory activity of cyanidin-3-galactoside and synergistic effect with @COMPOUND$.	1
1144	Cyanidin-3-galactoside, a natural @COMPOUND$, was investigated for its @PROTEIN$ inhibitory activity.	0
1145	@COMPOUND$, a natural anthocyanin, was investigated for its @PROTEIN$ inhibitory activity.	0
1146	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1147	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1148	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1149	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1150	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1151	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1152	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1153	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1154	The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1155	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1156	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1157	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1158	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1159	The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1160	The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1161	The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1162	The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1163	The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1164	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1165	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1166	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1167	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1168	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1169	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1170	The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1171	The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1172	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1173	The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1174	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1175	The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1176	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1177	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1178	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1179	The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1180	The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1181	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
1182	@PROTEIN$ act as crucial bacteriolytic enzymes in insect immune system by hydrolyzing the beta (1--&gt;4) bonds between @COMPOUND$ and N-acetylmuramic acid in the peptidoglycan of prokaryotic cell walls.	1
1183	@PROTEIN$ act as crucial bacteriolytic enzymes in insect immune system by hydrolyzing the beta (1--&gt;4) bonds between N-acetylglucosamine and @COMPOUND$ in the peptidoglycan of prokaryotic cell walls.	1
1184	@PROTEIN$ act as crucial bacteriolytic enzymes in insect immune system by hydrolyzing the beta (1--&gt;4) bonds between N-acetylglucosamine and N-acetylmuramic acid in the @COMPOUND$ of prokaryotic cell walls.	1
1185	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds @COMPOUND$ (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
1186	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a @COMPOUND$ with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
1187	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/@COMPOUND$), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
1188	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than @COMPOUND$ (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
1189	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than @COMPOUND$ (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
1190	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/@COMPOUND$) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
1191	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/@COMPOUND$), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
1192	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/@COMPOUND$) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
1193	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/@COMPOUND$) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
1194	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds @COMPOUND$ (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
1195	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a @COMPOUND$ with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
1196	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/@COMPOUND$), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
1197	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds @COMPOUND$ (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
1198	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a @COMPOUND$ with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
1199	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than @COMPOUND$ (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
1200	We investigated whether several different inflammatory markers including C-reactive protein (@PROTEIN$) and fibrinogen and white blood cells (WBCs) count, are associated with maximal @COMPOUND$ consumption (VO(2 max)) in women with polycystic ovary syndrome (PCOS).	0
1201	We investigated whether several different inflammatory markers including C-reactive protein (CRP) and @PROTEIN$ and white blood cells (WBCs) count, are associated with maximal @COMPOUND$ consumption (VO(2 max)) in women with polycystic ovary syndrome (PCOS).	0
1202	Cotransfection, @COMPOUND$, and electrophoretic mobility shift assay studies identified activating and repressive roles for @PROTEIN$ and PEA3 transcription factors, respectively.	0
1203	We have previously demonstrated that @COMPOUND$, a stable prostacyclin (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	1
1204	We have previously demonstrated that iloprost, a stable @COMPOUND$ (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	0
1205	In contrast, @COMPOUND$ induces a robust angiogenic response in wild-type mice, along with local upregulation of @PROTEIN$.	1
1206	The proportion of @PROTEIN$ molecules that are directed to the novel cleavage pathway is regulated by the ratio of free @COMPOUND$ and cholesteryl esters in cells.	1
1207	In the hormone receptor-positive breast cancer cell line T47-D expression of @PROTEIN$ and its soluble isoforms was increased by treatment with estradiol and @COMPOUND$.	1
1208	In the hormone receptor-positive breast cancer cell line T47-D expression of @PROTEIN$ and its soluble isoforms was increased by treatment with @COMPOUND$ and tamoxifen.	1
1209	In contrast to the behavior in aqueous solution, lactose binding in @COMPOUND$ resulted in an increase of the @PROTEIN$'s radius of gyration from 49+/-1 to 55.5+/-1 A.	1
1210	@PROTEIN$-alpha (TNF-alpha) levels were also investigated in rat serum, but there was no statistically significant difference between the TNF-alpha levels of the @COMPOUND$-treated rats groups and the control rats.	0
1211	Tumor necrosis factor-alpha (@PROTEIN$) levels were also investigated in rat serum, but there was no statistically significant difference between the TNF-alpha levels of the @COMPOUND$-treated rats groups and the control rats.	0
1212	Our study indicates that brain @PROTEIN$ activity decreases after @COMPOUND$ administration at doses of 30 mg/kg and 100 mg/kg.	1
1213	Chicken @PROTEIN$ does not share any phosphorylated sites with dogfish MBP ; However, it does contain phosphorylated serine and @COMPOUND$ residues in common with mammalian MBP.	1
1214	Chicken @PROTEIN$ does not share any phosphorylated sites with dogfish MBP ; However, it does contain phosphorylated @COMPOUND$ and threonine residues in common with mammalian MBP.	1
1215	@COMPOUND$/NaPB administration increased acetylation at H4 and increased NF-kappaB @PROTEIN$ translocation to the nucleus in G93A mice, consistent with a therapeutic effect.	1
1216	Riluzole/@COMPOUND$ administration increased acetylation at H4 and increased NF-kappaB @PROTEIN$ translocation to the nucleus in G93A mice, consistent with a therapeutic effect.	1
1217	Due to the absence of hydrophobic solute-material interactions, which limit the scope of microstructures fabricated from poly(dimethylsiloxane) for biocatalytic applications, the new microreactor was fully compatible with the alternate enzyme substrate 2-nitro-phenyl-beta-D-galactoside and the @COMPOUND$ product resulting from its hydrolysis catalyzed by @PROTEIN$.	1
1218	These findings suggest that multiple variations in the @PROTEIN$ gene are associated with remission in white non-Hispanic depressed adults treated with @COMPOUND$.	1
1219	The planar angle between the carbamoyl phosphate and @COMPOUND$ domains of the catalytic chain is more open at pH 8.5 than in @PROTEIN$ structures determined at lower pH values.	1
1220	The planar angle between the @COMPOUND$ and aspartate domains of the catalytic chain is more open at pH 8.5 than in @PROTEIN$ structures determined at lower pH values.	1
1221	At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to @PROTEIN$ with decreased affinity and binding enthalpy compared with RyR1.	0
1222	At 0.15 microM @COMPOUND$+), ((35)S) @PROTEIN$ bound to RyR2 with decreased affinity and binding enthalpy compared with RyR1.	0
1223	At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to RyR2 with decreased affinity and binding enthalpy compared with @PROTEIN$.	0
1224	The rates of ((35)S) CaM dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from @PROTEIN$ was little affected.	0
1225	The rates of ((35)S) CaM dissociation from @PROTEIN$ increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0
1226	The rates of ((35)S) @PROTEIN$ dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0
1227	In rats, infusion of angiotensin II increases @PROTEIN$ levels and arterial thickness which are reversed by treatment with the iron chelator @COMPOUND$.	1
1228	Furthermore, @COMPOUND$ regulated endogenous survival signaling by up-regulating phosphorylated @PROTEIN$ that returned to its basal level later.	1
1229	Furthermore, @COMPOUND$ induced nucleus translocalization of p53 and @PROTEIN$ and recruitment of autophagosomes.	1
1230	Furthermore, @COMPOUND$ induced nucleus translocalization of @PROTEIN$ and Akt and recruitment of autophagosomes.	1
1231	The ubiquitous enzyme dUTP nucleotidohydrolase (@PROTEIN$) catalyses the hydrolysis of dUTP to dUMP and can be considered as the first line of defence against incorporation of @COMPOUND$ into DNA.	0
1232	Recent findings indicate that the polypyrimidine tract-binding protein (@PROTEIN$), also named hnRNP I, by binding to the 3'-UTR (untranslated region) of the preproinsulin mRNA molecule, stabilizes the messenger, thereby participating in the @COMPOUND$-induced increase in preproinsulin mRNA.	1
1233	Recent findings indicate that the polypyrimidine tract-binding protein (PTB), also named @PROTEIN$, by binding to the 3'-UTR (untranslated region) of the preproinsulin mRNA molecule, stabilizes the messenger, thereby participating in the @COMPOUND$-induced increase in preproinsulin mRNA.	1
1234	In the central nervous system, @PROTEIN$ is involved in induction of a fever response and triggers the release of other cytokines, and may also influence transport of compounds into the brain, leading to cerebrospinal fluid leukocytosis, increased protein influx, and @COMPOUND$ accumulation.	1
1235	Both cell types expressed estrogen and @PROTEIN$, although only the epithelial LM05-E cells were stimulated by @COMPOUND$ and inhibited by tamoxifen.	0
1236	Both cell types expressed estrogen and @PROTEIN$, although only the epithelial LM05-E cells were stimulated by estradiol and inhibited by @COMPOUND$.	0
1237	This study was performed to investigate the effect of combined treatment with @COMPOUND$ and chromium on vascular endothelial dysfunction, with the aim of gaining insight to the mechanisms by detecting the expression levels of ox-LDL and @PROTEIN$.	0
1238	This study was performed to investigate the effect of combined treatment with niacin and @COMPOUND$ on vascular endothelial dysfunction, with the aim of gaining insight to the mechanisms by detecting the expression levels of ox-LDL and @PROTEIN$.	0
1239	In HF group, the serum levels of total @COMPOUND$ (TC), low-density lipoprotein (LDL), oxidized low-density lipoprotein (ox-LDL) and endothelin (ET) were higher, whereas the levels of @PROTEIN$ (HDL), serum NO were lower than those in CG group.	0
1240	These findings indicated that combined treatment with niacin and @COMPOUND$ has potential therapeutic protection of endothelial function by down-regulating ox-LDL/@PROTEIN$ signaling pathway.	1
1241	These findings indicated that combined treatment with @COMPOUND$ and chromium has potential therapeutic protection of endothelial function by down-regulating ox-LDL/@PROTEIN$ signaling pathway.	1
1242	The deduced amino acid sequence of Ai Lec was highly similar to those of the C-type @PROTEIN$ from other animals and contained a typical carbohydrate-recognition domain (CRD) of 131 residues, which has four conserved disulfide-bonded @COMPOUND$ residues that define the CRD and two additional cysteine residues at the amino terminus.	1
1243	@PROTEIN$ kinases can be activated by trans-phosphorylation of a @COMPOUND$ located in the central activation loop of the catalytic domain.	1
1244	However, because the required exposure of this @COMPOUND$ is not observed in the down-regulated X-ray structures of @PROTEIN$ kinases, transient partial opening of the activation loop appears to be necessary for such processes.	0
1245	The growth of L. minor (as fresh weight) and @COMPOUND$ content were significantly reduced and @PROTEIN$ (SOD) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	0
1246	The growth of L. minor (as fresh weight) and @COMPOUND$ content were significantly reduced and superoxide dismutase (@PROTEIN$) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	0
1247	The experiment also indicated that catalase (@PROTEIN$) activity was not significantly influenced by @COMPOUND$ for both the two tested aquatic plants.	0
1248	The experiment also indicated that @PROTEIN$ (CAT) activity was not significantly influenced by @COMPOUND$ for both the two tested aquatic plants.	0
1249	The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of @COMPOUND$ on @PROTEIN$ secretion are mediated via TLR-4.	1
1250	The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of @COMPOUND$ on MCP-1 secretion are mediated via @PROTEIN$-4.	1
1251	Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0
1252	Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0
1253	Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0
1254	Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0
1255	Whereas both peptides @COMPOUND$ (17-30) and lactoferrampin (265-284) did not have bactericidal activity, 40 microM of @PROTEIN$ chimera (a fusion of the two peptides) inhibited the growth of all Vibrio tested to the same extent as the antibiotic gentamicin.	0
1256	Whereas both peptides lactoferricin (17-30) and lactoferrampin (265-284) did not have bactericidal activity, 40 microM of @PROTEIN$ chimera (a fusion of the two peptides) inhibited the growth of all Vibrio tested to the same extent as the antibiotic @COMPOUND$.	0
1257	We have recently shown that the antidepressant @COMPOUND$ enhances T cell proliferation and T(H)1 cytokine production in vivo, without changes on @PROTEIN$/CD8 subsets.	0
1258	We found that @COMPOUND$ restored T cell proliferation and interleukin-2, @PROTEIN$ and tumor necrosis factor-alpha production by compensatory mechanisms.	1
1259	We found that @COMPOUND$ restored T cell proliferation and interleukin-2, interferon-gamma and @PROTEIN$-alpha production by compensatory mechanisms.	1
1260	Here we report a case of intragenic @PROTEIN$ microdeletion in renal cell carcinoma (RCC) associated with the effect of treatment by @COMPOUND$.	1
1261	Taking advantage of this prostate cancer-specific property of PSMA (E/P), we successfully introduced bacterial @PROTEIN$ into LNCaP cells where the tumoricidal effect of 5-fluorouracil (@COMPOUND$) was significantly increased when compared with the cells without the exogenous UPRT.	1
1262	Taking advantage of this prostate cancer-specific property of PSMA (E/P), we successfully introduced bacterial @PROTEIN$ into LNCaP cells where the tumoricidal effect of @COMPOUND$ (5-FU) was significantly increased when compared with the cells without the exogenous UPRT.	1
1263	@PROTEIN$ is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate @COMPOUND$-induced changes in ATP/ADP ratio and insulin secretion.	1
1264	UCP2 is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate @COMPOUND$-induced changes in ATP/ADP ratio and @PROTEIN$ secretion.	1
1265	@PROTEIN$ is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate glucose-induced changes in @COMPOUND$/ADP ratio and insulin secretion.	1
1266	UCP2 is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate glucose-induced changes in @COMPOUND$/ADP ratio and @PROTEIN$ secretion.	0
1267	Neither @PROTEIN$ expression nor UCP2 overexpression modified basal or @COMPOUND$-stimulated metabolic changes.	0
1268	Neither UCP1 expression nor @PROTEIN$ overexpression modified basal or @COMPOUND$-stimulated metabolic changes.	0
1269	The @PROTEIN$ activity was increased by Mn(2+), @COMPOUND$+), and Mg(2+), while strongly inhibited by Fe(2+) and Ba(2+).	1
1270	The @PROTEIN$ activity was increased by @COMPOUND$+), Cu(2+), and Mg(2+), while strongly inhibited by Fe(2+) and Ba(2+).	1
1271	The @PROTEIN$ activity was increased by Mn(2+), Cu(2+), and Mg(2+), while strongly inhibited by Fe(2+) and @COMPOUND$+).	1
1272	The @PROTEIN$ activity was increased by Mn(2+), Cu(2+), and Mg(2+), while strongly inhibited by @COMPOUND$+) and Ba(2+).	1
1273	Meanwhile, SDS, ethyleneglycoltetraacetic acid, urea, and @COMPOUND$ were found to have significantly inhibitory effect on @PROTEIN$ activity.	1
1274	Meanwhile, SDS, ethyleneglycoltetraacetic acid, @COMPOUND$, and ethylenediaminetetraacetic acid were found to have significantly inhibitory effect on @PROTEIN$ activity.	1
1275	In the present study, we screened the inhibitory effect of the extract from 50 Thai medicinal plants on an inducible-nitric oxide synthase (@PROTEIN$) expression induced by @COMPOUND$ (LPS) in mouse macrophages RAW 264.7.	1
1276	In the present study, we screened the inhibitory effect of the extract from 50 Thai medicinal plants on an inducible-@PROTEIN$ (iNOS) expression induced by @COMPOUND$ (LPS) in mouse macrophages RAW 264.7.	1
1277	Following thermal denaturation, rabbit reticulocyte lysate and @COMPOUND$ were added and @PROTEIN$ activity measured.	0
1278	We found that the acetylated @PROTEIN$ at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
1279	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (@PROTEIN$) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
1280	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and @PROTEIN$ (HDAC) 11 expression.	0
1281	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the @PROTEIN$ (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
1282	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (@PROTEIN$) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
1283	Although the current studies associating particular genes and their variants with seizure control or adverse events have inherent weaknesses and have not provided unifying conclusions, several results, for example that Asian patients with a particular HLA allele, @PROTEIN$ *1502, are at a higher risk for Stevens-Johnson syndrome when using @COMPOUND$, are helpful to increase our knowledge how genetic variation affects the treatment of epilepsy.	1
1284	However, OPN-(/-) mice showed increased serum levels of tumour necrosis factor (@PROTEIN$)-alpha, which could be due to systemically present @COMPOUND$ translocated to the gut.	1
1285	However, @PROTEIN$-(/-) mice showed increased serum levels of tumour necrosis factor (TNF)-alpha, which could be due to systemically present @COMPOUND$ translocated to the gut.	1
1286	The expression of the ERG1, ERG3, ERG7, @PROTEIN$, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
1287	The expression of the ERG1, ERG3, ERG7, ERG9, @PROTEIN$ and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
1288	The expression of the ERG1, ERG3, ERG7, ERG9, ERG11 and @PROTEIN$ genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
1289	The expression of the ERG1, @PROTEIN$, ERG7, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
1290	The expression of the @PROTEIN$, ERG3, ERG7, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
1291	The expression of the ERG1, ERG3, @PROTEIN$, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
1292	Expression of the @PROTEIN$ gene was found to be low or moderate and it was regulated by @COMPOUND$ addition more so than by biofilm formation.	1
1293	The expression of the @PROTEIN$ increased in the presence of @COMPOUND$ in some isolates.	1
1294	Concentrations of @COMPOUND$ 1000 and Na2SO4 were selected as independent variables to evaluate their impact on parameters of partitioning in aqueous two-phase system--the partition coefficient of @PROTEIN$, purification factor and pectinase yield.	0
1295	Concentrations of polyethylene glycol 1000 and @COMPOUND$ were selected as independent variables to evaluate their impact on parameters of partitioning in aqueous two-phase system--the partition coefficient of @PROTEIN$, purification factor and pectinase yield.	0
1296	In our microarray analysis we observed that Seven-in-Absentia Homolog 2 (SIAH2) levels were low in @PROTEIN$ (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
1297	In our microarray analysis we observed that @PROTEIN$ (SIAH2) levels were low in estrogen receptor (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
1298	In our microarray analysis we observed that Seven-in-Absentia Homolog 2 (@PROTEIN$) levels were low in estrogen receptor (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
1299	@COMPOUND$, an inhibitor of glial metabolism, inhibits the up-regulation of @PROTEIN$ expression, activity and NO production in the spinal cord induced by formalin test in rats.	1
1300	In order to explore the involvement of glia in the NO-mediated nociceptive transmission, the present study was undertaken to investigate the effect of @COMPOUND$ (FC), an inhibitor of glial metabolism, on @PROTEIN$ expression and activity and NO production in the spinal cord during the process of peripheral inflammatory pain and hyperalgesia induced by formalin test in rats.	0
1301	Oral administration of @COMPOUND$ remarkably prevented weight loss in the body and liver from DMN and inhibited the elevation of serum alanine transaminase (ALT), aspartate transaminase (@PROTEIN$), and total bilirubin levels.	1
1302	Oral administration of morin remarkably prevented weight loss in the body and liver from DMN and inhibited the elevation of serum alanine transaminase (ALT), aspartate transaminase (@PROTEIN$), and total @COMPOUND$ levels.	0
1303	We found that while OM24 treatment did not significantly affect UV-induced erythema and @COMPOUND$ dimer formation, OM24 treatment significantly reduced UV-induced @PROTEIN$ expression in keratinocytes.	0
1304	Here we show that @PROTEIN$ selectively increases the power of @COMPOUND$-induced, but not carbachol-induced, gamma oscillations in acute hippocampal slices.	1
1305	Here we show that @PROTEIN$ selectively increases the power of kainate-induced, but not @COMPOUND$-induced, gamma oscillations in acute hippocampal slices.	0
1306	These effects of @PROTEIN$beta are blocked by @COMPOUND$, a pan-specific antagonist of ErbB receptors, and are mediated specifically via ErbB4 receptors, because mice harboring a targeted mutation of ErbB4 do not respond to NRG-1.	1
1307	Of various agents tested in HaCaT cell cultures, only @COMPOUND$ (10(-6) M) and staurosporine (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or dexamethasone were without effect.	1
1308	Of various agents tested in HaCaT cell cultures, only retinoic acid (10(-6) M) and @COMPOUND$ (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or dexamethasone were without effect.	1
1309	Of various agents tested in HaCaT cell cultures, only retinoic acid (10(-6) M) and staurosporine (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or @COMPOUND$ were without effect.	0
1310	We have generated two novel chimeric @PROTEIN$-binding molecules, sFLT01 and sFLT02, which consist of the second immunoglobulin (IgG)-like domain of Flt-1 fused either to a human IgG1 Fc or solely to the CH3 domain of IgG1 Fc through a @COMPOUND$ linker 9Gly.	0
1311	We have generated two novel chimeric VEGF-binding molecules, sFLT01 and sFLT02, which consist of the second immunoglobulin (IgG)-like domain of @PROTEIN$ fused either to a human IgG1 Fc or solely to the CH3 domain of IgG1 Fc through a @COMPOUND$ linker 9Gly.	1
1312	By contrast, treatment of N2a cells with 1-10 microM @COMPOUND$ resulted in marked reductions in the expression of the axon growth-associated protein @PROTEIN$-43.	1
1313	@COMPOUND$-treated cells also showed an increased expression of the heat shock protein @PROTEIN$ compared to controls.	1
1314	We showed that in comparison to stage VI, stages I-V oocytes expressed higher levels of O-GlcNAc correlating changes in @PROTEIN$ expression, but not in @COMPOUND$ pools.	0
1315	We showed that in comparison to stage VI, stages I-V oocytes expressed higher levels of @PROTEIN$ correlating changes in OGT expression, but not in @COMPOUND$ pools.	0
1316	Chondrocytes grown in monolayer were treated with interleukin-1alpha (@PROTEIN$), insulin-like growth factor-I (IGF-I), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
1317	Chondrocytes grown in monolayer were treated with interleukin-1alpha (IL-1alpha), @PROTEIN$-like growth factor-I (IGF-I), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
1318	Chondrocytes grown in monolayer were treated with interleukin-1alpha (IL-1alpha), insulin-like growth factor-I (@PROTEIN$), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
1319	IL-1alpha and RhoG14V increased cytoplasmic @PROTEIN$ stress fiber formation, which was blocked by C3 Transferase, and @COMPOUND$.	1
1320	@PROTEIN$ and RhoG14V increased cytoplasmic actin stress fiber formation, which was blocked by C3 Transferase, and @COMPOUND$.	1
1321	Expression of RhoQ63L or RhoG14V resulted in increased MMP-13 expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit @PROTEIN$-induced MMP-13 expression.	0
1322	Expression of @PROTEIN$Q63L or RhoG14V resulted in increased MMP-13 expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit IL-1alpha-induced MMP-13 expression.	1
1323	Expression of RhoQ63L or RhoG14V resulted in increased @PROTEIN$ expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit IL-1alpha-induced MMP-13 expression.	0
1324	Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1325	Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1326	Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1327	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1328	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1329	Plasma total @COMPOUND$, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1330	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1331	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1332	Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1333	In absence of stretch, we could activate @PROTEIN$ and deactivate GK1 by 1-oleoyl-2-acetyl-sn-glycerol (@COMPOUND$) and other amphipaths.	1
1334	In absence of stretch, we could activate @PROTEIN$ and deactivate GK1 by @COMPOUND$ (OAG) and other amphipaths.	1
1335	In absence of stretch, we could activate Gns and deactivate @PROTEIN$ by @COMPOUND$ (OAG) and other amphipaths.	1
1336	In absence of stretch, we could activate Gns and deactivate @PROTEIN$ by 1-oleoyl-2-acetyl-sn-glycerol (@COMPOUND$) and other amphipaths.	1
1337	The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of @PROTEIN$ and PARP, and inhibition of bcl-2.	0
1338	The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of bax and PARP, and inhibition of @PROTEIN$.	0
1339	The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of bax and @PROTEIN$, and inhibition of bcl-2.	0
1340	Our findings suggest that @COMPOUND$ differentially affects higher cognitive functions, but does not support the hypothesis from animal studies, that some of the MDMA effects are causally mediated through action at the @PROTEIN$ receptor system.	0
1341	These results suggest that @PROTEIN$ does not play a significant role in clinical and functional manifestations in patients with schizophrenia who receive @COMPOUND$ treatment.	0
1342	@COMPOUND$ (H2S) is a novel gaseous mediator produced by @PROTEIN$ and cystathionine-gamma-lyase in the cardiovascular system, including the heart.	1
1343	Hydrogen sulfide (@COMPOUND$) is a novel gaseous mediator produced by @PROTEIN$ and cystathionine-gamma-lyase in the cardiovascular system, including the heart.	1
1344	@COMPOUND$ (H2S) is a novel gaseous mediator produced by cystathionine-beta-synthase and @PROTEIN$ in the cardiovascular system, including the heart.	1
1345	Hydrogen sulfide (@COMPOUND$) is a novel gaseous mediator produced by cystathionine-beta-synthase and @PROTEIN$ in the cardiovascular system, including the heart.	1
1346	Removal of extracellular Ca2+ or inhibition of the Ca2+-permeable cation channels with @COMPOUND$ blunted the effects of arsenic on @PROTEIN$-binding and cell shrinkage.	1
1347	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), @COMPOUND$ (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1348	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and @COMPOUND$ (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1349	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles @COMPOUND$ (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1350	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), @COMPOUND$ (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1351	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by @COMPOUND$ (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1352	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by @COMPOUND$ (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1353	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles @COMPOUND$ (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1354	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and @COMPOUND$ (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1355	Cell viability and reactive oxygen species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of @COMPOUND$.	0
1356	Cell viability and reactive @COMPOUND$ species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of reduced glutathione.	0
1357	Fibril growth was a second-order process with an enthalpy of activation (27+/-5 kcal mol(-1)), which is indistinguishable from that of tetramer formation by @PROTEIN$, which involves limited conformational changes including @COMPOUND$ trans to cis isomerization.	1
1358	Results showed that MENT treatments increased @PROTEIN$ secretion and proliferation rate with a potency ranged between T and @COMPOUND$.	1
1359	Results showed that @COMPOUND$ treatments increased @PROTEIN$ secretion and proliferation rate with a potency ranged between T and DHT.	1
1360	The studies with @COMPOUND$ showed that in BPH and CaP cells, the conversion of T into DHT significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of MENT to the 5-AR.	0
1361	The studies with finasteride showed that in BPH and CaP cells, the conversion of T into DHT significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of @COMPOUND$ to the 5-AR.	0
1362	The studies with finasteride showed that in BPH and CaP cells, the conversion of T into @COMPOUND$ significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of MENT to the 5-AR.	1
1363	mRNA expression of developmental regulatory factors was not influenced by foetal @COMPOUND$ exposure, except for significantly reduced adrenal @PROTEIN$.	1
1364	@COMPOUND$-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the cholesterol biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	0
1365	Nitrogen-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the @COMPOUND$ biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	1
1366	This is supported by the findings that intracellular Ca(2+) chelator @COMPOUND$ attenuated phosphorylated @PROTEIN$/2 expression and cell proliferation in hsBAFF-stimulated B cells.	1
1367	Taken together, the main finding of this study is that hsBAFF elicits higher but homeostatic (@COMPOUND$+))(i) levels, which regulates @PROTEIN$/2 activity and cell proliferation in in vitro B cells.	1
1368	Surgical removal of pheochromocytoma significantly increased body weight, decreased both systolic and diastolic blood pressure, fasting blood @COMPOUND$ and glycated @PROTEIN$ levels.	0
1369	In this study we have investigated a long-term pattern of expression and production of spinal COX-1 and @PROTEIN$ in the model of osteoarthritis induced in rats by injection of @COMPOUND$ (MIA) into the knee joint.	0
1370	In this study we have investigated a long-term pattern of expression and production of spinal @PROTEIN$ and COX-2 in the model of osteoarthritis induced in rats by injection of @COMPOUND$ (MIA) into the knee joint.	0
1371	The enzyme @PROTEIN$ (IDO) converts @COMPOUND$ to kynurenine, blocking T-cell activation and inducing immunosuppression.	1
1372	The enzyme indoleamine 2,3-dioxygenase (@PROTEIN$) converts tryptophan to @COMPOUND$, blocking T-cell activation and inducing immunosuppression.	1
1373	The enzyme indoleamine 2,3-dioxygenase (@PROTEIN$) converts @COMPOUND$ to kynurenine, blocking T-cell activation and inducing immunosuppression.	1
1374	The enzyme @PROTEIN$ (IDO) converts tryptophan to @COMPOUND$, blocking T-cell activation and inducing immunosuppression.	1
1375	Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of TNF by @COMPOUND$, indicating that suppressing @PROTEIN$ activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	1
1376	Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of @PROTEIN$ by @COMPOUND$, indicating that suppressing acetylcholinesterase activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	1
1377	Administration of @COMPOUND$ to alpha7nAChR knockout mice failed to suppress @PROTEIN$ levels, indicating that the alpha7nAChR-mediated cholinergic anti-inflammatory pathway is required for the anti-inflammatory effect of galantamine.	0
1378	The involvement of @COMPOUND$ and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
1379	The involvement of superoxide and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (@COMPOUND$ and PTIO, respectively).	1
1380	The involvement of superoxide and @COMPOUND$ was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
1381	Accordingly, @PROTEIN$ were blocked by the peroxynitrite scavenger @COMPOUND$ and could be mimicked by application of exogenous peroxynitrite.	1
1382	This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (oleic acid, @COMPOUND$).	1
1383	This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (@COMPOUND$, Triton X-100).	1
1384	In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by @COMPOUND$ (MTT), @PROTEIN$-FITC/propidium iodide (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0
1385	In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), @PROTEIN$-FITC/@COMPOUND$ (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0
1386	In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), @PROTEIN$-@COMPOUND$/propidium iodide (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0
1387	To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (@PROTEIN$ (2)) release and cyclooxygenase-2 (COX-2) expression in bovine synovial fibroblasts (SFs).	0
1388	To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (PGE (2)) release and cyclooxygenase-2 (@PROTEIN$) expression in bovine synovial fibroblasts (SFs).	0
1389	To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (PGE (2)) release and @PROTEIN$ (COX-2) expression in bovine synovial fibroblasts (SFs).	0
1390	In this study, we compared the effects of @PROTEIN$-like growth factor-I (IGF-I), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
1391	In this study, we compared the effects of insulin-like growth factor-I (IGF-I), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (@PROTEIN$), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
1392	In this study, we compared the effects of insulin-like growth factor-I (@PROTEIN$), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
1393	In this study, we compared the effects of insulin-like growth factor-I (IGF-I), @PROTEIN$ (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
1394	Meanwhile, both the enhanced expression of @PROTEIN$ and increased activation of NF-kappaB induced by CRH in aortas of LDLr-/-mice were also largely suppressed by @COMPOUND$, whereas these inhibitory effects were not observed in anti-Svg-30 group.	1
1395	Meanwhile, both the enhanced expression of VCAM-1 and increased activation of NF-kappaB induced by @PROTEIN$ in aortas of LDLr-/-mice were also largely suppressed by @COMPOUND$, whereas these inhibitory effects were not observed in anti-Svg-30 group.	0
1396	@PROTEIN$/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with @COMPOUND$ or LY294002 improved apoptosis in the resistant cell lines.	1
1397	@PROTEIN$/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or @COMPOUND$ improved apoptosis in the resistant cell lines.	1
1398	@PROTEIN$/Akt activity, analyzed by @COMPOUND$ trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or LY294002 improved apoptosis in the resistant cell lines.	1
1399	Vincristine but not @COMPOUND$ increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.	0
1400	@COMPOUND$ but not doxorubicin increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.	1
1401	Vincristine but not doxorubicin increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and @COMPOUND$ increased apoptosis in the three cell lines.	0
1402	Wortmannin and @COMPOUND$ inhibited P-@PROTEIN$ (Pgp) function and also increased NF-kappaB activity.	1
1403	@COMPOUND$ and LY294002 inhibited P-@PROTEIN$ (Pgp) function and also increased NF-kappaB activity.	1
1404	Namely, the results obtained for the most active compounds, 5-(chloroacetylamino) uracil (2) and its acyclic sugar analogue 18, suggest that formation of a covalent bond between reactive substituent and several possible targets within the @PROTEIN$ mechanism (sulphur of the @COMPOUND$ residue, basic part of the enzyme, N,N-methylene tetrahydrofolate or its reactive iminium forms) is the most probable mode of action.	1
1405	@COMPOUND$, a potent orally active angiogenesis inhibitor capable of inhibiting all known isoforms of Vascular Endothelial Growth Factor (@PROTEIN$) receptor, belongs to the class of aminophthalazines.	1
1406	Recent evidence for toxic @COMPOUND$ (O(2)(-)) production by marine microalgae is afforded particular attention given that release of O(2)(-) anions can be exacerbated by the binding of @PROTEIN$ to the microalgal cell wall ; a novel model for grazing-activated chemical defence is proposed.	1
1407	The @COMPOUND$ induced chemotaxis was accompanied by polarization of the @PROTEIN$ cytoskeleton, and by polymerization of F-actin.	1
1408	@COMPOUND$ in anionic DSPG liposomes stimulated murine @PROTEIN$ production in RAW 264 cells at concentrations 25-to 30-fold lower than free drug.	1
1409	To elucidate the mechanism by which @COMPOUND$ regulates adipose triglyceride @PROTEIN$ (ATGL).	1
1410	@PROTEIN$ is one of the members of the G protein-coupled receptor family that can catalyze a GDP-@COMPOUND$ exchange reaction on the retinal G protein transducin (Gt) upon photon absorption.	1
1411	Rhodopsin is one of the members of the G protein-coupled receptor family that can catalyze a @COMPOUND$-GTP exchange reaction on the retinal G protein @PROTEIN$ (Gt) upon photon absorption.	1
1412	Rhodopsin is one of the members of the G protein-coupled receptor family that can catalyze a GDP-@COMPOUND$ exchange reaction on the retinal G protein @PROTEIN$ (Gt) upon photon absorption.	1
1413	@PROTEIN$ is one of the members of the G protein-coupled receptor family that can catalyze a @COMPOUND$-GTP exchange reaction on the retinal G protein transducin (Gt) upon photon absorption.	1
1414	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, GST, GPx, @PROTEIN$, and CAT activities.	1
1415	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, @PROTEIN$, GPx, SOD, and CAT activities.	1
1416	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, GST, GPx, SOD, and @PROTEIN$ activities.	1
1417	The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of allantoin to creatinine (CR), PD to CR, the plasma @COMPOUND$-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0
1418	The results showed that the intakes of dry matter (DM), organic matter (OM), @COMPOUND$ (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of allantoin to creatinine (CR), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0
1419	The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary @COMPOUND$ derivatives (PD) excretion, the ratios of allantoin to creatinine (CR), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0
1420	The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of allantoin to creatinine (@COMPOUND$), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0
1421	The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of allantoin to @COMPOUND$ (CR), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0
1422	The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of @COMPOUND$ to creatinine (CR), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0
1423	Activation of interleukin-6/@PROTEIN$ in rat cholangiocyte proliferation induced by @COMPOUND$.	1
1424	Activation of @PROTEIN$/STAT3 in rat cholangiocyte proliferation induced by @COMPOUND$.	1
1425	Human bone marrow-derived mesenchymal stem cells and osteoblast differentiation on @COMPOUND$ with surface-grafted chitosan and immobilized bone @PROTEIN$-2.	0
1426	None of the compounds altered @PROTEIN$ gene expression, indicating that 3-@COMPOUND$ inhibits CYP11B1 activity on the protein level.	0
1427	None of the compounds altered Cyp11b1 gene expression, indicating that 3-@COMPOUND$ inhibits @PROTEIN$ activity on the protein level.	1
1428	Functional analysis demonstrated that elkj encoded a @PROTEIN$-elongase that mediated the elongation of EPA into @COMPOUND$ (22:5n-3), confirming the two-step conversion from EPA to DHA in marine microalga.	1
1429	Overexpression of Ets-1 enhanced significantly @PROTEIN$ mRNA levels, protein expression, GC activity and ANP-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	0
1430	Overexpression of Ets-1 enhanced significantly Npr1 mRNA levels, protein expression, GC activity and @PROTEIN$-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	1
1431	Overexpression of @PROTEIN$ enhanced significantly Npr1 mRNA levels, protein expression, GC activity and ANP-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	1
1432	"In the current study, these cells were cultured with three different media: "" @PROTEIN$-plus"" medium containing @COMPOUND$ and 100 ng/mL of rhBMP-2, ""odontogenic"" medium containing dexamethasone, and ""control"" medium without supplements."	0
1433	The allatostatins (@PROTEIN$), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are neuropeptides that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	1
1434	The @PROTEIN$ (ASTs), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are neuropeptides that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	1
1435	The allatostatins (ASTs), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are @PROTEIN$ that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	0
1436	Lecithin:retinol acyltransferase (@PROTEIN$) catalyzes the esterification of retinol (@COMPOUND$).	1
1437	As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad-REIC treatment were investigated in terms of the sensitivity of multidrug-resistant MCF7/ADR cells to @COMPOUND$ and of the P-@PROTEIN$ expression.	0
1438	As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad-@PROTEIN$ treatment were investigated in terms of the sensitivity of multidrug-resistant MCF7/ADR cells to @COMPOUND$ and of the P-glycoprotein expression.	0
1439	Ad-REIC treatment in MCF7/ADR cells also downregulated P-glycoprotein expresssion through @PROTEIN$ activation, and sensitized its drug resistance against @COMPOUND$.	0
1440	Ad-REIC treatment in MCF7/ADR cells also downregulated P-@PROTEIN$ expresssion through JNK activation, and sensitized its drug resistance against @COMPOUND$.	0
1441	Ad-@PROTEIN$ treatment in MCF7/ADR cells also downregulated P-glycoprotein expresssion through JNK activation, and sensitized its drug resistance against @COMPOUND$.	1
1442	@COMPOUND$, a homocamptothecin, targets @PROTEIN$.	1
1443	Both MudPIT and cDNA microarray analyses indicate that @COMPOUND$ treatment caused elevated levels of @PROTEIN$.	1
1444	Altogether these changes offer a straightforward explanation for how following the addition of Ca(2+), the @COMPOUND$ could escape and become available for bioluminescence on Renilla @PROTEIN$.	1
1445	Altogether these changes offer a straightforward explanation for how following the addition of @COMPOUND$+), the coelenterazine could escape and become available for bioluminescence on Renilla @PROTEIN$.	1
1446	The @COMPOUND$ functionalization was then used to immobilize bone @PROTEIN$ on the bioactive glasses.	1
1447	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (@COMPOUND$), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
1448	L-Kynurenine (@COMPOUND$), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
1449	L-@COMPOUND$ (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
1450	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to @COMPOUND$ (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
1451	L-Kynurenine (KYN), a @COMPOUND$ metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	0
1452	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by @COMPOUND$ aminotransferase (@PROTEIN$) I and KAT II.	1
1453	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1454	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1455	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1456	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
1457	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1458	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1459	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1460	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1461	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1462	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1463	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
1464	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1465	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1466	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1467	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1468	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1469	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1470	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
1471	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
1472	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1473	Treatment with @COMPOUND$ alone increased the levels of MDA and decreased SOD, @PROTEIN$ 0.05).	1
1474	Treatment with @COMPOUND$ alone increased the levels of MDA and decreased @PROTEIN$, CAT 0.05).	1
1475	We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for morphine, @COMPOUND$ or food.	1
1476	We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for @COMPOUND$, cocaine or food.	1
1477	Recent studies showed that LH orexin neurons that project to ventral tegmental area (VTA) have greater @PROTEIN$ induction in association with elevated @COMPOUND$ preference during protracted withdrawal than non-VTA-projecting orexin neurons, indicating that the VTA is an important site of action for orexin's role in reward processing.	0
1478	@PROTEIN$ are metalloproteins that function in electron transfer reactions and contain a @COMPOUND$ moiety covalently attached via thioether linkages between the co-factor and a CXXCH motif in the protein.	1
1479	MPc also increased @PROTEIN$ activity in all tissues with a concurrent decrease in @COMPOUND$ levels.	0
1480	On the other hand, pretreatment with the polyphenolic @COMPOUND$ resveratrol (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	0
1481	On the other hand, pretreatment with the polyphenolic stilbene @COMPOUND$ (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	1
1482	Moreover, the RSVL-induced @PROTEIN$-inhibitory effects were significantly reversed by the kinase-G inhibitor, KT-5823 (10 microM; 69%), but not by the kinase-A inhibitor (@COMPOUND$).	0
1483	Moreover, the RSVL-induced @PROTEIN$-inhibitory effects were significantly reversed by the kinase-G inhibitor, @COMPOUND$ (10 microM; 69%), but not by the kinase-A inhibitor (KT-5720).	1
1484	Adding @COMPOUND$ to the diet of the mice during the period of irradiation suppressed the activity and expression of @PROTEIN$ as well as the wrinkling and sagging formation.	1
1485	Dietary @COMPOUND$ prevents the expression of @PROTEIN$, at least partly, by inhibiting photodynamic action involved in the formation of Chol-OOHs.	1
1486	Exposure to @COMPOUND$ for 6 h induced expression of both caveolin-1 and cyclooxygenase (@PROTEIN$)-2.	1
1487	Exposure to @COMPOUND$ for 6 h induced expression of both @PROTEIN$ and cyclooxygenase (COX)-2.	1
1488	Pretreatment with @COMPOUND$ blocked fatty-acid-induced @PROTEIN$ and COX-2 expression in a time- and concentration-dependent manner.	1
1489	Pretreatment with @COMPOUND$ blocked fatty-acid-induced caveolin-1 and @PROTEIN$ expression in a time- and concentration-dependent manner.	1
1490	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in @PROTEIN$ and cyclin E expression, with no change in CDK2 and CDK4.	1
1491	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in cyclin D and cyclin E expression, with no change in @PROTEIN$ and CDK4.	0
1492	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and @PROTEIN$.	0
1493	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in @PROTEIN$ and cyclin E expression, with no change in CDK2 and CDK4.	1
1494	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in @PROTEIN$ and CDK4.	0
1495	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and @PROTEIN$.	0
1496	In addition, the @COMPOUND$-induced accumulation of the cell population in the G(2)/M phase resulted in a decrease in CDK1 together with @PROTEIN$ and cyclin B.	1
1497	In addition, the @COMPOUND$-induced accumulation of the cell population in the G(2)/M phase resulted in a decrease in @PROTEIN$ together with cyclin A and cyclin B.	1
1498	The expression of Bax and @PROTEIN$ of p53 downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
1499	The expression of Bax and cytochrome c of @PROTEIN$ downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
1500	The expression of @PROTEIN$ and cytochrome c of p53 downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
1501	@COMPOUND$ strongly decreased the expression of @PROTEIN$ 0.01).	1
1502	In contrast, the administration of @COMPOUND$ significantly attenuated the immobilization stress-induced decrease in @PROTEIN$ 0.01).	1
1503	@COMPOUND$ exhibited differential effects on @PROTEIN$ mRNA expression in the rat hippocampus and neocortex.	1
1504	These results suggest that @COMPOUND$ might have a neuroprotective effect by recovering stress-induced decreases in @PROTEIN$ mRNA expression.	1
1505	In conclusion, @COMPOUND$ overload in rats induced hypertriglyceridemia and @PROTEIN$ resistance associated with an enhanced oxidative stress.	1
1506	Clinical and biochemical parameters including @COMPOUND$ (FAM), glycated hemoglobin (HbA1c) and serum @PROTEIN$ were investigated in children and adolescents with 1 type diabetes with (+DC) and without (-DC) complications.	0
1507	Clinical and biochemical parameters including @COMPOUND$ (FAM), glycated @PROTEIN$ (HbA1c) and serum AGEs were investigated in children and adolescents with 1 type diabetes with (+DC) and without (-DC) complications.	0
1508	Leptin and soluble @PROTEIN$ receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1
1509	@PROTEIN$ and soluble leptin receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1
1510	Androgenic action correlates inversely with a polymorphic CAG repeat region in the AR gene encoding for glutamine residues the length of which appears to influence @PROTEIN$ (HDL) @COMPOUND$ levels.	1
1511	Androgenic action correlates inversely with a polymorphic CAG repeat region in the AR gene encoding for @COMPOUND$ residues the length of which appears to influence @PROTEIN$ (HDL) cholesterol levels.	1
1512	These vessels are formed by proliferating cells that incorporate @COMPOUND$ and express the endothelial cell markers vegfr2/@PROTEIN$ and fli1.	0
1513	These vessels are formed by proliferating cells that incorporate @COMPOUND$ and express the endothelial cell markers vegfr2/kdr and @PROTEIN$.	0
1514	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/@PROTEIN$ (IKK) and mitogen-activated protein kinases (MAPKs) by reducing oxidative stress in aged rats.	1
1515	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/IkappaB kinase (IKK) and @PROTEIN$ (MAPKs) by reducing oxidative stress in aged rats.	1
1516	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/IkappaB kinase (IKK) and mitogen-activated protein kinases (@PROTEIN$) by reducing oxidative stress in aged rats.	1
1517	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (@PROTEIN$)/IkappaB kinase (IKK) and mitogen-activated protein kinases (MAPKs) by reducing oxidative stress in aged rats.	1
1518	The molecular modulation of NF-kappaB by @COMPOUND$ was further revealed in endothelial YPEN-1 cells through ferulate's ability to suppress the activation of @PROTEIN$/IKK and MAPKs.	1
1519	The molecular modulation of NF-kappaB by @COMPOUND$ was further revealed in endothelial YPEN-1 cells through ferulate's ability to suppress the activation of NIK/IKK and @PROTEIN$.	1
1520	Based on these results, we conclude that @COMPOUND$'s antioxidative capacity suppressed the age-related increase in NF-kappaB activity through inhibition of @PROTEIN$/IKK and MAPKs in vivo.	1
1521	Based on these results, we conclude that @COMPOUND$'s antioxidative capacity suppressed the age-related increase in NF-kappaB activity through inhibition of NIK/IKK and @PROTEIN$ in vivo.	1
1522	@COMPOUND$ is a free radical molecule synthesized from L-arginine by @PROTEIN$ that plays a critical role in various physiological and pathological processes, including tumor growth and angiogenesis.	1
1523	Nitric oxide is a free radical molecule synthesized from @COMPOUND$ by @PROTEIN$ that plays a critical role in various physiological and pathological processes, including tumor growth and angiogenesis.	1
1524	Furthermore, restoration of KSR1 expression in KSR (-/-) MEFs following stable transduction of cells with a KSR1 expression vector, enhanced sensitivity of cells to tunicamycin and @COMPOUND$ and decreased @PROTEIN$/2 activation following exposure to these drugs.	0
1525	Furthermore, restoration of @PROTEIN$ expression in KSR (-/-) MEFs following stable transduction of cells with a KSR1 expression vector, enhanced sensitivity of cells to tunicamycin and @COMPOUND$ and decreased ERK1/2 activation following exposure to these drugs.	1
1526	We demonstrated the increase in the levels of p53, Bax, and @PROTEIN$ and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
1527	We demonstrated the increase in the levels of p53, Bax, and cytochrome c and decrease in the level of @PROTEIN$, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
1528	We demonstrated the increase in the levels of p53, @PROTEIN$, and cytochrome c and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
1529	We demonstrated the increase in the levels of @PROTEIN$, Bax, and cytochrome c and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
1530	@PROTEIN$ gene polymorphisms and high levels of @COMPOUND$ are associated with a high degree of steatosis and fibrosis, conditions associated with a low sustained virological response (SVR) rate.	0
1531	The discovery that a common polymorphism (@COMPOUND$TLPR, short variant) in the human serotonin transporter gene (@PROTEIN$) can influence personality traits and increase the risk for depression in adulthood has led to the hypothesis that a relative increase in the extracellular levels of serotonin (5-HT) during development could be critical for the establishment of brain circuits.	0
1532	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: @COMPOUND$, beta-estradiol, @PROTEIN$ and tumour necrosis factor.	0
1533	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the @PROTEIN$ network likely provide insight into the role of DTNBP1 in biological systems: @COMPOUND$, beta-estradiol, calmodulin and tumour necrosis factor.	1
1534	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, @COMPOUND$, @PROTEIN$ and tumour necrosis factor.	0
1535	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the @PROTEIN$ network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, @COMPOUND$, calmodulin and tumour necrosis factor.	1
1536	Hypothetically, @PROTEIN$ influences the transport of @COMPOUND$ across the blood-brain barrier.	1
1537	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, @PROTEIN$, ERG11, ERG24, ERG25 and ERG26.	1
1538	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, @PROTEIN$, ERG24, ERG25 and ERG26.	1
1539	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including @PROTEIN$, ERG7, ERG11, ERG24, ERG25 and ERG26.	1
1540	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, ERG24, @PROTEIN$ and ERG26.	1
1541	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, ERG24, ERG25 and @PROTEIN$.	1
1542	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, @PROTEIN$, ERG25 and ERG26.	1
1543	In prolonged OJ with LPS administration, hepatocyte apoptosis depending on @PROTEIN$ expression significantly increased in association with a decrease in @COMPOUND$ contents, thus resulting in liver necrapoptosis.	0
1544	Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of CTLA-4, @PROTEIN$ on Tregs, and IL-10 production after burns.	1
1545	Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of CTLA-4, Foxp3 on Tregs, and @PROTEIN$ production after burns.	1
1546	Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of @PROTEIN$, Foxp3 on Tregs, and IL-10 production after burns.	1
1547	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) @PROTEIN$ expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
1548	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, @PROTEIN$, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
1549	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and @PROTEIN$) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
1550	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) @PROTEIN$ expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
1551	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, @PROTEIN$, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
1552	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (@PROTEIN$-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
1553	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (@PROTEIN$-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
1554	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and @PROTEIN$) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
1555	@COMPOUND$ attenuated mast cell recruitment thereby decreased the expressions of @PROTEIN$ and 9 in rat liver carcinogenesis.	1
1556	@COMPOUND$ administered rats showed increased MCD as revealed by toluidine blue staining along with upregulated expressions of MMP-2 and @PROTEIN$.	1
1557	@COMPOUND$ administered rats showed increased MCD as revealed by toluidine blue staining along with upregulated expressions of @PROTEIN$ and MMP-9.	1
1558	@COMPOUND$ treatment inhibited this increase in MCD and downregulated the expressions of @PROTEIN$ and MMP-9 as revealed by Western blotting and immunohistochemistry.	1
1559	@COMPOUND$ treatment inhibited this increase in MCD and downregulated the expressions of MMP-2 and @PROTEIN$ as revealed by Western blotting and immunohistochemistry.	1
1560	In conclusion, @COMPOUND$ exerted beneficial effects on liver carcinogenesis by attenuating the recruitment of mast cells and thereby decreased the expressions of @PROTEIN$ and MMP-9.	1
1561	In conclusion, @COMPOUND$ exerted beneficial effects on liver carcinogenesis by attenuating the recruitment of mast cells and thereby decreased the expressions of MMP-2 and @PROTEIN$.	1
1562	While it is clearly demonstrated that members of the @PROTEIN$/6/7 subfamily are activated by @COMPOUND$, the mechanism by which phospholipase C activates members of the TRPC1/4/5 subfamily remains a mystery.	1
1563	While it is clearly demonstrated that members of the TRPC3/6/7 subfamily are activated by @COMPOUND$, the mechanism by which phospholipase C activates members of the @PROTEIN$/4/5 subfamily remains a mystery.	0
1564	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of @PROTEIN$ activates calcium entry and membrane currents in TRPC5-expressing but not in TRPC3-or TRPC7-expressing cells.	1
1565	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in TRPC5-expressing but not in @PROTEIN$-or TRPC7-expressing cells.	0
1566	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in TRPC5-expressing but not in TRPC3-or @PROTEIN$-expressing cells.	0
1567	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in @PROTEIN$-expressing but not in TRPC3-or TRPC7-expressing cells.	0
1568	Inclusion of polyphosphatidylinositol 4-phosphate or PIP2, but not @COMPOUND$, in the patch pipette inhibited @PROTEIN$ currents.	0
1569	@PROTEIN$ inhibits contraction and proliferation of human aortic smooth muscle cells by @COMPOUND$/PKA pathway activation.	1
1570	Preliminary tests in vitro showed POP is capable of enhancing concanavalin A (@PROTEIN$)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0
1571	Preliminary tests in vitro showed @PROTEIN$ is capable of enhancing concanavalin A (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	1
1572	Preliminary tests in vitro showed POP is capable of enhancing @PROTEIN$ (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0
1573	Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by @COMPOUND$ and specific abrogation of Akt1 protein using small-interfering RNA revealed a regulatory function of Akt1 in @PROTEIN$-mediated VEGF biosynthesis in keratinocytes.	0
1574	Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by @COMPOUND$ and specific abrogation of Akt1 protein using small-interfering RNA revealed a regulatory function of Akt1 in insulin-mediated @PROTEIN$ biosynthesis in keratinocytes.	0
1575	Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by @COMPOUND$ and specific abrogation of @PROTEIN$ protein using small-interfering RNA revealed a regulatory function of Akt1 in insulin-mediated VEGF biosynthesis in keratinocytes.	0
1576	Cross-linked hydrogels showed increased resistance to digestion by testicular @PROTEIN$ and hyaluronidase SD with increasing @COMPOUND$ concentration.	1
1577	Role of @PROTEIN$ in apoptosis induced by @COMPOUND$.	1
1578	These studies frequently showed that erythropoietic stimulating agents (ESA) with oral or IV iron often resulted in improvement in left ventricular systolic and diastolic function, dilation, and hypertrophy, stabilization or improvement in renal function, reduced hospitalizations, diuretic dose, mitral regurgitation, pulmonary artery pressure, plasma volume, heart rate, serum brain natriuretic peptide levels, and the inflammatory markers C reactive protein and @PROTEIN$, and an improvement in New York Heart Association class, exercise capacity, @COMPOUND$ utilization during exercise, sleep apnea, caloric intake, depression, and quality of life.	0
1579	These studies frequently showed that erythropoietic stimulating agents (ESA) with oral or IV iron often resulted in improvement in left ventricular systolic and diastolic function, dilation, and hypertrophy, stabilization or improvement in renal function, reduced hospitalizations, diuretic dose, mitral regurgitation, pulmonary artery pressure, plasma volume, heart rate, serum @PROTEIN$ levels, and the inflammatory markers C reactive protein and Interleukin 6, and an improvement in New York Heart Association class, exercise capacity, @COMPOUND$ utilization during exercise, sleep apnea, caloric intake, depression, and quality of life.	0
1580	DNA sequences of a calmodulin (@PROTEIN$)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
1581	DNA sequences of a calmodulin (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the @PROTEIN$ (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
1582	DNA sequences of a calmodulin (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (@PROTEIN$) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
1583	DNA sequences of a @PROTEIN$ (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
1584	Both expression of tac and @PROTEIN$ were induced by 2% @COMPOUND$.	1
1585	Contaminants of current high use in the LRGV, such as atrazine, and some of the highly persistent organochlorines, such as @COMPOUND$ and DDE, could be potentially associated with modulation of @PROTEIN$ activity in avian tissues.	1
1586	Contaminants of current high use in the LRGV, such as @COMPOUND$, and some of the highly persistent organochlorines, such as toxaphene and DDE, could be potentially associated with modulation of @PROTEIN$ activity in avian tissues.	1
1587	Contaminants of current high use in the LRGV, such as atrazine, and some of the highly persistent organochlorines, such as toxaphene and @COMPOUND$, could be potentially associated with modulation of @PROTEIN$ activity in avian tissues.	1
1588	In this view, this study aimed at the investigating the use of a crude @PROTEIN$ preparation from onion solid by-products for oxidising @COMPOUND$, a widespread o-diphenol, whose various derivatives may occur in food industry wastes, such as olive mill waste waters.	1
1589	@COMPOUND$ exposures that caused a loss of binding function were examined for effects on expression of key NK cell-@PROTEIN$ needed for binding to targets.	0
1590	Here, we have investigated how the post-synthetic acetylation of @PROTEIN$ affects its interaction with negatively supercoiled DNA by employing monoacetylated at Lys2 protein, isolated from @COMPOUND$-treated cells.	0
1591	@COMPOUND$ inhibited MIH induced Mos expression and its phosphorylation, which in turn reduced @PROTEIN$ phosphorylation and GVBD.	1
1592	@COMPOUND$ inhibited MIH induced @PROTEIN$ expression and its phosphorylation, which in turn reduced Myt1 phosphorylation and GVBD.	1
1593	@COMPOUND$ inhibited @PROTEIN$ induced Mos expression and its phosphorylation, which in turn reduced Myt1 phosphorylation and GVBD.	1
1594	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
1595	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
1596	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
1597	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
1598	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
1599	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0
1600	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
1601	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0
1602	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
1603	@COMPOUND$-mediated ubiquitination regulates @PROTEIN$.	1
1604	Short-acting @PROTEIN$ analogues, in comparison with regular human insulin (HRI), provide a greater control of postprandial @COMPOUND$, while their superiority on haemoglobin A1c (HbA1c) is controversial.	1
1605	Short-acting insulin analogues, in comparison with regular human insulin (@PROTEIN$), provide a greater control of postprandial @COMPOUND$, while their superiority on haemoglobin A1c (HbA1c) is controversial.	1
1606	Western blotting showed that @COMPOUND$ down-regulated @PROTEIN$ protein expression in the BA, which in the SAH-only group was significantly higher than that of the normal group.	1
1607	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein @PROTEIN$ (LPL), peroxisome proliferator activated receptor gamma2, and adipocyte-specific fatty acid binding protein (alphaP2)).	0
1608	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (LPL), peroxisome proliferator activated receptor gamma2, and adipocyte-specific @PROTEIN$ (alphaP2)).	0
1609	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (@PROTEIN$), peroxisome proliferator activated receptor gamma2, and adipocyte-specific fatty acid binding protein (alphaP2)).	0
1610	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (LPL), peroxisome proliferator activated receptor @PROTEIN$, and adipocyte-specific fatty acid binding protein (alphaP2)).	0
1611	@COMPOUND$ inhibited the levels of the anti-apoptotic proteins @PROTEIN$ and Bcl-xl, but promoted the levels of the pro-apoptotic protein Bax.	1
1612	@COMPOUND$ inhibited the levels of the anti-apoptotic proteins Bcl-2 and Bcl-xl, but promoted the levels of the pro-apoptotic @PROTEIN$.	1
1613	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (LIF), interleukin-6 (@PROTEIN$), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
1614	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (LIF), @PROTEIN$ (IL-6), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
1615	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (@PROTEIN$), interleukin-6 (IL-6), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
1616	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to @COMPOUND$ or fludarabine combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
1617	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or fludarabine combined with @COMPOUND$, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
1618	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or @COMPOUND$ combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
1619	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or fludarabine combined with @COMPOUND$, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
1620	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or @COMPOUND$ combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
1621	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to @COMPOUND$ or fludarabine combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
1622	Inhibition of mitogen-activated protein kinase (MAPK) and @PROTEIN$ prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1
1623	Inhibition of mitogen-activated protein kinase (@PROTEIN$) and Akt prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1
1624	Inhibition of @PROTEIN$ (MAPK) and Akt prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1
1625	@COMPOUND$ up-regulated Akt-mediated antiapoptotic X-linked inhibitor of apoptosis protein and phosphorylated proapoptotic @PROTEIN$.	1
1626	DNA sequences of upstream regions of coregulated operons in the adapted mutant are divergent, suggesting the presence of recognition sites for different @PROTEIN$ and indicating that adaptation of the omcB mutant to growth on soluble @COMPOUND$) has shifted the relevant expression networks involved to a more diverse molecular basis.	0
1627	E-selectin, which ligand was modified by beta1,4-@PROTEIN$-I, was correlated with @COMPOUND$-containing glycans following injecting LPS into spinal cord.	0
1628	Effects of @PROTEIN$ on amino acid transporters were examined using their substrates: (3)H-@COMPOUND$, (3)H-lysine, and (3)H-methylaminoisobutyric acid, respectively.	0
1629	Effects of @PROTEIN$ on amino acid transporters were examined using their substrates: (3)H-phenylalanine, (3)H-@COMPOUND$, and (3)H-methylaminoisobutyric acid, respectively.	0
1630	@COMPOUND$, an anticonvulsant and mood stabilizer, up-regulates @PROTEIN$, a neurotrophic/neuroprotective protein.	1
1631	In this study, we investigated the molecular mechanism through which @PROTEIN$ is up-regulated by @COMPOUND$ using cultured human neuron-like cells.	1
1632	@COMPOUND$, within therapeutically relevant ranges, induced time- and concentration-dependent up-regulations of both @PROTEIN$ messenger RNA and protein implicating an underlying gene transcriptional-mediated mechanism.	1
1633	@COMPOUND$ increased transcriptional activity of a human @PROTEIN$ promoter-reporter gene construct.	1
1634	ERK and/or PI3K pathway inhibitors and RSK1 small hairpin RNA knockdown reduced, but did not abolish, baseline and @COMPOUND$-induced promoter activities and lowered @PROTEIN$ protein levels.	0
1635	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the ERK and @PROTEIN$ cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
1636	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, @PROTEIN$, although other unknown mechanism(s) are likely involved.	1
1637	These data collectively suggest that @COMPOUND$ induces @PROTEIN$ regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
1638	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the @PROTEIN$ and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
1639	Given the known roles of @PROTEIN$ in the central nervous system, the current findings offer a partial yet complex molecular mechanistic explanation for the known neurobiological effects of @COMPOUND$ including neurite growth, neuronal survival, and neurogenesis.	0
1640	With covalent method, @COMPOUND$ was introduced to immobilize @PROTEIN$.	1
1641	Activities of antioxidant enzymes (@PROTEIN$, catalase, glutathione peroxidase, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
1642	Activities of antioxidant enzymes (superoxide dismutase, catalase, @PROTEIN$, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
1643	Activities of antioxidant enzymes (superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
1644	Activities of antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
1645	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by substance P and @PROTEIN$ in a manner similar to galanin, confirming a non-GalR1-mediated effect.	0
1646	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by substance P and calcitonin gene-related peptide in a manner similar to @PROTEIN$, confirming a non-GalR1-mediated effect.	0
1647	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by @PROTEIN$ and calcitonin gene-related peptide in a manner similar to galanin, confirming a non-GalR1-mediated effect.	0
1648	GSPs inhibited @COMPOUND$ and 8-Br-cGMP-induced activation of @PROTEIN$/2 in A549 cells.	1
1649	GSPs inhibited L-arginine and @COMPOUND$-induced activation of @PROTEIN$/2 in A549 cells.	1
1650	Enhancement of p53 expression in keratinocytes by the @COMPOUND$ apigenin is associated with RNA-binding protein @PROTEIN$.	0
1651	Enhancement of @PROTEIN$ expression in keratinocytes by the @COMPOUND$ apigenin is associated with RNA-binding protein HuR.	0
1652	Enhancement of p53 expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with @PROTEIN$ HuR.	0
1653	Enhancement of p53 expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with RNA-binding protein @PROTEIN$.	1
1654	Enhancement of @PROTEIN$ expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with RNA-binding protein HuR.	1
1655	Enhancement of p53 expression in keratinocytes by the @COMPOUND$ apigenin is associated with @PROTEIN$ HuR.	0
1656	We have reported previously that @COMPOUND$, a naturally occurring nonmutagenic flavonoid, increased wild-type @PROTEIN$ protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization.	1
1657	We have reported previously that apigenin, a naturally occurring nonmutagenic @COMPOUND$, increased wild-type @PROTEIN$ protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization.	0
1658	Instead, biosynthetic labeling showed that @COMPOUND$ increased nascent @PROTEIN$ protein synthesis by enhancing p53 translation.	1
1659	Furthermore, @COMPOUND$ treatment increased the level of association of the RNA binding protein HuR with endogenous @PROTEIN$ mRNA.	1
1660	Furthermore, @COMPOUND$ treatment increased the level of association of the RNA binding protein @PROTEIN$ with endogenous p53 mRNA.	1
1661	Furthermore, @COMPOUND$ treatment increased the level of association of the @PROTEIN$ HuR with endogenous p53 mRNA.	0
1662	@COMPOUND$ treatment also augmented @PROTEIN$ translocation into the cytoplasm.	1
1663	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (@PROTEIN$), mitogen-activated protein kinases (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
1664	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (CREB), mitogen-activated protein kinases (MAPKp44/42; @PROTEIN$/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
1665	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (CREB), @PROTEIN$ (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
1666	Immunoblot analysis of signaling molecules, including cyclic-@PROTEIN$ response element binding protein (CREB), mitogen-activated protein kinases (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	0
1667	@PROTEIN$ resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon alpha-2b plus @COMPOUND$.	1
1668	Aim To investigate retrospectively the impact of @PROTEIN$ resistance on treatment response in Chinese genotype 1 CHC patients receiving a 24-week course therapy with peginterferon alpha-2b/@COMPOUND$.	1
1669	There was an inverse relationship between @COMPOUND$ levels and @PROTEIN$ activity.	1
1670	In men there is a large interindividual variation of @PROTEIN$ levels and consequently of @COMPOUND$ (T) and E(2) levels.	1
1671	Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30ng/mL soluble @PROTEIN$ (sRANKL), (C) 30ng/mL sRANKL and 10ng/mL OPG, (D) 10ng/mL OPG, (E) 50ng/mL OPG, (F) 100ng/mL OPG and (G) 30ng/mL sRANKL, 6mmol/@COMPOUND$ and 3mmol/L P. sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of OPG in a dose-dependent manner.	0
1672	Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30ng/mL soluble RANKL (sRANKL), (C) 30ng/mL sRANKL and 10ng/mL @PROTEIN$, (D) 10ng/mL OPG, (E) 50ng/mL OPG, (F) 100ng/mL OPG and (G) 30ng/mL sRANKL, 6mmol/@COMPOUND$ and 3mmol/L P. sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of OPG in a dose-dependent manner.	0
1673	Over-expression of @PROTEIN$ decreased the yield of ethanol and 2,3-butanediol, meanwhile it increased the concentration of @COMPOUND$.	1
1674	Over-expression of @PROTEIN$ decreased the yield of @COMPOUND$ and 2,3-butanediol, meanwhile it increased the concentration of acetic acid.	1
1675	Over-expression of @PROTEIN$ decreased the yield of ethanol and @COMPOUND$, meanwhile it increased the concentration of acetic acid.	1
1676	@COMPOUND$ prevents acute liver damage after massive hepatectomy in rats through suppression of a CXC chemokine @PROTEIN$ and induction of heat shock proteins.	1
1677	Furthermore, HA induced dose-dependent elevation of reactive @COMPOUND$ species (ROS) level in SMCs, and antioxidant vitamin C and Trolox effectively suppressed HA-induced DNA damage and dysregulation of @PROTEIN$/Bax.	0
1678	Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant vitamin C and @COMPOUND$ effectively suppressed HA-induced DNA damage and dysregulation of Bcl-2/@PROTEIN$.	1
1679	Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant vitamin C and @COMPOUND$ effectively suppressed HA-induced DNA damage and dysregulation of @PROTEIN$/Bax.	1
1680	Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant @COMPOUND$ and Trolox effectively suppressed HA-induced DNA damage and dysregulation of @PROTEIN$/Bax.	1
1681	Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant @COMPOUND$ and Trolox effectively suppressed HA-induced DNA damage and dysregulation of Bcl-2/@PROTEIN$.	1
1682	Furthermore, HA induced dose-dependent elevation of reactive @COMPOUND$ species (ROS) level in SMCs, and antioxidant vitamin C and Trolox effectively suppressed HA-induced DNA damage and dysregulation of Bcl-2/@PROTEIN$.	0
1683	The adsorption of ovine @PROTEIN$ onto @COMPOUND$-modified surfaces was reduced relative to unmodified surfaces, and in vitro ovine blood contact through a rocking test revealed marked reductions in platelet deposition and bulk phase platelet activation relative to unmodified TiAl6V4 and polystyrene controls.	1
1684	The culture tests using MSCs show that the level of alkaline phosphatase (@PROTEIN$) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and @COMPOUND$.	1
1685	The culture tests using MSCs show that the level of @PROTEIN$ (ALP) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and @COMPOUND$.	1
1686	The level was unchanged in MSCs cultured on PV-H. In the case of supplementing Dex and @COMPOUND$ to the medium, the level of @PROTEIN$ activity in MSCs cultured on SPV-H was higher than that on PV-H at all time points during the 21-day culture.	1
1687	The @PROTEIN$ and LUC genes were chosen because they can be used as markers for the easy detection of transgenic plants, while @COMPOUND$ tail better enables the isolation of protein expressed in plant tissue.	0
1688	Expression was performed in fusion to @COMPOUND$ binding protein using chemically defined minimal medium, followed by a single-step affinity capture and enzymatic cleavage using tobacco etch virus @PROTEIN$.	0
1689	The amplification of gltA gene encoding @PROTEIN$ of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during vanillin production from @COMPOUND$, to CoA, which is essential for vanillin production.	1
1690	The amplification of @PROTEIN$ gene encoding citrate synthase of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during vanillin production from @COMPOUND$, to CoA, which is essential for vanillin production.	1
1691	The amplification of gltA gene encoding @PROTEIN$ of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during @COMPOUND$ production from ferulic acid, to CoA, which is essential for vanillin production.	1
1692	The amplification of @PROTEIN$ gene encoding citrate synthase of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during @COMPOUND$ production from ferulic acid, to CoA, which is essential for vanillin production.	1
1693	The @PROTEIN$ amplification of the glyoxylate bypass in the icdA null mutant remarkably increased the production rate of @COMPOUND$ with a little increase in the amount of vanillin production.	1
1694	Treatment of dermal fibroblasts with @COMPOUND$) induced expression of @PROTEIN$ (1.2+/-0.2, 1.7+/-0.2, and 1.8+/-0.2 relative fold increase) and BMP-6 (9.1+/-0.3, 23.3+/-2.1, and 30.4+/-3.0 relative fold increase) at 3, 14, and 21 days, respectively.	1
1695	Treatment of dermal fibroblasts with @COMPOUND$) induced expression of BMP-4 (1.2+/-0.2, 1.7+/-0.2, and 1.8+/-0.2 relative fold increase) and @PROTEIN$ (9.1+/-0.3, 23.3+/-2.1, and 30.4+/-3.0 relative fold increase) at 3, 14, and 21 days, respectively.	1
1696	The aims of this study were: (i) to characterize the basal circadian rhythm of adrenocorticotropin hormone (@PROTEIN$) and cortisol in IBS vs healthy controls; (ii) to compare stimulated ACTH, cortisol and @COMPOUND$ responses to a pelvic visceral stressor (sigmoidoscopy) in IBS and controls; and (iii) to correlate neuroendocrine responses with colonic mucosal cytokine expression and symptoms in IBS.	0
1697	The aims of this study were: (i) to characterize the basal circadian rhythm of adrenocorticotropin hormone (@PROTEIN$) and @COMPOUND$ in IBS vs healthy controls; (ii) to compare stimulated ACTH, cortisol and noradrenaline responses to a pelvic visceral stressor (sigmoidoscopy) in IBS and controls; and (iii) to correlate neuroendocrine responses with colonic mucosal cytokine expression and symptoms in IBS.	0
1698	In Study 1, basal @COMPOUND$ levels were analysed in 41 IBS and 25 controls using 24-h collections of plasma @PROTEIN$ and cortisol (q10 min sampling).	0
1699	A 3-fold increase in the expression of the @PROTEIN$ gene was associated with decreased @COMPOUND$ methylation of the analysed promoter region in the vegetarian group compared with the age-matched omnivores group.	0
1700	Combustion products of @COMPOUND$ inhibit @PROTEIN$ activity and induce expression of oxidative DNA damage repair enzymes in human bronchial epithelial cells.	0
1701	The aim of the present study was to examine whether increased serum Hsp70 levels are related to clinical characteristics and standard laboratory parameters of preeclamptic patients, as well as to markers of inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) or endothelial injury (@PROTEIN$), trophoblast debris (cell-free fetal DNA) and oxidative stress (@COMPOUND$).	0
1702	The aim of the present study was to examine whether increased serum @PROTEIN$ levels are related to clinical characteristics and standard laboratory parameters of preeclamptic patients, as well as to markers of inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) or endothelial injury (fibronectin), trophoblast debris (cell-free fetal DNA) and oxidative stress (@COMPOUND$).	0
1703	Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1704	Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1705	Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1706	Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1707	Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1708	Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1709	Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1710	Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1711	Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1712	Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1713	Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1714	Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1715	Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1716	Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1717	Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1718	Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1719	Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1720	Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1721	Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1722	Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1723	In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, @COMPOUND$, an immunosuppressive agent known to regulate tumor growth and signal transduction mediated by the @PROTEIN$ receptor, is compared to paclitaxel in combination therapy employing monospecific or bispecific oligos.	1
1724	In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, Rapamycin, an immunosuppressive agent known to regulate tumor growth and signal transduction mediated by the @PROTEIN$ receptor, is compared to @COMPOUND$ in combination therapy employing monospecific or bispecific oligos.	0
1725	In this study we investigated the superoxide radicals scavenging effect and @PROTEIN$ inhibitory activity by @COMPOUND$, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.	1
1726	In this study we investigated the @COMPOUND$ radicals scavenging effect and @PROTEIN$ inhibitory activity by magnesium lithospermate B, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.	0
1727	Superoxide radicals were generated both in beta-NADH/@COMPOUND$ system and xanthine/@PROTEIN$ system.	0
1728	Superoxide radicals were generated both in @COMPOUND$/PMS system and xanthine/@PROTEIN$ system.	0
1729	Superoxide radicals were generated both in beta-NADH/PMS system and @COMPOUND$/@PROTEIN$ system.	1
1730	@COMPOUND$ radicals were generated both in beta-NADH/PMS system and xanthine/@PROTEIN$ system.	1
1731	In addition, @COMPOUND$ significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the xanthine/@PROTEIN$ reactions.	1
1732	In addition, magnesium lithospermate B significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the @COMPOUND$/@PROTEIN$ reactions.	1
1733	Four different molecules contain galactofuranose in A. fumigatus: (i) the @COMPOUND$ present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted @PROTEIN$ (iii) a GPI-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	0
1734	Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted @PROTEIN$ (iii) a GPI-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an @COMPOUND$.	0
1735	Four different molecules contain galactofuranose in A. fumigatus: (i) the @COMPOUND$ present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted glycoproteins (iii) a @PROTEIN$-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	0
1736	Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O @COMPOUND$ moieties of secreted @PROTEIN$ (iii) a GPI-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	1
1737	Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted glycoproteins (iii) a @PROTEIN$-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an @COMPOUND$.	0
1738	Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O @COMPOUND$ moieties of secreted glycoproteins (iii) a @PROTEIN$-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	0
1739	The estimated @PROTEIN$ level and the IMCL content in these patients were correlated with body mass index, percentage of body fat, other measures of abdominal obesity, serum lipoproteins, fasting and post-oral @COMPOUND$ load serum insulin levels and other surrogate markers of insulin resistance.	0
1740	The estimated CRP level and the IMCL content in these patients were correlated with body mass index, percentage of body fat, other measures of abdominal obesity, serum lipoproteins, fasting and post-oral @COMPOUND$ load serum @PROTEIN$ levels and other surrogate markers of insulin resistance.	1
1741	Studies suggest that @PROTEIN$ activation in osteoblasts is the underlying cause of glucocorticoid- and estrogen deficiency-mediated osteoporosis, and at least partially underlies the teratogenic effects of @COMPOUND$ on limb development.	1
1742	The goal of this study was to determine the mechanisms by which @COMPOUND$ induces @PROTEIN$ gene expression in airway epithelial cells.	1
1743	Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced @PROTEIN$/2-MAPK activation and MUC5B gene expression.	1
1744	Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced ERK1/2-@PROTEIN$ activation and MUC5B gene expression.	1
1745	Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced ERK1/2-MAPK activation and @PROTEIN$ gene expression.	1
1746	We here show that calumenin in the presence of @COMPOUND$+) binds to @PROTEIN$ with a dissociation constant K (d) around 0.4 muM.	1
1747	It represents transition in @COMPOUND$-deprived conditions, known to lead to H2 production in Chlamydomonas reinhardtii, and the two main processes then induced which are an over-accumulation of intracellular starch and a progressive reduction of @PROTEIN$ activity for anoxia achievement.	1
1748	We examined whether @COMPOUND$ produced locally in the brain may contribute to the activation of @PROTEIN$ in the CNS.	1
1749	Macrophages isolated from iron deficient rats, or pregnant rats at day 21 of gestation, either supplemented with a single dose of @COMPOUND$, 10 mg, at the commencement of pregnancy, or not, showed significant increases of macrophage ferroportin mRNA expression, which was paralleled by significant decreases in hepatic @PROTEIN$ mRNA expression.	1
1750	Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1
1751	Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1
1752	Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1
1753	Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1
1754	@COMPOUND$ stimulates antioxidant response element-mediated expression of @PROTEIN$ in mouse macrophages.	1
1755	The current study investigated whether @COMPOUND$ induces transcription of @PROTEIN$ (Gcl), via ARE driven gene expression in mouse macrophages.	0
1756	The current study investigated whether @COMPOUND$ induces transcription of glutamate-cysteine ligase (@PROTEIN$), via ARE driven gene expression in mouse macrophages.	0
1757	Real-time RT-PCR revealed increased mRNA-expression of the catalytic subunit of Gcl (Gclc) after treatment with @COMPOUND$, and this occurred via increased transcription as demonstrated with @PROTEIN$ promoter reporter constructs for Gclc.	0
1758	Ligand-induced @PROTEIN$-downregulation modulates cell death associated proteins and enhances chemosensitivity to @COMPOUND$ in THP-1 acute myeloid leukemia cells.	1
1759	Only EGF activated @PROTEIN$ signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced PSA transcript in A549 cells.	0
1760	Only EGF activated ERK signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced @PROTEIN$ transcript in A549 cells.	0
1761	Only @PROTEIN$ activated ERK signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced PSA transcript in A549 cells.	0
1762	High @COMPOUND$ induced endothelial cell growth inhibition is associated with an increase in @PROTEIN$ secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway.	1
1763	High @COMPOUND$ induced endothelial cell growth inhibition is associated with an increase in TGFbeta1 secretion and inhibition of @PROTEIN$ prenylation via suppression of the mevalonate pathway.	1
1764	The influence of the prenylation status of @PROTEIN$ on the observed changes in endothelial cell growth under high @COMPOUND$ conditions has not previously been examined.	0
1765	Calcineurin inhibitors (CsA, @COMPOUND$ and pimecrolimus) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1
1766	Calcineurin inhibitors (CsA, FK-506 and @COMPOUND$) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1
1767	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (FK-506) and @COMPOUND$ inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1768	In conclusion, the results suggest that calcineurin inhibitors @COMPOUND$, tacrolimus (FK-506) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1769	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, @COMPOUND$ (FK-506) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1770	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (@COMPOUND$) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1771	In sum, @COMPOUND$ exposure lowered TOSC, a result that at least in part can be related to lowering of antioxidant enzymes like @PROTEIN$.	1
1772	It was shown that PAR significantly increased serum ALT, @PROTEIN$, ALP, liver MDA levels and significantly decreased liver @COMPOUND$-Px activity, when compared to the control group (Group 1).	0
1773	It was shown that PAR significantly increased serum ALT, AST, @PROTEIN$, liver MDA levels and significantly decreased liver @COMPOUND$-Px activity, when compared to the control group (Group 1).	0
1774	Biological testing of the compound demonstrated a significant antidiabetic activity by reducing the elevated blood glucose levels and restoring the @PROTEIN$ levels in @COMPOUND$-induced diabetic rats.	0
1775	Biological testing of the compound demonstrated a significant antidiabetic activity by reducing the elevated blood @COMPOUND$ levels and restoring the @PROTEIN$ levels in streptozotocin-induced diabetic rats.	0
1776	The activity of guanylyl @PROTEIN$ was determined by the amount of @COMPOUND$ generated in responses to sodium nitroprusside (SNP) or ANP.	1
1777	Both SAHA and @COMPOUND$ induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of @PROTEIN$/Bcl-2 expression.	1
1778	Both @COMPOUND$ and MS-275 induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of @PROTEIN$/Bcl-2 expression.	1
1779	Both SAHA and @COMPOUND$ induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of Bax/@PROTEIN$ expression.	1
1780	Both @COMPOUND$ and MS-275 induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of Bax/@PROTEIN$ expression.	1
1781	Immunolocalization of @PROTEIN$ in the boar epididymis: the effect of GnRH agonist @COMPOUND$.	0
1782	E(2) increased the expression of @PROTEIN$ and caveolin-2 mRNA and proteins, but pre-treatment with @COMPOUND$ (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.	1
1783	E(2) increased the expression of caveolin-1 and @PROTEIN$ mRNA and proteins, but pre-treatment with @COMPOUND$ (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.	1
1784	Phospho-@PROTEIN$ was significantly blocked by @COMPOUND$ or pyrazolopyrimidine 2 (PP2 ; a Src-kinase inhibitor).	1
1785	Phospho-@PROTEIN$ was significantly blocked by ICI 182,780 or @COMPOUND$ 2 (PP2 ; a Src-kinase inhibitor).	1
1786	LY 294002 (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-@COMPOUND$ incorporation.	1
1787	LY 294002 (a PI3K inhibitor) or @COMPOUND$ (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-thymidine incorporation.	1
1788	@COMPOUND$ (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-thymidine incorporation.	1
1789	Furthermore, inhibition of caveolin-1 expression using a caveolin-1 siRNA significantly attenuated E(2)-induced up-regulation of proto-oncogenes, @PROTEIN$, ((3)H)-@COMPOUND$ incorporation, overall cell number, and percent of the cell population in S phase, while mediating a concomitant increase in the G0/G1 population.	0
1790	The effect on activation voltage but not that on amplitude was absent when expressing a cAMP-insensitive mutant (@PROTEIN$R/E), while a C-terminal truncated form of HCN2 (HCN2DeltaCx) exhibited only the voltage dependent but not the amplitude effect of @COMPOUND$.	1
1791	In contrast to newborn myocytes, @COMPOUND$ had no effect on @PROTEIN$ under control conditions in adult myocytes but induced a negative shift with no change in amplitude when saturated cAMP was added to the pipette solution.	0
1792	In contrast to newborn myocytes, erbstatin had no effect on @PROTEIN$ under control conditions in adult myocytes but induced a negative shift with no change in amplitude when saturated @COMPOUND$ was added to the pipette solution.	0
1793	Arginine-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the @COMPOUND$ residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
1794	@COMPOUND$-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
1795	Arginine-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of @COMPOUND$ to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
1796	A D-amino acid oxidase gene (dao) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of @PROTEIN$ without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1
1797	A D-amino acid oxidase gene (@PROTEIN$) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of DAAO without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1
1798	In response to a @COMPOUND$-containing atherogenic diet, C57BL/6J mice significantly increased expression of @PROTEIN$ in the aorta, while mice lacking UCP2, in the absence of any other genetic modification, displayed significant endothelial dysfunction following the atherogenic diet.	1
1799	These data establish that in the vasculature @PROTEIN$ functions as an adaptive antioxidant defense to protect against the development of atherosclerosis in response to a fat and @COMPOUND$ diet.	1
1800	To confirm that mouse @PROTEIN$-PG possesses a single GAG chain attached to Ser (89), we substituted Ser (89) by @COMPOUND$ (89).	1
1801	PC-1 is the primary generator of @COMPOUND$ in osteoblastic cells; therefore, regulated expression of PC-1 by @PROTEIN$s may be a principal mechanism by which FGF signaling affects bone mineralization.	1
1802	PC-1 is the primary generator of @COMPOUND$ in osteoblastic cells; therefore, regulated expression of PC-1 by @PROTEIN$ may be a principal mechanism by which FGF signaling affects bone mineralization.	1
1803	For proof of principle, we use L-lactate and @COMPOUND$ as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced pyruvate.	0
1804	For proof of principle, we use @COMPOUND$ and D-lactate as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced pyruvate.	0
1805	For proof of principle, we use L-lactate and D-lactate as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced @COMPOUND$.	0
1806	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce @COMPOUND$ from xylose while metabolizing glucose (Cirino et al.	1
1807	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce xylitol from xylose while metabolizing @COMPOUND$ (Cirino et al.	1
1808	For the case of xylose-proton symport, omitting the @PROTEIN$ (glucose-6-phosphate dehydrogenase) or PntAB (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
1809	For the case of xylose-proton symport, omitting the Zwf (glucose-6-phosphate dehydrogenase) or @PROTEIN$ (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
1810	Experimentally, deleting pgi (encoding @PROTEIN$) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.	1
1811	Experimentally, deleting @PROTEIN$ (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.	1
1812	Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (@PROTEIN$ and pntA) has no significant effect on the measured yield.	0
1813	Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and @PROTEIN$) has no significant effect on the measured yield.	0
1814	In the process studied, the enzyme cellobiose dehydrogenase (@PROTEIN$) oxidizes lactose at the C-1 position of the reducing sugar moiety to lactobionolactone, which spontaneously hydrolyzes to @COMPOUND$.	1
1815	In the process studied, the enzyme cellobiose dehydrogenase (@PROTEIN$) oxidizes @COMPOUND$ at the C-1 position of the reducing sugar moiety to lactobionolactone, which spontaneously hydrolyzes to lactobionic acid.	1
1816	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for alkaline phosphatase and @PROTEIN$ polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1817	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for alkaline phosphatase and @PROTEIN$ polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1818	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for @PROTEIN$ and reverse transcriptase polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1819	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for alkaline phosphatase and reverse transcriptase polymerase chain reaction (RT-@PROTEIN$) analysis of pluripotency state markers viz.	0
1820	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for alkaline phosphatase and reverse transcriptase polymerase chain reaction (RT-@PROTEIN$) analysis of pluripotency state markers viz.	0
1821	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for @PROTEIN$ and reverse transcriptase polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1822	SM (@COMPOUND$), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of @PROTEIN$/neu expression by SM was investigated.	0
1823	SM (solamargine), a major @COMPOUND$ glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/@PROTEIN$ expression by SM was investigated.	0
1824	SM (@COMPOUND$), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/@PROTEIN$ expression by SM was investigated.	0
1825	SM (solamargine), a major @COMPOUND$ glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of @PROTEIN$/neu expression by SM was investigated.	0
1826	Since ondansetron completely reversed the effects of @COMPOUND$ on DA neuronal activity, the effects of MAOA inhibition appeared to be mediated by @PROTEIN$ receptors.	0
1827	Since ondansetron completely reversed the effects of @COMPOUND$ on DA neuronal activity, the effects of @PROTEIN$ inhibition appeared to be mediated by 5-HT3 receptors.	0
1828	Since @COMPOUND$ completely reversed the effects of clorgyline on DA neuronal activity, the effects of MAOA inhibition appeared to be mediated by @PROTEIN$ receptors.	0
1829	Since @COMPOUND$ completely reversed the effects of clorgyline on DA neuronal activity, the effects of @PROTEIN$ inhibition appeared to be mediated by 5-HT3 receptors.	0
1830	The effects of @PROTEIN$ were reversed by the mitochondrial KATP blocker, @COMPOUND$, indicating that mitochondrial KATP channels participate in the regulation of astrocyte activation.	1
1831	While bass in all @COMPOUND$ treatment groups had significantly inhibited brain @PROTEIN$ activity, only the medium and high treatment groups showed a dose- and time-dependent increase in time to capture prey.	1
1832	The aim of this phase 0 study was to investigate whether @COMPOUND$ passes the blood-tumor barrier, and is phosphorylated in the tumor by @PROTEIN$ (dCK) to gemcitabine nucleotides in order to enable radiosensitization, and whether it is deaminated by deoxycytidine deaminase (dCDA) to dFdU.	1
1833	The aim of this phase 0 study was to investigate whether @COMPOUND$ passes the blood-tumor barrier, and is phosphorylated in the tumor by deoxycytidine kinase (@PROTEIN$) to gemcitabine nucleotides in order to enable radiosensitization, and whether it is deaminated by deoxycytidine deaminase (dCDA) to dFdU.	1
1834	In conclusion, dentin mineralization in a corrected @COMPOUND$ and vitamin D environment compensates the adverse effect of @PROTEIN$ mutation.	0
1835	In conclusion, dentin mineralization in a corrected phosphate and @COMPOUND$ environment compensates the adverse effect of @PROTEIN$ mutation.	0
1836	The considered biological model system consisted of a coating antibody (goat IgG), bovine serum albumin (@PROTEIN$) as blocking agent, and a complementary antibody labelled with @COMPOUND$ (anti-goat IgG).	0
1837	The considered biological model system consisted of a coating antibody (goat IgG), bovine @PROTEIN$ (BSA) as blocking agent, and a complementary antibody labelled with @COMPOUND$ (anti-goat IgG).	0
1838	Prolonged L-alanine exposure induces changes in metabolism, @COMPOUND$+) handling and desensitization of @PROTEIN$ secretion in clonal pancreatic beta-cells.	0
1839	Prolonged L-@COMPOUND$ exposure induces changes in metabolism, Ca(2+) handling and desensitization of @PROTEIN$ secretion in clonal pancreatic beta-cells.	1
1840	Collectively, these results illustrate the phenomenon of beta-cell desensitization by amino acids, indicating that prolonged exposure to alanine can induce reversible alterations to metabolic flux, @COMPOUND$+) handling and @PROTEIN$ secretion.	0
1841	Collectively, these results illustrate the phenomenon of beta-cell desensitization by amino acids, indicating that prolonged exposure to @COMPOUND$ can induce reversible alterations to metabolic flux, Ca(2+) handling and @PROTEIN$ secretion.	1
1842	Acylation-stimulating protein (@PROTEIN$) has been shown to positively stimulate fatty acid esterification and @COMPOUND$ uptake in adipocytes.	1
1843	Using a set of experiments aimed at manipulate a putative @COMPOUND$/NMDA/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of @PROTEIN$ mRNA in a dose-response manner.	1
1844	Using a set of experiments aimed at manipulate a putative l-glutamate/@COMPOUND$/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of @PROTEIN$ mRNA in a dose-response manner.	1
1845	Reaction parameters for the production of XOS from corncob using @PROTEIN$ from Aspergillus oryzae MTCC 5154 were optimized and an XOS yield of 10.2+/-0.14 mg ml(-1) corresponding to 81+/-3.9% with 73.5% @COMPOUND$ was obtained.	0
1846	@COMPOUND$ inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated @PROTEIN$ activation in vascular endothelial cells.	1
1847	Cilostazol is a selective inhibitor of phosphodiesterase 3 that increases intracellular cyclic AMP (@COMPOUND$) levels and activates @PROTEIN$, thereby inhibiting platelet aggregation and inducing peripheral vasodilation.	0
1848	@COMPOUND$ is a selective inhibitor of phosphodiesterase 3 that increases intracellular cyclic AMP (cAMP) levels and activates @PROTEIN$, thereby inhibiting platelet aggregation and inducing peripheral vasodilation.	1
1849	We hypothesized that @COMPOUND$ may prevent inflammatory cytokine induced-nuclear factor (NF)-kappaB activation by activating AMP-activated protein kinase (@PROTEIN$) in vascular endothelial cells.	1
1850	We hypothesized that @COMPOUND$ may prevent inflammatory cytokine induced-nuclear factor (NF)-kappaB activation by activating AMP-activated @PROTEIN$ (AMPK) in vascular endothelial cells.	1
1851	Serum @COMPOUND$ (E2) levels were not altered at any time point after @PROTEIN$, demonstrating that the increased KiSS-1 expression observed was not caused by an elevation in E2.	0
1852	In addition, treatment of primary mouse lung fibroblasts with @COMPOUND$ stimulated @PROTEIN$ activity and collagen formation in vitro.	1
1853	These data support the idea that @COMPOUND$ may play a role in airway diseases, including asthma and pulmonary fibrosis, through NOS inhibition and enhancement of @PROTEIN$ activity.	1
1854	These data support the idea that @COMPOUND$ may play a role in airway diseases, including asthma and pulmonary fibrosis, through @PROTEIN$ inhibition and enhancement of arginase activity.	1
1855	Osteopontin (@PROTEIN$) inhibits the growth of @COMPOUND$ (COM) and other crystal phases in a phosphorylation-dependent manner.	1
1856	@COMPOUND$ replacement to euglycemia causes hypoxia, acidosis, and decreased @PROTEIN$ secretion in fetal sheep with intrauterine growth restriction.	1
1857	@COMPOUND$ stimulated @PROTEIN$ secretion (GSIS) was lower in the Glu group.	1
1858	These data confirm that endogenous miR-34a regulates @PROTEIN$ levels and supports the notion that miR-34a contributes to the effects of @COMPOUND$ and VPA on GRM7.	1
1859	Gene expression of mitogen-activated protein kinase (@PROTEIN$) phosphatase-1 was also increased by the addition of @COMPOUND$.	1
1860	Achieving CCgR within 12 months and maintaining it without an increase in @PROTEIN$-ABL transcripts might indicate that low-dose @COMPOUND$ therapy can produce acceptable outcomes without excess toxicity.	1
1861	Achieving CCgR within 12 months and maintaining it without an increase in BCR-@PROTEIN$ transcripts might indicate that low-dose @COMPOUND$ therapy can produce acceptable outcomes without excess toxicity.	1
1862	Rac1 (-/-) platelets displayed defective thrombus formation on collagen under flow conditions which could be fully restored by co-infusion of ADP and the @COMPOUND$) analog U46619, indicating that impaired @PROTEIN$-, but not G-protein signaling, was responsible for the observed defect.	0
1863	@PROTEIN$ (-/-) platelets displayed defective thrombus formation on collagen under flow conditions which could be fully restored by co-infusion of ADP and the @COMPOUND$) analog U46619, indicating that impaired GPVI-, but not G-protein signaling, was responsible for the observed defect.	0
1864	@PROTEIN$ 13910 CC genotype is associated with @COMPOUND$ intolerance, a condition often resulting in reduced milk intake.	1
1865	Osteointegration of @COMPOUND$ or its alloy with bone can be greatly improved by calcium phosphate coatings, and further enhanced by an extracellular @PROTEIN$ layer such as collagen.	1
1866	Osteointegration of titanium or its alloy with bone can be greatly improved by @COMPOUND$ coatings, and further enhanced by an extracellular @PROTEIN$ layer such as collagen.	0
1867	Use of @PROTEIN$ and fibronectin to influence osteoblast responses to @COMPOUND$ scaffolds.	1
1868	Use of tissue transglutaminase and @PROTEIN$ to influence osteoblast responses to @COMPOUND$ scaffolds.	1
1869	To explore the possibility of controlling cell interaction with biomaterials, @COMPOUND$ scaffolds were modified using the enzyme @PROTEIN$ (tTgase) in conjunction with fibronectin.	1
1870	To explore the possibility of controlling cell interaction with biomaterials, @COMPOUND$ scaffolds were modified using the enzyme tissue transglutaminase (tTgase) in conjunction with @PROTEIN$.	1
1871	Four MPTP monkeys received L-DOPA/@COMPOUND$ plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1872	Four MPTP monkeys received L-DOPA/Benserazide plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of @COMPOUND$ ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1873	Four MPTP monkeys received L-DOPA/@COMPOUND$ plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1874	Four MPTP monkeys received @COMPOUND$/Benserazide plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1875	Four MPTP monkeys received L-DOPA/Benserazide plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of @COMPOUND$ ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1876	Four MPTP monkeys received @COMPOUND$/Benserazide plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1877	Hence, MPTP lesion, L-DOPA treatment and prevention of LID with CI-1041 and cabergoline, or reduction with @COMPOUND$ were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
1878	Hence, MPTP lesion, @COMPOUND$ treatment and prevention of LID with CI-1041 and cabergoline, or reduction with Ro 61-8048 were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
1879	Hence, MPTP lesion, L-DOPA treatment and prevention of LID with CI-1041 and @COMPOUND$, or reduction with Ro 61-8048 were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
1880	@PROTEIN$ (UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase), a three-domain bacterial protein, catalyses a highly specific incorporation of D-glutamate to the cytoplasmic intermediate UDP-N-acetyl-muramoyl-L-alanine (@COMPOUND$) utilizing ATP hydrolysis to ADP and P(i).	1
1881	On the basis of structural studies of @PROTEIN$ complexes, a stepwise catalytic mechanism was proposed that commences with a formation of the acyl-phosphate intermediate, followed by a nucleophilic attack of @COMPOUND$ that, through the formation of a tetrahedral reaction intermediate and subsequent phosphate dissociation, affords the final product, UDP-N-acetyl-muramoyl-L-alanine-D-glutamate (UMAG).	1
1882	Although the overall amino acid identity between @PROTEIN$ and the LeuT(Aa) is only 17%, it increases to above 50% in the first shell of the putative 5-HT binding site, allowing de novo computational docking of @COMPOUND$ derivatives in atomic detail.	0
1883	Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble palmitic acid derivative at Cys 1 and Cys 7, was reacted with mPEG-@COMPOUND$ (mPEG-Suc, 5 kDa).	1
1884	Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble @COMPOUND$ derivative at Cys 1 and Cys 7, was reacted with mPEG-succinimide (mPEG-Suc, 5 kDa).	1
1885	Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble palmitic acid derivative at Cys 1 and Cys 7, was reacted with @COMPOUND$-succinimide (mPEG-Suc, 5 kDa).	1
1886	Our findings suggest that @PROTEIN$ substituted with a PEG of an appropriate Mw at Lys (34) could be used as a promising type 2 anti-diabetic agent to timely control postprandial @COMPOUND$ levels.	1
1887	The antidepressant @COMPOUND$ blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (@PROTEIN$) expression in the hippocampus of rats.	1
1888	@PROTEIN$ activity was also inhibited for all the soils treated with @COMPOUND$ (from 0.1 to 50mg/kg dry soil), but a declining inhibition was observed after 2 days of incubation.	1
1889	The magnitude of autophagosome formation is tightly regulated by intracellular and extracellular amino acid concentrations and @COMPOUND$ levels via signaling pathways that include the nutrient sensing kinase @PROTEIN$.	1
1890	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/@COMPOUND$ clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and somatostatin.	0
1891	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/L) @COMPOUND$ clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and somatostatin.	0
1892	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/L) glucose clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and @COMPOUND$.	0
1893	or=6 ng/ml) was associated with increased expression of mrp-1 and @PROTEIN$ and decreased @COMPOUND$, while higher level resistance (10 ng/ml) was primarily associated with the increased expression of P-glycoproteins.	0
1894	or=6 ng/ml) was associated with increased expression of mrp-1 and pgp-1 and decreased @COMPOUND$, while higher level resistance (10 ng/ml) was primarily associated with the increased expression of P-@PROTEIN$.	0
1895	or=6 ng/ml) was associated with increased expression of @PROTEIN$-1 and pgp-1 and decreased @COMPOUND$, while higher level resistance (10 ng/ml) was primarily associated with the increased expression of P-glycoproteins.	0
1896	@COMPOUND$ reduced amounts of the caspase inhibitor XIAP, and API-2 increased amounts of the BH3-only protein @PROTEIN$.	0
1897	@PROTEIN$ accumulated in mitochondria in response to API-2, whereas release of cytochrome c from mitochondria required both API-2 and @COMPOUND$.	0
1898	Bax accumulated in mitochondria in response to API-2, whereas release of @PROTEIN$ from mitochondria required both API-2 and @COMPOUND$.	1
1899	We suggest that @COMPOUND$ elicits events that activate Bax once it translocates to mitochondria and that inactivation of @PROTEIN$ signals these events and the down-regulation of XIAP.	1
1900	We suggest that @COMPOUND$ elicits events that activate @PROTEIN$ once it translocates to mitochondria and that inactivation of cdk9 signals these events and the down-regulation of XIAP.	1
1901	Intravenous @COMPOUND$ enhances @PROTEIN$ activity giving cardioprotection.	1
1902	We investigated whether acute intravenous @COMPOUND$, through an effect on cyclooxygenase (COX)-2 and heat shock protein (@PROTEIN$) 72, might induce preconditioning.	1
1903	We investigated whether acute intravenous @COMPOUND$, through an effect on cyclooxygenase (@PROTEIN$)-2 and heat shock protein (HSP) 72, might induce preconditioning.	1
1904	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher @PROTEIN$ content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1905	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, @PROTEIN$, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1906	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and @PROTEIN$ (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1907	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, @PROTEIN$, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1908	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (@PROTEIN$) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1909	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, @PROTEIN$, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1910	Moreover, @COMPOUND$ supplementation significantly increased both basal and @PROTEIN$ stimulated tyrosine phosphorylation of the insulin receptor in skeletal muscle and liver tissues.	0
1911	Moreover, @COMPOUND$ supplementation significantly increased both basal and insulin stimulated tyrosine phosphorylation of the @PROTEIN$ in skeletal muscle and liver tissues.	1
1912	Moreover, taurine supplementation significantly increased both basal and insulin stimulated @COMPOUND$ phosphorylation of the @PROTEIN$ in skeletal muscle and liver tissues.	1
1913	Moreover, taurine supplementation significantly increased both basal and @PROTEIN$ stimulated @COMPOUND$ phosphorylation of the insulin receptor in skeletal muscle and liver tissues.	1
1914	These results indicate that @COMPOUND$ controls glucose homeostasis by regulating the expression of genes required for glucose-stimulated @PROTEIN$ secretion.	1
1915	These results indicate that taurine controls @COMPOUND$ homeostasis by regulating the expression of genes required for glucose-stimulated @PROTEIN$ secretion.	1
1916	In addition, @COMPOUND$ enhances peripheral @PROTEIN$ sensitivity.	1
1917	Furthermore, treatment of @COMPOUND$ and EPA also synergistically blocked the activation of downstream @PROTEIN$ molecule.	1
1918	The NSCs and neuroblasts had epidermal growth factor receptor (EGFR) and platelet-derived growth factor receptor alpha (@PROTEIN$) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0
1919	The NSCs and neuroblasts had @PROTEIN$ (EGFR) and platelet-derived growth factor receptor alpha (PDGFRalpha) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0
1920	The NSCs and neuroblasts had epidermal growth factor receptor (@PROTEIN$) and platelet-derived growth factor receptor alpha (PDGFRalpha) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0
1921	Ependymal and displaced ependymal cells also expressed EGFR and @PROTEIN$ on their cilia but did not incorporate @COMPOUND$.	0
1922	Ependymal and displaced ependymal cells also expressed @PROTEIN$ and PDGFRalpha on their cilia but did not incorporate @COMPOUND$.	0
1923	Whereas Zn2+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive oxygen and @COMPOUND$ species, stimulation of PBR expression may augment HE development.	1
1924	Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and @COMPOUND$ species, stimulation of @PROTEIN$ expression may augment HE development.	0
1925	Whereas @COMPOUND$+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of @PROTEIN$ expression may augment HE development.	0
1926	Whereas Zn2+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive @COMPOUND$ and nitrogen oxide species, stimulation of PBR expression may augment HE development.	1
1927	Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive @COMPOUND$ and nitrogen oxide species, stimulation of @PROTEIN$ expression may augment HE development.	0
1928	Whereas @COMPOUND$+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of PBR expression may augment HE development.	1
1929	Accordingly, the TLR3 agonist @COMPOUND$) (PIC) induced higher release of @PROTEIN$ in primary and purified astroglia than in microglia.	1
1930	Accordingly, the TLR3 agonist poly(I:C) (@COMPOUND$) induced higher release of @PROTEIN$ in primary and purified astroglia than in microglia.	1
1931	As siRNA, @COMPOUND$ induced @PROTEIN$, Stat1, VCAM-1, and Cox-2 and increased TLR3 mRNA expression.	1
1932	As siRNA, @COMPOUND$ induced IP-10, Stat1, @PROTEIN$, and Cox-2 and increased TLR3 mRNA expression.	1
1933	As siRNA, @COMPOUND$ induced IP-10, @PROTEIN$, VCAM-1, and Cox-2 and increased TLR3 mRNA expression.	1
1934	As siRNA, @COMPOUND$ induced IP-10, Stat1, VCAM-1, and Cox-2 and increased @PROTEIN$ mRNA expression.	1
1935	As siRNA, @COMPOUND$ induced IP-10, Stat1, VCAM-1, and @PROTEIN$ and increased TLR3 mRNA expression.	1
1936	Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-@PROTEIN$/CD86 interactions in CD4 (+) T lymphocytes.	1
1937	Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-CD80/@PROTEIN$ interactions in CD4 (+) T lymphocytes.	1
1938	Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte @PROTEIN$ (CD152)-CD80/CD86 interactions in CD4 (+) T lymphocytes.	1
1939	Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (@PROTEIN$)-CD80/CD86 interactions in CD4 (+) T lymphocytes.	1
1940	Further experiments demonstrated that CTLA-4-@PROTEIN$/CD86 interactions reduced cell cycling upon activation with @COMPOUND$ and high amounts of I or TG (high SOS) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
1941	Further experiments demonstrated that CTLA-4-@PROTEIN$/CD86 interactions reduced cell cycling upon activation with PMA and high amounts of I or TG (high @COMPOUND$) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
1942	Further experiments demonstrated that @PROTEIN$-CD80/CD86 interactions reduced cell cycling upon activation with PMA and high amounts of I or TG (high @COMPOUND$) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
1943	Further experiments demonstrated that CTLA-4-CD80/@PROTEIN$ interactions reduced cell cycling upon activation with @COMPOUND$ and high amounts of I or TG (high SOS) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
1944	Further experiments demonstrated that @PROTEIN$-CD80/CD86 interactions reduced cell cycling upon activation with @COMPOUND$ and high amounts of I or TG (high SOS) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
1945	Further experiments demonstrated that CTLA-4-CD80/@PROTEIN$ interactions reduced cell cycling upon activation with PMA and high amounts of I or TG (high @COMPOUND$) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
1946	@COMPOUND$ decreased fasting glucose by 20 % and liver weights by 37 % compared with those in the CLA group; it maintained circulating @PROTEIN$, HOMA1-IR and HOMA1 for beta cell function at levels found in the control group.	1
1947	FSO decreased fasting @COMPOUND$ by 20 % and liver weights by 37 % compared with those in the CLA group; it maintained circulating @PROTEIN$, HOMA1-IR and HOMA1 for beta cell function at levels found in the control group.	0
1948	The purpose of this study was to investigate the effect of dietary supplementation with @COMPOUND$ on @PROTEIN$ resistance and associated metabolic risk factors in man.	1
1949	@COMPOUND$ treatment had no effect on @PROTEIN$ sensitivity, insulin secretion or glucose tolerance but did reduce diastolic blood pressure (mean change: placebo-0.058 (se 0.75) mmHg; EGCG-2.68 (se 0.72) mmHg; P = 0.014).	0
1950	EGCG treatment had no effect on @PROTEIN$ sensitivity, insulin secretion or @COMPOUND$ tolerance but did reduce diastolic blood pressure (mean change: placebo-0.058 (se 0.75) mmHg; EGCG-2.68 (se 0.72) mmHg; P = 0.014).	0
1951	In conclusion, regular intake of @COMPOUND$ had no effect on @PROTEIN$ resistance but did result in a modest reduction in diastolic blood pressure.	0
1952	We found that postovulatory administration of 1.5 mg of @COMPOUND$ to women with a subsequent or existing early pregnancy did not affect the immunohistochemical expressions of @PROTEIN$ (ER (alpha), ER (beta)), P receptors (PR(B), PR(A+B)), androgen receptor (AR), or proliferation index Ki67 in the first-trimester decidua and chorionic villi.	0
1953	We found that postovulatory administration of 1.5 mg of @COMPOUND$ to women with a subsequent or existing early pregnancy did not affect the immunohistochemical expressions of estrogen receptors (ER (alpha), ER (beta)), P receptors (PR(B), PR(A+B)), @PROTEIN$ (AR), or proliferation index Ki67 in the first-trimester decidua and chorionic villi.	0
1954	@COMPOUND$ effect on HS cell viability was markedly reduced in hypoxic condition without an induction of chemoresistant related protein, P-@PROTEIN$.	0
1955	High-level toxin production occurred after detectable spore germination in all experiments except those with C. difficile PCR ribotype 027 and @COMPOUND$, in which marked @PROTEIN$ production preceded detectable germination, which coincided with isolate recovery on fluoroquinolone-containing medium.	0
1956	Furthermore, @PROTEIN$ overexpression reduced @COMPOUND$ anion generation after H/R, whereas glutathione levels were significantly improved compared with WT controls.	1
1957	Furthermore, @PROTEIN$ overexpression reduced superoxide anion generation after H/R, whereas @COMPOUND$ levels were significantly improved compared with WT controls.	1
1958	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (@PROTEIN$) and CaMKII, and those alterations were reversed after insulin administration.	1
1959	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after @PROTEIN$ administration.	1
1960	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (@PROTEIN$) and CaMKII, and those alterations were reversed after insulin administration.	1
1961	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and @PROTEIN$, and those alterations were reversed after insulin administration.	1
1962	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of @PROTEIN$-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after insulin administration.	1
1963	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after @PROTEIN$ administration.	1
1964	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of @PROTEIN$-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after insulin administration.	1
1965	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and @PROTEIN$, and those alterations were reversed after insulin administration.	1
1966	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, @PROTEIN$ expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
1967	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, PKC-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), @PROTEIN$ medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
1968	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, @PROTEIN$-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
1969	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, PKC-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), @PROTEIN$ medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
1970	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, @PROTEIN$ expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	1
1971	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, @PROTEIN$-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	1
1972	Although the @COMPOUND$ levels in hippocampus (HC) and hypothalamus (HT) were not altered, the @PROTEIN$ expression and PKC 0.05) in level in HC.	0
1973	Although the @COMPOUND$ levels in hippocampus (HC) and hypothalamus (HT) were not altered, the @PROTEIN$-alpha expression and PKC 0.05) in level in HC.	0
1974	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (@PROTEIN$) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1975	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (@PROTEIN$) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1976	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and @PROTEIN$ in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1977	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (@PROTEIN$) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1978	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (@PROTEIN$) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1979	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and @PROTEIN$ in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1980	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (@PROTEIN$) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1981	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (@PROTEIN$) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1982	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (@COMPOUND$), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
1983	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate @COMPOUND$-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
1984	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 @COMPOUND$ specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
1985	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/CXCR4 and Ang1/@PROTEIN$ pathways and thereby likely increases SVZ neuroblast cell migration.	1
1986	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/CXCR4 and @PROTEIN$/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
1987	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates @PROTEIN$/CXCR4 and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
1988	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/@PROTEIN$ and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
1989	The MEK inhibitor @COMPOUND$ did not inhibit neurite outgrowth, and Y-27632 and staurosporine did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of ODQ on neurite outgrowth is independent of the ERK signaling pathway.	0
1990	The MEK inhibitor PD98059 did not inhibit neurite outgrowth, and Y-27632 and staurosporine did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of @COMPOUND$ on neurite outgrowth is independent of the ERK signaling pathway.	0
1991	The MEK inhibitor PD98059 did not inhibit neurite outgrowth, and Y-27632 and @COMPOUND$ did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of ODQ on neurite outgrowth is independent of the ERK signaling pathway.	0
1992	We used this model to identify a potent competitive inhibitor, N1,N7-dihexyl-1,7-diamino-4-azaheptane, and to develop an affinity column, 1,16-diamino4,13-diazahexadecane-linked @COMPOUND$, which was useful for the purification of @PROTEIN$.	1
1993	Rapid determination of @COMPOUND$ using engineered Escherichia coli overexpressing @PROTEIN$.	1
1994	Purification, characterization, and preliminary X-ray diffraction analysis of a @COMPOUND$-specific @PROTEIN$ from Cymbosema roseum seeds.	1
1995	Effects on haemolytic activity of single @COMPOUND$ substitutions in the Bordetella pertussis @PROTEIN$ pore-forming fragment.	1
1996	Associations between the uptake of 111In-@COMPOUND$-trastuzumab, @PROTEIN$ density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.	1
1997	The @COMPOUND$ (the final product of ATP hydrolysis by @PROTEIN$), have a recognized neuroprotective actions in the central nervous system (CNS) in pathological conditions.	1
1998	To this end, the cultured fibroblasts were analyzed for very @COMPOUND$ (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, @PROTEIN$ (DHAPAT) activity, peroxisomal thiolase, and catalase immunofluorescence.	0
1999	To this end, the cultured fibroblasts were analyzed for very @COMPOUND$ (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, dihydroxyacetone-phosphate acyltransferase (DHAPAT) activity, peroxisomal thiolase, and @PROTEIN$ immunofluorescence.	0
2000	To this end, the cultured fibroblasts were analyzed for very @COMPOUND$ (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, dihydroxyacetone-phosphate acyltransferase (@PROTEIN$) activity, peroxisomal thiolase, and catalase immunofluorescence.	0
2001	To this end, the cultured fibroblasts were analyzed for very @COMPOUND$ (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, dihydroxyacetone-phosphate acyltransferase (DHAPAT) activity, peroxisomal @PROTEIN$, and catalase immunofluorescence.	0
2002	Superoxide dismutase (SOD), @PROTEIN$ (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
2003	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), @PROTEIN$ (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
2004	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (@PROTEIN$) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
2005	Superoxide dismutase (@PROTEIN$), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
2006	Superoxide dismutase (SOD), @PROTEIN$ (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
2007	@PROTEIN$ (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
2008	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (@PROTEIN$) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
2009	@PROTEIN$ (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
2010	Superoxide dismutase (@PROTEIN$), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
2011	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), @PROTEIN$ (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
2012	Inhibition of apoptotic signaling and neointimal hyperplasia by @COMPOUND$ and @PROTEIN$ following vascular injury.	1
2013	Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of HMGB1-mediated reactive @COMPOUND$ species generation, cytokine secretion, and @PROTEIN$ expression by primary monocytes and macrophage-like THP-1 cell lines.	0
2014	Forced cytoplasmic overexpression of @PROTEIN$ profoundly attenuated the upregulation of HMGB1-mediated reactive @COMPOUND$ species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.	1
2015	Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of @PROTEIN$-mediated reactive @COMPOUND$ species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.	1
2016	NO, a gas, is produced from L-@COMPOUND$ by different isoforms of @PROTEIN$ (NOS) and serves many normal physiologic purposes, such as promoting vasodilation of blood vessels and mediating communication between nervous system cells.	1
2017	NO, a gas, is produced from L-@COMPOUND$ by different isoforms of nitric oxide synthase (@PROTEIN$) and serves many normal physiologic purposes, such as promoting vasodilation of blood vessels and mediating communication between nervous system cells.	1
2018	1x10(-5) mol L(-1)), most of the site marker reacted with the quercetin-@PROTEIN$, but free @COMPOUND$ was present at higher concentrations.	0
2019	Under optimum conditions, the fluorescence intensity of @PROTEIN$-GNPs is linearly proportional to @COMPOUND$ concentration from 6.0x10(-8)mol/L to 8.0x10(-6)mol/L with a detection limit of 1.0x10(-8)mol/L.	1
2020	Monolayer surface pressure measurement showed VT1, but not VT2, bound @COMPOUND$) at cellular DRM surface pressures, and confirmed loss of VT1 and @PROTEIN$ (but not VT2) specific C18Gb(3) binding.	0
2021	@PROTEIN$ inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary @COMPOUND$.	0
2022	Immunofluorescence analysis revealed that two known virulence-associated surface proteins featuring @COMPOUND$-X-Thr-Gly motif, @PROTEIN$-released protein and surface antigen one, were absent in the DeltasrtA.	0
2023	Immunofluorescence analysis revealed that two known virulence-associated @PROTEIN$ featuring @COMPOUND$-X-Thr-Gly motif, muramidase-released protein and surface antigen one, were absent in the DeltasrtA.	1
2024	Immunofluorescence analysis revealed that two known virulence-associated @PROTEIN$ featuring Leu-Pro-X-Thr-@COMPOUND$ motif, muramidase-released protein and surface antigen one, were absent in the DeltasrtA.	1
2025	Immunofluorescence analysis revealed that two known virulence-associated surface proteins featuring Leu-Pro-X-Thr-@COMPOUND$ motif, @PROTEIN$-released protein and surface antigen one, were absent in the DeltasrtA.	0
2026	In addition, neuronal @PROTEIN$, another component of the NMDA/@COMPOUND$/cGMP intracellular pathway, has been reported to be dysregulated in schizophrenia patients.	1
2027	In addition, neuronal @PROTEIN$, another component of the NMDA/nitric oxide/@COMPOUND$ intracellular pathway, has been reported to be dysregulated in schizophrenia patients.	1
2028	A role for @PROTEIN$ in @COMPOUND$-induced fever in Pekin ducks (Anas platyrhynchos): is natriuretic peptide an endogenous antipyretic in birds.	0
2029	We induced fever in Pekin ducks with @COMPOUND$ and, at the same time, treated the animals with @PROTEIN$ antiserum at a dose that effectively inhibited the known renal actions of endogenously secreted natriuretic peptide.	0
2030	Among the Gram-negative bacteria, 100% of the Escherichia coli isolates (including extended spectrum @PROTEIN$ (ESBL)-producers) were @COMPOUND$-susceptible, while about 10% of the Enterobacter cloacae and Klebsiella pneumoniae isolates were resistant.	1
2031	The data presented here show that NH4Cl (5 mM) mediates astroglial cell swelling, and that treatment with NH4Cl or @COMPOUND$ (25 mM) causes rearrangements of @PROTEIN$ filaments and reduces astroglial glutamate uptake capacity.	1
2032	Thus, under cadmium stress, @PROTEIN$ and gamma-glutamyl transferase seem to work together to assure an efficient @COMPOUND$ turnover stored in the vacuole.	1
2033	Thus, under @COMPOUND$ stress, @PROTEIN$ and gamma-glutamyl transferase seem to work together to assure an efficient glutathione turnover stored in the vacuole.	1
2034	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (dopamine-2, @COMPOUND$ type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
2035	No relationships were observed among mercury, @COMPOUND$, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
2036	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (@COMPOUND$-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
2037	No relationships were observed among mercury, @COMPOUND$, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
2038	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (@COMPOUND$-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
2039	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (dopamine-2, @COMPOUND$ type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
2040	No relationships were observed among @COMPOUND$, selenium, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
2041	No relationships were observed among @COMPOUND$, selenium, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
2042	Despite responsive antioxidative defense (increased activities of superoxide dismutase, ascorbate @PROTEIN$, and pyrogallol peroxidase), @COMPOUND$+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	0
2043	Despite responsive antioxidative defense (increased activities of @PROTEIN$, ascorbate peroxidase, and pyrogallol peroxidase), @COMPOUND$+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	0
2044	However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like p22 (phox), @PROTEIN$ (phox), and Nox4.	1
2045	However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like @PROTEIN$ (phox), p47 (phox), and Nox4.	1
2046	However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like p22 (phox), p47 (phox), and @PROTEIN$.	1
2047	Decreased expression of @PROTEIN$, the binding site for @COMPOUND$, during epileptogenesis and chronic epilepsy.	1
2048	We previously showed that gene expression of @PROTEIN$ (SV2A), the binding site for the antiepileptic drug @COMPOUND$, is reduced during epileptogenesis in the rat.	1
2049	We previously showed that gene expression of synaptic vesicle protein 2A (@PROTEIN$), the binding site for the antiepileptic drug @COMPOUND$, is reduced during epileptogenesis in the rat.	1
2050	We also demonstrated that the deletion of the @PROTEIN$ gene doubled ATP-driven @COMPOUND$ synthesis and increased cellular ATP synthetic activity.	1
2051	Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of @PROTEIN$ phosphorylation and reactive @COMPOUND$ species generation.	0
2052	In the present study, we showed that selenocystine (SeC), a naturally occurring selenoamino acid, induced caspase-independent apoptosis in MCF-7 breast carcinoma cells, which was accompanied by poly(ADP-ribose) polymerase (@PROTEIN$) cleavage, caspase activation, DNA fragmentation, @COMPOUND$ exposure and nuclear condensation.	0
2053	In the present study, we showed that selenocystine (SeC), a naturally occurring selenoamino acid, induced caspase-independent apoptosis in MCF-7 breast carcinoma cells, which was accompanied by poly(@PROTEIN$-ribose) polymerase (PARP) cleavage, caspase activation, DNA fragmentation, @COMPOUND$ exposure and nuclear condensation.	0
2054	Silencing and attenuating of @PROTEIN$ activation with RNA interference and @COMPOUND$ treatment, respectively, partially suppressed SeC-induced cell apoptosis.	1
2055	Within 10min of NH(2) Cl treatment, c-Jun N-terminal kinase (@PROTEIN$) activation and elevation of cytosolic @COMPOUND$+) were observed.	0
2056	Within 10min of NH(2) @COMPOUND$ treatment, c-Jun N-terminal kinase (@PROTEIN$) activation and elevation of cytosolic Ca(2+) were observed.	0
2057	Within 10min of NH(2) Cl treatment, c-@PROTEIN$ N-terminal kinase (JNK) activation and elevation of cytosolic @COMPOUND$+) were observed.	0
2058	Within 10min of NH(2) @COMPOUND$ treatment, c-@PROTEIN$ N-terminal kinase (JNK) activation and elevation of cytosolic Ca(2+) were observed.	0
2059	Induction in the activity of @PROTEIN$ and azoreductase was observed during decolorization of @COMPOUND$ in the batch culture, which represented their role in degradation.	1
2060	Induction in the activity of lignin peroxidase and @PROTEIN$ was observed during decolorization of @COMPOUND$ in the batch culture, which represented their role in degradation.	1
2061	Treatment with @COMPOUND$ resulted in dose- and time-dependent inhibition of growth of BeWo cells with IC(50) values of 2.01 and 1.19 microM for 7 and 24 h respectively, accompanied by downregulation of @PROTEIN$.	1
2062	Obesity increases @PROTEIN$ resistance and @COMPOUND$ intolerance and also exacerbates metabolic abnormalities present in type 2 diabetes.	0
2063	Inhibition of @PROTEIN$ kinase by @COMPOUND$ : Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.	1
2064	The investigation included simulated docking experiments to fit @COMPOUND$ within the binding pocket of @PROTEIN$ followed by experimental in vitro and in vivo validations.	1
2065	Studies using 1-@COMPOUND$ (1-MT), the specific inhibitor of IDO, showed that this enzyme is important in @PROTEIN$ (IFN-gamma)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	0
2066	Studies using 1-methyl-tryptophan (@COMPOUND$), the specific inhibitor of IDO, showed that this enzyme is important in interferon-gamma (@PROTEIN$)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
2067	Studies using 1-@COMPOUND$ (1-MT), the specific inhibitor of IDO, showed that this enzyme is important in interferon-gamma (@PROTEIN$)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
2068	Studies using 1-methyl-tryptophan (@COMPOUND$), the specific inhibitor of IDO, showed that this enzyme is important in @PROTEIN$ (IFN-gamma)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
2069	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, Substance P, cannabinoid receptors 1 and 2 (CB(1), CB(2)), and the neuronal activation marker @PROTEIN$ in the least shrew (Cryptotis parva).	0
2070	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, @PROTEIN$, cannabinoid receptors 1 and 2 (CB(1), CB(2)), and the neuronal activation marker Fos in the least shrew (Cryptotis parva).	0
2071	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, Substance P, @PROTEIN$ and 2 (CB(1), CB(2)), and the neuronal activation marker Fos in the least shrew (Cryptotis parva).	0
2072	To observe the inhibitory effects of TSP-1 functional fragments, critical for @PROTEIN$ binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
2073	To observe the inhibitory effects of @PROTEIN$ functional fragments, critical for CD36 binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
2074	To observe the inhibitory effects of TSP-1 functional fragments, critical for CD36 binding, on the activation of L-@PROTEIN$, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
2075	The pERE@PROTEIN$9 vector was delivered to a single MCF-7 using a nanoneedle and the effect of @COMPOUND$, which is an antagonist of estrogen, was observed using the GFP expression level.	0
2076	By @COMPOUND$ treatment, the fluorescence intensity of the @PROTEIN$ was decreased by 30-50% within 24h.	1
2077	Effect of different @PROTEIN$ dosages on cell viability and @COMPOUND$ production by Kluyveromyces marxianus in SSF processes.	1
2078	Crustacean hyperglycemic hormone (@PROTEIN$) not only plays an important role in the modulation of hemolymph @COMPOUND$ level but also functions in other biological events including molting, reproduction and stress response.	1
2079	@PROTEIN$ (CHH) not only plays an important role in the modulation of hemolymph @COMPOUND$ level but also functions in other biological events including molting, reproduction and stress response.	1
2080	As a proof-of-concept, @PROTEIN$-coated QDs (ConA-QDs) and @COMPOUND$-coated AuNPs (Dex-AuNPs) were used to detect the mannosylated proteins.	0
2081	As a proof-of-concept, Concanavalin A-coated QDs (@PROTEIN$-QDs) and @COMPOUND$-coated AuNPs (Dex-AuNPs) were used to detect the mannosylated proteins.	0
2082	In this study, a representative FRET system (@PROTEIN$ donor and YFP acceptor) is compared with the BRET(2) system (Renilla luciferase donor, green fluorescent protein (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0
2083	In this study, a representative FRET system (CFP donor and YFP acceptor) is compared with the BRET(2) system (Renilla luciferase donor, green fluorescent protein (2) (@PROTEIN$ (2)) acceptor and @COMPOUND$ substrate).	0
2084	In this study, a representative FRET system (CFP donor and YFP acceptor) is compared with the BRET(2) system (Renilla @PROTEIN$ donor, green fluorescent protein (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0
2085	In this study, a representative FRET system (CFP donor and @PROTEIN$ acceptor) is compared with the BRET(2) system (Renilla luciferase donor, green fluorescent protein (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0
2086	In this study, a representative FRET system (CFP donor and YFP acceptor) is compared with the BRET(2) system (Renilla luciferase donor, @PROTEIN$ (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0
2087	If no pretreatment applied, hydrolyses of the textiles by cellulase and @PROTEIN$ for 24 h followed by simultaneous saccharification and fermentation (SSF) in 4 days, resulted in 0.140-0.145 g @COMPOUND$/g textiles, which was 25-26% of the corresponding theoretical yield.	1
2088	If no pretreatment applied, hydrolyses of the textiles by @PROTEIN$ and beta-glucosidase for 24 h followed by simultaneous saccharification and fermentation (SSF) in 4 days, resulted in 0.140-0.145 g @COMPOUND$/g textiles, which was 25-26% of the corresponding theoretical yield.	1
2089	In cystic fibrosis, this equilibrium is disrupted by mutations in the cystic fibrosis transmembrane conductance regulator (@PROTEIN$) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent Cl (-) secretion and predominant @COMPOUND$ (+) absorption.	1
2090	In cystic fibrosis, this equilibrium is disrupted by mutations in the cystic fibrosis transmembrane conductance regulator (@PROTEIN$) gene resulting in the absence of functional CFTR protein, which in turn results in deficient @COMPOUND$-dependent Cl (-) secretion and predominant Na (+) absorption.	1
2091	In cystic fibrosis, this equilibrium is disrupted by mutations in the @PROTEIN$ (CFTR) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent Cl (-) secretion and predominant @COMPOUND$ (+) absorption.	1
2092	In cystic fibrosis, this equilibrium is disrupted by mutations in the @PROTEIN$ (CFTR) gene resulting in the absence of functional CFTR protein, which in turn results in deficient @COMPOUND$-dependent Cl (-) secretion and predominant Na (+) absorption.	1
2093	In cystic fibrosis, this equilibrium is disrupted by mutations in the cystic fibrosis transmembrane conductance regulator (@PROTEIN$) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent @COMPOUND$ (-) secretion and predominant Na (+) absorption.	1
2094	In cystic fibrosis, this equilibrium is disrupted by mutations in the @PROTEIN$ (CFTR) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent @COMPOUND$ (-) secretion and predominant Na (+) absorption.	1
2095	Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&gt;G) of the @PROTEIN$, which results in a leucine-to-@COMPOUND$ substitution at codon 173.	1
2096	Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&gt;G) of the @PROTEIN$, which results in a @COMPOUND$-to-arginine substitution at codon 173.	1
2097	@COMPOUND$ inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of @PROTEIN$ in rat mesangial cells.	1
2098	Previous studies support the hypotheses that @PROTEIN$ is involved in AngII-induced water, but not @COMPOUND$ intake and that MAP kinase plays a role in NaCl consumption, but not water intake, after injection of AngII.	0
2099	Pretreatment with the PKC inhibitor chelerythrine attenuated @PROTEIN$-induced water intake, but @COMPOUND$ intake was unaffected.	0
2100	Pretreatment with the PKC inhibitor @COMPOUND$ attenuated @PROTEIN$-induced water intake, but NaCl intake was unaffected.	1
2101	In contrast, pretreatment with U0126, a MAP kinase inhibitor, had no effect on @PROTEIN$-induced water intake, but attenuated @COMPOUND$ intake.	0
2102	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood @COMPOUND$ and low @PROTEIN$ cholesterol were not.	0
2103	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood glucose and low @PROTEIN$ @COMPOUND$ were not.	1
2104	Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in @COMPOUND$ and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as corticotropin-releasing factor (@PROTEIN$), in the extended amygdala.	1
2105	Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in @COMPOUND$ and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as @PROTEIN$ (CRF), in the extended amygdala.	1
2106	Neither enzymatic activity of transaminases (@PROTEIN$ and ALT) nor @COMPOUND$ levels were significantly altered.	0
2107	On other hand, @PROTEIN$ gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to @COMPOUND$ or erlotinib.	1
2108	On other hand, @PROTEIN$ gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to gefitinib or @COMPOUND$.	1
2109	Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, monocyte chemotactic protein-1, @COMPOUND$, osteopontin, and @PROTEIN$ were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.	0
2110	Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, @PROTEIN$, @COMPOUND$, osteopontin, and alkaline phosphatase were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.	0
2111	Transitions in the @COMPOUND$ microenvironment and secondary structure of two monocot @PROTEIN$ from Sauromatum guttatum and Arisaema tortuosum under different denaturing conditions were studied by steady state and time resolved fluorescence and CD spectroscopy.	0
2112	Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M Gdn-@COMPOUND$ or 6 M Urea or at pH 2.0 and below.	1
2113	Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M Gdn-HCl or 6 M @COMPOUND$ or at pH 2.0 and below.	1
2114	Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M @COMPOUND$-HCl or 6 M Urea or at pH 2.0 and below.	1
2115	In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (ICAM-1) and @PROTEIN$ (MCP-1), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0
2116	In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (@PROTEIN$) and monocyte chemoattractant protein-1 (MCP-1), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0
2117	In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (@PROTEIN$), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0
2118	We examined @COMPOUND$ (1,25(OH)(2)D(3))-induced expression of 25-hydroxyvitamin D(3) 24-hydroxylase (CYP24) and apical calcium channel (@PROTEIN$) mRNA levels in 2-, 9-, and 15-day cultures Caco-2 cells that model proliferating, post-proliferative, and differentiated enterocytes.	1
2119	We examined @COMPOUND$ (1,25(OH)(2)D(3))-induced expression of 25-hydroxyvitamin D(3) 24-hydroxylase (@PROTEIN$) and apical calcium channel (TRPV6) mRNA levels in 2-, 9-, and 15-day cultures Caco-2 cells that model proliferating, post-proliferative, and differentiated enterocytes.	1
2120	Here, we tested the hypothesis that interactions with @PROTEIN$ play a role in the DNA-damaging properties of @COMPOUND$.	0
2121	Next, we selected @COMPOUND$ as the most DNA-damaging Alternaria metabolite for further studies of interactions with @PROTEIN$.	0
2122	Stabilisation of covalent @PROTEIN$ II-DNA intermediates by @COMPOUND$ was also detectable in cell culture, and here, the IIalpha isoform was preferentially targeted.	1
2123	In contrast, SKI-1 (@PROTEIN$ or site-1) is a membrane-bound serine protease inhibitable by @COMPOUND$.	1
2124	In contrast, @PROTEIN$ (S1P or site-1) is a membrane-bound serine protease inhibitable by @COMPOUND$.	1
2125	In contrast, SKI-1 (S1P or site-1) is a membrane-bound @PROTEIN$ inhibitable by @COMPOUND$.	1
2126	The progressive ankylosis gene (ank) is a @PROTEIN$ that transports intracellular @COMPOUND$ to the extracellular milieu.	1
2127	@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to @COMPOUND$-glucose deprivation in murine neonatal organotypic hippocampal slices.	1
2128	@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to oxygen-@COMPOUND$ deprivation in murine neonatal organotypic hippocampal slices.	1
2129	The role of tumor necrosis factor (@PROTEIN$) receptors 1 and 2 in @COMPOUND$ (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	1
2130	The role of @PROTEIN$ (TNF) receptors 1 and 2 in @COMPOUND$ (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	1
2131	Accommodation of @COMPOUND$ and its analogues by @PROTEIN$ is dominated by hydrophobic interactions.	1
2132	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or @COMPOUND$ red (RuR).	0
2133	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or @COMPOUND$ red (RuR).	0
2134	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or ruthenium red (@COMPOUND$).	0
2135	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), @COMPOUND$ (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (RuR).	0
2136	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (@COMPOUND$).	0
2137	Cells were grown for 24 h with @COMPOUND$ in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or ruthenium red (RuR).	0
2138	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), @COMPOUND$ (L-NAME), @PROTEIN$ (SOD), or ruthenium red (RuR).	0
2139	Cells were grown for 24 h with @COMPOUND$ in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (RuR).	0
2140	Synaptic vesicle-bound @PROTEIN$ can support vesicular @COMPOUND$ uptake.	1
2141	We examined the expression of @PROTEIN$ and ASCT1 in @COMPOUND$ (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.	1
2142	We examined the expression of Phgdh and @PROTEIN$ in @COMPOUND$ (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.	1
2143	A significant decrease in @PROTEIN$ in the whole hippocampus was observed after MP4 with a tendency to recover to normal values in @COMPOUND$ by western blot assay.	1
2144	Heart glycogen represents a store of glucosyl residues which are mobilized by the catalysis of @PROTEIN$ (GP) and are mainly destined to serve as substrates for the generation of @COMPOUND$.	0
2145	The aim of this study was to determine the changes in serum @PROTEIN$, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
2146	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (@PROTEIN$), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
2147	The aim of this study was to determine the changes in serum leptin, @PROTEIN$-alpha (TNF-alpha), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
2148	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (@PROTEIN$), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
2149	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
2150	Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant-174G&gt;C with circulating @COMPOUND$ levels, @PROTEIN$ levels, and body mass index.	0
2151	Joint analysis of individual participants' data from 17 studies on the association of the @PROTEIN$ variant-174G&gt;C with circulating @COMPOUND$ levels, interleukin-6 levels, and body mass index.	0
2152	Effect of @PROTEIN$ *3 genotype on the stereoselective pharmacokinetics of @COMPOUND$ in healthy subjects.	1
2153	In conclusion, the present study showed that despite the evidence that @COMPOUND$ is stereoselectively metabolized, @PROTEIN$ *3 genotype did not affect stereoselective disposition of amlodipine.	0
2154	Differences in the expression of inwardly rectifying potassium channels (Kir4.1), glial fibrillary @PROTEIN$ (GFAP), and @COMPOUND$ levels in cortical astrocytes were detected using immunohistochemical methods.	0
2155	Differences in the expression of inwardly rectifying potassium channels (@PROTEIN$), glial fibrillary acidic protein (GFAP), and @COMPOUND$ levels in cortical astrocytes were detected using immunohistochemical methods.	0
2156	Differences in the expression of inwardly rectifying potassium channels (Kir4.1), glial fibrillary acidic protein (@PROTEIN$), and @COMPOUND$ levels in cortical astrocytes were detected using immunohistochemical methods.	0
2157	In addition, we used PET to evaluate the striatal dopamine transporter availability (@PROTEIN$) with ((11)C)d-threo-@COMPOUND$ in the patient group.	1
2158	Associated with the mitochondrial permeabilization, PdC also induced the release of @PROTEIN$, which is sensitive to inhibition by @COMPOUND$.	1
2159	Here, the @PROTEIN$-mediated (45)Ca(2+) uptake was compared in @COMPOUND$ (+)-loaded pig coronary artery smooth muscle and endothelial cells.	0
2160	The recent approval of sunitinib, sorafenib, @COMPOUND$ and bevacizumab in combination with @PROTEIN$ has revolutionized the management of renal cell carcinoma.	0
2161	The recent approval of sunitinib, @COMPOUND$, temsirolimus and bevacizumab in combination with @PROTEIN$ has revolutionized the management of renal cell carcinoma.	0
2162	The recent approval of @COMPOUND$, sorafenib, temsirolimus and bevacizumab in combination with @PROTEIN$ has revolutionized the management of renal cell carcinoma.	0
2163	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: p53, p300, and @PROTEIN$.	1
2164	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: @PROTEIN$, p300, and CREB-binding protein.	1
2165	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: p53, @PROTEIN$, and CREB-binding protein.	1
2166	In @PROTEIN$-D patients, plasma triglycerides, apolipoprotein B-48 (apoB-48), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0
2167	In CD36-D patients, plasma triglycerides, apolipoprotein B-48 (@PROTEIN$), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0
2168	In CD36-D patients, plasma triglycerides, @PROTEIN$ (apoB-48), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0
2169	Identification of @PROTEIN$ as a candidate gene for regulation of responsiveness to dietary @COMPOUND$ in rats.	1
2170	Here we narrowed Dihc2 to a region including 33 genes and predicted transcripts and identified RGD1309450_predicted, a homologous gene of @PROTEIN$, as a strong candidate for responsiveness to dietary @COMPOUND$.	1
2171	@COMPOUND$ is a strong correlate of @PROTEIN$ levels in men and postmenopausal women.	1
2172	Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% @COMPOUND$ at 140 degrees C for 30 min and enzymatic hydrolysis with cellulase (15 filter per unit (FPU)/g cellulose) and @PROTEIN$ (50 cellobiose units (CBU)/g cellulose).	0
2173	Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% @COMPOUND$ at 140 degrees C for 30 min and enzymatic hydrolysis with @PROTEIN$ (15 filter per unit (FPU)/g cellulose) and beta-glucosidase (50 cellobiose units (CBU)/g cellulose).	0
2174	Catalase, myeloperoxidase (@PROTEIN$), glutathione peroxidase (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
2175	Catalase, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), @PROTEIN$ (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
2176	@PROTEIN$, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
2177	Catalase, myeloperoxidase (MPO), @PROTEIN$ (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
2178	Catalase, myeloperoxidase (MPO), @PROTEIN$ (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
2179	@PROTEIN$, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
2180	Catalase, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), @PROTEIN$ (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
2181	Catalase, myeloperoxidase (@PROTEIN$), glutathione peroxidase (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
2182	In this study we examined the possible antigenotoxic effect of selenium (Se) in rats chronically exposed to low levels of @COMPOUND$ (MeHg) and the association between @PROTEIN$ (GSH-Px) activity and DNA lesions (via comet assay) in the same exposed animals.	0
2183	In this study we examined the possible antigenotoxic effect of selenium (Se) in rats chronically exposed to low levels of methylmercury (@COMPOUND$) and the association between @PROTEIN$ (GSH-Px) activity and DNA lesions (via comet assay) in the same exposed animals.	0
2184	To investigate any similarities in the inhibition of @PROTEIN$ by quinacrine and @COMPOUND$, molecular modeling techniques were adopted and revealed that quinacrine molecule anchors inside the same binding pocket of the protein where disulfiram is also attached.	1
2185	administered during 7 days at 20 mg/kg per day (subacute treatment), @COMPOUND$ abrogated LPS-induced erythrocytes lipoperoxidation and catalase (@PROTEIN$) activity depression to control levels.	1
2186	administered during 7 days at 20 mg/kg per day (subacute treatment), @COMPOUND$ abrogated LPS-induced erythrocytes lipoperoxidation and @PROTEIN$ (CAT) activity depression to control levels.	1
2187	H2S can be produced from @COMPOUND$ by enzymes such as @PROTEIN$.	1
2188	The present study was undertaken to test the hypothesis that PPARalpha activator @COMPOUND$ plays a key role in left ventricular hypertrophic remodelling via the formation of c-@PROTEIN$/c-jun heterodimers in spontaneous hypertensive rats (SHRs).	1
2189	The present study was undertaken to test the hypothesis that PPARalpha activator @COMPOUND$ plays a key role in left ventricular hypertrophic remodelling via the formation of c-fos/c-@PROTEIN$ heterodimers in spontaneous hypertensive rats (SHRs).	1
2190	In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), @PROTEIN$ (about 454 %) and P-HSF (about 371 %) when compared with ferrous @COMPOUND$ or ferritin without AA.	0
2191	In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), HSF (about 454 %) and P-HSF (about 371 %) when compared with ferrous @COMPOUND$ or @PROTEIN$ without AA.	0
2192	SWCNT coatings were thus functionalized with poly(@COMPOUND$-pyrrole) and applied to the anchoring of glucose oxidase (@PROTEIN$), modified with beta-cyclodextrin.	1
2193	SWCNT coatings were thus functionalized with poly(@COMPOUND$-pyrrole) and applied to the anchoring of @PROTEIN$ (GOX), modified with beta-cyclodextrin.	1
2194	This allows the immobilization of @COMPOUND$-tagged @PROTEIN$.	1
2195	@COMPOUND$-induced bone @PROTEIN$ (BMP) 2 expression during bone regeneration: an immunohistochemical study.	1
2196	@COMPOUND$-induced bone morphogenetic protein (@PROTEIN$) 2 expression during bone regeneration: an immunohistochemical study.	1
2197	Although we reported that 8-Cl-cAMP induces growth inhibition via p38 mitogen-activated protein kinase (@PROTEIN$) and a metabolite of 8-Cl-cAMP, 8-Cl-@COMPOUND$ mediates this process, the action mechanism of 8-Cl-cAMP is still uncertain.	1
2198	Certain non-steroidal anti-inflammatory drugs, e.g., the @PROTEIN$-specific nonsteroidal anti-inflammatory drugs, @COMPOUND$, raise Abeta(42) levels.	1
2199	This was significantly in accordance with intracellular oxidative stress levels measured by glutathione depletion, @COMPOUND$ production, @PROTEIN$ inhibition as well as reactive oxygen species generation.	0
2200	This was significantly in accordance with intracellular oxidative stress levels measured by glutathione depletion, malondialdehyde production, @PROTEIN$ inhibition as well as reactive @COMPOUND$ species generation.	0
2201	This was significantly in accordance with intracellular oxidative stress levels measured by @COMPOUND$ depletion, malondialdehyde production, @PROTEIN$ inhibition as well as reactive oxygen species generation.	0
2202	@COMPOUND$, @PROTEIN$ and CRP as markers of silent brain infarction.	0
2203	@COMPOUND$, IL-6 and @PROTEIN$ as markers of silent brain infarction.	0
2204	We found previously that increased levels of polyamine oxidase (PAO) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (@PROTEIN$)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
2205	We found previously that increased levels of polyamine oxidase (@PROTEIN$) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
2206	We found previously that increased levels of @PROTEIN$ (PAO) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
2207	We found previously that increased levels of polyamine oxidase (PAO) (acetylpolyamine oxidase (AcPAO) plus @PROTEIN$ (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
2208	We then investigated whether silent brain infarction (SBI) can be detected by measuring @COMPOUND$, @PROTEIN$, or other biomarkers.	0
2209	It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), @PROTEIN$ (IL-6) and C-reactive protein (CRP) were significantly higher in SBI than in normal subjects.	0
2210	It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), interleukin-6 (@PROTEIN$) and C-reactive protein (CRP) were significantly higher in SBI than in normal subjects.	0
2211	It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), interleukin-6 (IL-6) and C-reactive protein (@PROTEIN$) were significantly higher in SBI than in normal subjects.	0
2212	Human skin keratinocytes HaCat attacked by Staphylococcus aureus @PROTEIN$ showed a transient drop of cellular @COMPOUND$ levels whereas in toxin-perforated bovine mammary epithelial cells (BMEC), the ATP levels dropped more slowly.	1
2213	A novel @COMPOUND$-specific @PROTEIN$ from Phaseolus coccineus seeds with potent antineoplastic and antifungal activities.	1
2214	A novel @PROTEIN$ (PCL) with specificity towards @COMPOUND$ was purified from Phaseolus coccineus L. (P. multiflorus willd) seeds using ion exchange chromatography on CM and DEAE-Sepharose, and gel filtration on Sephacryl S-200 column.	1
2215	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (@PROTEIN$) activation.	0
2216	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/@PROTEIN$ (MAPK) activation.	0
2217	We have previously shown that ROS-induced @PROTEIN$ expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MAPK) activation.	1
2218	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and @PROTEIN$ (EGFR)/mitogen-activated protein kinase (MAPK) activation.	0
2219	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (@PROTEIN$)/mitogen-activated protein kinase (MAPK) activation.	0
2220	Alkaline phosphatase activity and @PROTEIN$ expression of the osteoblasts cultured on the @COMPOUND$ scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.	0
2221	@PROTEIN$ activity and osteonectin expression of the osteoblasts cultured on the @COMPOUND$ scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.	0
2222	The @PROTEIN$ activity of osteoblasts cultured on @COMPOUND$ scaffolds is comparable with that from two commercially-available scaffolds-OPLA and collagen scaffolds (Becton-Dickinson (BD) Inc., Franklin Lakes, NJ, USA).	0
2223	The vasodilating effect of @COMPOUND$ and dorzolamide involves mechanisms other than @PROTEIN$ inhibition.	0
2224	The vasodilating effect of acetazolamide and @COMPOUND$ involves mechanisms other than @PROTEIN$ inhibition.	0
2225	The objective of the present study was to investigate the effects of a high-@COMPOUND$ diet on @PROTEIN$ expression and IR localization and activity in the rat liver.	1
2226	@PROTEIN$ and P53 play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to rapamycin and @COMPOUND$.	1
2227	P27 and @PROTEIN$ play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to @COMPOUND$ and paclitaxel.	1
2228	@PROTEIN$ and P53 play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to @COMPOUND$ and paclitaxel.	1
2229	P27 and @PROTEIN$ play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to rapamycin and @COMPOUND$.	1
2230	A novel hydrogen peroxide (H2O2) biosensor was developed by immobilizing @PROTEIN$ on the @COMPOUND$ modified electrochemical pretreated glassy carbon electrode (PGCE) via the bridging of an ethylenediamine monolayer.	1
2231	To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied the effects of @PROTEIN$ pathway with an activator of the protein kinase C, 12-O-tetradecanoylphorbol-13-acetate (TPA), during @COMPOUND$-induced erythroid differentiation of K562 erythroleukemia cells.	0
2232	To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied the effects of @PROTEIN$ pathway with an activator of the protein kinase C, @COMPOUND$ (TPA), during hemin-induced erythroid differentiation of K562 erythroleukemia cells.	1
2233	Taken together, our results suggested the involvement of @PROTEIN$ in TPA-potentiated apoptosis induction during @COMPOUND$-mediated erythroid differentiation in K562 cells.	0
2234	At glutamatergic synapses, increased binding to the @COMPOUND$-B site located in the @PROTEIN$ (NMDAR) can enhance neurotransmission via NMDARs.	1
2235	In vitro effect of radiation, antibody to epidermal growth factor receptor and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant @PROTEIN$ and over-expressed EGFR.	1
2236	In vitro effect of radiation, antibody to epidermal growth factor receptor and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant P53 and over-expressed @PROTEIN$.	1
2237	In vitro effect of radiation, antibody to @PROTEIN$ and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR.	0
2238	The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by HOBt/@COMPOUND$.	1
2239	The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by @COMPOUND$/HBTU.	1
2240	Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-@COMPOUND$) structures and their characterization for @PROTEIN$-galectin-mediated binding of ECM glycoproteins to biomaterial surfaces.	1
2241	Chemo-enzymatic synthesis of @COMPOUND$ (poly-LacNAc) structures and their characterization for CGL2-@PROTEIN$-mediated binding of ECM glycoproteins to biomaterial surfaces.	1
2242	Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-@COMPOUND$) structures and their characterization for CGL2-@PROTEIN$-mediated binding of ECM glycoproteins to biomaterial surfaces.	1
2243	Chemo-enzymatic synthesis of @COMPOUND$ (poly-LacNAc) structures and their characterization for @PROTEIN$-galectin-mediated binding of ECM glycoproteins to biomaterial surfaces.	1
2244	Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-@COMPOUND$) structures and their characterization for CGL2-galectin-mediated binding of ECM @PROTEIN$ to biomaterial surfaces.	1
2245	Chemo-enzymatic synthesis of @COMPOUND$ (poly-LacNAc) structures and their characterization for CGL2-galectin-mediated binding of ECM @PROTEIN$ to biomaterial surfaces.	1
2246	@COMPOUND$ (poly-LacNAc) structures have been identified as important ligands for @PROTEIN$-mediated cell adhesion to extra-cellular matrix (ECM) proteins.	1
2247	Poly-N-acetyllactosamine (poly-@COMPOUND$) structures have been identified as important ligands for @PROTEIN$-mediated cell adhesion to extra-cellular matrix (ECM) proteins.	1
2248	We here present the biofunctionalization of surfaces with poly-@COMPOUND$ structures and subsequent binding of ECM @PROTEIN$.	1
2249	A mixture of poly-@COMPOUND$-structures covalently coupled to functionalized microtiter plates were identified for best binding to our model galectin His(6) @PROTEIN$.	1
2250	A mixture of poly-@COMPOUND$-structures covalently coupled to functionalized microtiter plates were identified for best binding to our model @PROTEIN$ His(6) CGL2.	1
2251	Seasonal variation of the metal (Zn, Fe, @COMPOUND$) and @PROTEIN$ concentrations in the liver cytosol of the European chub (Squalius cephalus L.).	0
2252	@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
2253	Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
2254	Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
2255	@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
2256	Loss-of-expression of @PROTEIN$ in tumor tissues has been suggested to correlate with tumor progression and to the relatively poorer outcomes of @COMPOUND$ analog treatment in some clinical trials.	1
2257	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, @PROTEIN$ (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
2258	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (@PROTEIN$, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
2259	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (@PROTEIN$), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
2260	We also examined cellular impedance responsiveness of PC 12 cells in response to phenotypic alteration especially with regard to modulation of ion fluxes using nerve growth factor (@PROTEIN$), dexamethasone and @COMPOUND$.	0
2261	We also examined cellular impedance responsiveness of PC 12 cells in response to phenotypic alteration especially with regard to modulation of ion fluxes using nerve growth factor (@PROTEIN$), @COMPOUND$ and forskolin.	0
2262	This paper investigates the effect of sterilisation by gamma irradiation (dose 2.5Mrad) on the following properties of @COMPOUND$ (PCL): (1) degradation rate (catalysed by @PROTEIN$), (2) mechanical properties, (3) the ability of cells to attach and subsequently grow on its surface.	1
2263	In order to investigate the role of spinal @PROTEIN$ in the phenomenon of @COMPOUND$-precipitated withdrawal we examined the effect of herpes simplex virus vector-mediated overexpression of proenkephalin in lumbar dorsal root ganglia in rats with neuropathic pain treated with morphine.	1
2264	The @PROTEIN$ were isolated by @COMPOUND$ treatment of crude extracts followed by chromatography on chitin.	1
2265	One hundred and forty-four HCV-2- and HCV-3-infected patients initiated Peg-@PROTEIN$-2a (180 microg/week) and @COMPOUND$ (1000 or 1200 mg/day); those with viral clearance at week 4 were randomized to either Peg-IFN alpha-2a monotherapy (n = 59) or continuing combination therapy (n = 61) until week 12.	0
2266	Thus in HCV-2- and HCV-3-infected patients, withdrawal of @COMPOUND$ and continuation of Peg-@PROTEIN$-2a monotherapy may be appropriate to attain an SVR, providing viraemia is cleared early during therapy and associated with low baseline viral load.	0
2267	The @PROTEIN$-deficient mouse, which develops atherosclerotic lesions rapidly when fed @COMPOUND$, was used to determine the ability of dried plums to reduce atherosclerosis.	0
2268	Inhibition in the brain is dominated by the neurotransmitter @COMPOUND$ (GABA); operating through @PROTEIN$.	1
2269	Inhibition in the brain is dominated by the neurotransmitter gamma-aminobutyric acid (@COMPOUND$); operating through @PROTEIN$.	1
2270	The inhibitors include mitogen-inducible gene-6 (@PROTEIN$)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
2271	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (@PROTEIN$).	0
2272	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/@PROTEIN$/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
2273	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/@PROTEIN$, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
2274	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, @PROTEIN$ (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
2275	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (@PROTEIN$)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
2276	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/@PROTEIN$, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
2277	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/@PROTEIN$ (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
2278	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (@PROTEIN$)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
2279	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (@PROTEIN$)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
2280	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the hemoglobin A (1c), non-fasting plasma @PROTEIN$, fasting blood @COMPOUND$ levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total cholesterol) with neutral effect on body weight.	0
2281	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the @PROTEIN$ (1c), non-fasting plasma insulin, fasting blood @COMPOUND$ levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total cholesterol) with neutral effect on body weight.	0
2282	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the @PROTEIN$ (1c), non-fasting plasma insulin, fasting blood glucose levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total @COMPOUND$) with neutral effect on body weight.	0
2283	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the hemoglobin A (1c), non-fasting plasma @PROTEIN$, fasting blood glucose levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total @COMPOUND$) with neutral effect on body weight.	0
2284	Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (@COMPOUND$) of Ascaris suum fused with cholera @PROTEIN$ subunit.	0
2285	Inhibition of human poly(A)-specific @PROTEIN$ (PARN) by @COMPOUND$ nucleotides: kinetic analysis.	1
2286	Inhibition of human poly(A)-specific ribonuclease (@PROTEIN$) by @COMPOUND$ nucleotides: kinetic analysis.	1
2287	The aqueous extract was found to be more effective than @COMPOUND$, a classical anticarcinogenic drug, with respect to its action on antioxidant enzymes and @PROTEIN$ in the liver of mice with developing lymphomas.	1
2288	Cu,Zn-@PROTEIN$-driven free radical modifications: @COMPOUND$- and carbonate radical anion-initiated protein radical chemistry.	0
2289	The understanding of the mechanism, oxidant(s) involved and how and what protein radicals are produced during the reaction of wild-type @PROTEIN$ (Cu,Zn-superoxide dismutase) with @COMPOUND$ and their fate is incomplete, but a better understanding of the role of this reaction is needed.	1
2290	The understanding of the mechanism, oxidant(s) involved and how and what protein radicals are produced during the reaction of wild-type SOD1 (Cu,Zn-@PROTEIN$) with @COMPOUND$ and their fate is incomplete, but a better understanding of the role of this reaction is needed.	1
2291	Finally, we propose a biochemical mechanism to explain CO(*-) production from CO2, enhanced protein radical formation and protection by (bi)carbonate against @COMPOUND$-induced fragmentation of the @PROTEIN$ active site.	1
2292	Imidazoline-induced amplification of glucose- and @COMPOUND$-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1
2293	Imidazoline-induced amplification of @COMPOUND$- and carbachol-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1
2294	@COMPOUND$-induced amplification of glucose- and carbachol-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1
2295	The picture of signalling mechanisms underlying the wound-regulated FAD7 expression, and potential roles of @PROTEIN$ proteins as attenuators of wound-induced @COMPOUND$ biosynthesis, are discussed.	0
2296	The picture of signalling mechanisms underlying the wound-regulated @PROTEIN$ expression, and potential roles of CPL proteins as attenuators of wound-induced @COMPOUND$ biosynthesis, are discussed.	0
2297	KiSS-1 mRNA was significantly increased by seizure activity in rats and when neuronal activity in organotypic hippocampal slice cultures was enhanced by kainate or @COMPOUND$, while mRNA for @PROTEIN$ remained essentially unchanged.	0
2298	KiSS-1 mRNA was significantly increased by seizure activity in rats and when neuronal activity in organotypic hippocampal slice cultures was enhanced by @COMPOUND$ or picrotoxin, while mRNA for @PROTEIN$ remained essentially unchanged.	0
2299	In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal cytochrome c oxidase (@PROTEIN$) activity after 49 days of @COMPOUND$ exposure.	1
2300	In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal @PROTEIN$ oxidase (COX) activity after 49 days of @COMPOUND$ exposure.	1
2301	@COMPOUND$, hematocrit, blood urea nitrogen, total protein, albumin, @PROTEIN$ 0.05) after transport regardless of space allowance.	0
2302	At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were @COMPOUND$ (7-@PROTEIN$) positive and annexin V negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	0
2303	At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were @COMPOUND$ (7-AAD) positive and @PROTEIN$ negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	0
2304	"Iron uptake by the ubiquitous iron-storage protein ferritin involves the oxidation of two @COMPOUND$) ions located at the highly conserved dinuclear "" @PROTEIN$ centre"" in individual subunits."	1
2305	"Iron uptake by the ubiquitous iron-storage protein @PROTEIN$ involves the oxidation of two @COMPOUND$) ions located at the highly conserved dinuclear "" ferroxidase centre"" in individual subunits."	1
2306	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear ferroxidase site) of recombinant human H-chain @PROTEIN$ (rHuHF) in their complexes with reactive Fe(II) and redox-inactive @COMPOUND$).	1
2307	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear @PROTEIN$ site) of recombinant human H-chain ferritin (rHuHF) in their complexes with reactive @COMPOUND$) and redox-inactive Zn(II).	1
2308	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear @PROTEIN$ site) of recombinant human H-chain ferritin (rHuHF) in their complexes with reactive Fe(II) and redox-inactive @COMPOUND$).	1
2309	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear ferroxidase site) of recombinant human H-chain @PROTEIN$ (rHuHF) in their complexes with reactive @COMPOUND$) and redox-inactive Zn(II).	1
2310	The aim of this study was to determine the effect of @COMPOUND$ on endothelial function in anti-tumour necrosis factor (@PROTEIN$)-naive RA patients.	1
2311	Compared with nonperfused constructs, flow perfused constructs demonstrated improved cells proliferation and differentiation according to cell viability, @COMPOUND$ consumption, @PROTEIN$ activity, and osteopontin.	0
2312	Behavior of rat periodontal ligament cells on @PROTEIN$-immobilized @COMPOUND$ surfaces treated by plasma modification.	1
2313	The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on fibroblast growth factor-2 (@PROTEIN$)-immobilized titanium surfaces treated by @COMPOUND$ (O2) plasma.	1
2314	The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on fibroblast growth factor-2 (@PROTEIN$)-immobilized titanium surfaces treated by oxygen (@COMPOUND$) plasma.	1
2315	The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on @PROTEIN$ (FGF-2)-immobilized titanium surfaces treated by @COMPOUND$ (O2) plasma.	1
2316	The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on fibroblast growth factor-2 (@PROTEIN$)-immobilized @COMPOUND$ surfaces treated by oxygen (O2) plasma.	1
2317	The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on @PROTEIN$ (FGF-2)-immobilized titanium surfaces treated by oxygen (@COMPOUND$) plasma.	1
2318	The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on @PROTEIN$ (FGF-2)-immobilized @COMPOUND$ surfaces treated by oxygen (O2) plasma.	1
2319	These were treated with @COMPOUND$ plasma and dipped in @PROTEIN$ solution.	0
2320	These findings suggest that @COMPOUND$ plasma modification can immobilize @PROTEIN$ onto a titanium surface.	1
2321	These findings suggest that oxygen plasma modification can immobilize @PROTEIN$ onto a @COMPOUND$ surface.	1
2322	The cells were mixed with @COMPOUND$ (beta-TCP) granules followed by osteoblast induction with recombinant human @PROTEIN$ (rhBMP-2) (first mixture), or were first induced with rhBMP-2 on plastic dishes and then mixed with the beta-TCP granules (last mixture) just prior to the operation.	0
2323	The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of @COMPOUND$ and lead, on brain monoamine oxidase (@PROTEIN$), an important neural enzyme.	1
2324	The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of @COMPOUND$ and lead, on brain @PROTEIN$ (MAO), an important neural enzyme.	1
2325	Methylene@COMPOUND$ dehydrogenase) @PROTEIN$) formyltetrahydrofolate synthetase (MTHFD1) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1
2326	Methylene@COMPOUND$ dehydrogenase) methenyltetrahydrofolate cyclohydrolase) formyltetrahydrofolate synthetase (@PROTEIN$) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1
2327	Methylene@COMPOUND$ dehydrogenase) methenyltetrahydrofolate cyclohydrolase) @PROTEIN$ (MTHFD1) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1
2328	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and @PROTEIN$ genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
2329	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, @PROTEIN$, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
2330	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and BRAF genes, methylation at @COMPOUND$ sites of @PROTEIN$ and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	1
2331	An oncogenetic tree model was built using data on mutations of TP53, @PROTEIN$, APC, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
2332	An oncogenetic tree model was built using data on mutations of @PROTEIN$, KRAS2, APC, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
2333	We characterized this selenoprotein @PROTEIN$ which had a single Sec residue at the catalytic site but no @COMPOUND$ (Cys) residues in the protein sequence.	0
2334	Zn2+-linked dimerization of @PROTEIN$ from Helicobacter pylori, a chaperone involved in @COMPOUND$ trafficking and urease activation.	1
2335	Zn2+-linked dimerization of UreG from Helicobacter pylori, a chaperone involved in @COMPOUND$ trafficking and @PROTEIN$ activation.	0
2336	The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a @COMPOUND$-carbamate functional group concomitantly with the delivery of two Ni(2+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1
2337	The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a lysine-carbamate functional group concomitantly with the delivery of two @COMPOUND$+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1
2338	The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a lysine-@COMPOUND$ functional group concomitantly with the delivery of two Ni(2+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1
2339	Residue-wise conformational stability of @PROTEIN$ dimer from native-state @COMPOUND$ exchange.	1
2340	Whereas the role of locally produced 1, @COMPOUND$ is not yet clear, it is possible that it contributes importantly to vitamin D-mediated inhibition of parathyroid cell growth, so @PROTEIN$ can be considered a candidate parathyroid tumor suppressor gene in that its acquired inactivation in a parathyroid cell could confer a tumorigenic growth advantage.	0
2341	Whereas the role of locally produced 1, 25-dihydroxy@COMPOUND$ is not yet clear, it is possible that it contributes importantly to vitamin D-mediated inhibition of parathyroid cell growth, so @PROTEIN$ can be considered a candidate parathyroid tumor suppressor gene in that its acquired inactivation in a parathyroid cell could confer a tumorigenic growth advantage.	0
2342	Mechanistically, we showed EphA2 knockdown suppressed @PROTEIN$-induced @COMPOUND$ 536 phosphorylation of NFkappaB, an event critical of ICAM-1 transcriptional upregulation.	1
2343	Mechanistically, we showed EphA2 knockdown suppressed thrombin-induced @COMPOUND$ 536 phosphorylation of NFkappaB, an event critical of @PROTEIN$ transcriptional upregulation.	1
2344	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, hemoglobin, transferrin saturation and @PROTEIN$ did not change significantly.	0
2345	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, hemoglobin, @PROTEIN$ saturation and ferritin did not change significantly.	0
2346	Total antioxidant capacity, @PROTEIN$, @COMPOUND$-reactive substances, hemoglobin, transferrin saturation and ferritin did not change significantly.	0
2347	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, @PROTEIN$, transferrin saturation and ferritin did not change significantly.	0
2348	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of cholesterol to @COMPOUND$ by cholesterol side-chain cleavage enzyme (@PROTEIN$).	1
2349	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of @COMPOUND$ to pregnenolone by @PROTEIN$ (CYP11A).	1
2350	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of @COMPOUND$ to pregnenolone by cholesterol side-chain cleavage enzyme (@PROTEIN$).	1
2351	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of cholesterol to @COMPOUND$ by @PROTEIN$ (CYP11A).	1
2352	LH, FSH, 17 @COMPOUND$, progesterone, aldosterone and @PROTEIN$ were assayed at the seventh, fourteenth, twenty-first and twenty-eighth days of the cycle after 30 min of recumbency.	0
2353	LH, FSH, 17 beta-estradiol, @COMPOUND$, aldosterone and @PROTEIN$ were assayed at the seventh, fourteenth, twenty-first and twenty-eighth days of the cycle after 30 min of recumbency.	0
2354	Aldosterone was positively related to @PROTEIN$ and @COMPOUND$.	0
2355	@PROTEIN$ activity and @COMPOUND$ levels may therefore be altered in 22q11DS individuals.	0
2356	@PROTEIN$ (158) genotype and plasma @COMPOUND$ levels were determined in the 22q11DS children.	0
2357	Quinone formation is closely linked to other representative hypotheses such as mitochondrial dysfunction, inflammation, oxidative stress, and dysfunction of the @PROTEIN$-proteasome system, in the pathogenesis of neurodegenerative diseases such as Parkinson's disease and @COMPOUND$-induced neurotoxicity.	0
2358	The effect of @COMPOUND$ exposure on birds was examined by measuring aerobic metabolism, blood hemoglobin content, plasma @PROTEIN$, and body weight for up to 21 d postdose.	1
2359	The effect of @COMPOUND$ exposure on birds was examined by measuring aerobic metabolism, blood @PROTEIN$ content, plasma cholinesterases, and body weight for up to 21 d postdose.	1
2360	Of the 18 E. coli isolated from healthy calves, @COMPOUND$ (16.6%) and intimin (55.5%) genes were identified by @PROTEIN$.	0
2361	Of the 18 E. coli isolated from healthy calves, @COMPOUND$ (16.6%) and @PROTEIN$ (55.5%) genes were identified by PCR.	0
2362	@COMPOUND$, F41, STa, Stx1 and @PROTEIN$ were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.	0
2363	K99, @COMPOUND$, STa, Stx1 and @PROTEIN$ were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.	0
2364	These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of @COMPOUND$-dependent @PROTEIN$ secretion, suppression of glucagon secretion, slowing of gastric emptying, and reduction of food intake.	1
2365	These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of @COMPOUND$-dependent insulin secretion, suppression of @PROTEIN$ secretion, slowing of gastric emptying, and reduction of food intake.	0
2366	Induction of @PROTEIN$ by @COMPOUND$ was also decreased in the BD group.	1
2367	Efforts in the field of synthetic vaccine carriers are focussing on decorating the particle surface with ligands for DC receptors such as heparan @COMPOUND$ glycosaminoglycan structures, integrins, Siglecs, ga@PROTEIN$, C-type lectins and toll-like receptors.	0
2368	Efforts in the field of synthetic vaccine carriers are focussing on decorating the particle surface with ligands for DC receptors such as heparan @COMPOUND$ glycosaminoglycan structures, integrins, Siglecs, @PROTEIN$, C-type lectins and toll-like receptors.	0
2369	Reversal of the inhibitory effect of @COMPOUND$ on @PROTEIN$ generation by rFVIIa, aPCC and PCC.	1
2370	Reversal of the inhibitory effect of fondaparinux on @PROTEIN$ generation by rFVIIa, a@COMPOUND$ and PCC.	1
2371	It appears that GSTM1 null and GSTT1 null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these @PROTEIN$ (mostly alkylating agents and @COMPOUND$).	1
2372	It appears that GSTM1 null and @PROTEIN$ null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these GSTs (mostly alkylating agents and @COMPOUND$).	1
2373	It appears that @PROTEIN$ null and GSTT1 null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these GSTs (mostly alkylating agents and @COMPOUND$).	1
2374	@COMPOUND$ attenuates antigen-specific IgE production through the modulation of @PROTEIN$/Th2 balance in ovalbumin-sensitized BALB/c mice.	1
2375	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	1
2376	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2377	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2378	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
2379	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	1
2380	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2381	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
2382	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2383	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	1
2384	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
2385	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2386	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2387	These results indicate that @COMPOUND$-induced TNF-alpha shedding could be attributed to @PROTEIN$ activation, which is regulated, in part, by PKC-delta and AR.	1
2388	These results indicate that @COMPOUND$-induced @PROTEIN$ shedding could be attributed to TACE activation, which is regulated, in part, by PKC-delta and AR.	1
2389	These results indicate that @COMPOUND$-induced TNF-alpha shedding could be attributed to TACE activation, which is regulated, in part, by @PROTEIN$ and AR.	0
2390	We conclude that gastrocnemius, heart, and liver mitochondria of streptozotocin diabetic rats are not irrevocably altered toward excess @COMPOUND$ production either by @PROTEIN$ or complex III.	1
2391	Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA @PROTEIN$ (MGMT).	1
2392	Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA methyltransferase (@PROTEIN$).	1
2393	Despite their inhibitory effects on inflammatory gene expression, loss of @PROTEIN$ or LXRs in macrophages did not exert major effects on obesity or @COMPOUND$ tolerance induced by a high-fat diet.	0
2394	Our results do not exclude a contribution of macrophage @PROTEIN$ and LXR expression to systemic metabolism in certain contexts, but these factors do not appear to be dominant contributors to @COMPOUND$ tolerance in a high-fat-fed Th1-biased bone marrow transplant model.	0
2395	The dark side of @COMPOUND$ deficiency: II. Type 2 diabetes and @PROTEIN$ resistance.	1
2396	A considerable body of evidence exists suggesting a link among reduced @COMPOUND$ plasma levels, type 2 diabetes (T2D), and @PROTEIN$ resistance (IR).	1
2397	Androgen therapy of hypogonadal men improves @PROTEIN$ sensitivity, fasting @COMPOUND$, and HbA1c levels.	0
2398	A mechanism for the bioreduction of H2PtCl6 and PtCl2 into @COMPOUND$ nanoparticles by a @PROTEIN$ enzyme from Fusarium oxysporum is proposed.	1
2399	Responses of limbic and extrapyramidal @PROTEIN$ systems to @COMPOUND$ treatment.	1
2400	Radioisotopic localization of (90) @COMPOUND$-ibritumomab tiuxetan in patients with @PROTEIN$+ non-Hodgkin's lymphoma.	1
2401	We solved the crystal structures of Aquifex aeolicus @PROTEIN$ and its complex with adenosine 5 '-(alpha,beta-methylene) triphosphate (@COMPOUND$).	1
2402	We solved the crystal structures of Aquifex aeolicus @PROTEIN$ and its complex with adenosine 5 '-(alpha,beta-@COMPOUND$) triphosphate (AMPCPP).	1
2403	"In @PROTEIN$. @COMPOUND$, the N-terminal loop, including the two residues, assumes different conformations (""open"" and ""closed"") between the two subunits."	1
2404	The results indicated that @PROTEIN$ receptors within the nucleus accumbens are involved in the acquisition and expression of @COMPOUND$-induced CPP in sensitized rats.	1
2405	Effect of obestatin on insulin, @PROTEIN$ and @COMPOUND$ secretion in the perfused rat pancreas.	0
2406	Effect of @PROTEIN$ on insulin, glucagon and @COMPOUND$ secretion in the perfused rat pancreas.	1
2407	Effect of obestatin on @PROTEIN$, glucagon and @COMPOUND$ secretion in the perfused rat pancreas.	0
2408	The potentiated effect of obestatin on @COMPOUND$-induced @PROTEIN$ output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
2409	The potentiated effect of @PROTEIN$ on @COMPOUND$-induced insulin output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
2410	The potentiated effect of obestatin on glucose-induced @PROTEIN$ output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
2411	The potentiated effect of @PROTEIN$ on glucose-induced insulin output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
2412	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (@COMPOUND$ (+), K(+), Cl (-)) contents, immunostained for albumin and glial fibrillary @PROTEIN$ (GFAP), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
2413	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (@COMPOUND$ (+), K(+), Cl (-)) contents, immunostained for albumin and glial fibrillary acidic protein (@PROTEIN$), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
2414	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (Na (+), K(+), @COMPOUND$ (-)) contents, immunostained for albumin and glial fibrillary acidic protein (@PROTEIN$), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
2415	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (Na (+), K(+), @COMPOUND$ (-)) contents, immunostained for albumin and glial fibrillary @PROTEIN$ (GFAP), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
2416	We administered @COMPOUND$ to newborn rats on postnatal days (PN) 1-4 at doses spanning the threshold for detectable @PROTEIN$ inhibition (0.1 mg/kg/day) and the first signs of loss of viability (0.2 mg/kg/day).	1
2417	We also assess prostaglandin (PGE (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and @PROTEIN$.	0
2418	We also assess prostaglandin (PGE (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for @PROTEIN$ and COX-2.	0
2419	We also assess prostaglandin (PGE (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and @PROTEIN$.	0
2420	We also assess prostaglandin (PGE (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for @PROTEIN$ and COX-2.	0
2421	We also assess prostaglandin (@PROTEIN$ (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and COX-2.	0
2422	We also assess prostaglandin (@PROTEIN$ (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and COX-2.	0
2423	High-dose steroid therapy for the former symptoms of AHS, and immunoglobulin, @PROTEIN$, and @COMPOUND$ for the latter agranulocytosis were successfully performed.	0
2424	0.05 vs. aortic IR) plasma levels of @COMPOUND$, P-selectin, intercellular adhesion molecule-1 (ICAM-I), and tissue levels of malondialdehyde and @PROTEIN$.	0
2425	Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of @PROTEIN$ or NPC2 proteins, leading to an accumulation of unesterified @COMPOUND$ and glycosphingolipids (GSLs) in the lysosomes.	1
2426	Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of NPC1 or @PROTEIN$ proteins, leading to an accumulation of unesterified @COMPOUND$ and glycosphingolipids (GSLs) in the lysosomes.	1
2427	@PROTEIN$-diminished arginine and indolamine 2,3-dioxygenase-diminished tryptophan) or @COMPOUND$ (NO) production.	0
2428	@PROTEIN$-diminished @COMPOUND$ and indolamine 2,3-dioxygenase-diminished tryptophan) or nitric oxide (NO) production.	1
2429	@PROTEIN$-diminished arginine and indolamine 2,3-dioxygenase-diminished @COMPOUND$) or nitric oxide (NO) production.	0
2430	The aim of the present study was to determine whether memory impairments were present in young women at increased familial risk of depression and whether memory performance was related either to @COMPOUND$ secretion or to allelic variation in the promoter region of the serotonin transporter gene (5-@PROTEIN$).	0
2431	The relative gene expression of @PROTEIN$ 0.05) in-@COMPOUND$ calves compared with+ Cu or-Cu+Mn calves.	1
2432	Effects of a flaxseed-derived @COMPOUND$ supplement on C-reactive protein, @PROTEIN$ and retinol-binding protein 4 in type 2 diabetic patients.	1
2433	Effects of a flaxseed-derived @COMPOUND$ supplement on C-reactive protein, IL-6 and retinol-binding @PROTEIN$ in type 2 diabetic patients.	1
2434	The present study explored the effects of flaxseed-derived @COMPOUND$ on inflammatory factors and @PROTEIN$ concentrations in type 2 diabetics, who have higher levels of these biomarkers.	1
2435	Here we report the discovery of a series of novel adamantyl @COMPOUND$ as selective inhibitors of human 11beta-HSD1 in HEK-293 cells transfected with the @PROTEIN$ gene.	1
2436	Polymorphism in the @PROTEIN$ gene, plasma lipoprotein(a), cardiovascular disease, and low-dose @COMPOUND$ therapy.	0
2437	We investigated whether this allele was associated with elevated @PROTEIN$ and cardiovascular risk in the Women's Health Study, a randomized trial of low-dose @COMPOUND$, and whether aspirin reduced cardiovascular risk in minor allele carriers.	0
2438	The study was prompted to characterize the B-type @PROTEIN$ activities in the terrestrial snail Xeropicta derbentina and to evaluate its sensitivity to organophosphorus and @COMPOUND$ pesticides.	1
2439	Specific @PROTEIN$ and carboxylesterase activities were mainly obtained with @COMPOUND$ (K(m)=77.2 mM; V(max)=38.2 mU/mg protein) and 1-naphthyl acetate (K(m)=222 mM, V(max)=1095 mU/mg protein) substrates, respectively.	1
2440	Specific @PROTEIN$ and carboxylesterase activities were mainly obtained with acetylthiocholine (K(m)=77.2 mM; V(max)=38.2 mU/mg protein) and @COMPOUND$ (K(m)=222 mM, V(max)=1095 mU/mg protein) substrates, respectively.	1
2441	We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2442	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2443	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, @PROTEIN$, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2444	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2445	We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2446	We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2447	We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2448	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2449	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2450	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, @PROTEIN$ (HDL), triglycerides and parathormone).	0
2451	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, @PROTEIN$ (HDL), triglycerides and parathormone).	0
2452	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2453	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, @PROTEIN$, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2454	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0
2455	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2456	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2457	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2458	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, @PROTEIN$ (HDL), triglycerides and parathormone).	0
2459	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0
2460	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2461	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, @PROTEIN$, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2462	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0
2463	We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2464	We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2465	Serum @COMPOUND$ (25-OHD), calcium, @PROTEIN$ and phosphorus were measured.	0
2466	Serum 25-hydroxyvitamin D (25-OHD), calcium, @PROTEIN$ and @COMPOUND$ were measured.	0
2467	In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated @COMPOUND$ (DEX)-induced @PROTEIN$ (GCR)-alpha nuclear translocation in both CD4 (+) and CD8(+) T cells.	1
2468	In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated @COMPOUND$ (DEX)-induced glucocorticoid receptor (GCR)-alpha nuclear translocation in both @PROTEIN$ (+) and CD8(+) T cells.	1
2469	Linear regression analyses showed that @COMPOUND$ and phospholipid efflux and cellular apoA-I binding correlated significantly with the ability of @PROTEIN$ to form cell surface lipid domains.	1
2470	Linear regression analyses showed that @COMPOUND$ and phospholipid efflux and cellular @PROTEIN$ binding correlated significantly with the ability of ABCA1 to form cell surface lipid domains.	0
2471	Inflammation plays a role in trans-10, cis-12 (10,12)-@COMPOUND$ (CLA)-mediated delipidation and @PROTEIN$ resistance in adipocytes.	0
2472	Near-infrared fluorescence detection of @COMPOUND$-biotin-mediated @PROTEIN$ labeling.	1
2473	Near-infrared fluorescence detection of ATP-@COMPOUND$-mediated @PROTEIN$ labeling.	1
2474	Wheat germ @PROTEIN$ had a high activity and enantioselectivity only in n-hexane with a high initial water activity (alpha(w) = 0.97), especially with @COMPOUND$ (C 32%, E &gt; 200).	1
2475	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines @PROTEIN$ (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2476	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines @PROTEIN$ (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2477	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-@PROTEIN$ (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2478	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (@PROTEIN$), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2479	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (@PROTEIN$), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2480	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (@PROTEIN$)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2481	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (@PROTEIN$)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2482	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (@PROTEIN$), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2483	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and @PROTEIN$, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2484	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (@PROTEIN$), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2485	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (@PROTEIN$)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2486	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (@PROTEIN$)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2487	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and @PROTEIN$, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2488	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-@PROTEIN$ (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2489	The results suggest that modulation of matrix @PROTEIN$, oxidants, cytokines, and NOSs with omapatrilat and @COMPOUND$ contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.	1
2490	The results suggest that modulation of matrix @PROTEIN$, oxidants, cytokines, and NOSs with @COMPOUND$ and candesartan contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.	1
2491	We recently reported @COMPOUND$ (Hcy)-induced @PROTEIN$-phosphorylation was suppressed by pertussis toxin (PTX), which suggested the involvement of GPCRs in initiating signal transduction.	1
2492	Association between @COMPOUND$ (247) polymorphism of @PROTEIN$ and cerebral infarction in a Chinese population.	1
2493	The purpose of this study was to identify associations between the @COMPOUND$ (247) polymorphism of @PROTEIN$ gene and CI in a Chinese cohort.	1
2494	Possible binding site for the substrate, prostaglandin H(2) (@COMPOUND$)), was identified by systematically probing the refined molecular structure of @PROTEIN$.	1
2495	Anti-P mAb promoted @PROTEIN$ overproduction in a dose- and time-dependent manner in both @COMPOUND$ (LPS)-activated RAW 264.7 cells and primary human macrophages.	0
2496	Increased secretion of hyperimmune antibodies following @COMPOUND$ stimulation of @PROTEIN$-activated human B cells in vitro.	1
2497	Both CTSs targeted enhanced @PROTEIN$ (eYFP) to a @COMPOUND$-sensitive compartment, indicative of Golgi localization.	0
2498	Coexpression with H6PDH potentiated @PROTEIN$ reductase activity at high @COMPOUND$.	1
2499	@PROTEIN$ dehydrogenase activity was observed in H4IIE cells only at subphysiological @COMPOUND$ levels, indicating a highly efficient supply of substrate for H6PDH and NADPH generation in the ER-lumen.	1
2500	There are data to suggest that psychological intervention can influence neuroendocrine (e.g., @COMPOUND$) and immune function indicators, especially lymphocyte proliferation and @PROTEIN$ cytokine production.	0
2501	The proteins identified belong to the photosynthesis, carbohydrate and @COMPOUND$ metabolism, and @PROTEIN$ functional categories.	0
2502	In the present study, we investigated whether CD147/basigin is involved, via its association with @PROTEIN$ and 4 to transport @COMPOUND$, in glycolysis and then contributes to the progression of A375 melanoma cells.	1
2503	In the present study, we investigated whether CD147/@PROTEIN$ is involved, via its association with MCT1 and 4 to transport @COMPOUND$, in glycolysis and then contributes to the progression of A375 melanoma cells.	1
2504	TCblR belongs to the @PROTEIN$ family, with 2 low-density lipoprotein receptor type A domains separated by a complement-like @COMPOUND$-rich region.	1
2505	TCblR belongs to the low-density lipoprotein receptor family, with 2 low-density lipoprotein receptor @PROTEIN$ domains separated by a complement-like @COMPOUND$-rich region.	1
2506	Variability of AChE, BChE, and @PROTEIN$ genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with @COMPOUND$ and Rivastigmine.	1
2507	Variability of AChE, BChE, and @PROTEIN$ genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and @COMPOUND$.	1
2508	Variability of @PROTEIN$, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and @COMPOUND$.	1
2509	Variability of @PROTEIN$, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with @COMPOUND$ and Rivastigmine.	1
2510	Extended-release PEG-@COMPOUND$ allows for long-term imaging of firefly @PROTEIN$ activity in vivo.	1
2511	Spectrofluorimetric determination of vitamin B(1) using horseradish @PROTEIN$ as catalyst in the presence of @COMPOUND$.	1
2512	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: @PROTEIN$, lpa2 and lpa3.	1
2513	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, @PROTEIN$ and lpa3.	1
2514	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, lpa2 and @PROTEIN$.	1
2515	Bevacizumab (Avastin), ranibizumab (Lucentis) and pegaptanib sodium (@COMPOUND$) are anti-@PROTEIN$ medications that have been used in the treatment of CNV.	1
2516	Bevacizumab (Avastin), ranibizumab (Lucentis) and @COMPOUND$ (Macugen) are anti-@PROTEIN$ medications that have been used in the treatment of CNV.	1
2517	Some of the peptide derivatives inhibited @PROTEIN$-mediated uptake of ((3)H) @COMPOUND$-Sar.	1
2518	Effect of enzyme supplementation at moderate @PROTEIN$ loadings on initial @COMPOUND$ and xylose release from corn stover solids pretreated by leading technologies.	0
2519	Following an oral @COMPOUND$ challenge, there was a weak trend for glucose-stimulated @PROTEIN$ release to be increased in the offspring of dams fed the folate-deficient diet.	1
2520	Association between serum retinol-binding @PROTEIN$ and small dense low-density lipoprotein @COMPOUND$ levels in young adult women.	1
2521	By using the system, we obtained four event timing data sets (stimulation by @PROTEIN$ with and without @COMPOUND$ at the concentrations of 0.01, 0.1, and 1 microM).	0
2522	Low-density lipoprotein @COMPOUND$ and non-@PROTEIN$ cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study.	0
2523	Only a small number of population-based cohort studies have directly compared the predictive value of low-density lipoprotein @COMPOUND$ (LDL-C) and non-@PROTEIN$ cholesterol (non-HDLC) for coronary artery disease in Asian populations, such as Japan.	0
2524	Finally, we show that Vcx1 helps return cytosolic @COMPOUND$+) toward resting levels after shock with high extracellular Ca(2+) much more effectively than @PROTEIN$ and that calcineurin, a protein phosphatase regulator of Vcx1 and Pmc1, had no detectable effects on these factors within the first few minutes of its activation.	0
2525	It is a serious problem that effective treatment choices to T315I, in the @PROTEIN$ kinase domain that shows a strong tolerance in @COMPOUND$ do not exist clinically.	1
2526	Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (@PROTEIN$) are required for glucose-, @COMPOUND$- and KCl-induced Egr-1 expression.	1
2527	Moreover, diacylgycerol-dependent @PROTEIN$ isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for @COMPOUND$-, tolbutamide- and KCl-induced Egr-1 expression.	1
2528	Moreover, diacylgycerol-dependent @PROTEIN$ isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for glucose-, @COMPOUND$- and KCl-induced Egr-1 expression.	1
2529	Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for glucose-, @COMPOUND$- and KCl-induced @PROTEIN$ expression.	1
2530	Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for @COMPOUND$-, tolbutamide- and KCl-induced @PROTEIN$ expression.	1
2531	Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (@PROTEIN$) are required for @COMPOUND$-, tolbutamide- and KCl-induced Egr-1 expression.	1
2532	Moreover, diacylgycerol-dependent @PROTEIN$ C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for @COMPOUND$-, tolbutamide- and KCl-induced Egr-1 expression.	1
2533	Moreover, diacylgycerol-dependent @PROTEIN$ C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for glucose-, @COMPOUND$- and KCl-induced Egr-1 expression.	1
2534	Long-term blinded placebo-controlled study of SNT-MC17/@COMPOUND$ in the @PROTEIN$ deficient mdx mouse: cardiac protection and improved exercise performance.	1
2535	Long-term blinded placebo-controlled study of @COMPOUND$/idebenone in the @PROTEIN$ deficient mdx mouse: cardiac protection and improved exercise performance.	1
2536	The study aim was to determine whether urine albumin/@COMPOUND$ ratio (UACR), high-sensitivity C-reactive protein (hsCRP) or N-terminal pro-@PROTEIN$ (Nt-proBNP) added to risk prediction based on HeartScore and history of diabetes or cardiovascular disease.	0
2537	Transgene optimization significantly improves SIN vector titers, @PROTEIN$ expression and reconstitution of @COMPOUND$ production in X-CGD cells.	0
2538	@COMPOUND$ concentration in the liver and in plasma alanine aminotransferase (ALT) and aspartate transaminase (@PROTEIN$) activities were determined.	1
2539	We previously reported that inhibition of @PROTEIN$-kinase (ROCK) by hydroxyl @COMPOUND$ improves cognitive deficit and neuronal damage in rats with chronic cerebral ischemia (Huang et al., Cell Mol Neurobiol 28:757-768, 2008).	1
2540	Finally, in the presence of OGD and @COMPOUND$ mesylate, superoxide dismutase (@PROTEIN$) activity was increased by 50% for cortex and by 58% for hippocampus, compared to OGD only group.	1
2541	Finally, in the presence of OGD and @COMPOUND$ mesylate, @PROTEIN$ (SOD) activity was increased by 50% for cortex and by 58% for hippocampus, compared to OGD only group.	1
2542	Na+/H+ exchanger isoform 3 (@PROTEIN$) is responsible for net uptake of @COMPOUND$ and water from the gastrointestinal (GI) tract.	1
2543	Elevated amounts of @PROTEIN$, one of the @COMPOUND$-generating reactions of glycolysis, in wood frog brain during freezing would enhance the glycolytic capacity of the organ and support the maintenance of cellular energetics under the ischemic conditions of the frozen state.	1
2544	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (@PROTEIN$), and nitric oxide (NO).	1
2545	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), and @COMPOUND$ (NO).	0
2546	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of @PROTEIN$-alpha (TNF-alpha), interleukin 6 (IL-6), and @COMPOUND$ (NO).	0
2547	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (@PROTEIN$), interleukin 6 (IL-6), and @COMPOUND$ (NO).	0
2548	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (@PROTEIN$), interleukin 6 (IL-6), and nitric oxide (NO).	1
2549	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), and nitric oxide (NO).	1
2550	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (@PROTEIN$), and @COMPOUND$ (NO).	0
2551	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of @PROTEIN$-alpha (TNF-alpha), interleukin 6 (IL-6), and nitric oxide (NO).	1
2552	Silencing of @PROTEIN$, the key entry-point enzyme for @COMPOUND$ biosynthesis led to flavonoid-deficient roots.	1
2553	In plants cyanide is converted to beta-cyano-L-alanine, which is subsequently detoxified to aspartic acid and @COMPOUND$ by @PROTEIN$.	1
2554	In plants cyanide is converted to beta-cyano-L-alanine, which is subsequently detoxified to @COMPOUND$ and ammonia by @PROTEIN$.	1
2555	In conclusion, female rats undernourished in utero had normophagic obesity as adults but had an absence of @COMPOUND$-induced hypophagia and low hypothalamic levels of the @PROTEIN$ receptor.	0
2556	Compensatory adaptations for the functional serotonergic impairment were evidenced, such as an enhanced release of @COMPOUND$ in response to a meal allied to up-regulated hypothalamic @PROTEIN$ and transporter expression.	1
2557	However, in supraphysiological doses, @PROTEIN$ administration may completely normalize beta as well as alpha cell sensitivity to @COMPOUND$.	1
2558	The induction of signal transduction by serum and growth factors significantly increases the level of @PROTEIN$ ubiquitination, while the treatment of cells with UV and @COMPOUND$ has the opposite effect.	1
2559	Interaction of @COMPOUND$ with bovine @PROTEIN$ : determination of the binding mechanism and binding site by spectroscopic methods.	1
2560	The interaction between @COMPOUND$ (MG) and bovine @PROTEIN$ (BSA) under simulative physiological conditions was investigated by the methods of fluorescence spectroscopy, UV-vis absorption and circular dichroism (CD) spectroscopy.	1
2561	The interaction between @COMPOUND$ (MG) and bovine serum albumin (@PROTEIN$) under simulative physiological conditions was investigated by the methods of fluorescence spectroscopy, UV-vis absorption and circular dichroism (CD) spectroscopy.	1
2562	The binding distance (r) between MG and the @COMPOUND$ residue of @PROTEIN$ was obtained to be 4.79 nm according to Förster theory of non-radioactive energy transfer.	1
2563	Unlike @COMPOUND$, Cystatin C (@PROTEIN$) is believed to be independent of body composition in both adults and children.	0
2564	Unlike @COMPOUND$, @PROTEIN$ C (CysC) is believed to be independent of body composition in both adults and children.	0
2565	Levels of endothelial @PROTEIN$ and inducible nitric oxide synthase did not differ among the groups, nor did total nitrite plus @COMPOUND$ levels.	0
2566	Thereafter we determined that hCG effect could be partially blocked by pharmacologic inhibition of @PROTEIN$ pathway with 50 microM @COMPOUND$ but not by the inhibition of the phosphatidylinositol 3-kinase pathway with 0.1 microm wortmannin.	1
2567	Thereafter we determined that hCG effect could be partially blocked by pharmacologic inhibition of @PROTEIN$ pathway with 50 microM PD98059 but not by the inhibition of the phosphatidylinositol 3-kinase pathway with 0.1 microm @COMPOUND$.	0
2568	Lung injury was assessed by measuring vascular permeability (via @COMPOUND$), edema, neutrophil infiltration (via myeloperoxidase (@PROTEIN$), and expression of proinflammatory cytokines.	0
2569	Cholesterol efflux from ((3)H) @COMPOUND$-acetyl-LDL-loaded monocyte-derived macrophages to standard apolipoprotein A-I (@PROTEIN$), HDL(2), and serum was measured.	1
2570	@COMPOUND$ efflux from ((3)H) cholesterol-oleate-acetyl-LDL-loaded monocyte-derived macrophages to standard apolipoprotein A-I (@PROTEIN$), HDL(2), and serum was measured.	1
2571	Cholesterol efflux from ((3)H) @COMPOUND$-acetyl-LDL-loaded monocyte-derived macrophages to standard @PROTEIN$ (apoA-I), HDL(2), and serum was measured.	1
2572	@COMPOUND$ efflux from ((3)H) cholesterol-oleate-acetyl-LDL-loaded monocyte-derived macrophages to standard @PROTEIN$ (apoA-I), HDL(2), and serum was measured.	1
2573	In this study, the degradation of @PROTEIN$- and R-@COMPOUND$ under anaerobic conditions was studied.	0
2574	Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified @COMPOUND$ residues in the @PROTEIN$ (NDRG1-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	1
2575	Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified @COMPOUND$ residues in the n-myc downstream-regulated gene 1 protein (@PROTEIN$-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	1
2576	@PROTEIN$ expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with @COMPOUND$-based chemotherapy.	1
2577	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as @PROTEIN$ and catalase, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, @COMPOUND$ and selenium, incorporated in conventional treatment regimen.	0
2578	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as superoxide dismutase and @PROTEIN$, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, @COMPOUND$ and selenium, incorporated in conventional treatment regimen.	0
2579	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as @PROTEIN$ and catalase, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, vitamin E and @COMPOUND$, incorporated in conventional treatment regimen.	0
2580	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as superoxide dismutase and @PROTEIN$, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, vitamin E and @COMPOUND$, incorporated in conventional treatment regimen.	0
2581	This study was designed to determine the effect of molsidomine (MO), a precursor of @COMPOUND$ (NO) donor, on hypoxia inducible factor alpha (@PROTEIN$) and Sonic hedgehog (Shh) levels considered to be involved in the development of testes ischemia/reperfusion (I-R) injury.	1
2582	This study was designed to determine the effect of @COMPOUND$ (MO), a precursor of nitric oxide (NO) donor, on hypoxia inducible factor alpha (@PROTEIN$) and Sonic hedgehog (Shh) levels considered to be involved in the development of testes ischemia/reperfusion (I-R) injury.	1
2583	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (@COMPOUND$, fluconazole and itraconazole) by the reference method of the Clinical and Laboratory Standards Institute.	0
2584	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (amphotericin B, @COMPOUND$ and itraconazole) by the reference method of the Clinical and Laboratory Standards Institute.	0
2585	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (amphotericin B, fluconazole and @COMPOUND$) by the reference method of the Clinical and Laboratory Standards Institute.	0
2586	To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S((@COMPOUND$))KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine serum albumin (@PROTEIN$) as a control.	0
2587	To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S((@COMPOUND$))KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine @PROTEIN$ (BSA) as a control.	0
2588	Colon cancer cells maintain low levels of @COMPOUND$ to avoid cell death caused by inhibition of @PROTEIN$/HDAC3.	0
2589	Colon cancer cells maintain low levels of @COMPOUND$ to avoid cell death caused by inhibition of HDAC1/@PROTEIN$.	0
2590	This process is associated with an increase in intracellular levels of @COMPOUND$, increase in the acetylation status of @PROTEIN$, and enhanced cell death.	0
2591	The @COMPOUND$/@PROTEIN$ (PKA) signaling cascade is crucial for synaptic plasticity in a wide variety of species.	1
2592	Epigenetic reprogramming of breast cancer cells by @COMPOUND$ occurs regardless of @PROTEIN$ status.	0
2593	In the present study, we have investigated the effect of @PROTEIN$ on ABCA1 expression and @COMPOUND$ efflux in THP-1 macrophage-derived foam cells.	1
2594	In the present study, we have investigated the effect of IFN-gamma on @PROTEIN$ expression and @COMPOUND$ efflux in THP-1 macrophage-derived foam cells.	0
2595	As such, the aim of the present study was to investigate whether @PROTEIN$-inhibition with @COMPOUND$, a molecule distinctly different from torcetrapib, impacts on vascular function, a well-established surrogate of atherosclerotic vascular disease, as well as markers of inflammation and oxidative stress in patients with type II hyperlipidemia.	1
2596	In this review we discuss the @PROTEIN$ that transport arsenic and @COMPOUND$ into cells, from bacteria to humans, as well as some of the efflux proteins involved in detoxification.	1
2597	Pathways involved in the hydrolysis of nitrile pollutants (aliphatic nitriles, @COMPOUND$ analogues) and the corresponding enzymes (@PROTEIN$, nitrile hydratase) are described in detail.	1
2598	We report that the PP inhibition of proteolysis in young rats was mediated by the increased @PROTEIN$ secretion and resulted from a down-regulation of both lysosomal and @COMPOUND$+)-dependent proteolysis.	0
2599	Aqueous extract of cumin was tested for its antiglycating ability against @COMPOUND$-induced glycation of goat lens total soluble protein (TSP), alpha-crystallin from goat lens and a nonlenticular protein bovine @PROTEIN$ (BSA).	1
2600	Aqueous extract of cumin was tested for its antiglycating ability against @COMPOUND$-induced glycation of goat lens total soluble protein (@PROTEIN$), alpha-crystallin from goat lens and a nonlenticular protein bovine serum albumin (BSA).	1
2601	Aqueous extract of cumin was tested for its antiglycating ability against @COMPOUND$-induced glycation of goat lens total soluble protein (TSP), alpha-crystallin from goat lens and a nonlenticular protein bovine serum albumin (@PROTEIN$).	1
2602	To investigate the effects of selenium on mRNA expressions of proinflammatory cytokines and inducible nitric oxide synthase (@PROTEIN$) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a @COMPOUND$-treated diabetes mellitus group.	0
2603	To investigate the effects of selenium on mRNA expressions of proinflammatory cytokines and inducible @PROTEIN$ (iNOS) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a @COMPOUND$-treated diabetes mellitus group.	0
2604	To investigate the effects of @COMPOUND$ on mRNA expressions of proinflammatory cytokines and inducible @PROTEIN$ (iNOS) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a selenite-treated diabetes mellitus group.	1
2605	To investigate the effects of @COMPOUND$ on mRNA expressions of proinflammatory cytokines and inducible nitric oxide synthase (@PROTEIN$) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a selenite-treated diabetes mellitus group.	1
2606	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, @PROTEIN$-alpha and interferon-gamma ; mRNA expression and activity of iNOS.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
2607	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, tumor necrosis factor-alpha and interferon-gamma ; mRNA expression and activity of @PROTEIN$.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
2608	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, tumor necrosis factor-alpha and @PROTEIN$ ; mRNA expression and activity of iNOS.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
2609	Decreases in PNNs, aggrecan and @COMPOUND$ were observed only in the terminal stages and correlated with the distribution of @PROTEIN$ (BSE) and activated glial cells.	1
2610	To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of @COMPOUND$-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal @PROTEIN$ precursors, GAD67, cytochrome oxidase subunit I) by quantitative in situ hybridization histochemistry.	1
2611	To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of @COMPOUND$-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal neuropeptide precursors, GAD67, @PROTEIN$) by quantitative in situ hybridization histochemistry.	1
2612	To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of @COMPOUND$-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal neuropeptide precursors, @PROTEIN$, cytochrome oxidase subunit I) by quantitative in situ hybridization histochemistry.	1
2613	"Participating in a significant fraction of the fundamental paths connecting the ligands to the phenotypes, cofactor @COMPOUND$ and complex Gbeta/Ggamma were identified as ""housekeeping"" molecules, through which all pathways of @PROTEIN$ network are cross-talking."	1
2614	The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (@PROTEIN$) and ATG12 proteins to their respective targets, @COMPOUND$ and the ATG5 protein.	1
2615	The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (ATG8) and @PROTEIN$ proteins to their respective targets, @COMPOUND$ and the ATG5 protein.	1
2616	The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (ATG8) and ATG12 proteins to their respective targets, @COMPOUND$ and the @PROTEIN$ protein.	0
2617	Levels of Atg transcripts and/or the @PROTEIN$-@COMPOUND$ adduct increase during leaf senescence and nitrogen and fixed-carbon limitations, indicating that autophagy plays a key role in nutrient remobilization.	1
2618	This study confirmed QTL previously identified for pH except those on @PROTEIN$, 11, 12, and X, and found 11 new 5% genome-wise significant QTL for @COMPOUND$-related traits.	0
2619	The objective of this study was to examine the effect of level and duration of feeding of an n-3 PUFA-enriched fish oil (@COMPOUND$) supplement in combination with soybean oil (SO) on the transcriptional regulation of @PROTEIN$ gene expression in bovine muscle.	1
2620	Whole blood and plasma were analyzed for total Se, @PROTEIN$ activity in whole blood (GPX-1) and plasma, and thyroid hormones (thyroxine and @COMPOUND$) in plasma.	0
2621	Whole blood and plasma were analyzed for total Se, @PROTEIN$ activity in whole blood (GPX-1) and plasma, and thyroid hormones (@COMPOUND$ and triiodothyronine) in plasma.	0
2622	Whole blood and plasma were analyzed for total Se, glutathione peroxidase activity in whole blood (@PROTEIN$) and plasma, and thyroid hormones (thyroxine and @COMPOUND$) in plasma.	0
2623	Whole blood and plasma were analyzed for total Se, glutathione peroxidase activity in whole blood (@PROTEIN$) and plasma, and thyroid hormones (@COMPOUND$ and triiodothyronine) in plasma.	0
2624	Studies have shown that administration of @COMPOUND$ (estrogen) after trauma-hemorrhage normalized cardiac @PROTEIN$ levels and restored cardiac functions under those conditions.	1
2625	Chemopreventive potential of @COMPOUND$ in mouse skin tumors through regulation of mitochondrial and @PROTEIN$/AKT signaling pathways.	1
2626	@COMPOUND$ plus low-dose trastuzumab in @PROTEIN$ positive metastatic breast cancer.	0
2627	This phase II study, evaluated the activity and cardiotoxicity of first-line @COMPOUND$ plus low-dose trastuzumab (LD-T) in patients with @PROTEIN$ positive MBC.	0
2628	Each of the developed consortium has a phosphate solubilizer, @COMPOUND$ fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0
2629	Each of the developed consortium has a @COMPOUND$ solubilizer, nitrogen fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0
2630	Using cannabinoid receptor antagonists and cannabinoid receptor gene deficient mice (CB(1) (-/-) and CB(2) (-/-)), we showed that both CB(1) and CB(2) receptors were involved in the @COMPOUND$-induced attenuation of serum IL-12 and @PROTEIN$.	0
2631	Promoter analysis of the @PROTEIN$, 4, and 11 genes in HeLa cells did not reveal a cis-regulatory element responsive to @COMPOUND$ in their 5'-flanking sequences.	0
2632	@PROTEIN$- and caspase-3-mediated superoxide-induced apoptosis of rat hepatic stellate cells: reversal by @COMPOUND$.	1
2633	In vivo administration of a synthetic phospholipid, named hereafter phospho-ceramide analogue-1 (PCERA-1), was previously found to suppress @COMPOUND$ (LPS)-induced @PROTEIN$ blood levels.	1
2634	Pre-gravid physical activity and reduced risk of @COMPOUND$ intolerance in pregnancy : the role of @PROTEIN$ sensitivity.	1
2635	Thus, we sought to study the relationships between types of pre-gravid physical activity and metabolic parameters in pregnancy, including @COMPOUND$ tolerance, @PROTEIN$ sensitivity and beta-cell function.	0
2636	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of @PROTEIN$-II, Beclin-1, BAG-1 and cardioprotection.	1
2637	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, Beclin-1, @PROTEIN$ and cardioprotection.	1
2638	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, @PROTEIN$, BAG-1 and cardioprotection.	1
2639	When myosin molecules work as an aggregate, the sliding movement of a myosin filament driven by the power strokes of some myosin heads makes other myosin heads that have completed their power strokes detach from the @PROTEIN$ without consuming @COMPOUND$.	0
2640	To determine the efficacy and safety of @PROTEIN$ and etanercept plus @COMPOUND$ versus sulfasalazine in patients with rheumatoid arthritis (RA) despite sulfasalazine therapy.	0
2641	Twenty seven patients were mobilized with @COMPOUND$ and @PROTEIN$ and 28 with etoposide, G-CSF and rituximab.	0
2642	This work describes the influence of two polar lipids, Sn-1/3 and Sn-@COMPOUND$, on the activity of @PROTEIN$ in biphasic systems and in microemulsions.	1
2643	In previous communications, we have shown that Sn-@COMPOUND$ can replace Sn-1,3 regiospecific @PROTEIN$ at the oil-water interface, causing a drastically reduced rate of lipolysis.	1
2644	Previous studies have demonstrated an association between genetic polymorphisms of the mu opioid receptor gene (@PROTEIN$) and response to @COMPOUND$ treatment.	1
2645	The cells expressed @PROTEIN$ sensitive to @COMPOUND$ (2) and decreased by siRNA, which both reduced fast volume changes.	1
2646	Two conserved @COMPOUND$ repeats within the COMM domain were found to be critically required for @PROTEIN$ binding.	1
2647	Wet-wrap treatment using dilutions of @COMPOUND$ ointment and fluticasone propionate cream in human @PROTEIN$ (+/+) mice with atopic dermatitis.	0
2648	Wet-wrap treatment using dilutions of tacrolimus ointment and @COMPOUND$ cream in human @PROTEIN$ (+/+) mice with atopic dermatitis.	0
2649	The use of low-dose COCs is preferable in PCOS, especially among patients with @COMPOUND$ intolerance, @PROTEIN$ resistance and uncomplicated diabetes mellitus.	0
2650	In this study, we examined the role of @PROTEIN$ in @COMPOUND$ and cholesterol trafficking in mice lacking ATP-binding cassette (ABC) transporters G5 and G8 (G5/G8(-/-) mice).	0
2651	We found that mice lacking ABCG5/G8 and @PROTEIN$ (triple knockout (TKO) mice) did not accumulate @COMPOUND$ in plasma and the liver.	0
2652	We found that mice lacking @PROTEIN$/G8 and NPC1L1 (triple knockout (TKO) mice) did not accumulate @COMPOUND$ in plasma and the liver.	0
2653	In conclusion, @PROTEIN$ is essential for @COMPOUND$ to enter the body in mice.	1
2654	The slow BSO-induced @COMPOUND$ depletion allows separation of two redox-related phases, namely, early thiol disequilibrium and late frank oxidative stress; each phase contributes to the progressive activation of a @PROTEIN$-p50 homodimer.	0
2655	In contrast, Notch-signaling inhibition by the @COMPOUND$ (GSI ; z-Leu-Leu-Nle-CHO) and the specific @PROTEIN$ down-regulation by small-interfering RNA accelerate spontaneous B-CLL cell apoptosis.	0
2656	The present study was performed to investigate the effects of strenuous exercise and calcium supplementation on @COMPOUND$ and @PROTEIN$ levels in athletes at rest and exhaustion.	0
2657	One-month supplementation with calcium does not influence the @COMPOUND$ and @PROTEIN$ 0.05).	0
2658	In the pericentral necrotic zone after @COMPOUND$-treatment, no induction of @PROTEIN$ was found.	0
2659	These data suggested novel functions of (@COMPOUND$+))(i) and CaM in @PROTEIN$ signaling.	1
2660	These data suggested novel functions of (@COMPOUND$+))(i) and @PROTEIN$ in BDNF signaling.	0
2661	Comparison of the Arc transcription profiles between @COMPOUND$+)-stimulated and @PROTEIN$-stimulated neurons demonstrated that the regulatory mechanisms were distinctively tailored to the complex features of neuronal activity.	0
2662	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific @PROTEIN$ (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II ribosome-inactivating protein (Type-II RIPs, SNA-V), found in the same species.	1
2663	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific lectin (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II @PROTEIN$ (Type-II RIPs, SNA-V), found in the same species.	0
2664	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific lectin (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II ribosome-inactivating protein (Type-II @PROTEIN$, SNA-V), found in the same species.	0
2665	Infusion of each receptor antagonist alone similarly reduced basal unstressed volume and blood flow in @PROTEIN$-treated CHF patients, but not in healthy volunteers or @COMPOUND$-treated CHF patients.	0
2666	In @COMPOUND$-treated heart failure, venous responses to @PROTEIN$ are preserved but arterial responses are reduced compared with healthy controls.	0
2667	Hepatic stellate cell activation in focal nodular hyperplasia with a central scar was accompanied by the expression of @COMPOUND$ and inducible @PROTEIN$ in the liver.	0
2668	Expression of @COMPOUND$ and inducible @PROTEIN$ was rarely seen in focal nodular hyperplasia without a central scar, focal nodular hyperplasia-like nodules, or nodular regenerative hyperplasia.	0
2669	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
2670	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
2671	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
2672	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
2673	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
2674	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
2675	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
2676	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
2677	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
2678	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
2679	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
2680	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
2681	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and @PROTEIN$ were detected, while those secreting glucagon and insulin were not.	0
2682	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and PYY were detected, while those secreting glucagon and @PROTEIN$ were not.	0
2683	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and PYY were detected, while those secreting @PROTEIN$ and insulin were not.	0
2684	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and PYY were detected, while those secreting @PROTEIN$ and insulin were not.	0
2685	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and @PROTEIN$ were detected, while those secreting glucagon and insulin were not.	0
2686	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and PYY were detected, while those secreting glucagon and @PROTEIN$ were not.	0
2687	Cell fractionation by @COMPOUND$ gradient and differential centrifugation demonstrated that in bradykinin-stimulated cells, @PROTEIN$ localized in fractions corresponding to caveolae.	0
2688	However, there are conflicting data regarding the role of Gpr30 as an @PROTEIN$ (ER): several laboratories were unable to demonstrate @COMPOUND$ binding to GPR30 or estradiol-activated signal transduction in Gpr30-expressing cells.	0
2689	Our data demonstrate that in vivo @PROTEIN$ is dispensable for the mediation of @COMPOUND$ effects in reproductive organs.	0
2690	Here we characterize @PROTEIN$ mRNA and SORD expression during mouse spermatogenesis and examine the ability of @COMPOUND$ to support epididymal sperm motility and tyrosine phosphorylation.	0
2691	Here we characterize Sord mRNA and @PROTEIN$ expression during mouse spermatogenesis and examine the ability of @COMPOUND$ to support epididymal sperm motility and tyrosine phosphorylation.	0
2692	Here we characterize Sord mRNA and @PROTEIN$ expression during mouse spermatogenesis and examine the ability of sorbitol to support epididymal sperm motility and @COMPOUND$ phosphorylation.	0
2693	Here we characterize @PROTEIN$ mRNA and SORD expression during mouse spermatogenesis and examine the ability of sorbitol to support epididymal sperm motility and @COMPOUND$ phosphorylation.	0
2694	Increase in @COMPOUND$ clearance in the early postnatal period likely reflects maturation of @PROTEIN$-mediated N-demethylation.	1
2695	The present study was designed to evaluate the impact of zinc status before burn on the recovery of injury with focus on plasma @PROTEIN$ and @COMPOUND$ levels.	0
2696	Blood and tissue samples were collected 3, 6, and 24 h after injury in order to study biochemical parameters and the @COMPOUND$/@PROTEIN$ response in relation with the zinc status.	0
2697	In addition, the burn-induced insulin resistance, leading to protein catabolism, was emphasized, with higher plasma insulin, @COMPOUND$, and @PROTEIN$ levels in zinc-deficient animals versus normal-fed rats.	0
2698	In addition, the burn-induced @PROTEIN$ resistance, leading to protein catabolism, was emphasized, with higher plasma insulin, @COMPOUND$, and leptin levels in zinc-deficient animals versus normal-fed rats.	0
2699	The most predictive model of @PROTEIN$ response for the pediatric cohort had, as the major variables, @COMPOUND$ clearance x dialysis duration/total body water (Kt/V), urea reduction ratio (URR), intact parathyroid hormone (iPTH), blood loss, normalized protein catabolic rates (nPCR) and indices of malnutrition and inflammation, whereas adults had iron and folate deficiencies as the dominant variables.	1
2700	The most predictive model of @PROTEIN$ response for the pediatric cohort had, as the major variables, urea clearance x dialysis duration/total body water (Kt/V), urea reduction ratio (URR), intact parathyroid hormone (iPTH), blood loss, normalized protein catabolic rates (nPCR) and indices of malnutrition and inflammation, whereas adults had iron and @COMPOUND$ deficiencies as the dominant variables.	1
2701	In summary @PROTEIN$ resistance in the pediatric dialysis cohort was predicted by nutritional deficits, inflammation, poor dialysis, and hyperparathyroidism, while iron and @COMPOUND$ deficits were the major determinants in adults.	1
2702	@COMPOUND$ selectively causes Bax- and @PROTEIN$-mediated apoptosis in human lung cancer cells.	1
2703	@COMPOUND$ selectively causes @PROTEIN$- and Bak-mediated apoptosis in human lung cancer cells.	1
2704	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (@PROTEIN$), both arginase and inducible nitric oxide synthase (iNOS) in murine Mphi.	0
2705	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (IFN-gamma), both @PROTEIN$ and inducible nitric oxide synthase (iNOS) in murine Mphi.	1
2706	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of @PROTEIN$ (IFN-gamma), both arginase and inducible nitric oxide synthase (iNOS) in murine Mphi.	0
2707	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (IFN-gamma), both arginase and inducible @PROTEIN$ (iNOS) in murine Mphi.	1
2708	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (IFN-gamma), both arginase and inducible nitric oxide synthase (@PROTEIN$) in murine Mphi.	1
2709	Therefore, a very interesting observation of this study was that the @COMPOUND$-mediated arginase activity is dependent on @PROTEIN$ priming.	1
2710	Therefore, a very interesting observation of this study was that the @COMPOUND$-mediated @PROTEIN$ activity is dependent on IFN-gamma priming.	1
2711	This report reveals a singular effect of the combination of @COMPOUND$ and @PROTEIN$, one of the mayor cytokines produced in response to CpG administration in vivo.	1
2712	In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0
2713	In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1
2714	In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1
2715	In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0
2716	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (@PROTEIN$), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2717	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), @PROTEIN$ (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2718	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (@PROTEIN$), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2719	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (@PROTEIN$) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2720	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and @PROTEIN$ (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2721	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), @PROTEIN$ (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2722	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (@PROTEIN$), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2723	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (@PROTEIN$), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2724	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: @PROTEIN$ (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2725	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol @PROTEIN$ (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2726	It could results from the fact that phenolic compounds (@COMPOUND$), which could be also substrates for different @PROTEIN$, were the first line of defence against metal stress.	1
2727	The affinity characteristics of developed immunosensors were investigated in reaction with @COMPOUND$, and @PROTEIN$.	1
2728	The detection limit for @COMPOUND$ was 10 ngmL(-1) and for @PROTEIN$ 0.01 ngmL(-1).	0
2729	This was achieved by (1) direct comparison of the sensitivity of ASIC1, ASIC2, @PROTEIN$ and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
2730	This was achieved by (1) direct comparison of the sensitivity of ASIC1, @PROTEIN$, ASIC3 and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
2731	This was achieved by (1) direct comparison of the sensitivity of @PROTEIN$, ASIC2, ASIC3 and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
2732	This was achieved by (1) direct comparison of the sensitivity of ASIC1, ASIC2, ASIC3 and @PROTEIN$ knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
2733	Following @COMPOUND$ injection, ASIC1 (-/-) and ASIC2 (-/-), but not @PROTEIN$ (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	0
2734	Following @COMPOUND$ injection, ASIC1 (-/-) and @PROTEIN$ (-/-), but not ASIC3 (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	1
2735	Following @COMPOUND$ injection, ASIC1 (-/-) and ASIC2 (-/-), but not ASIC3 (-/-) or @PROTEIN$ (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	0
2736	Following @COMPOUND$ injection, @PROTEIN$ (-/-) and ASIC2 (-/-), but not ASIC3 (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	1
2737	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total @COMPOUND$ (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2738	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, @COMPOUND$, sodium, and potassium.	0
2739	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total @COMPOUND$ (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2740	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, @COMPOUND$, sodium, and potassium.	0
2741	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), @COMPOUND$ (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2742	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), @COMPOUND$, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2743	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), @COMPOUND$ (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2744	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), @COMPOUND$, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2745	In addition, serum levels of @COMPOUND$, adiponectin, and @PROTEIN$ were measured.	0
2746	In addition, @COMPOUND$-activated @PROTEIN$ levels were high during fasting and low during HF diet.	1
2747	After 7 d central @PROTEIN$ treatment, the total content of @COMPOUND$ was analyzed by quantitative shotgun lipidomics mass spectrometry.	0
2748	Previously we have shown that @COMPOUND$ has antiinflammatory actions not explicable by activation of @PROTEIN$,but possibly by the glucocorticoid receptor (GR).	0
2749	Previously we have shown that @COMPOUND$ has antiinflammatory actions not explicable by activation of PPARgamma,but possibly by the @PROTEIN$ (GR).	1
2750	To begin to understand the mechanisms for the development of acute insulin resistance, @COMPOUND$ phosphorylation of insulin receptor substrate (@PROTEIN$)-1 and c-Jun N-terminal kinase phosphorylation/activation was investigated.	1
2751	To begin to understand the mechanisms for the development of acute @PROTEIN$ resistance, @COMPOUND$ phosphorylation of insulin receptor substrate (IRS)-1 and c-Jun N-terminal kinase phosphorylation/activation was investigated.	0
2752	To begin to understand the mechanisms for the development of acute insulin resistance, @COMPOUND$ phosphorylation of insulin receptor substrate (IRS)-1 and c-@PROTEIN$ N-terminal kinase phosphorylation/activation was investigated.	0
2753	FMD of the brachial artery and plasma concentrations of oxLDL, LDL-@COMPOUND$, and @PROTEIN$ were measured in 624 men and women (age range 50 to 87 years), participating in a population-based cohort study.	0
2754	After adjustment for age, sex, @COMPOUND$ tolerance status, and Framingham risk score, the oxLDL/@PROTEIN$ ratio was negatively related to FMD (P = 0.017).	0
2755	The @PROTEIN$ isolated from the youngest group had the highest capacity to form @COMPOUND$ and AGEs under glycation in vitro.	1
2756	Inhibitory activities of Cassia tora and its @COMPOUND$ constituents on @PROTEIN$.	1
2757	@COMPOUND$) was injected into pregnant mice 3 hr after the @PROTEIN$ administration to label the neural progenitor cells.	0
2758	The secretion of endorphins, @COMPOUND$ (P(4)), human chorionic gonadotropin, 17beta-estradiol, and @PROTEIN$ by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	0
2759	The secretion of endorphins, progesterone (P(4)), human chorionic gonadotropin, @COMPOUND$, and @PROTEIN$ by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	0
2760	A specific @COMPOUND$-labelled probe, obtained by PCR amplification of a 270-bp fragment of the gene coding the LCDV @PROTEIN$, was used for ISH.	1
2761	In particular, a Cimicifuga heracleifolia extract (CHE) was reported to inhibit the formation of @COMPOUND$ and the @PROTEIN$ activity in cultured rat islet.	0
2762	No differences in estradiol, @COMPOUND$, or @PROTEIN$ plasma concentrations were observed in exposed males or females compared to controls.	0
2763	No differences in @COMPOUND$, testosterone, or @PROTEIN$ plasma concentrations were observed in exposed males or females compared to controls.	0
2764	Macrophages located in the media differentiate into giant cells and/or produce reactive oxygen species, @COMPOUND$ and matrix metallo-@PROTEIN$.	0
2765	Macrophages located in the media differentiate into giant cells and/or produce reactive @COMPOUND$ species, nitric oxide and matrix metallo-@PROTEIN$.	0
2766	Studies on the interaction of dicholesteroyl diselenide (DCDS) and @COMPOUND$ (DPDS) with hepatic @PROTEIN$ (ALA-D) and different isoforms of lactate dehydrogenase (LDH) from different tissues were investigated.	0
2767	Studies on the interaction of dicholesteroyl diselenide (DCDS) and @COMPOUND$ (DPDS) with hepatic delta-aminolevulinic acid dehydratase (ALA-D) and different isoforms of lactate dehydrogenase (@PROTEIN$) from different tissues were investigated.	0
2768	A single @COMPOUND$ insertion/deletion (4G/5G) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1
2769	A single guanosine insertion/deletion (4G/@COMPOUND$) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1
2770	@COMPOUND$ is an effective chemo-sensitizer via @PROTEIN$ inhibition.	1
2771	The objective of the present experiment was to examine the influence of mean physiological concentration of insulin-like growth factor-I (@PROTEIN$) on frozen-thawed Surti buffalo (Bubalus bubalis) spermatozoa functional parameters, i.e., motility, plasmalemma integrity, acrosomal integrity, functional membrane integrity, lipid peroxidation and @COMPOUND$ uptake in vitro.	1
2772	Frozen-thawed semen samples (n=6) were washed in @COMPOUND$ and divided into two equal parts (control and @PROTEIN$ groups).	0
2773	@COMPOUND$ utilization was significantly higher in @PROTEIN$ 0.01) of incubation.	0
2774	This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the @PROTEIN$ gene, c.2545G--&gt;C, leading to a codon encoding for @COMPOUND$ instead of glycine (p.Gly849Arg).	1
2775	This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the @PROTEIN$ gene, c.2545G--&gt;C, leading to a codon encoding for arginine instead of @COMPOUND$ (p.Gly849Arg).	1
2776	We also found a strong inhibitory effect of @COMPOUND$ on hypoxia-induced endothelial cell formation of cords and @PROTEIN$ expression, the main mediator of hypoxia-mediated effects and a key driver of angiogenesis and metastasis.	1
2777	Control @COMPOUND$-loaded @PROTEIN$ nanoparticles with IgG2a antibodies yielded only marginal effects.	1
2778	Engineered @COMPOUND$-containing glutaredoxin displays strong @PROTEIN$ activity rivaling natural enzyme.	0
2779	Engineered @COMPOUND$-containing @PROTEIN$ displays strong glutathione peroxidase activity rivaling natural enzyme.	1
2780	The potassium channels blockade by either @COMPOUND$ or @PROTEIN$ also resulted in a potent inhibition of HEDS-induced aortic relaxation, whereas apamine only slightly reduced it.	0
2781	The potassium channels blockade by either tetraethylammonium or @PROTEIN$ also resulted in a potent inhibition of HEDS-induced aortic relaxation, whereas @COMPOUND$ only slightly reduced it.	0
2782	ROS activated almost immediately in a time- and concentration-dependent manner the MAPK pathways p38, ERK and @PROTEIN$ (their activation was abrogated by the antioxidant @COMPOUND$).	1
2783	ROS activated almost immediately in a time- and concentration-dependent manner the MAPK pathways p38, @PROTEIN$ and JNK (their activation was abrogated by the antioxidant @COMPOUND$).	1
2784	ROS activated almost immediately in a time- and concentration-dependent manner the @PROTEIN$ pathways p38, ERK and JNK (their activation was abrogated by the antioxidant @COMPOUND$).	1
2785	ROS activated almost immediately in a time- and concentration-dependent manner the MAPK pathways @PROTEIN$, ERK and JNK (their activation was abrogated by the antioxidant @COMPOUND$).	1
2786	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, @COMPOUND$, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2787	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of @COMPOUND$, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2788	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, @COMPOUND$ and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2789	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, @COMPOUND$, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2790	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, @COMPOUND$, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2791	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, @COMPOUND$, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2792	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, @COMPOUND$, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2793	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, @COMPOUND$, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2794	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and @COMPOUND$ ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2795	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of @COMPOUND$, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2796	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, @COMPOUND$, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2797	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, @COMPOUND$ and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2798	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, @COMPOUND$, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2799	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, @COMPOUND$, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2800	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and @COMPOUND$ ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2801	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, @COMPOUND$, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2802	The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, @COMPOUND$ (MDA) production, inflammatory cell infiltration, interleukin-6 (@PROTEIN$) expression and caspase-3 activity.	0
2803	The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, @COMPOUND$ (MDA) production, inflammatory cell infiltration, @PROTEIN$ (IL-6) expression and caspase-3 activity.	0
2804	Elevation of antioxidative capacity, as evidenced by decreased MDA level and increased @PROTEIN$ activity and @COMPOUND$ level, was detected only in the chronic daily-administration group.	0
2805	@PROTEIN$ secretion is highly sensitive to desorption of plasma membrane @COMPOUND$.	1
2806	TKTL 1 was highest expressed in cell lines derived from more invasive tumors but the expression level was not strongly correlated to proliferation rate, to @PROTEIN$ expression or to the response to @COMPOUND$.	0
2807	Magnesium (Mg), @PROTEIN$ (IL-8), and @COMPOUND$ levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
2808	Magnesium (Mg), interleukin 8 (@PROTEIN$), and @COMPOUND$ levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
2809	@COMPOUND$ (Mg), @PROTEIN$ (IL-8), and malondialdehyde levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
2810	@COMPOUND$ (Mg), interleukin 8 (@PROTEIN$), and malondialdehyde levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
2811	Study of multiple binding constants of @COMPOUND$ with human @PROTEIN$ by capillary electrophoresis-frontal analysis and multivariate regression.	1
2812	In this paper, to evaluate the pharmacokinetic and pharmacodynamic properties of @COMPOUND$ (DXM), the interaction between DXM and @PROTEIN$ was studied by capillary electrophoresis-frontal analysis (CE-FA).	1
2813	Arthropod @PROTEIN$ transport and store @COMPOUND$ and are composed of six subunits, or multiples thereof depending on the species.	0
2814	The protein is insensitive to lactate, but affected by urate which markedly increased @PROTEIN$-@COMPOUND$ affinity, acting as the physiological major positive effector.	1
2815	Enzymatic activities of an H(2)O(2) independent oxidase along with @PROTEIN$ and an azoreductase suggest their prominent role during the decolorization of reactive yellow @COMPOUND$.	1
2816	Enzymatic activities of an H(2)O(2) independent oxidase along with laccase and an @PROTEIN$ suggest their prominent role during the decolorization of reactive yellow @COMPOUND$.	1
2817	@PROTEIN$ activity was prominent in presence of cofactors @COMPOUND$ and NADP in mineral salt medium.	1
2818	@PROTEIN$ activity was prominent in presence of cofactors NADH and @COMPOUND$ in mineral salt medium.	1
2819	The increase of @COMPOUND$ availability caused the induction of the antioxidant enzyme @PROTEIN$, which indicates that the defensive mechanisms of the cells against oxidative stress were effective and cells could cope with increased pressure.	1
2820	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1
2821	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1
2822	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1
2823	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1
2824	In the present study, the mRNA expression and promoter @COMPOUND$ methylation of @PROTEIN$ isoforms (i.e.	0
2825	The present study is the first report that demonstrates selective inactivation of @PROTEIN$ isoforms through the promoter @COMPOUND$ methylation pathway in leukaemias.	1
2826	@PROTEIN$ monogalactosyldiacylglycerol synthases are involved in @COMPOUND$ starvation-induced lipid remodeling, and are crucial for low-phosphate adaptation.	1
2827	This study was performed to evaluate the effects of @COMPOUND$ on breast cancer cell lines with respect to the activity of @PROTEIN$ and Akt : a downstream modulator of cell growth and survival.	1
2828	This study was performed to evaluate the effects of @COMPOUND$ on breast cancer cell lines with respect to the activity of PDGFR beta and @PROTEIN$ : a downstream modulator of cell growth and survival.	1
2829	Recently, we reported stimulatory effect of ghrelin alone and in combination with growth hormone (GH) on @COMPOUND$ secretion, @PROTEIN$ activity in parallel with inhibitory effect on cell apoptosis.	0
2830	Recently, we reported stimulatory effect of ghrelin alone and in combination with @PROTEIN$ (GH) on @COMPOUND$ secretion, aromatase activity in parallel with inhibitory effect on cell apoptosis.	1
2831	Recently, we reported stimulatory effect of @PROTEIN$ alone and in combination with growth hormone (GH) on @COMPOUND$ secretion, aromatase activity in parallel with inhibitory effect on cell apoptosis.	1
2832	In cultures treated together ghrelin and (D-Lys-3)-GHRP-6, @COMPOUND$ secretion, @PROTEIN$ activity and cell proliferation returned to control levels.	0
2833	In cultures treated together @PROTEIN$ and (D-Lys-3)-GHRP-6, @COMPOUND$ secretion, aromatase activity and cell proliferation returned to control levels.	1
2834	This is the first finding that @COMPOUND$ plays a role in innate immunity by cooperating with natural ligands, @PROTEIN$.	1
2835	Effect of polyols on the solubility of bovine serum albumin (@PROTEIN$) in the presence of @COMPOUND$ glycols (PEGs) was investigated in order to strengthen the understanding of the observed effects of polyols and PEGs on protein properties in solution.	0
2836	Effect of polyols on the solubility of bovine @PROTEIN$ (BSA) in the presence of @COMPOUND$ glycols (PEGs) was investigated in order to strengthen the understanding of the observed effects of polyols and PEGs on protein properties in solution.	0
2837	After 2 and 6 weeks of treatment, parotid gland was removed and total protein and @COMPOUND$ (free and total) concentration and amylase and @PROTEIN$ activities were determined.	0
2838	To investigate the change pattern of @PROTEIN$ (SP) and @COMPOUND$ (NO) in the portal vein during the recto-anal inhibitory reflex (RAIR), and its physiological significance; the influence of external splanchnic nerve (ESN) of rectum and anus to the RAIR.	0
2839	A @PROTEIN$ (F2) and lipase-like materials (F1) were purified from the culture supernatant of P. monteilii TKU009 with soybean powder as the sole carbon/@COMPOUND$ source.	0
2840	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2841	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2842	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2843	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2844	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2845	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2846	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2847	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2848	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2849	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2850	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2851	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2852	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2853	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2854	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2855	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2856	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2857	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2858	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2859	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2860	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2861	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2862	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2863	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2864	Our data indicate that genetic differences in @PROTEIN$ gene expression may predispose individual differences in the responsivity to repeated intake of @COMPOUND$.	1
2865	Angiotensin II (@PROTEIN$) is the key peptide hormone in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
2866	Angiotensin II (Ang II) is the key @PROTEIN$ in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
2867	Angiotensin II (Ang II) is the key peptide hormone in the renin-@PROTEIN$-@COMPOUND$ system (RAAS).	1
2868	@PROTEIN$ (Ang II) is the key peptide hormone in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
2869	The enzyme responsible for D-@COMPOUND$ biosynthesis, @PROTEIN$ (SR), is therefore a promising target for treatment of neuropathologies related to glutamate receptor excitotoxicity, such as stroke or Alzheimer's disease.	1
2870	Hepatocyte apoptosis was estimated morphologically using @PROTEIN$ combined with @COMPOUND$, or toluidine blue staining.	0
2871	Hepatocyte apoptosis was estimated morphologically using @PROTEIN$ combined with propidium iodide, or @COMPOUND$ staining.	0
2872	The FFA fractions elicited pro-inflammatory responses inducing @PROTEIN$ and intracellular adhesion molecule expression and reactive @COMPOUND$ species (ROS) production in human aortic endothelial cells (HAECs).	0
2873	@PROTEIN$ single nucleotide polymorphism G2677T/A and haplotype are correlated with response to @COMPOUND$-cisplatin chemotherapy in patients with non-small-cell lung cancer.	1
2874	Functional expression of @PROTEIN$ responsible for protection against oxidative stress through promotion of @COMPOUND$ synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells.	1
2875	Functional expression of beta2 adrenergic receptors responsible for protection against oxidative stress through promotion of @COMPOUND$ synthesis after @PROTEIN$ upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells.	0
2876	Exposure to adrenaline not only increased cAMP formation, phosphorylation of cAMP responsive element (CRE) binding protein (@PROTEIN$) on serine133 and CRE reporter activity in a manner sensitive to @COMPOUND$, but also rendered C3H10T1/2 cells resistant to the cytotoxicity of hydrogen peroxide, but not of either 2,4-dinitirophenol or tunicamycin.	1
2877	Exposure to adrenaline not only increased cAMP formation, phosphorylation of cAMP responsive element (CRE) binding protein (@PROTEIN$) on serine133 and CRE reporter activity in a manner sensitive to propranolol, but also rendered C3H10T1/2 cells resistant to the cytotoxicity of @COMPOUND$, but not of either 2,4-dinitirophenol or tunicamycin.	1
2878	@COMPOUND$ (imatinib) is a potent and selective inhibitor of the tyrosine kinases, Bcr-Abl, @PROTEIN$ and platelet-derived growth factor receptors (PDGFRs).	1
2879	Imatinib mesylate (@COMPOUND$) is a potent and selective inhibitor of the tyrosine kinases, Bcr-@PROTEIN$, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1
2880	@COMPOUND$ (imatinib) is a potent and selective inhibitor of the tyrosine kinases, @PROTEIN$-Abl, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1
2881	Imatinib mesylate (@COMPOUND$) is a potent and selective inhibitor of the tyrosine kinases, Bcr-Abl, @PROTEIN$ and platelet-derived growth factor receptors (PDGFRs).	1
2882	Imatinib mesylate (@COMPOUND$) is a potent and selective inhibitor of the tyrosine kinases, @PROTEIN$-Abl, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1
2883	@COMPOUND$ (imatinib) is a potent and selective inhibitor of the tyrosine kinases, Bcr-@PROTEIN$, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1
2884	The large and diverse family of @PROTEIN$ monooxygenases (CYPs) was systematically analyzed to identify selectivity- and specificity-determining residues in the substrate recognition site 5, which is located in close vicinity to the @COMPOUND$ center.	1
2885	The large and diverse family of cytochrome P450 monooxygenases (@PROTEIN$) was systematically analyzed to identify selectivity- and specificity-determining residues in the substrate recognition site 5, which is located in close vicinity to the @COMPOUND$ center.	0
2886	In 98.4% of all @PROTEIN$ sequences a preferentially hydrophobic residue is located at position 5 after the ExxR motif that is predicted to point close to the @COMPOUND$ center.	0
2887	We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human serum albumin (@PROTEIN$) using various biophysical methods.	1
2888	We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human @PROTEIN$ (HSA) using various biophysical methods.	1
2889	We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human @PROTEIN$ (HSA) using various biophysical methods.	1
2890	We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human serum albumin (@PROTEIN$) using various biophysical methods.	1
2891	From the observed Förster-type fluorescence resonance energy transfer (FRET), the donor (Trp 214 in @PROTEIN$) to acceptor (@COMPOUND$) distance is calculated to be 3.2 nm.	1
2892	A number of site-specific modifications of the nucleosome core histones-including the trimethylated forms of @PROTEIN$ lysines K4, K9, and @COMPOUND$-are of particular interest for postmortem research, because these marks differentiate between active and inactive chromatin and seem to remain relatively stable during tissue autolysis.	1
2893	We here demonstrate that @PROTEIN$ confers a sensitivity towards near ultraviolet (UVA) light, which rapidly causes @COMPOUND$+) entry.	1
2894	In the presence of the photosensitising agents @COMPOUND$ (100 nM) or hypericin (10 nM), the sensitivity of light-induced @PROTEIN$ activation was increased and extended towards the visible spectrum.	1
2895	In the presence of the photosensitising agents acridine orange (100 nM) or @COMPOUND$ (10 nM), the sensitivity of light-induced @PROTEIN$ activation was increased and extended towards the visible spectrum.	1
2896	To verify the possible involvement of lipids and several other compounds including @COMPOUND$ (H(2)O(2)) and glyceraldehyde-3-phosphate dehydrogenase (@PROTEIN$) in the response of Hordeum vulgare to early potassium deprivation, plants were grown in hydroponic conditions for 30d with a modified Hewitt nutrient solution containing 3mM K(+).	0
2897	To verify the possible involvement of lipids and several other compounds including @COMPOUND$ (H(2)O(2)) and @PROTEIN$ (G3PDH) in the response of Hordeum vulgare to early potassium deprivation, plants were grown in hydroponic conditions for 30d with a modified Hewitt nutrient solution containing 3mM K(+).	0
2898	The angiogenic potential of vascular endothelial growth factor (@PROTEIN$) and its @COMPOUND$ pressure-dependent regulation suggest a strong connection between this growth factor and the 'delay phenomenon'.	1
2899	Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated @PROTEIN$ activation in response to @COMPOUND$.	1
2900	@COMPOUND$ toxicity and @PROTEIN$-dependent detoxification in astrocytes.	1
2901	After serum @COMPOUND$ reached a stable nadir in the transplant recipients, @PROTEIN$ and its hemodynamic determinants were evaluated and the whole allograft K(f) was computed.	0
2902	Furthermore, constitutive expression of an @COMPOUND$-insensitive, active form of @PROTEIN$ protein mimicked the effects of low oxygen, inhibiting the differentiation of trophoblast giant cells.	0
2903	However, the effect of inoculum size of @PROTEIN$-negative, @COMPOUND$-resistant H. influenzae (BLNAR) on MICs for carbapenems has not been investigated.	0
2904	@COMPOUND$ has been the mainstay of endocrine therapy for @PROTEIN$-positive breast cancer.	1
2905	The bifunctional enzyme @PROTEIN$/N-acetylmannosamine kinase (GNE) is the key enzyme for the biosynthesis of @COMPOUND$, terminal components of glycoconjugates associated with a variety of physiological and pathological processes.	1
2906	The bifunctional enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (@PROTEIN$) is the key enzyme for the biosynthesis of @COMPOUND$, terminal components of glycoconjugates associated with a variety of physiological and pathological processes.	1
2907	A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal @PROTEIN$ and glial Cx43 hemichannel activity, favoring @COMPOUND$ release and generation of preconditioning.	1
2908	A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal Cx36 and glial @PROTEIN$ hemichannel activity, favoring @COMPOUND$ release and generation of preconditioning.	1
2909	4) PKA regulates neurotransmission without @PROTEIN$ involvement because, after @COMPOUND$ or CaC modulation of the PKC activity, coupling to the ACh release of PKA can normally be stimulated with Sp-8-BrcAMP or inhibited with H-89.	0
2910	In contrast, PKA inhibition prevent @PROTEIN$ stimulation (with the @COMPOUND$) and coupling to ACh output.	1
2911	The inhibition of female rabbit sexual behavior by @COMPOUND$ : @PROTEIN$-dependent and-independent effects.	1
2912	Reproductive experience alters @COMPOUND$ and @PROTEIN$ levels in the rat dam.	0
2913	The expressions of serotonin receptors (5-hydroxytryptamine receptor), corticotropin-releasing hormone (@PROTEIN$) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
2914	The expressions of serotonin receptors (5-hydroxytryptamine receptor), @PROTEIN$ (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
2915	The expressions of serotonin receptors (@PROTEIN$), corticotropin-releasing hormone (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
2916	The expressions of @PROTEIN$ (5-hydroxytryptamine receptor), corticotropin-releasing hormone (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
2917	After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, estrone (E1) and @COMPOUND$ (E2), detected suggesting that the pathway of @PROTEIN$ is not important in these cell lines.	0
2918	After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, @COMPOUND$ (E1) and estradiol (E2), detected suggesting that the pathway of @PROTEIN$ is not important in these cell lines.	0
2919	The aim of this study was to investigate the effects of acute and chronic exercise on @COMPOUND$ reactive substances, as an indicator of lipid peroxidation, in the hippocampus, which has a high concentration of @PROTEIN$, and prefrontal cortex and striatum, which have high dopamine content.	0
2920	The aim of this study was to investigate the effects of acute and chronic exercise on thiobarbituric acid reactive substances, as an indicator of lipid peroxidation, in the hippocampus, which has a high concentration of @PROTEIN$, and prefrontal cortex and striatum, which have high @COMPOUND$ content.	0
2921	Additionally we examined antioxidant enzyme activities, @PROTEIN$ and glutathione peroxidase and nitrite-@COMPOUND$ levels to assess the effects of reactive oxygen and nitrogen species.	0
2922	Additionally we examined antioxidant enzyme activities, superoxide dismutase and @PROTEIN$ and nitrite-@COMPOUND$ levels to assess the effects of reactive oxygen and nitrogen species.	0
2923	Immunohistochemical colabeling for nesfatin-1 and @PROTEIN$, histidine decarboxylase, or @COMPOUND$ revealed two subtypes of nesfatin-1-positive endocrine cells.	0
2924	Immunohistochemical colabeling for nesfatin-1 and ghrelin, @PROTEIN$, or @COMPOUND$ revealed two subtypes of nesfatin-1-positive endocrine cells.	0
2925	Cells in the midportion of the glands coexpressed nesfatin-1 and @PROTEIN$, whereas few cells in the glandular base coexpressed nesfatin-1 and @COMPOUND$ or histidine decarboxylase.	0
2926	Cells in the midportion of the glands coexpressed nesfatin-1 and ghrelin, whereas few cells in the glandular base coexpressed nesfatin-1 and @COMPOUND$ or @PROTEIN$.	0
2927	Importantly, @PROTEIN$ and PAI-1 proteins and tPA activity were low/nondetectable in granulosa cells obtained after treatment with hCG and the PG synthesis inhibitor @COMPOUND$.	1
2928	Importantly, tPA and @PROTEIN$ proteins and tPA activity were low/nondetectable in granulosa cells obtained after treatment with hCG and the PG synthesis inhibitor @COMPOUND$.	1
2929	To determine whether hCG stimulation of tPA and @PROTEIN$ requires PGE2, granulosa cells obtained at 0 h were cultured with hCG plus @COMPOUND$ to inhibit PG production; some cells also received PGE2 or an agonist selective for one PGE2 receptor (EP).	0
2930	To determine whether hCG stimulation of @PROTEIN$ and PAI-1 requires PGE2, granulosa cells obtained at 0 h were cultured with hCG plus @COMPOUND$ to inhibit PG production; some cells also received PGE2 or an agonist selective for one PGE2 receptor (EP).	0
2931	The role of @COMPOUND$ in the treatment of obesity through @PROTEIN$ antagonism.	1
2932	In conclusion, the enhanced H(2)O(2) contraction in resistance arteries from SHRs seems to be mediated by increased TXA(2) release from @PROTEIN$ followed by elevations in vascular smooth muscle (@COMPOUND$+))(i) levels and O(2)(.	0
2933	Herein we show that @PROTEIN$ expression is subject to posttranscriptional regulation by microRNA (miRNA)-@COMPOUND$.	1
2934	Exogenous expression of @PROTEIN$ mRNA lacking the 3'-UTR partially rescued the miR-@COMPOUND$ induced cell-cycle block.	1
2935	Occupancy of one canonical @PROTEIN$ binding site was demonstrated by chromatin immunoprecipitation analysis and shown to be required for miR-@COMPOUND$ expression in K562 cells.	1
2936	The central homeostasis is characterized by increased cerebrocortical synaptosomal T(3) content, deiodinase type II (@PROTEIN$) activity, and @COMPOUND$ content.	0
2937	This review provides an introduction to epigenetic concepts for renal investigators and an overview of our work detailing an epigenetic pathway for @COMPOUND$ signaling and the control of epithelial @PROTEIN$-alpha (ENaCalpha) subunit gene expression in the collecting duct.	0
2938	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/@COMPOUND$ (GCV) therapy directed by the @PROTEIN$ (CEA) promoter.	1
2939	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (@COMPOUND$) therapy directed by the carcinoembryonic antigen (@PROTEIN$) promoter.	1
2940	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/@COMPOUND$ (GCV) therapy directed by the carcinoembryonic antigen (@PROTEIN$) promoter.	1
2941	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (@COMPOUND$) therapy directed by the @PROTEIN$ (CEA) promoter.	1
2942	Cytopathic effects of AxdAdB-3 plus AxCEAprTK (an adenovirus expressing HSVtk directed by CEA promoter) or AxCAHSVtk (an adenovirus expressing HSVtk directed by a nonspecific @PROTEIN$ promoter) with @COMPOUND$ administration were examined in several GBC lines and normal cells.	0
2943	This mutation in the @PROTEIN$ gene replaces a @COMPOUND$ encoding codon with a stop signal.	1
2944	Cyclophilin A (CypA), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (@PROTEIN$) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	0
2945	Cyclophilin A (@PROTEIN$), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (PPIase) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	1
2946	@PROTEIN$ (CypA), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (PPIase) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	1
2947	While studies have shown that @COMPOUND$ does not exhibit nonspecific actions on @PROTEIN$, its effects on steroid hormone production have not been reported.	0
2948	New treatments for type 2 diabetes mellitus are needed to retain @PROTEIN$-@COMPOUND$ coupling and lower the risk of weight gain and hypoglycaemia.	1
2949	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2950	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (@PROTEIN$).	0
2951	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2952	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and @PROTEIN$ (GST).	0
2953	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of @PROTEIN$ (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2954	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2955	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), @PROTEIN$ (GPx) and glutathione S-transferase (GST).	0
2956	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2957	In accord with published results, we could show that treatment with @COMPOUND$ resulted in depletion of @PROTEIN$, a known Hsp90 client protein.	1
2958	In accord with published results, we could show that treatment with @COMPOUND$ resulted in depletion of Chk1, a known @PROTEIN$ client protein.	0
2959	In addition, we observed a time- and dose-dependent decrease in @PROTEIN$ kinase level, a negative regulator of mitosis, after @COMPOUND$ treatment in gastrointestinal cancer cells.	1
2960	As with @PROTEIN$, they are involved in making @COMPOUND$ available to apo-enzymes inside the cell.	1
2961	Multiple studies suggest increased conversion of @COMPOUND$ to bile acids by @PROTEIN$ (CYP7A1) protects against dyslipidemia and atherosclerosis.	1
2962	Multiple studies suggest increased conversion of @COMPOUND$ to bile acids by cholesterol 7alpha-hydroxylase (@PROTEIN$) protects against dyslipidemia and atherosclerosis.	1
2963	Treatment with pioglitazone, associated with @COMPOUND$, showed a reduction of @PROTEIN$ monocyte production after their in vitro activation with LPS.	1
2964	Regulation of T-type @PROTEIN$.1 channels expression by synthetic glucocorticoid @COMPOUND$ in neonatal cardiac myocytes.	1
2965	The supernatant of the majority of the strains did not release the aglycone from @COMPOUND$, suggesting that cell-associated beta-glucosidases (beta-@PROTEIN$) are mainly responsible for the metabolism of soybean glyco-conjugates.	0
2966	The supernatant of the majority of the strains did not release the aglycone from @COMPOUND$, suggesting that cell-associated @PROTEIN$ (beta-Glu) are mainly responsible for the metabolism of soybean glyco-conjugates.	0
2967	Role of @PROTEIN$ as a biomarker for predicting resistance to @COMPOUND$ in breast cancer.	1
2968	Acute regulation is mediated by the @PROTEIN$ (StAR), which facilitates the rapid influx of @COMPOUND$ into mitochondria, where P450scc resides.	1
2969	Acute regulation is mediated by the steroidogenic acute regulatory protein (@PROTEIN$), which facilitates the rapid influx of @COMPOUND$ into mitochondria, where P450scc resides.	1
2970	In the absence of @PROTEIN$ in the zona glomerulosa, C21 deoxy steroids are produced, leading to the mineralocorticoid, @COMPOUND$.	0
2971	In the presence of the 17alpha-hydroxylase but not the 17,20 lyase activity of @PROTEIN$ in the zona fasciculata, C21, 17-hydroxy steroids are produced, leading to the glucocorticoid, @COMPOUND$.	0
2972	The relative pharmacological efficacy for chitosan @COMPOUND$ and chitosan succinate microspheres (18.66+/-3.84%, 16.24+/-4%) was almost three-fold higher than the efficacy of the oral @PROTEIN$ administration (4.68+/-1.52%).	0
2973	Induction of autophagy in malignant rhabdoid tumor cells by the histone deacetylase inhibitor @COMPOUND$ through @PROTEIN$ translocation.	1
2974	Furthermore, the effect of @COMPOUND$ on @PROTEIN$ has not been reported previously.	1
2975	In the present study, we investigated the cellular and molecular mechanisms of @PROTEIN$ regulation by @COMPOUND$ in VSMCs (vascular SMCs).	1
2976	Pretransplant conditioning consisted of @COMPOUND$, l-@PROTEIN$ and TBI (2 Gy).	0
2977	Despite pre- and post-operative PP and immunosuppressive treatment consisting of steroids, CycA, daclizumab, and @PROTEIN$, daily protein excretion and serum @COMPOUND$ increased.	0
2978	Despite pre- and post-operative PP and immunosuppressive treatment consisting of steroids, @PROTEIN$, daclizumab, and MMF, daily protein excretion and serum @COMPOUND$ increased.	0
2979	Inhibition of @PROTEIN$ by @COMPOUND$ analogues: Implications for anticancer activity.	1
2980	Effects of CYP2C19 and @PROTEIN$ genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and @COMPOUND$.	0
2981	Effects of @PROTEIN$ and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and @COMPOUND$.	0
2982	Anti-gastric cancer effects of @COMPOUND$, a selective COX-2 inhibitor, through inhibition of @PROTEIN$ signaling.	1
2983	Effect of renin-angiotensin-@COMPOUND$ system inhibition, dietary sodium restriction, and/or diuretics on urinary @PROTEIN$ excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.	0
2984	Among the R-Nx strains, a substitution of @COMPOUND$ to Cys at position 81 (Gly81à Cys) of the @PROTEIN$ gene in 10 strains isolated from wild birds and ovine foetuses, and of Asp to Tyr at position 87 (Asp87à Tyr) in one strain isolated from ewe faeces, were revealed by sequencing the gene.	1
2985	Gene sequencing detected an additional seven GCG repeats in the first @COMPOUND$ tract of the @PROTEIN$ gene, a mutation which leads to an expansion of the normal 16 alanine residues to 23.	1
2986	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2987	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2988	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2989	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2990	We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn su@COMPOUND$ dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2991	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2992	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2993	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2994	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2995	We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn su@COMPOUND$ dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2996	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2997	THII significantly diminished these changes in @COMPOUND$ and @PROTEIN$.	0
2998	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and @COMPOUND$ (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
2999	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (@COMPOUND$), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
3000	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (@COMPOUND$) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
3001	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (@COMPOUND$), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
3002	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and @COMPOUND$ (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
3003	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of @COMPOUND$ (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
3004	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of @COMPOUND$ (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
3005	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (@COMPOUND$) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
3006	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1
3007	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
3008	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
3009	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
3010	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1
3011	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1
3012	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
3013	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1
3014	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
3015	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
3016	Synthesis of GDP-@COMPOUND$ from exogenous mannose requires @PROTEIN$ or phosphotransferase enzymes together with PMM and GMPP.	1
3017	Synthesis of GDP-@COMPOUND$ from exogenous mannose requires hexokinase or phosphotransferase enzymes together with @PROTEIN$ and GMPP.	1
3018	Preincubation of airway epithelial cells with @COMPOUND$ (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in @PROTEIN$ after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	1
3019	Preincubation of airway epithelial cells with lycopene (dissolved in @COMPOUND$) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in @PROTEIN$ after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	0
3020	Preincubation of airway epithelial cells with @COMPOUND$ (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in @PROTEIN$ after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	1
3021	Preincubation of airway epithelial cells with lycopene (dissolved in @COMPOUND$) delivered lycopene into the cells and resulted in a 24% reduction in @PROTEIN$ after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	0
3022	Spinal and bulbar muscular atrophy (SBMA) is a motor neuron disease caused by @COMPOUND$ expansion mutation in the @PROTEIN$ (AR).	1
3023	Also, our previous studies implicated the SphK1/@PROTEIN$ pathway in the induction of the @COMPOUND$ cascade, a major inflammatory pathway involved in colon carcinogenesis.	1
3024	In the azoxymethane (@COMPOUND$) murine model of colon cancer, SphK1 and @PROTEIN$ were significantly elevated in colon cancer tissues compared to normal mucosa.	1
3025	In the @COMPOUND$ (AOM) murine model of colon cancer, SphK1 and @PROTEIN$ were significantly elevated in colon cancer tissues compared to normal mucosa.	1
3026	Uptake of @COMPOUND$, losartan, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
3027	Uptake of valsartan, @COMPOUND$, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
3028	Uptake of valsartan, losartan, and @COMPOUND$ was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
3029	In contrast to cefadroxil, no @PROTEIN$-specific uptake of @COMPOUND$ and losartan was found.	0
3030	In contrast to cefadroxil, no @PROTEIN$-specific uptake of valsartan and @COMPOUND$ was found.	0
3031	In contrast to @COMPOUND$, no @PROTEIN$-specific uptake of valsartan and losartan was found.	1
3032	The 2-(acylamino)-3-thiophenecarboxylates suppressed @PROTEIN$-mediated @COMPOUND$ (-) current in T84 colonic cells in response to cholera and Escherichia coli (STa) toxins, and prevented intestinal fluid accumulation in a closed-loop mouse model of secretory diarrhea.	1
3033	We investigated the hypothesis that modulation of EPC biology and attenuation of allograft vasculopathy by increased @PROTEIN$ @COMPOUND$ after human apo A-I (AdA-I) transfer requires scavenger receptor (SR)-BI expression in bone marrow-derived EPCs.	1
3034	Hormone-sensitive lipase (@PROTEIN$) is a key regulator of @COMPOUND$ esters metabolism.	1
3035	@PROTEIN$ (HSL) is a key regulator of @COMPOUND$ esters metabolism.	1
3036	@PROTEIN$ and free @COMPOUND$ are independent risk factors for benign prostatic hyperplasia.	0
3037	The objective of the present study was to test the @PROTEIN$, @COMPOUND$ and metabolic syndrome hypotheses as promoters of BPH.	0
3038	@COMPOUND$ plus single-dose @PROTEIN$ glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.	0
3039	To evaluate @COMPOUND$ (AVP) and @PROTEIN$ plasma concentrations in patients with vasodilatory shock after cardiac surgery.	0
3040	In this study, we report a novel @PROTEIN$ defect in a Tunisian family, in which @COMPOUND$ 23 is substituted by a Stop codon causing a premature termination of translation.	1
3041	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of @COMPOUND$, 2b and 3a, were studied.	0
3042	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) @COMPOUND$ (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
3043	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, @COMPOUND$-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
3044	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and @COMPOUND$-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
3045	The presented study is aimed at reactivation of @COMPOUND$-inhibited butyrylcholinesterase since this enzyme play an important role in Alzheimer's disease as deputy for @PROTEIN$ and furthermore it could be applied as a scavenger in case of overdosing.	0
3046	Among them, @COMPOUND$ and 5 had significant @PROTEIN$ inhibitory activities.	1
3047	Here we report the docking study of four @COMPOUND$ catechins and four alkylating anticancer drugs into the @PROTEIN$ model, as GSTs were found to be affected by tea catechins.	1
3048	Here we report the docking study of four @COMPOUND$ catechins and four alkylating anticancer drugs into the GST P1-1 model, as @PROTEIN$ were found to be affected by tea catechins.	1
3049	The protein glycation inhibitory activity of ethanolic extract of Lawsonia inermis (henna) plant tissues was evaluated in vitro using the model system of bovine @PROTEIN$ and @COMPOUND$.	0
3050	In vitro effects of @COMPOUND$ treatment on fish liver @PROTEIN$ activity.	1
3051	NMR-derived @COMPOUND$-bound structure of @PROTEIN$ from the halophile Haloferax volcanii.	1
3052	The biological roles of the @COMPOUND$-regulated conformational equilibrium of @PROTEIN$ are discussed in terms of the self and non-self discrimination mechanism.	1
3053	The Iowa Gambling Task (IGT) was used to examine (i) social decision-making in women with borderline personality disorder (BPD), and (ii) the relationship between impaired decision-making and the tryptophan hydroxylase-1 (@PROTEIN$) gene, involved in @COMPOUND$ synthesis.	1
3054	Effects of acceptor composition and mechanism of @PROTEIN$-mediated cellular free @COMPOUND$ efflux.	1
3055	Reduced responses of alpha-MSH or @PROTEIN$-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0
3056	Reduced responses of alpha-MSH or Nac-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type @PROTEIN$ system in nonsurvivors.	0
3057	Reduced responses of alpha-MSH or Nac-beta-END IRM to @PROTEIN$ and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0
3058	Reduced responses of @PROTEIN$ or Nac-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0
3059	The purpose of this retrospective study was to compare the effects of @PROTEIN$ and @COMPOUND$ in the management of HIT.	0
3060	The outer membrane @PROTEIN$ is involved in @COMPOUND$ tolerance and overproduction in Escherichia coli.	1
3061	Gene expression analysis revealed that the @PROTEIN$ gene encoding the outer membrane channel is essential for @COMPOUND$ tolerance in E. coli cells.	1
3062	The present study was performed to elucidate the relationship between the expression of ABCB1/MDR1 and ABCC1/@PROTEIN$ with resistance to either @COMPOUND$ or PM00104.	1
3063	The present study was performed to elucidate the relationship between the expression of ABCB1/MDR1 and @PROTEIN$/MRP1 with resistance to either @COMPOUND$ or PM00104.	1
3064	The present study was performed to elucidate the relationship between the expression of @PROTEIN$/MDR1 and ABCC1/MRP1 with resistance to either @COMPOUND$ or PM00104.	1
3065	The present study was performed to elucidate the relationship between the expression of ABCB1/@PROTEIN$ and ABCC1/MRP1 with resistance to either @COMPOUND$ or PM00104.	1
3066	The previous amphotericin B, @PROTEIN$, hyperbaric @COMPOUND$ and nasal and left maxillary sinus surgical debridement therapy was ineffective in stopping the progression of the infection to the brain.	0
3067	The previous @COMPOUND$, @PROTEIN$, hyperbaric oxygen and nasal and left maxillary sinus surgical debridement therapy was ineffective in stopping the progression of the infection to the brain.	0
3068	Bacterial strains differed in their ability to synthesize @COMPOUND$ and hydrogen cyanide compounds, as well as in their @PROTEIN$ activity.	0
3069	Bacterial strains differed in their ability to synthesize auxin and @COMPOUND$ compounds, as well as in their @PROTEIN$ activity.	0
3070	Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the @COMPOUND$-dependent glutathione peroxidases, @PROTEIN$.	1
3071	Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the @COMPOUND$-dependent @PROTEIN$, GPx2.	1
3072	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), @COMPOUND$ (NO) and dopamine (DA) in aged mice.	0
3073	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), nitric oxide (NO) and @COMPOUND$ (DA) in aged mice.	0
3074	The purpose of this study was to investigate whether or not the role of @COMPOUND$ (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), nitric oxide (NO) and dopamine (DA) in aged mice.	0
3075	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), @COMPOUND$ (NO) and dopamine (DA) in aged mice.	0
3076	The purpose of this study was to investigate whether or not the role of @COMPOUND$ (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), nitric oxide (NO) and dopamine (DA) in aged mice.	1
3077	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), nitric oxide (NO) and @COMPOUND$ (DA) in aged mice.	0
3078	Model analysis of local @COMPOUND$ delivery with liposome-encapsulated @PROTEIN$.	1
3079	The role of @COMPOUND$+)-insensitive @PROTEIN$, if any, in sperm volume regulation was studied in transgenic mice.	0
3080	Therefore, the @COMPOUND$+)-sensitive @PROTEIN$, which was localized in elongated spermatids and spermatozoa, is a likely candidate for a water channel responsible for physiological sperm volume regulation crucial to in vivo fertilization.	1
3081	Increased intrahepatic vascular tone in cirrhosis has been attributed to a decrease of hepatic @COMPOUND$ (NO) secondary to disturbances in the post-translational regulation of the enzyme @PROTEIN$.	0
3082	@PROTEIN$ deficiency is a rare autosomal disorder of de novo @COMPOUND$ synthesis, which results in the accumulation of succinylpurines in body fluids.	1
3083	Both patients had an increased @COMPOUND$/SAICAr ratio of 1.6, and exhibited a novel homozygous missense mutation (c.674T&gt;C; p.Met225Thr) in the exon 6 of the @PROTEIN$ gene.	1
3084	The profile of global DNA and @PROTEIN$ (ER)-alpha gene methylation during cancer development was determined by analysis of @COMPOUND$ (5-MeC) using immunohistochemical (IHC) staining, dot blot analysis or a quantitative gene methylation assay (QGMA).	0
3085	The profile of global DNA and @PROTEIN$ (ER)-alpha gene methylation during cancer development was determined by analysis of 5-methylcytosine (5-@COMPOUND$) using immunohistochemical (IHC) staining, dot blot analysis or a quantitative gene methylation assay (QGMA).	0
3086	Zebularine suppresses the apoptotic potential of @COMPOUND$ via cAMP/PKA/@PROTEIN$ pathway against human oral squamous cell carcinoma cells.	1
3087	Zebularine suppresses the apoptotic potential of 5-fluorouracil via @COMPOUND$/PKA/@PROTEIN$ pathway against human oral squamous cell carcinoma cells.	0
3088	Donor testicular cells were prepared from heterozygous chicken beta actin (CAG)/enhanced @PROTEIN$ (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
3089	Donor testicular cells were prepared from heterozygous chicken beta actin (@PROTEIN$)/enhanced green fluorescent protein (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
3090	Donor testicular cells were prepared from heterozygous chicken @PROTEIN$ (CAG)/enhanced green fluorescent protein (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
3091	Models of noncoupled dinuclear @COMPOUND$ centers in @PROTEIN$.	1
3092	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (@PROTEIN$), dopamine beta-monooxygenase (DBM), and nitrite reductase (NiR) were designed into the small soluble protein azurin.	1
3093	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), dopamine beta-monooxygenase (DBM), and nitrite reductase (NiR) were designed into the small soluble protein @PROTEIN$.	1
3094	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), dopamine beta-monooxygenase (DBM), and nitrite reductase (@PROTEIN$) were designed into the small soluble protein azurin.	1
3095	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), @PROTEIN$ (DBM), and nitrite reductase (NiR) were designed into the small soluble protein azurin.	1
3096	Intraprotein electron transfer (IET) from @COMPOUND$ (FMN) to heme is essential in NO synthesis by NO synthase (@PROTEIN$).	1
3097	Intraprotein electron transfer (IET) from flavin mononucleotide (FMN) to @COMPOUND$ is essential in NO synthesis by NO synthase (@PROTEIN$).	1
3098	Intraprotein electron transfer (IET) from flavin mononucleotide (@COMPOUND$) to heme is essential in NO synthesis by NO synthase (@PROTEIN$).	1
3099	The esterase and @PROTEIN$ activities were determined by the hydrolysis of pNPB and @COMPOUND$, respectively.	1
3100	The @PROTEIN$ and lipase activities were determined by the hydrolysis of pNPB and @COMPOUND$, respectively.	1
3101	In the present work, the activity of the enzymes xylose reductase (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (@PROTEIN$) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
3102	In the present work, the activity of the enzymes @PROTEIN$ (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (G6PD) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
3103	Inhibition of human @PROTEIN$ by @COMPOUND$ and irreversible formation of advanced glycation end products.	1
3104	Inhibitory effects of Cefazolin and @COMPOUND$ on the activity of mushroom @PROTEIN$.	1
3105	Inhibitory effects of @COMPOUND$ and Cefodizime on the activity of mushroom @PROTEIN$.	1
3106	The order of the cytotoxicity of the compounds was; IV &gt; III &gt; II &gt; I &gt; V. @COMPOUND$, had the highest Hammett and log P values (0.23 and 4.21, respectively) and exerted both highest cytotoxicity and strongest @PROTEIN$ inhibition.	1
3107	Tests were carried out on cell cultures of human keratinocytes and mouse 3T3 fibroblasts incubated with radiolabeled acetate, and on homogenates prepared from yeast cells expressing human @PROTEIN$, incubated with radiolabeled @COMPOUND$.	0
3108	Inhibition of rat liver @PROTEIN$ and L by the peptide aldehyde @COMPOUND$ and its analogues.	1
3109	Preliminary structure-activity relationships and a molecular modeling study for 9a have revealed that the @COMPOUND$ moiety plays a key role in the interaction of this series of derivatives with @PROTEIN$ by acting as an anchor in its peripheral anionic site.	1
3110	Heme oxygenase-1 (@PROTEIN$) and @COMPOUND$ (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.	0
3111	@PROTEIN$ (HO-1) and @COMPOUND$ (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.	0
3112	One potential target for reducing T cell migration is inhibition of the @COMPOUND$+)-activated neutral protease @PROTEIN$.	1
3113	One potential target for reducing T cell migration is inhibition of the @COMPOUND$+)-activated @PROTEIN$ calpain.	0
3114	A shift toward proinflammatory microglial activation is indicated by the release of interleukin-6, @PROTEIN$-alpha, and @COMPOUND$ and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide.	0
3115	A shift toward proinflammatory microglial activation is indicated by the release of @PROTEIN$, tumor necrosis factor-alpha, and @COMPOUND$ and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide.	0
3116	@COMPOUND$, a newer anticonvulsant, does not undergo @PROTEIN$ metabolism and does not alter the pharmacokinetics of chemotherapy, antiemetics, and corticosteroids, which are metabolized by the liver.	0
3117	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) @COMPOUND$ (3) binding and @PROTEIN$ protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	0
3118	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by @COMPOUND$ (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and @PROTEIN$ protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	0
3119	As this effect might be related to deregulation of @PROTEIN$ (Cx43) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1
3120	As this effect might be related to deregulation of connexin 43 (@PROTEIN$) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1
3121	Inhibition of either proteasomes or lysosomes with their specific inhibitors largely restored total @PROTEIN$ protein levels, thus suggesting that both proteasomes and lysosomes may participate in the @COMPOUND$-enhanced Cx43 internalization and degradation.	1
3122	Finally, @COMPOUND$ also interfered with restoration of gap junction plaques following the inhibition of @PROTEIN$ transport to plasma membrane.	1
3123	Taken together, multiple modes of action seem to contribute to downregulation of @PROTEIN$ in @COMPOUND$-treated rat liver epithelial cells.	1
3124	@COMPOUND$ demonstrates potent inhibition of @PROTEIN$-4 activity with excellent tolerability at doses of up to and including 200 mg qd.	1
3125	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with @COMPOUND$ or @PROTEIN$ receptor with 2-methyl-6-(phenylethynyl)-pyridine (MPEP).	0
3126	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-801 or @PROTEIN$ receptor with 2-methyl-6-(phenylethynyl)-pyridine (@COMPOUND$).	1
3127	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-801 or @PROTEIN$ receptor with @COMPOUND$ (MPEP).	1
3128	Here, PCA is applied to three problems in @PROTEIN$ research: (i) distinguishing origins of heparin preparations, (ii) structural analysis of heparin derivatives, and (iii) classification of @COMPOUND$ (CS).	1
3129	By using purified bovine @PROTEIN$, the reduction was observed in the presence of @COMPOUND$ (P)H. These results suggest that FLU-1 N-OH is involved in flutamide-induced hepatotoxicity and that cytosolic reduction of FLU-1 N-OH plays a major role in protection against flutamide-induced hepatotoxicity.	1
3130	Recent studies have provided important insight into the homeoprotein LIM homeobox transcription factor 1alpha (@PROTEIN$) and its role in the commitment of cells to a midbrain @COMPOUND$ (mDA) fate in the developing mouse.	1
3131	Recent studies have provided important insight into the homeoprotein @PROTEIN$ homeobox transcription factor 1alpha (Lmx1a) and its role in the commitment of cells to a midbrain @COMPOUND$ (mDA) fate in the developing mouse.	1
3132	Recognition of @COMPOUND$ components of pectin by @PROTEIN$.	1
3133	By using a combination of fluorescence microscopy, flow cytometry, and force spectroscopy, it has been possible to demonstrate, for the first time, specific binding of a pectin @COMPOUND$ to the recombinant form of human @PROTEIN$.	1
3134	@PROTEIN$ has been identified as an endoplasmic reticulum (ER)-resident @COMPOUND$+) sensor that regulates store-operated calcium entry (SOCE) in immune cells and platelets, but the identity of the platelet SOC channel has remained elusive.	1
3135	A sensitive and specific ELISA detects @COMPOUND$-containing @PROTEIN$ in HDL.	1
3136	The renin-angiotensin-@COMPOUND$ system: approaches to guide @PROTEIN$ inhibition in patients with coronary artery disease.	0
3137	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between @COMPOUND$-clavulanate and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
3138	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, @COMPOUND$ and aztreonam.	1
3139	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and @COMPOUND$, ceftriaxone, ceftazidime and aztreonam.	1
3140	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, @COMPOUND$, ceftazidime and aztreonam.	1
3141	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, ceftazidime and @COMPOUND$.	1
3142	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-@COMPOUND$ and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
3143	The binding of @COMPOUND$ to human @PROTEIN$ was used as the model system in order to evaluate the performance of automated SPME.	1
3144	@COMPOUND$ (NO) and interlukin-6 (@PROTEIN$) are highly reactive mediators that have been shown to play different roles in a variety of different biological process.	0
3145	Mitochondrial @PROTEIN$ (ALDH-2)--maker of and marker for nitrate tolerance in response to @COMPOUND$ treatment.	1
3146	Mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)--maker of and marker for nitrate tolerance in response to @COMPOUND$ treatment.	1
3147	Mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)--maker of and marker for @COMPOUND$ tolerance in response to nitroglycerin treatment.	1
3148	Mitochondrial @PROTEIN$ (ALDH-2)--maker of and marker for @COMPOUND$ tolerance in response to nitroglycerin treatment.	1
3149	Finally, we will address the question whether @PROTEIN$-2 inactivation by nitroglycerin could be a useful marker for clinical nitrate tolerance and discuss the redox-regulation of this enzyme by oxidative stress and @COMPOUND$.	0
3150	Finally, we will address the question whether @PROTEIN$-2 inactivation by @COMPOUND$ could be a useful marker for clinical nitrate tolerance and discuss the redox-regulation of this enzyme by oxidative stress and dihydrolipoic acid.	0
3151	Finally, we will address the question whether @PROTEIN$-2 inactivation by nitroglycerin could be a useful marker for clinical @COMPOUND$ tolerance and discuss the redox-regulation of this enzyme by oxidative stress and dihydrolipoic acid.	0
3152	In the present study, we have characterized the effect of @COMPOUND$ on the accumulation of the small heat shock protein (@PROTEIN$), HSP30, in Xenopus laevis A6 kidney epithelial cells.	1
3153	In the present study, we have characterized the effect of @COMPOUND$ on the accumulation of the small heat shock protein (HSP), @PROTEIN$, in Xenopus laevis A6 kidney epithelial cells.	1
3154	Immunocytochemical analysis of @COMPOUND$-treated A6 cells revealed @PROTEIN$ accumulation primarily in the cytoplasm in a punctate pattern supplemented with larger HSP30 staining structures.	1
3155	Also, @PROTEIN$ co-localized with the F-actin cytoskeleton at higher @COMPOUND$ concentrations.	1
3156	Also, HSP30 co-localized with the F-@PROTEIN$ cytoskeleton at higher @COMPOUND$ concentrations.	0
3157	In order to suppress the emergence of such resistant variants, we introduced charged and hydrophilic amino acids, @COMPOUND$ (E) and lysine (K), at the solvent accessible site of @PROTEIN$.	1
3158	In order to suppress the emergence of such resistant variants, we introduced charged and hydrophilic amino acids, glutamic acid (E) and @COMPOUND$ (K), at the solvent accessible site of @PROTEIN$.	1
3159	Cloning, expression, and characterization of @COMPOUND$-induced @PROTEIN$ from the earthworms Metaphire posthuma and Polypheretima elongata.	1
3160	Complementary (c)DNA was verified as the @PROTEIN$ gene by the characteristics of its predicted translation product, namely a high @COMPOUND$ content, conserved CXC motifs, and a molecular weight of around 8 kDa.	1
3161	These earthworms could be used to evaluate heavy-metal pollution in soil due to the inducible @PROTEIN$ by @COMPOUND$ exposure.	1
3162	Despite the reciprocal relationship that exists between inflammation and thrombosis, we asked whether thrombosis can develop without inflammation, and whether stress-related hormones (@PROTEIN$ and @COMPOUND$) influence platelet-mediated thrombosis.	0
3163	The culture medium was analyzed for pH value, concentration of free calcium and @COMPOUND$ and @PROTEIN$.	0
3164	Surprisingly, no role of @PROTEIN$/2 or STAT-3 was found in the protein-mediated protection of hepatocytes during @COMPOUND$ exposure.	0
3165	Surprisingly, no role of ERK1/2 or @PROTEIN$-3 was found in the protein-mediated protection of hepatocytes during @COMPOUND$ exposure.	0
3166	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl oxygen in uracil or @COMPOUND$, cause substantial reductions in XDG and @PROTEIN$ activities.	0
3167	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl @COMPOUND$ in uracil or xanthine, cause substantial reductions in XDG and @PROTEIN$ activities.	0
3168	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl oxygen in @COMPOUND$ or xanthine, cause substantial reductions in XDG and @PROTEIN$ activities.	0
3169	@PROTEIN$-@COMPOUND$ coated microspheres: role of the inner gel in binding and release of the KRFK peptide.	1
3170	Furthermore, increased production of high inducible nitric oxide synthase (iNOS) and @PROTEIN$ (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
3171	Furthermore, increased production of high inducible @PROTEIN$ (iNOS) and cyclooxygenase 2 (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
3172	Furthermore, increased production of high inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (@PROTEIN$) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
3173	Furthermore, increased production of high inducible nitric oxide synthase (@PROTEIN$) and cyclooxygenase 2 (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
3174	After intravenous administration of either DOTAP/@COMPOUND$ or DOTMA/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0
3175	After intravenous administration of either DOTAP/cholesterol or @COMPOUND$/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0
3176	After intravenous administration of either @COMPOUND$/cholesterol or DOTMA/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0
3177	@COMPOUND$ was the most potent regulator of @PROTEIN$ affinity, with concentrations of 5 mmol L(-1) causing an increase in p(50) from 5 to 19 mm Hg at pH 7.5, while the order of potency of the other phosphates was IHP&gt;ATP&gt;BPG.	1
3178	Functional inactivation of @PROTEIN$/@COMPOUND$ in human mesothelioma.	0
3179	The tumor suppressor @COMPOUND$ is encoded by the neurofibromatosis type 2 gene (@PROTEIN$) which is located on chromosome 22q12 and mutations in this gene have been found in 40% of mesothelioma.	1
3180	@COMPOUND$-induced expression of the orphan nuclear receptor @PROTEIN$ in MA-10 Leydig cells involves a CaMKI pathway.	1
3181	@COMPOUND$-induced expression of the orphan nuclear receptor Nur77 in MA-10 Leydig cells involves a @PROTEIN$ pathway.	1
3182	In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the @PROTEIN$/@COMPOUND$ (cAMP) signaling pathway.	1
3183	In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the @PROTEIN$/cyclic adenosine monophosphate (@COMPOUND$) signaling pathway.	1
3184	Here, we report that @COMPOUND$-mediated induction of @PROTEIN$ expression at the protein, mRNA, and promoter levels in MA-10 cells involves different mechanisms.	1
3185	In addition, our detailed analysis of the @PROTEIN$ promoter in MA-10 cells revealed that distinct regulatory elements are involved in basal and @COMPOUND$-induced Nur77 transcription.	1
3186	Comparing expression of @COMPOUND$ and @PROTEIN$ in testicular tissue from men with obstructive and nonobstructive azoospermia.	0
3187	Based on fasting @PROTEIN$ and @COMPOUND$, several indices of insulin sensitivity have been developed in adults.	0
3188	LDL from all subjects stimulated both the basal and @PROTEIN$-induced @COMPOUND$ and cortisol release from adrenocortical cells.	1
3189	LDL from all subjects stimulated both the basal and @PROTEIN$-induced aldosterone and @COMPOUND$ release from adrenocortical cells.	1
3190	Quantitative analysis yielded 0.81 and 1.8 microM for EC(50) values of @COMPOUND$-induced cell edge translocation of abl-KD-@PROTEIN$ (GFP) and wild-type abl-GFP, respectively.	1
3191	@PROTEIN$/KC was detected as early as 6 hours after @COMPOUND$ instillation and returned to basal levels after Day 8.	1
3192	DF2162 treatment reduced @COMPOUND$-induced expression of @PROTEIN$, a marker of angiogenesis, in the lung.	1
3193	@COMPOUND$ (KYNA) is an agonist of the G-protein-coupled receptor @PROTEIN$, which is predominantly expressed in gastrointestinal tissues.	1
3194	Kynurenic acid (@COMPOUND$) is an agonist of the G-protein-coupled receptor @PROTEIN$, which is predominantly expressed in gastrointestinal tissues.	1
3195	Molecular dynamics simulation techniques have been used to study the unbinding pathways of @COMPOUND$) from the ligand-binding pocket of the vitamin D receptor (@PROTEIN$).	1
3196	Relaxation to @PROTEIN$ (10(-8) M) was unaffected by L-NAME (3 x 10(-4) M) and indomethacin (10(-6) M) suggesting no involvement of @COMPOUND$ or prostaglandins in the CGRP-induced relaxation.	0
3197	Relaxation to @PROTEIN$ (10(-8) M) was unaffected by L-NAME (3 x 10(-4) M) and @COMPOUND$ (10(-6) M) suggesting no involvement of nitric oxide or prostaglandins in the CGRP-induced relaxation.	0
3198	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and @PROTEIN$) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0
3199	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (@PROTEIN$), microglia (CD11b), or reactive glia (GFAP).	0
3200	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (@PROTEIN$).	0
3201	Cells positive for @PROTEIN$ mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	1
3202	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (@PROTEIN$), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0
3203	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (@PROTEIN$, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0
3204	By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (Timp3 and Rprm) and four putative TSGs (Atp1B2, @PROTEIN$, FoxJ1 and Smpd3) silenced in this line.	1
3205	By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (@PROTEIN$ and Rprm) and four putative TSGs (Atp1B2, Dusp2, FoxJ1 and Smpd3) silenced in this line.	1
3206	By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (Timp3 and Rprm) and four putative TSGs (Atp1B2, Dusp2, @PROTEIN$ and Smpd3) silenced in this line.	1
3207	By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (Timp3 and Rprm) and four putative TSGs (Atp1B2, Dusp2, FoxJ1 and @PROTEIN$) silenced in this line.	1
3208	Therapeutic strategy to rescue mutation-induced exon skipping in @PROTEIN$ by adaptation of @COMPOUND$ snRNA.	1
3209	As a therapeutic strategy, @COMPOUND$ snRNAs were adapted to the novel @PROTEIN$ mutation and tested for its potential to reverse missplicing.	1
3210	Urinary concentrations of @COMPOUND$, dihydrogenistein, O-desmethylangolensin, and equol exceeded @PROTEIN$ aglycone equivalents.	0
3211	Urinary concentrations of dihydrodaidzein, dihydrogenistein, O-desmethylangolensin, and @COMPOUND$ exceeded @PROTEIN$ aglycone equivalents.	0
3212	Urinary concentrations of dihydrodaidzein, dihydrogenistein, @COMPOUND$, and equol exceeded @PROTEIN$ aglycone equivalents.	0
3213	Urinary concentrations of dihydrodaidzein, @COMPOUND$, O-desmethylangolensin, and equol exceeded @PROTEIN$ aglycone equivalents.	0
3214	To prevent @COMPOUND$ incorporation into DNA, representatives of the dUTP nucleotidohydrolase (@PROTEIN$) enzyme family eliminate excess dUTP.	1
3215	@COMPOUND$ chain coordination involves Mg2+ and is analogous to that of @PROTEIN$.	1
3216	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3217	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3218	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3219	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3220	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3221	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3222	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3223	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3224	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3225	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3226	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3227	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3228	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3229	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3230	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3231	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3232	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3233	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3234	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3235	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
3236	It controls the expression of a total of 11 genes, the @PROTEIN$ regulon, in a @COMPOUND$-dependent manner.	1
3237	In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including GTH-releasing hormones, @PROTEIN$, @COMPOUND$, ghrelin, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.	0
3238	In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including GTH-releasing hormones, pituitary adenylate cyclase-activating polypeptide, @COMPOUND$, @PROTEIN$, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.	0
3239	In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including @PROTEIN$-releasing hormones, pituitary adenylate cyclase-activating polypeptide, @COMPOUND$, ghrelin, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.	0
3240	Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, protein kinase C, @COMPOUND$, NO, protein kinase A, ERK/@PROTEIN$, and Smads allows for integrated control by different neuroendocrine factors.	0
3241	Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, protein kinase C, @COMPOUND$, NO, protein kinase A, @PROTEIN$/MAPK, and Smads allows for integrated control by different neuroendocrine factors.	0
3242	Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, @PROTEIN$, @COMPOUND$, NO, protein kinase A, ERK/MAPK, and Smads allows for integrated control by different neuroendocrine factors.	0
3243	Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, protein kinase C, @COMPOUND$, NO, @PROTEIN$, ERK/MAPK, and Smads allows for integrated control by different neuroendocrine factors.	0
3244	An enzymatic reaction between @COMPOUND$ and @PROTEIN$ produced oxygen bubbles and thus many internal pores within microsphere were naturally developed.	1
3245	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (@PROTEIN$), luteinizing hormone (LH) and testosterone/@COMPOUND$ (Te/E(2)).	0
3246	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via @PROTEIN$ (GnRH), luteinizing hormone (LH) and testosterone/@COMPOUND$ (Te/E(2)).	0
3247	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via @PROTEIN$ (GnRH), luteinizing hormone (LH) and @COMPOUND$/estradiol (Te/E(2)).	0
3248	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (@PROTEIN$), luteinizing hormone (LH) and @COMPOUND$/estradiol (Te/E(2)).	0
3249	We present a robust and simple method for the direct detection of multiple point mutations in the Mycobacterium tuberculosis @PROTEIN$ gene during the development of @COMPOUND$ (RIF) resistance using an electrochemical genosensor.	1
3250	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the @PROTEIN$ (CD39) and the ecto-5'-nucleotidase (CD73).	1
3251	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (@PROTEIN$) and the ecto-5'-nucleotidase (CD73).	1
3252	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (CD39) and the @PROTEIN$ (CD73).	1
3253	In contrast, @PROTEIN$.24, CYP2D6.26, and CYP2D6.27 allelic isoforms all showed active drug-metabolizing activities toward both codeine and @COMPOUND$ O-demethylation.	1
3254	In contrast, @PROTEIN$.24, CYP2D6.26, and CYP2D6.27 allelic isoforms all showed active drug-metabolizing activities toward both @COMPOUND$ and dextromethorphan O-demethylation.	1
3255	Mechanism-based inactivation of @PROTEIN$ by tienilic acid and (+/-)-@COMPOUND$ : a comparison of kinetics and probe substrate selection.	1
3256	Mechanism-based inactivation of @PROTEIN$ by @COMPOUND$ and (+/-)-suprofen : a comparison of kinetics and probe substrate selection.	1
3257	In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of @PROTEIN$ (P450) 2C9 by @COMPOUND$ and (+/-)-suprofen using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	1
3258	In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of @PROTEIN$ (P450) 2C9 by tienilic acid and (+/-)-@COMPOUND$ using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	1
3259	@PROTEIN$ activity was evaluated by measuring @COMPOUND$+) entry or pore formation using spectrofluorometry or flow cytometry.	1
3260	These Ca2+-independent @PROTEIN$ display remarkable specificity for the length of the sn-2 residue, but this selectivity is lost as the residue gains @COMPOUND$ functions.	0
3261	At the end of treatment, BMI, WHR, HbA1c, fasting @COMPOUND$, @PROTEIN$, HOMA-IR, alanine aminotransferase values decreased in both groups.	0
3262	Among these indicators is @COMPOUND$ (PS) translocation from the inner to the outer leaflet of the plasma membrane, which can be detected by annexinV (@PROTEIN$) conjugation.	1
3263	Among these indicators is @COMPOUND$ (PS) translocation from the inner to the outer leaflet of the plasma membrane, which can be detected by @PROTEIN$ (ANXA5) conjugation.	1
3264	Effects of chronic inflammation and @COMPOUND$ tolerance on the expression of phospho-ERK 1/2 and phospho-@PROTEIN$ in the injured tissue.	1
3265	Effects of chronic inflammation and @COMPOUND$ tolerance on the expression of phospho-@PROTEIN$/2 and phospho-P38 in the injured tissue.	1
3266	The results of the present study show that @PROTEIN$ phosphorylation is unaltered by inflammation or @COMPOUND$ tolerance, each one individually, in the plantar tissue.	0
3267	In contrast, no significant differences in phospho-@PROTEIN$ expression were observed between naïve and tolerant animals acutely injected with saline or @COMPOUND$ in presence of CFA inflammation.	0
3268	These results suggest that @PROTEIN$ but not p38 could be implicated in the development of @COMPOUND$ tolerance during peripheral inflammation.	1
3269	The anterior pituitary gland contains five types of cells secreting specific hormones (growth hormone, @PROTEIN$ (ACTH), gonadotropic hormone, prolactin, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0
3270	The anterior pituitary gland contains five types of cells secreting specific hormones (growth hormone, adrenocorticotropic hormone (ACTH), gonadotropic hormone, @PROTEIN$, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0
3271	The anterior pituitary gland contains five types of cells secreting specific hormones (@PROTEIN$, adrenocorticotropic hormone (ACTH), gonadotropic hormone, prolactin, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0
3272	A comprehensive literature review of clinical studies in children evaluating s-@PROTEIN$ or CysC-based formulas and plasma @COMPOUND$ or creatinine-based formulas against an exogenous reference method using receiver operating characteristics (ROC) curves or Bland-Altman plots is presented.	0
3273	The comparison of s-@PROTEIN$ with plasma @COMPOUND$ indicated that s-CysC was superior to plasma creatinine in five of 13 studies; four studies showed no difference, and, in four studies, no statistical comparison was made.	0
3274	By combining endosperm @PROTEIN$/SDH suppression with embryo LKR/SDH suppression through crosses, the @COMPOUND$ level in embryo was reduced and resulted in higher lysine accumulation in mature kernels.	1
3275	By combining endosperm LKR/@PROTEIN$ suppression with embryo LKR/SDH suppression through crosses, the @COMPOUND$ level in embryo was reduced and resulted in higher lysine accumulation in mature kernels.	1
3276	Resistin, an adipokine-linked obesity with type 2 diabetes, impairs @COMPOUND$-stimulated @PROTEIN$ secretion (GSIS) in beta-cells.	1
3277	@PROTEIN$ was immunostained with mouse anti-FLAG primary antibody and @COMPOUND$-conjugated goat anti-mouse IgG secondary antibody.	1
3278	Intramuscular triacylglycerol does not appear to be a ubiquitous marker of @PROTEIN$ resistance, although specific IMCL intermediates such as long-chain fatty acyl-CoAs, ceramide, and @COMPOUND$ may inhibit insulin signal transduction.	1
3279	Light stimulates @COMPOUND$ hydrolysis via the G-protein @PROTEIN$, which directly binds to and activates phosphodiesterase.	1
3280	Inhibition of gamma-glutamyl transferase (@PROTEIN$, EC 2.3.2.2)-catalyzed extracellular GSH degradation with @COMPOUND$ significantly blocked GSH efflux, suggesting that GSH breakdown is a driving force for GSH export.	0
3281	@PROTEIN$ is a polypeptide hormone that is present in mammals and its main function is the maintenance of adequate @COMPOUND$ level.	1
3282	In addition, @PROTEIN$ facilitates bi-directional flux of @COMPOUND$ by modifying the phospholipid content of the plasma membrane.	1
3283	Overall, @PROTEIN$ is the cell surface receptor responsible for selective uptake of lipoprotein @COMPOUND$ and its ultimate delivery to sites of hormone synthesis in steroidogenic tissues.	1
3284	We looked at the toxicity of non-drug-containing liposomes on (3)H-@COMPOUND$ incorporation by @PROTEIN$ (Con A)-stimulated human lymphocytes, splenocytes and Epstein-Barr virus (EBV)-transformed human B-cell lymphoblastoid cell line (LCL).	1
3285	We looked at the toxicity of non-drug-containing liposomes on (3)H-@COMPOUND$ incorporation by concanavalin A (@PROTEIN$)-stimulated human lymphocytes, splenocytes and Epstein-Barr virus (EBV)-transformed human B-cell lymphoblastoid cell line (LCL).	1
3286	This explains the anti-canonical nature of the Trp150 to @COMPOUND$ substitution, and also reveals a strong long distance coupling between Trp150 and Asp49 of @PROTEIN$, because these two residues are more than 25 angstroms apart.	1
3287	This effect is independent of any change in neutrophil adhesion or adhesion molecule expression but is related to the ability of statins to reduce @COMPOUND$-induced @PROTEIN$ activity in neutrophils.	1
3288	This was confirmed by the ability of the @PROTEIN$ precursor @COMPOUND$ to rescue the statin-mediated reduction in neutrophil transendothelial migration.	1
3289	We hypothesized that conditioned medium from macrophages pretreated with palmitate or LPS would directly affect @PROTEIN$ action and @COMPOUND$ uptake in muscle cells.	0
3290	Surprisingly, and opposite to its effects on adipose cells, conditioned medium from LPS-treated macrophages stimulated myoblast insulin-stimulated @COMPOUND$ uptake, @PROTEIN$ translocation, and Akt phosphorylation without affecting stress kinases or inflammation indexes.	0
3291	Surprisingly, and opposite to its effects on adipose cells, conditioned medium from LPS-treated macrophages stimulated myoblast @PROTEIN$-stimulated @COMPOUND$ uptake, GLUT4 translocation, and Akt phosphorylation without affecting stress kinases or inflammation indexes.	1
3292	Surprisingly, and opposite to its effects on adipose cells, conditioned medium from LPS-treated macrophages stimulated myoblast insulin-stimulated @COMPOUND$ uptake, GLUT4 translocation, and @PROTEIN$ phosphorylation without affecting stress kinases or inflammation indexes.	0
3293	Because both TCDD and HFD are associated with increased breast cancer risk, we examined their effects on metabolic syndrome-associated phenotypes in three mouse models of breast cancer: 7,12-dimethylbenz(a) @COMPOUND$ (DMBA), Tg(MMTV-Neu)202Mul/J (@PROTEIN$), and TgN(MMTV-PyMT)634Mul/J (PyMT), all on an FVB/N genetic background.	0
3294	Because both TCDD and HFD are associated with increased breast cancer risk, we examined their effects on metabolic syndrome-associated phenotypes in three mouse models of breast cancer: 7,12-dimethylbenz(a) anthracene (@COMPOUND$), Tg(MMTV-Neu)202Mul/J (@PROTEIN$), and TgN(MMTV-PyMT)634Mul/J (PyMT), all on an FVB/N genetic background.	0
3295	@PROTEIN$ kinase inhibition by @COMPOUND$ ameliorates diabetes-induced microvascular damage.	1
3296	Involvement of the @PROTEIN$/Rho kinase (ROCK) pathway in diabetic microvasculopathy and therapeutic potential of @COMPOUND$, a selective ROCK inhibitor, are investigated.	1
3297	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (@PROTEIN$) concentration, pancreatic hormone levels, and glucose metabolism.	0
3298	This study investigated the acute effects of treatment with @COMPOUND$ on @PROTEIN$ (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
3299	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, @PROTEIN$ levels, and glucose metabolism.	0
3300	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, @PROTEIN$ (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
3301	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (@PROTEIN$-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
3302	In the present study we determined the effect of @PROTEIN$ on the secretome by comparing incorporation rates of (13)C-labeled @COMPOUND$ in the presence and absence of insulin.	0
3303	@PROTEIN$ as an alternative to @COMPOUND$ in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.	0
3304	@PROTEIN$ cytokine profile may be related to the risk of the vaginal erosions following placement of @COMPOUND$ meshes.	1
3305	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
3306	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
3307	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
3308	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
3309	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
3310	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
3311	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
3312	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
3313	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
3314	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
3315	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
3316	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
3317	The oxidative stress in the mollusk was observed at the U site during spring and at the R site during summer and autumn according to the differences in Mn-superoxide dismutase and @PROTEIN$ activities, O (2) (*-) production, lipid peroxidation, and @COMPOUND$ levels.	0
3318	The oxidative stress in the mollusk was observed at the U site during spring and at the R site during summer and autumn according to the differences in Mn-@PROTEIN$ and catalase activities, O (2) (*-) production, lipid peroxidation, and @COMPOUND$ levels.	0
3319	These results suggest that @COMPOUND$ by activation of ERK1/2 and @PROTEIN$/Akt signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1
3320	These results suggest that @COMPOUND$ by activation of @PROTEIN$/2 and PI3K/Akt signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1
3321	These results suggest that @COMPOUND$ by activation of ERK1/2 and PI3K/@PROTEIN$ signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1
3322	This decrease was not modified by @PROTEIN$ or @COMPOUND$, demonstrating that ONOO (-) was responsible for the effect.	0
3323	This decrease was not modified by @PROTEIN$ or Trolox, demonstrating that @COMPOUND$ (-) was responsible for the effect.	0
3324	Cell viability (MTT colorimetric determination) and transmembrane mitochondrial potential (J-C1 fluorescence) were concentration-dependently reduced 24 h after NaN (3); neither nuclear fragmentation by @COMPOUND$, nor @PROTEIN$ positivity by flow cytometry were detected, ruling out the occurrence of apoptosis.	0
3325	We assessed plasma @COMPOUND$ (pHVA) and plasma @PROTEIN$ (pPRL), two correlates of dopaminergic activity, in 116 subjects with CAG repeats expansion in the HD gene, 26 presymptomatic (18 females) and 90 with overt symptomatology (43 females).	0
3326	Profile of serum @PROTEIN$ and IL-10 shortly after ovariectomy and @COMPOUND$ replacement in rats.	0
3327	Profile of serum IL-1beta and @PROTEIN$ shortly after ovariectomy and @COMPOUND$ replacement in rats.	0
3328	A low plasma @PROTEIN$ @COMPOUND$ (HDL-c) concentration is an important risk factor for the development of atherosclerotic cardiovascular disease.	1
3329	A hydrogel was fabricated by chemically crosslinking alpha-@PROTEIN$ with @COMPOUND$ at high pressure CO(2).	1
3330	We evaluated whether inhibition of @PROTEIN$ (hsp90) function by @COMPOUND$ derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.	1
3331	We evaluated whether inhibition of heat shock protein 90 (@PROTEIN$) function by @COMPOUND$ derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.	1
3332	Cytochrome P450 (CYP) 1A1 and @PROTEIN$ are inducible by @COMPOUND$ (dioxin) in the human breast cancer cell line, MCF-7.	1
3333	Cytochrome P450 (@PROTEIN$) 1A1 and CYP1B1 are inducible by @COMPOUND$ (dioxin) in the human breast cancer cell line, MCF-7.	1
3334	@PROTEIN$ (CYP) 1A1 and CYP1B1 are inducible by @COMPOUND$ (dioxin) in the human breast cancer cell line, MCF-7.	1
3335	@COMPOUND$ treatment leads to recruitment of the aryl hydrocarbon receptor to the enhancer regions but not to the proximal promoter regions of both the @PROTEIN$ and CYP1B1 genes.	0
3336	@COMPOUND$ treatment leads to recruitment of the aryl hydrocarbon receptor to the enhancer regions but not to the proximal promoter regions of both the CYP1A1 and @PROTEIN$ genes.	0
3337	@COMPOUND$ treatment leads to recruitment of the @PROTEIN$ to the enhancer regions but not to the proximal promoter regions of both the CYP1A1 and CYP1B1 genes.	1
3338	These results suggest that nucleosomal remodeling is less significant for @COMPOUND$-mediated induction of @PROTEIN$ than that of CYP1A1 and may be related to the more modest inducibility of the former.	1
3339	These results suggest that nucleosomal remodeling is less significant for @COMPOUND$-mediated induction of CYP1B1 than that of @PROTEIN$ and may be related to the more modest inducibility of the former.	1
3340	These observations provide novel insights into the functional roles of the endogenous coactivators in @COMPOUND$ induction of the human CYP1A1 and @PROTEIN$ genes in their natural chromosomal configurations.	1
3341	These observations provide novel insights into the functional roles of the endogenous coactivators in @COMPOUND$ induction of the human @PROTEIN$ and CYP1B1 genes in their natural chromosomal configurations.	1
3342	Decreased oral absorption of @COMPOUND$ after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-@PROTEIN$ to the first-pass metabolism in intestinal epithelial cells.	0
3343	Each residue was modified with one to three @COMPOUND$ units, and the most dominant @PROTEIN$ glycoform was modified with nine hexose units.	1
3344	The transcription factors @PROTEIN$ and retinoid X receptors participate in @COMPOUND$-induced locomotor activities.	1
3345	We now show that treatment of cells with phosphomimic @PROTEIN$ (uPA138E/303E, @COMPOUND$ 138 and 303 substituted with glutamic acid) strongly inhibits matrix-induced cell migration.	1
3346	When cells were subjected to hypoxia (1% @COMPOUND$), the expression of @PROTEIN$ had a significant increase in cancer cells.	1
3347	Treatment ACCs cells with SFN and @COMPOUND$ in combination, led to synergistic inhibition on cell growth and a decreased expression in nuclear NF-kappaB @PROTEIN$ protein.	1
3348	Our results demonstrate synergism between SFN and @COMPOUND$ at higher doses against the ACC-M and ACC-2 cells, which was associated with the decreased expression of nuclear NF-kappaB @PROTEIN$ protein.	1
3349	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (@PROTEIN$, catalase, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0
3350	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and @COMPOUND$).	0
3351	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0
3352	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, @PROTEIN$, glutathione-S-transferase and @COMPOUND$).	0
3353	Antiobesity effect of @COMPOUND$ involves the @PROTEIN$ and PPAR-gamma signal pathways.	1
3354	Antiobesity effect of @COMPOUND$ involves the AMPK and @PROTEIN$ signal pathways.	1
3355	This inhibitory effect of @COMPOUND$ on adipocyte differentiation was accompanied by @PROTEIN$ inhibition in rosiglitazone-treated cells.	1
3356	Taken together, these results suggest that the antiobesity effect of red ginseng rich constituent, @COMPOUND$, involves the @PROTEIN$ signaling pathway and PPAR-gamma inhibition.	1
3357	Taken together, these results suggest that the antiobesity effect of red ginseng rich constituent, @COMPOUND$, involves the AMPK signaling pathway and @PROTEIN$ inhibition.	1
3358	Selenocystine is taken up well by the b(0,+) rBAT system, while @COMPOUND$ is a low-affinity substrate only for @PROTEIN$ and PAT1.	1
3359	Selenocystine is taken up well by the b(0,+) rBAT system, while @COMPOUND$ is a low-affinity substrate only for SIT1 and @PROTEIN$.	1
3360	Both promoters are partially regulated by @COMPOUND$ via @PROTEIN$ and other RARs.	1
3361	Circulating @COMPOUND$, adiponectin, leptin, @PROTEIN$, hsCRP and insulin levels were determined both at baseline and after TLC intervention and statin treatment.	0
3362	Circulating @COMPOUND$, adiponectin, leptin, TNF-alpha, hsCRP and @PROTEIN$ levels were determined both at baseline and after TLC intervention and statin treatment.	0
3363	Circulating @COMPOUND$, adiponectin, @PROTEIN$, TNF-alpha, hsCRP and insulin levels were determined both at baseline and after TLC intervention and statin treatment.	0
3364	VEGF, @PROTEIN$ and @COMPOUND$ levels in exhaled breath condensate and serum of patients with lung cancer.	0
3365	@PROTEIN$, TNF-alpha and @COMPOUND$ levels in exhaled breath condensate and serum of patients with lung cancer.	0
3366	The aim of the present study was to evaluate the levels of VEGF, @COMPOUND$ and @PROTEIN$ in EBC and serum of patients with primary lung cancer prior to the initiation of any treatment, in order to evaluate their possible diagnostic role.	0
3367	The aim of the present study was to evaluate the levels of @PROTEIN$, @COMPOUND$ and TNF-alpha in EBC and serum of patients with primary lung cancer prior to the initiation of any treatment, in order to evaluate their possible diagnostic role.	0
3368	Furthermore, associations between VEGF, @COMPOUND$ and @PROTEIN$ levels in EBC and serum with clinicopathologic factors were investigated.	0
3369	Furthermore, associations between @PROTEIN$, @COMPOUND$ and TNF-alpha levels in EBC and serum with clinicopathologic factors were investigated.	0
3370	Currently, adreno-corticotrophic hormone (@PROTEIN$), steroids and @COMPOUND$ (VGB) form the mainstay of its treatment.	0
3371	The addition of a protein kinase C (PKC) activator, @COMPOUND$, rescued PhIP-inhibited @PROTEIN$ expression in LTA-stimulated cells.	1
3372	This action was mimicked solely by 100 nm CH-275, a selective agonist at the somatostatin type 1 receptor (@PROTEIN$), but not by 100 nm BIM-23027, L-362855, or @COMPOUND$ ; agonists selective for the other four SSTRs known to exist in MIN6.	0
3373	Transcription of @PROTEIN$ in the rodent ovary and placenta: alternative modes of @COMPOUND$ dependent and independent regulation.	1
3374	The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, @COMPOUND$, by the cholesterol side-chain cleavage cytochrome P450 (@PROTEIN$) enzyme complex takes place in the inner mitochondrial membranes.	1
3375	The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, @COMPOUND$, by the cholesterol side-chain cleavage @PROTEIN$ (CYP11A1) enzyme complex takes place in the inner mitochondrial membranes.	1
3376	Collectively, these studies identify a novel role for @COMPOUND$ (3) and the @PROTEIN$ in the control of adipocyte metabolism and lipid storage in vivo.	0
3377	Direct @PROTEIN$ (MR) activation with @COMPOUND$ has deleterious effects on the cerebral vasculature.	1
3378	Therefore, we hypothesized that systemic @PROTEIN$ inhibition with @COMPOUND$ (CBX) would cause remodeling of the middle cerebral artery (MCA) and increase the damage caused by cerebral ischemia.	1
3379	In this study, we attempted to evaluate the effects of @COMPOUND$ on F-@PROTEIN$ and microtubular cytoskeletons in human hepatoma HepG2 cells and its possible molecular mechanisms.	1
3380	Consequently, @COMPOUND$-caused cytoskeletal interruption led to suppression of @PROTEIN$ expression and its metabolizing activity.	1
3381	To test this hypothesis, we measured the effect of @PROTEIN$ on RyR2 channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator @COMPOUND$ acetoxymethyl ester.	0
3382	To test this hypothesis, we measured the effect of AMT on @PROTEIN$ channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator @COMPOUND$ acetoxymethyl ester.	0
3383	To test this hypothesis, we measured the effect of @PROTEIN$ on RyR2 channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator Fura-2 @COMPOUND$ ester.	0
3384	To test this hypothesis, we measured the effect of AMT on @PROTEIN$ channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator Fura-2 @COMPOUND$ ester.	0
3385	Activity of muscle citrate synthase and @PROTEIN$, as well as maximal @COMPOUND$ uptake and 10-km performance time, remained unaltered in both groups.	0
3386	Activity of muscle @PROTEIN$ and 3-hydroxyacyl-CoA dehydrogenase, as well as maximal @COMPOUND$ uptake and 10-km performance time, remained unaltered in both groups.	0
3387	@PROTEIN$, @COMPOUND$ and ghrelin were detectable in the culture medium.	0
3388	Glucagon, @COMPOUND$ and @PROTEIN$ were detectable in the culture medium.	0
3389	@PROTEIN$ (MTs) are @COMPOUND$-rich, metal-binding proteins that are useful biomarkers for monitoring pollution by heavy metals.	1
3390	The deduced amino acid sequence has 18 @COMPOUND$ residues, implying that S. henanense @PROTEIN$ binds six equivalents of bivalent metal ions (Cd) as opposed to the seven in its mammalian counterparts.	1
3391	Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, @PROTEIN$, @COMPOUND$, HbA1C, PTH, Mg and creatinine analysis.	0
3392	Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, alkaline phosphatase, phosphorus, HbA1C, @PROTEIN$, Mg and @COMPOUND$ analysis.	0
3393	Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, alkaline phosphatase, @COMPOUND$, HbA1C, @PROTEIN$, Mg and creatinine analysis.	0
3394	Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, @PROTEIN$, phosphorus, HbA1C, PTH, Mg and @COMPOUND$ analysis.	0
3395	Treatment of Platelet Rich Plasma (PRP) with the dialyzed supernatant from the leucocyte suspension incubated with 80 microM @COMPOUND$ resulted in parallel syntheses of NO and @PROTEIN$ as determined by methemoglobin assay and enzyme linked immunosorbent assay respectively.	1
3396	Muscular oxidative stress and inflammation induced by @COMPOUND$ or MS were assessed by measurements of isoprostanes and @PROTEIN$ levels.	1
3397	Pre-treatment with @PROTEIN$ abolished the post-MS-enhanced HFV response whereas diclofenac lowered the peak HFV response to MS and @COMPOUND$.	0
3398	Pre-treatment with @PROTEIN$ abolished the post-MS-enhanced HFV response whereas @COMPOUND$ lowered the peak HFV response to MS and H2O2.	0
3399	The decreased level of GSH as well as @PROTEIN$ and GSH-Px activities in @COMPOUND$-treated mice were significantly increased by NTA pretreatment.	1
3400	In this study, fluorescence microscopy and elemental analysis were exploited to show that the 3,4-dihydroxyphenyl-L-alanine (@COMPOUND$) residues of mussel @PROTEIN$ colocalize with Fe and Ca distributions in the cuticle of Mytilus galloprovincialis mussel byssal threads.	1
3401	We measured pain using a visual analog pain scale at five time points in 0-48 h, oxycodone use for pain, @COMPOUND$ for fever, C-reactive protein (@PROTEIN$), and total and percent gammadeltaT-cells.	0
3402	Association between @PROTEIN$ resistance, @COMPOUND$ intolerance, and hypertension in pregnancy.	0
3403	These results suggest that @PROTEIN$ resistance and relative @COMPOUND$ intolerance are associated with an increased risk of new-onset hypertension in pregnancy, particularly preeclampsia, and support the hypothesis that insulin resistance may play a role in the pathogenesis of this disorder.	0
3404	These @PROTEIN$ are likely to perform similar functions to those reported for other mammalian ADHs in the metabolism of ingested and endogenous @COMPOUND$ and aldehydes.	1
3405	@PROTEIN$ and II form a ubiquitous @COMPOUND$-dependent pathway for the detoxification of reactive and mutagenic ketoaldehydes.	1
3406	Blood was collected before and repeatedly afterward for determination of NF-kappaB activity, leukocyte subset numbers, @COMPOUND$, norepinephrine, and in vitro-stimulated @PROTEIN$ production.	0
3407	Blood was collected before and repeatedly afterward for determination of NF-kappaB activity, leukocyte subset numbers, cortisol, @COMPOUND$, and in vitro-stimulated @PROTEIN$ production.	0
3408	Higher NF-kappaB stress responses were associated with lower @COMPOUND$ stress responses (beta=-.37, p=.05), higher pre-stress @PROTEIN$ production (beta=.38, p=.043), and high chronic in combination with low acute stress, or vice versa (beta=-.61, p=.06).	0
3409	The combination of @COMPOUND$-rich repeat (LRR) and immunoglobulin-like (Ig) domains is found in the domain architecture of the @PROTEIN$ neurotrophin receptor protein.	1
3410	Quantum chemical studies for oxidation of @COMPOUND$ by @PROTEIN$.	1
3411	TnBP (@COMPOUND$) and polysorbate 20 during the manufacture of the factor VIII/@PROTEIN$ concentrate Optivate has been investigated.	0
3412	Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower alkaline phosphatase, alanine aminotransferase, phosphate, and urine specific gravity, but higher @PROTEIN$ and @COMPOUND$ concentrations than hyperthyroid cats.	0
3413	Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower alkaline phosphatase, alanine aminotransferase, @COMPOUND$, and urine specific gravity, but higher @PROTEIN$ and creatinine concentrations than hyperthyroid cats.	0
3414	Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower @PROTEIN$, alanine aminotransferase, @COMPOUND$, and urine specific gravity, but higher lipase and creatinine concentrations than hyperthyroid cats.	0
3415	Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower @PROTEIN$, alanine aminotransferase, phosphate, and urine specific gravity, but higher lipase and @COMPOUND$ concentrations than hyperthyroid cats.	0
3416	A role for @PROTEIN$ receptors in @COMPOUND$ signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells.	1
3417	2-Deoxyglucose decreased @COMPOUND$H/NAD (+) and NADPH/NADP(+) ratios by 59 and 50%, respectively, and intact cell @PROTEIN$ activity by 74%; lactate restored NADH/NAD (+), but not NADPH/NADP(+) or NQO1 activity.	0
3418	We propose that the coordinated regulation of @PROTEIN$ cytoskeletal reorganization and macropinocytosis-mediated retrograde membrane trafficking may contribute to @COMPOUND$+)-induced axon growth inhibition.	1
3419	Cocaine stimulated @PROTEIN$, @COMPOUND$, and LH, whereas cocaine+nalbuphine in combination produced a smaller increase in ACTH, and decreased cortisol and LH.	0
3420	Thus it appears that nalbuphine attenuated cocaine's effects on @PROTEIN$, @COMPOUND$, and LH.	0
3421	Diminished levels of L-arginine and endothelial @PROTEIN$ (eNOS) uncoupling through deficiency of @COMPOUND$ (BH(4)) may contribute to endothelial dysfunction.	1
3422	Diminished levels of L-@COMPOUND$ and endothelial nitric oxide synthase (@PROTEIN$) uncoupling through deficiency of tetrahydrobiopterin (BH(4)) may contribute to endothelial dysfunction.	0
3423	Diminished levels of L-arginine and endothelial nitric oxide synthase (@PROTEIN$) uncoupling through deficiency of @COMPOUND$ (BH(4)) may contribute to endothelial dysfunction.	1
3424	Diminished levels of L-@COMPOUND$ and endothelial @PROTEIN$ (eNOS) uncoupling through deficiency of tetrahydrobiopterin (BH(4)) may contribute to endothelial dysfunction.	0
3425	Serum testosterone, estradiol, sex hormone binding globulin (@PROTEIN$), and @COMPOUND$ levels were measured in 1947 postmenopausal women aged 45-84 years (30% White, 14% Chinese-American, 31% Black, and 25% Hispanic) and not on hormone therapy.	0
3426	Serum testosterone, @COMPOUND$, sex hormone binding globulin (@PROTEIN$), and dehydroepiandrosterone levels were measured in 1947 postmenopausal women aged 45-84 years (30% White, 14% Chinese-American, 31% Black, and 25% Hispanic) and not on hormone therapy.	0
3427	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3428	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3429	In addition to lipid peroxidation, the activities of antioxidant enzymes such as @PROTEIN$, catalase, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3430	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and @PROTEIN$ and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3431	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3432	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3433	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, @PROTEIN$, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3434	In addition to lipid peroxidation, the activities of antioxidant enzymes such as @PROTEIN$, catalase, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3435	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, @PROTEIN$, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3436	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and @PROTEIN$ and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3437	This study shows that changes in lipid peroxidation, @PROTEIN$, catalase, glutathione reductase, glutathione S-transferase and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0
3438	This study shows that changes in lipid peroxidation, superoxide dismutase, @PROTEIN$, glutathione reductase, glutathione S-transferase and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0
3439	This study shows that changes in lipid peroxidation, superoxide dismutase, catalase, @PROTEIN$, glutathione S-transferase and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0
3440	This study shows that changes in lipid peroxidation, superoxide dismutase, catalase, glutathione reductase, @PROTEIN$ and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0
3441	At the same time, both types of conduits were permeable to three compounds tested including @COMPOUND$, lysozyme and bovine @PROTEIN$, indicating the suitability of the conduits for free exchanges of nutrients.	0
3442	At the same time, both types of conduits were permeable to three compounds tested including @COMPOUND$, @PROTEIN$ and bovine serum albumin, indicating the suitability of the conduits for free exchanges of nutrients.	0
3443	The inhibitory effect of @COMPOUND$ on the migration of ES-2 ovarian carcinoma cells involves a @PROTEIN$-dependent pathway.	1
3444	This inhibitory effect is possibly mediated by a @COMPOUND$-dependent activation of the small GTPase @PROTEIN$ via Epac.	1
3445	This inhibitory effect is possibly mediated by a @COMPOUND$-dependent activation of the small GTPase Rap1 via @PROTEIN$.	1
3446	Gender differences in corticotropin and @COMPOUND$ secretion and @PROTEIN$ mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats.	0
3447	Gender differences in @PROTEIN$ and @COMPOUND$ secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats.	0
3448	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (@PROTEIN$) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
3449	@PROTEIN$, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
3450	BDNF, NGF, @PROTEIN$ (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
3451	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and @PROTEIN$ procedures.	0
3452	BDNF, @PROTEIN$, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
3453	BDNF, NGF, adrenocorticotropic hormone (@PROTEIN$), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
3454	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and @PROTEIN$ (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
3455	A substrate regeneration cycle coupling @PROTEIN$ with l-@COMPOUND$ (AsA: 0, 1.0, 3.0, 10.0 and 50.0 mmol/l; as reducing reagent system) was applied to the chemo-mechanical reaction unit in order to amplify the output signal of the tonometric biosensor.	0
3456	In vitro and in vivo models simulating the bee sting have been developed using live honeybees and, as the envenomation sites, pig ears and rat legs; MALDI MSI has been used to map, over time, the diffusion and distribution of three venom allergens (@COMPOUND$ m 1, Api m 4, and Api m 6) and two venom toxins (apamine and @PROTEIN$).	0
3457	The effect was lactose-inhibitable and required galectin-3 affinity for @COMPOUND$, a saccharide typically found on @PROTEIN$, since a mutant lacking this activity was without effect.	1
3458	The effect was lactose-inhibitable and required @PROTEIN$ affinity for @COMPOUND$, a saccharide typically found on cell surface glycoproteins, since a mutant lacking this activity was without effect.	1
3459	Despite widespread expression of @PROTEIN$ (EGF) receptors (EGFRs) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as @COMPOUND$ exhibit limited activity in this cancer.	0
3460	Despite widespread expression of epidermal growth factor (EGF) receptors (@PROTEIN$) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as @COMPOUND$ exhibit limited activity in this cancer.	0
3461	It is noteworthy that FGF2 and FGF9 as well as @PROTEIN$ IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
3462	It is noteworthy that @PROTEIN$ and FGF9 as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
3463	It is noteworthy that FGF2 and @PROTEIN$ as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
3464	It is noteworthy that FGF2 and FGF9 as well as FGFR1 IIIc and/or @PROTEIN$ IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
3465	In late gestation, the postprandial increases in @COMPOUND$ and @PROTEIN$ were delayed, and smaller, after a high-fiber meal than after a control meal.	0
3466	During lactation, @COMPOUND$ and @PROTEIN$ profiles after a standard meal did not differ between sows from treatment groups.	0
3467	Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of @COMPOUND$, prolactin, tumor necrosis factor-alpha, and @PROTEIN$ 0.01).	0
3468	Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of @COMPOUND$, prolactin, @PROTEIN$-alpha, and haptoglobin 0.01).	0
3469	Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of @COMPOUND$, @PROTEIN$, tumor necrosis factor-alpha, and haptoglobin 0.01).	0
3470	Domain shape annealing is observed from branched to rounded shapes after @PROTEIN$ activity quenching by @COMPOUND$, with a decay halftime of approximately 10 min.	0
3471	Using neighborhood approaches, we were able to assign seven novel functional partners in @PROTEIN$ synthesis, @COMPOUND$ metabolism, and quorum sensing to BLUF domain-containing proteins (involved in light sensing).	0
3472	Chondroitin lyases (or @PROTEIN$) are a family of enzymes that depolymerize @COMPOUND$ (CS) and dermatan sulfate (DS) galactosaminoglycans, which have gained prominence as important players in central nervous system biology.	1
3473	We have assessed the impact of the functional C-1019G variant of the @PROTEIN$ receptor on the response to @COMPOUND$ or haloperidol in a prospective, randomized, double-blind study.	1
3474	We have assessed the impact of the functional C-1019G variant of the @PROTEIN$ receptor on the response to risperidone or @COMPOUND$ in a prospective, randomized, double-blind study.	1
3475	This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) and cytosine methylation inhibitor @COMPOUND$ (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in @PROTEIN$ silencing by hypoxia.	1
3476	This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor @COMPOUND$ (TSA) and cytosine methylation inhibitor 5-aza-2-deoxycytidine (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in @PROTEIN$ silencing by hypoxia.	1
3477	@COMPOUND$ overcomes cell-adhesion-mediated drug resistance through downregulation of @PROTEIN$ expression in multiple myeloma.	1
3478	The purpose of this study was to examine the distribution and action of @COMPOUND$-@PROTEIN$ conjugate (DOXTRF) in a leukaemia cell line (HL60), a multidrug-resistant leukaemia cell line (HL60ADR) and a normal tissue cell line (human fibroblasts).	1
3479	Purification of an @PROTEIN$ involved in the conversion of methional to @COMPOUND$ in Oenococcus oeni IOEB 8406.	1
3480	Purification of an @PROTEIN$ involved in the conversion of @COMPOUND$ to methionol in Oenococcus oeni IOEB 8406.	1
3481	An @COMPOUND$ (P)H-dependent @PROTEIN$ involved in the reduction of methional was then purified to homogeneity.	1
3482	An NAD (P)H-dependent @PROTEIN$ involved in the reduction of @COMPOUND$ was then purified to homogeneity.	1
3483	Sequencing of the purified enzyme and amino acid sequence comparison with the database revealed the presence of a conserved sequence motif specific to the medium-chain zinc-containing @COMPOUND$ (P)H-dependent @PROTEIN$.	1
3484	The purified @PROTEIN$ does not seem to be involved in the modification of buttery and lactic notes or to be involved in the specific formation of volatile @COMPOUND$ during MLF.	0
3485	The function of the purified @PROTEIN$ remains unclear, although the role of the sulfur atom in @COMPOUND$ molecules in the interaction between enzyme and substrate was evidenced.	0
3486	The function of the purified @PROTEIN$ remains unclear, although the role of the @COMPOUND$ in methional molecules in the interaction between enzyme and substrate was evidenced.	0
3487	All strains tested positive for @PROTEIN$ activity while none where capable of @COMPOUND$ degradation.	0
3488	In the present work we studied the effect of @PROTEIN$ and-3 on neuronal @COMPOUND$ release and the short-term regulation of tyrosine hydroxylase in the olfactory bulb.	0
3489	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
3490	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
3491	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
3492	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
3493	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
3494	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST) and @PROTEIN$ (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
3495	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
3496	@PROTEIN$ receptors are membrane cation channels gated by extracellular @COMPOUND$.	1
3497	End-point measures were HOMA (homoeostasis model assessment)-IR, androgens, lipids, inflammatory markers (hsCRP (high-sensitivity C-reactive protein)) and endothelial function (FMD (flow-mediated dilation), ADMA (@COMPOUND$), PAI-1 (plasminogen activator inhibitor-1) and vWF (@PROTEIN$)).	0
3498	End-point measures were HOMA (homoeostasis model assessment)-IR, androgens, lipids, inflammatory markers (hsCRP (high-sensitivity C-reactive protein)) and endothelial function (FMD (flow-mediated dilation), @COMPOUND$ (asymmetric dimethylarginine), PAI-1 (plasminogen activator inhibitor-1) and vWF (@PROTEIN$)).	0
3499	This study investigated the effects of atorvastatin on @PROTEIN$ and ABCC1 mRNA expression on peripheral blood mononuclear cells (PBMC) and their relationship with gene polymorphisms and lowering-@COMPOUND$ response.	0
3500	This study investigated the effects of atorvastatin on ABCB1 and @PROTEIN$ mRNA expression on peripheral blood mononuclear cells (PBMC) and their relationship with gene polymorphisms and lowering-@COMPOUND$ response.	0
3501	While the three @PROTEIN$ isotypes showed comparable Km and k(cat) for L-serine and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by @COMPOUND$.	1
3502	While the three @PROTEIN$ isotypes showed comparable Km and k(cat) for @COMPOUND$ and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by L-cysteine.	1
3503	We propose that multiple @PROTEIN$ isotypes with different properties may play complementary roles in the regulation of the @COMPOUND$ biosynthetic pathway in E. histolytica under different conditions, e.g.	1
3504	Treatment with @PROTEIN$ or @COMPOUND$ eliminated these PF changes, yielding results comparable with controls for each of these parameters.	0
3505	These early results indicate that treatment with @PROTEIN$ and to a lesser extent @COMPOUND$ reduces some of the direct inflammatory response and damage associated with SM-induced lung injury.	0
3506	Pretreatment with DEX abrogated @PROTEIN$ inhibition by sst (2)-preferring analogue @COMPOUND$ in TT.	1
3507	@COMPOUND$ enhances the activity of nuclear factor-kappaB pathway through @PROTEIN$ and BLT2 receptors in atherosclerosis.	1
3508	@PROTEIN$ activity and total nitrite and @COMPOUND$ concentrations in serum: novel biochemical markers for type 2 diabetes.	0
3509	The aim of this study was to evaluate the activity of semicarbazide-sensitive amine oxidase (@PROTEIN$) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0
3510	The aim of this study was to evaluate the activity of @PROTEIN$ (SSAO) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0
3511	Serum lipid, creatinine, @COMPOUND$, @PROTEIN$, HbA(1C) and urinary albumin concentration were measured.	0
3512	Serum lipid, @COMPOUND$, uric acid, @PROTEIN$, HbA(1C) and urinary albumin concentration were measured.	0
3513	@COMPOUND$ activity showed highest correlations to @PROTEIN$ II and microtubule targeting drugs.	1
3514	Ulcerated tissues were processed to assess ulcer area, @COMPOUND$, @PROTEIN$ (PCNA) and cleaved caspase-3.	0
3515	Ulcerated tissues were processed to assess ulcer area, @COMPOUND$, proliferating cell nuclear antigen (@PROTEIN$) and cleaved caspase-3.	0
3516	Serum NO, @PROTEIN$ and @COMPOUND$ were measured.	0
3517	Serum @COMPOUND$ and @PROTEIN$ levels were significantly lower in FM patients than controls.	0
3518	@COMPOUND$ and DHEA-sulfate response to rapid adrenocorticotropic hormone (@PROTEIN$) stimulation was inadequate.	0
3519	Cortisol and @COMPOUND$ response to rapid @PROTEIN$ (ACTH) stimulation was inadequate.	0
3520	Cortisol and @COMPOUND$ response to rapid adrenocorticotropic hormone (@PROTEIN$) stimulation was inadequate.	0
3521	@COMPOUND$ and DHEA-sulfate response to rapid @PROTEIN$ (ACTH) stimulation was inadequate.	0
3522	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
3523	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
3524	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
3525	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
3526	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
3527	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
3528	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
3529	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
3530	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
3531	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
3532	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
3533	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
3534	The intracellular levels of @PROTEIN$ and G6PDH after permeabilization of these stored cells with cetyltrimetylammonium bromide (@COMPOUND$) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	1
3535	The intracellular levels of ADH and @PROTEIN$ after permeabilization of these stored cells with cetyltrimetylammonium bromide (@COMPOUND$) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	1
3536	Streptokinase (SK), @PROTEIN$ (GOx) and @COMPOUND$ (PC) were immobilized onto PGLD to obtain a blood compatible bioconjugate with glucose sensing properties.	0
3537	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of @PROTEIN$ expression that requires the activation of p38MAPK and ERK.	1
3538	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of iNOS expression that requires the activation of p38MAPK and @PROTEIN$.	0
3539	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of iNOS expression that requires the activation of @PROTEIN$ and ERK.	0
3540	A crude peel extract and purified fraction of Flemingia vestita, as well as a crude rhizome extract of Stephania glabra and fractions were tested with respect to the activity of @PROTEIN$, NO efflux and @COMPOUND$ concentration in the cestode Raillietina echinobothrida in order to find out the possible mode of anthelmintic action of these plant-derived components.	0
3541	In this study, we describe the crystal structure of yeast @PROTEIN$ in complex with @COMPOUND$ (chitobiose).	1
3542	Mutagenesis studies confirm the critical role of the @COMPOUND$-interacting residues in substrate binding and suggest that efficient oligosaccharide binding is required for @PROTEIN$ activity.	1
3543	Prediction of the effect of erythromycin, @COMPOUND$, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
3544	Prediction of the effect of @COMPOUND$, diltiazem, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
3545	This condition is caused by mutations in the PTH/@PROTEIN$ receptor that result in ligand-independent @COMPOUND$ accumulation, thus rendering the receptor constitutively active.	1
3546	This condition is caused by mutations in the @PROTEIN$/PTHrP receptor that result in ligand-independent @COMPOUND$ accumulation, thus rendering the receptor constitutively active.	1
3547	Adiponectin, an adipokine secreted by the white adipose tissue, plays an important role in regulating @COMPOUND$ and lipid metabolism and controlling energy homeostasis in @PROTEIN$-sensitive tissues.	0
3548	@PROTEIN$ is involved in @COMPOUND$-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.	1
3549	Expression of @COMPOUND$ : @PROTEIN$ in gastric mucosa, intestinal metaplasia, and gastric carcinoma.	0
3550	@COMPOUND$ : @PROTEIN$ (ppGalNAc-T6) is one of the enzymes responsible for the initial step in O-glycosylation.	1
3551	In addition, SAH caused large increases in markers of inflammation, including @PROTEIN$ and NFkappaB, and markers of cell injury or cell death, including IgG endocytosis and caspase-3 activation, with @COMPOUND$ significantly reducing these effects.	1
3552	We conclude that block of @PROTEIN$ by @COMPOUND$ may ameliorate several pathologic effects associated with inflammation that lead to cortical dysfunction after SAH.	1
3553	Intrinsic fluorescence of @COMPOUND$-214 in @PROTEIN$ was monitored upon addition of the chemicals.	1
3554	The COMT enzyme breaks down extracellular @COMPOUND$ (DA) and has a particularly important role in the prefrontal cortex (PFC) where @PROTEIN$ are sparse.	1
3555	The @PROTEIN$ enzyme breaks down extracellular @COMPOUND$ (DA) and has a particularly important role in the prefrontal cortex (PFC) where DA transporters are sparse.	1
3556	CYP719A subfamily of @PROTEIN$ oxygenases and @COMPOUND$ alkaloid biosynthesis in Eschscholzia californica.	0
3557	The metal-@COMPOUND$ connectivity of recombinant Cd(7)-MT10 @PROTEIN$ from the sea mussel Mytilus galloprovincialis has been investigated for the first time by means of multinuclear, multidimensional NMR spectroscopy.	1
3558	Radical scavenging activity of lipophilized products from @PROTEIN$-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids.	1
3559	Validation of a food frequency questionnaire measurement of dietary acrylamide intake using @PROTEIN$ adducts of acrylamide and @COMPOUND$.	1
3560	Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and @PROTEIN$-mediated @COMPOUND$ uptake in healthy obese subjects.	1
3561	Currently, @COMPOUND$ (PLP)-dependent @PROTEIN$ (CBS) is thought to be the major H(2)S-producing enzyme in the brain.	1
3562	The purpose of this study was to propose a new preparation method to fabricate @PROTEIN$-loaded poly(lactic-coglycolic acid) (@COMPOUND$) microparticles satisfying protein loading, release profiles, burst release, and particularly stability of the encapsulated protein.	1
3563	This injury induces central sensitization leading to tactile allodynia and is mediated by activation of @COMPOUND$+) permeable AMPA/kainate receptors through @PROTEIN$ and PKA.	1
3564	Stimulation of choline @PROTEIN$ by @COMPOUND$, a neural cell adhesion molecule ligand.	1
3565	Incubation of L6 myotubes with palmitate (for 16 h) increases intramyocellular ceramide and reduces @PROTEIN$-stimulated PKB activation and @COMPOUND$ uptake.	0
3566	Incubation of L6 myotubes with palmitate (for 16 h) increases intramyocellular ceramide and reduces insulin-stimulated @PROTEIN$ activation and @COMPOUND$ uptake.	0
3567	This is the first @PROTEIN$ with a known primary structure and a glutamine instead of @COMPOUND$ residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	1
3568	This is the first @PROTEIN$ with a known primary structure and a @COMPOUND$ instead of glycine residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	1
3569	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood @COMPOUND$, or plasma concentrations of catecholamines, @PROTEIN$, and cortisol.	0
3570	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood glucose, or plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
3571	During hypoxemia, treatment with acidified saline increased the magnitude of the fetal bradycardia and femoral vasoconstriction and concomitantly increased chemoreflex function and enhanced the increments in plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
3572	The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase pyrimidin-4-ylamine (@COMPOUND$).	0
3573	The induction of @PROTEIN$ by @COMPOUND$ was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase pyrimidin-4-ylamine (BAY 41-2272).	1
3574	The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase @COMPOUND$ (BAY 41-2272).	0
3575	The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (@COMPOUND$) or by the protein kinase pyrimidin-4-ylamine (BAY 41-2272).	0
3576	Modulation of Rac1 activity by @COMPOUND$/@PROTEIN$ regulates pulmonary endothelial barrier function.	0
3577	Modulation of @PROTEIN$ activity by @COMPOUND$/DDAH regulates pulmonary endothelial barrier function.	1
3578	Endometriosis is associated with @COMPOUND$ resistance in the baboon (Papio anubis) oviduct: evidence based on the localization of @PROTEIN$ 1 (OVGP1).	0
3579	Endometriosis is associated with @COMPOUND$ resistance in the baboon (Papio anubis) oviduct: evidence based on the localization of oviductal glycoprotein 1 (@PROTEIN$).	1
3580	Transgenic mice that overexpress rat @PROTEIN$ in their proximal tubule cells were given either @COMPOUND$, perindopril, or hydralazine while untreated or apocynin-treated non-transgenic littermates served as controls.	0
3581	Transgenic mice that overexpress rat @PROTEIN$ in their proximal tubule cells were given either apocynin, @COMPOUND$, or hydralazine while untreated or apocynin-treated non-transgenic littermates served as controls.	0
3582	Transgenic mice that overexpress rat @PROTEIN$ in their proximal tubule cells were given either apocynin, perindopril, or @COMPOUND$ while untreated or apocynin-treated non-transgenic littermates served as controls.	0
3583	Requirement of @PROTEIN$ for antidepressive efficiency of @COMPOUND$ : implication in adult hippocampal neurogenesis.	1
3584	Collectively, these findings suggest that @PROTEIN$ is required for the antidepressive action of @COMPOUND$ via regulating adult hippocampal neurogenesis.	1
3585	Although no significant change in the apparent K(m) was revealed in animals that exhibited an escalation in the rate of cocaine intake, an increased @COMPOUND$ uptake rate was found suggesting an upregulation of @PROTEIN$ number in response to a history of high cocaine intake.	1
3586	Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the @PROTEIN$ and SERT, or 10 mg/kg per day @COMPOUND$, a monoamine oxidase inhibitor, produced antidepressant-like effects on behavior without altering NET or SERT expression.	0
3587	Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the NET and @PROTEIN$, or 10 mg/kg per day @COMPOUND$, a monoamine oxidase inhibitor, produced antidepressant-like effects on behavior without altering NET or SERT expression.	0
3588	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, @COMPOUND$ transport and GluRs, BDNF and @PROTEIN$, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and ATP generation.	0
3589	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, glutamate transport and GluRs, @PROTEIN$ and TrkB, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and @COMPOUND$ generation.	0
3590	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, @COMPOUND$ transport and GluRs, BDNF and TrkB, numerous @PROTEIN$ family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and ATP generation.	0
3591	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, glutamate transport and GluRs, BDNF and @PROTEIN$, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and @COMPOUND$ generation.	0
3592	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, @PROTEIN$, glutamate transport and GluRs, BDNF and TrkB, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and @COMPOUND$ generation.	0
3593	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, @PROTEIN$, @COMPOUND$ transport and GluRs, BDNF and TrkB, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and ATP generation.	0
3594	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, glutamate transport and GluRs, BDNF and TrkB, numerous @PROTEIN$ family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and @COMPOUND$ generation.	0
3595	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, @COMPOUND$ transport and GluRs, @PROTEIN$ and TrkB, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and ATP generation.	0
3596	Brains from persons with major depressive disorder reveal decreased expression for genes in @COMPOUND$ transport and metabolism, neurotrophic signaling (eg, @PROTEIN$, BDNF and VGF), and MAP kinase pathways.	0
3597	Brains from persons with major depressive disorder reveal decreased expression for genes in @COMPOUND$ transport and metabolism, neurotrophic signaling (eg, FGF, @PROTEIN$ and VGF), and MAP kinase pathways.	0
3598	Brains from persons with major depressive disorder reveal decreased expression for genes in @COMPOUND$ transport and metabolism, neurotrophic signaling (eg, FGF, BDNF and @PROTEIN$), and MAP kinase pathways.	0
3599	However, detection of @COMPOUND$ and Zn in @PROTEIN$ after PAGE-LA-ICP-MS depends on the conditions of the PAGE method because possible metal losses can occur (either with SDS-PAGE or with native PAGE).	1
3600	Recent studies have suggested that a decrease in the specific activity of the 2-@PROTEIN$ complex (ODHC) is important for @COMPOUND$ overproduction by Corynebacterium glutamicum.	1
3601	Real-time polymerase chain reaction analysis of hypoxic, NO-@COMPOUND$ treated PC-3 cells showed downregulation of lysyl oxidase and @PROTEIN$ mRNA expression.	1
3602	Real-time polymerase chain reaction analysis of hypoxic, NO-@COMPOUND$ treated PC-3 cells showed downregulation of @PROTEIN$ and carbonic anhydrase IX mRNA expression.	1
3603	Established risk cardiovascular factors like hypertension, atherogenic dyslipidaemia, and @COMPOUND$ intolerance occur in the setting of @PROTEIN$ resistance and central adiposity, with genetic and environmental influences modulating the ultimate risk.	1
3604	Gas exchange was monitored and blood samples were collected during exercise for GH, @PROTEIN$, insulin, and blood glucose and @COMPOUND$ determination.	0
3605	Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, @PROTEIN$, and blood @COMPOUND$ and lactate determination.	0
3606	Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, @PROTEIN$, and blood glucose and @COMPOUND$ determination.	0
3607	Gas exchange was monitored and blood samples were collected during exercise for GH, @PROTEIN$, insulin, and blood @COMPOUND$ and lactate determination.	0
3608	Because o-quinones are very unstable, we used an oxymetric method to characterize the kinetics of this substrate, based on measurements of the @COMPOUND$ consumed in the @PROTEIN$ reaction.	1
3609	Plasma levels of @COMPOUND$, cortisol, and @PROTEIN$ were measured.	0
3610	Plasma levels of citalopram, @COMPOUND$, and @PROTEIN$ were measured.	0
3611	An increase in @COMPOUND$ and @PROTEIN$ concentrations was observed from the EOI until 60 min after the EOI.	0
3612	Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from genipin-crosslinked gelatin within @COMPOUND$ (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0
3613	Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from @COMPOUND$-crosslinked gelatin within polycaprolactone (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0
3614	In this study, 10% (w/v) gelatin was mixed with @PROTEIN$, crosslinked with 0%, 0.1%, 0.5%, and 1% (w/v) @COMPOUND$, and then sucked into the wall of PCL conduits.	0
3615	It was found from this group that @COMPOUND$ was the best alternative to warfarin for examining the interactions of drugs at Sudlow site I on @PROTEIN$.	1
3616	Effects of @PROTEIN$/ANKK1 gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1
3617	Effects of DRD2/@PROTEIN$ gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1
3618	The majority of patients with acute depression shows an exaggerated plasma corticotrophin (@PROTEIN$) and @COMPOUND$ response to this test that normalizes gradually during successful antidepressant therapy.	0
3619	We examined plasma @PROTEIN$ and @COMPOUND$ responses to the dex/CRH test in acutely depressed inpatients treated either with mirtazapine (n=55) or a monoamine reuptake inhibitor (n=105) according to doctor's choice and compared the test results with healthy controls (n=40).	0
3620	Both extracts increased AMP-kinase phosphorylation and @PROTEIN$ phosphorylation by 2.5-to 4-fold, but with different time courses: maximal phosphorylation with @COMPOUND$ was evident within 30 min of treatment, whereas with black tea phosphorylation was slower to develop, with maximal phosphorylation occurring &gt; or =3 hours after treatment.	1
3621	However, the ethyl ester of commipheric acid (150 mg/kg, twice daily) lowered fasting blood @COMPOUND$ and plasma @PROTEIN$, and plasma triglycerides without affecting food intake or body weight.	0
3622	This finding led the authors to propose that @PROTEIN$ may be involved in the pathogenesis of psoriasis through its potential role in @COMPOUND$ biosynthesis and stimulation of keratinocyte proliferation.	1
3623	In this study, we began the characterization of @PROTEIN$ protein in order to determine whether it might play a role in @COMPOUND$ biosynthesis.	0
3624	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by glutathione-S-transferases (@PROTEIN$) and glutathione peroxidases (GPx).	1
3625	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by glutathione-S-transferases (GST) and @PROTEIN$ (GPx).	1
3626	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by @PROTEIN$ (GST) and glutathione peroxidases (GPx).	1
3627	Peripheral @PROTEIN$ gastroprotection against @COMPOUND$ : the role of exendin, NO, CGRP, prostaglandins and blood flow.	0
3628	Peripheral GLP-1 gastroprotection against @COMPOUND$ : the role of exendin, NO, @PROTEIN$, prostaglandins and blood flow.	0
3629	@COMPOUND$ was administered through an orogastric cannula right after the injection of @PROTEIN$ (1, 10, 100, 1000 or 10,000 ng/kg; i.p.).	0
3630	It inhibited Trypanosoma brucei @PROTEIN$ with an IC(50) value of 240 microM and has been shown to be a competitive reversible inhibitor (Ki=200+/-10 microM) of this enzyme with respect to its cofactor @COMPOUND$ (+).	1
3631	We have also described LD between @PROTEIN$ alleles and HLA class II DRB1 allelic groups and found significant LD between DRB104-G01B, DRB113-G010401, DRB114-G010108, DRB115-@COMPOUND$, DRB103-G0101A and DRB103-G01B.	0
3632	We have also described LD between HLA-G alleles and HLA class II @PROTEIN$ allelic groups and found significant LD between DRB104-G01B, DRB113-G010401, DRB114-G010108, DRB115-@COMPOUND$, DRB103-G0101A and DRB103-G01B.	0
3633	It is suggested that in this animal model, characterized by TSH elevation and low-grade inflammation, an increased expression and function of @PROTEIN$, resulting in @COMPOUND$ generation, accounts for an impaired NO availability.	1
3634	These changes were associated with an alleviation of hyperglycemia, @COMPOUND$ intolerance, and @PROTEIN$ resistance.	0
3635	We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused @COMPOUND$, and in response to infused endothelin-1 (@PROTEIN$) with and without MK-801, an NMDA receptor blocker.	0
3636	We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused @COMPOUND$, and in response to infused @PROTEIN$ (ET-1) with and without MK-801, an NMDA receptor blocker.	0
3637	Immunofluorescence microscopy of live human umbilical vein endothelial cells showed that @PROTEIN$ multimers rapidly formed strings several hundred micrometers long on the cell surface after stimulation with @COMPOUND$.	1
3638	Soluble P-selectin reduced the number of platelet-decorated @PROTEIN$ strings in the absence of @COMPOUND$+) and Mg(2+) but had no effect in the presence of these cations.	1
3639	To examine the relationship of functional expression of @PROTEIN$ to prognosis in AML, we studied marrow samples from 175 adult AML patients who underwent induction chemotherapy with anthracycline and @COMPOUND$ on Southwest Oncology Group trials.	0
3640	Inhibition of @PROTEIN$ by @COMPOUND$ in vivo suppressed the inflammatory response in mice infected with F. tularensis LVS and conferred a survival advantage.	1
3641	To prevent the effects of interfering anionic species, such as uric acid and ascorbic acid, on the sensor response, the Pt-Ir electrode was coated with @COMPOUND$, and then @PROTEIN$ was immobilized on the coated electrode.	0
3642	To prevent the effects of interfering anionic species, such as @COMPOUND$ and ascorbic acid, on the sensor response, the Pt-Ir electrode was coated with Nafion, and then @PROTEIN$ was immobilized on the coated electrode.	0
3643	To prevent the effects of interfering anionic species, such as uric acid and @COMPOUND$, on the sensor response, the Pt-Ir electrode was coated with Nafion, and then @PROTEIN$ was immobilized on the coated electrode.	0
3644	A naturally occurring glycine to @COMPOUND$ mutation at position 169 (G169D) in the putative transmembrane domain 4 (@PROTEIN$) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	1
3645	A naturally occurring @COMPOUND$ to aspartic acid mutation at position 169 (G169D) in the putative transmembrane domain 4 (@PROTEIN$) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	1
3646	The aim of this study was to monitor the level of serum free @COMPOUND$ in combination with @PROTEIN$ (Myo) and creatine kinase (total activity and CK-MB level) for usefulness as a predictor of AMI in ICU patients.	0
3647	Curcuminoids inhibited @PROTEIN$ in the in-vitro assay with IC(50) value of 19.67, @COMPOUND$ 16.84, demethoxycurcumin 33.14 and curcumin 67.69 microM.	1
3648	L-@COMPOUND$ was the most effective promoter of @PROTEIN$ absorption compared with others CPPs.	1
3649	A dose-dependent relationship of L-@COMPOUND$ and @PROTEIN$ bioavailability was statically significant.	1
3650	There was no significant difference in the release of @PROTEIN$ in nasal lavage fluid and the integrity of nasal respiratory epithelium when L-@COMPOUND$ was present.	0
3651	Osteoblasts up-regulate the expression of extracellular @PROTEIN$ following attachment to @COMPOUND$).	1
3652	Pharmacological stimulation of @PROTEIN$ channels with @COMPOUND$ (10 nM) selectively enhanced the frequency of glutamate-mediated spontaneous (sEPSCs) and miniature excitatory postsynaptic currents (mEPSCs) recorded from putative striatal medium spiny neurons.	1
3653	Consistently, the totality of striatal neurons responded to capsaicin (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (@COMPOUND$).	1
3654	Consistently, the totality of striatal neurons responded to @COMPOUND$ (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA).	1
3655	Consistently, the totality of striatal neurons responded to capsaicin (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator @COMPOUND$ (PMA).	1
3656	The effects of capsaicin and of @COMPOUND$ were absent after pharmacological or genetic inactivation of @PROTEIN$ channels.	1
3657	The effects of @COMPOUND$ and of PMA were absent after pharmacological or genetic inactivation of @PROTEIN$ channels.	1
3658	Finally, we provided evidence for @COMPOUND$ as an endovanilloid substance in the striatum, since genetic inhibition of anandamide degradation resulted in a tonic activation of @PROTEIN$ channels modulating glutamate but not GABA release.	1
3659	With the exception of significantly elevated serum @PROTEIN$ after @COMPOUND$, no effects in the secondary outcome measures were detected.	1
3660	@COMPOUND$ toxicity is aggravated in people deficient of 6-glucose phosphate dehydrogenase or @PROTEIN$.	1
3661	Fluoroimmunoassay based on the fluorescent property of quantum dot was used along with immunoassay to detect 2,4-D. CdTe capped with mercaptopropionic acid, was conjugated using N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and a coupling reagent like @COMPOUND$ (NHS) to alkaline phosphatase (@PROTEIN$) which was in turn conjugated to 2,4-D molecule.	1
3662	Fluoroimmunoassay based on the fluorescent property of quantum dot was used along with immunoassay to detect 2,4-D. CdTe capped with mercaptopropionic acid, was conjugated using N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and a coupling reagent like @COMPOUND$ (NHS) to @PROTEIN$ (ALP) which was in turn conjugated to 2,4-D molecule.	1
3663	The SoxN protein is proposed to harbor the heme b of lower reduction potential and the @COMPOUND$ (s), and @PROTEIN$ the other heme b.	0
3664	Seleno-L-methionine (SeMet) can be oxidized to L-methionine selenoxide (MetSeO) by flavin-containing monooxygenase 3 (@PROTEIN$) and rat liver microsomes in the presence of @COMPOUND$.	1
3665	Regulatory roles for Tiam1, a guanine nucleotide exchange factor for @PROTEIN$, in @COMPOUND$-stimulated insulin secretion in pancreatic beta-cells.	0
3666	Regulatory roles for Tiam1, a guanine nucleotide exchange factor for Rac1, in @COMPOUND$-stimulated @PROTEIN$ secretion in pancreatic beta-cells.	1
3667	Regulatory roles for @PROTEIN$, a guanine nucleotide exchange factor for Rac1, in @COMPOUND$-stimulated insulin secretion in pancreatic beta-cells.	0
3668	Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for Rac1, a @PROTEIN$, in @COMPOUND$-stimulated insulin secretion (GSIS).	0
3669	Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for Rac1, a small G-protein, in @COMPOUND$-stimulated @PROTEIN$ secretion (GSIS).	1
3670	Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for @PROTEIN$, a small G-protein, in @COMPOUND$-stimulated insulin secretion (GSIS).	0
3671	@COMPOUND$-bound form) and membrane association of @PROTEIN$ in INS 832/13 cells and rat islets.	0
3672	This vector allows the co-expression of alpha-Hb as a fusion protein with @PROTEIN$ (GST-alpha-Hb) and beta-Hb with an additional @COMPOUND$ at the N-terminal extremity (rbeta-Hb).	0
3673	This vector allows the co-expression of alpha-Hb as a fusion protein with Glutathione S-Transferase (@PROTEIN$-alpha-Hb) and beta-Hb with an additional @COMPOUND$ at the N-terminal extremity (rbeta-Hb).	0
3674	@PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
3675	Superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
3676	@PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
3677	Superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
3678	Superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
3679	Superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
3680	Superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
3681	Superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
3682	Superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
3683	Superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
3684	The erythrocyte @PROTEIN$ activity was higher in @COMPOUND$ group and there was a statistically significant increase, when compared with the erdosteine plus ischemia/reperfusion group.	1
3685	The ethidium bromide (EB) demyelinating model was associated with vitamin E (Vit E) and @COMPOUND$ (Ebs) treatment to evaluate @PROTEIN$ (AChE) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0
3686	The ethidium bromide (EB) demyelinating model was associated with vitamin E (Vit E) and @COMPOUND$ (Ebs) treatment to evaluate acetylcholinesterase (@PROTEIN$) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0
3687	The ethidium bromide (EB) demyelinating model was associated with @COMPOUND$ (Vit E) and ebselen (Ebs) treatment to evaluate @PROTEIN$ (AChE) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0
3688	The ethidium bromide (EB) demyelinating model was associated with @COMPOUND$ (Vit E) and ebselen (Ebs) treatment to evaluate acetylcholinesterase (@PROTEIN$) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0
3689	In vivo @PROTEIN$ blockade by @COMPOUND$ significantly increased infarct volumes at 24 h in mice undergoing 30 min of transient middle cerebral artery occlusion (tMCAO).	1
3690	Glutathione S-transferases (@PROTEIN$) are multifunctional phase II detoxification enzymes that catalyze the attachment of electrophilic substrates to @COMPOUND$.	1
3691	@PROTEIN$ (GSTs) are multifunctional phase II detoxification enzymes that catalyze the attachment of electrophilic substrates to @COMPOUND$.	1
3692	@PROTEIN$ (HIF-1alpha) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1
3693	Hypoxia-inducible factor-1alpha (@PROTEIN$) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1
3694	The mechanism of lysoPAF-mediated inhibition of neutrophils involves an elevation in the intracellular @COMPOUND$ level, and pharmacological blockade of @PROTEIN$ completely reverses the inhibitory effect of lysoPAF.	1
3695	Sympathetic neurogenic Ca2+ signalling in rat arteries: ATP, @COMPOUND$ and @PROTEIN$.	0
3696	Sympathetic neurogenic Ca2+ signalling in rat arteries: @COMPOUND$, noradrenaline and @PROTEIN$.	0
3697	DnaB (BA) demonstrated a strong DNA @PROTEIN$ activity that required ATP or @COMPOUND$.	1
3698	@PROTEIN$ (BA) demonstrated a strong DNA helicase activity that required ATP or @COMPOUND$.	1
3699	@PROTEIN$ (BA) demonstrated a strong DNA helicase activity that required @COMPOUND$ or dATP.	1
3700	DnaB (BA) demonstrated a strong DNA @PROTEIN$ activity that required @COMPOUND$ or dATP.	1
3701	HmuY and @PROTEIN$ are @COMPOUND$ binding proteins required for P. gingivalis growth.	1
3702	The effect of tropomyosin on @PROTEIN$ filaments was independent of ionic strength, but became stronger as the @COMPOUND$ concentration increased.	1
3703	The effect of @PROTEIN$ on actin filaments was independent of ionic strength, but became stronger as the @COMPOUND$ concentration increased.	1
3704	Activation of Bax and @PROTEIN$ was demonstrated in peripheral blood mononuclear cells, and induction of apoptosis was related to overall @COMPOUND$ exposure, as monitored by the plasma concentration of oligonucleosomal DNA/histone complexes.	0
3705	Activation of @PROTEIN$ and Bak was demonstrated in peripheral blood mononuclear cells, and induction of apoptosis was related to overall @COMPOUND$ exposure, as monitored by the plasma concentration of oligonucleosomal DNA/histone complexes.	0
3706	Liver @COMPOUND$ DNA adducts and acrylamide and glycidamide N-terminal valine @PROTEIN$ adducts were also determined.	0
3707	Liver glycidamide DNA adducts and acrylamide and glycidamide N-terminal @COMPOUND$ @PROTEIN$ adducts were also determined.	1
3708	Liver glycidamide DNA adducts and @COMPOUND$ and glycidamide N-terminal valine @PROTEIN$ adducts were also determined.	0
3709	The acyl @PROTEIN$ peptide features a unique post-translational modification of O-n-octanoylation at @COMPOUND$ 3, and is the only gastrointestinal signal that increases meal size.	1
3710	Tests of the blood samples obtained at the ED revealed leucocytosis (11 070.6+/-4302.5/microl), increased blood @COMPOUND$, @PROTEIN$, CK and CK-MB levels.	0
3711	Molecular and biochemical characterization of a distinct @PROTEIN$ involved in @COMPOUND$ production from Aeromonas media.	1
3712	TyrA had a relatively higher affinity to @COMPOUND$ substrate L-dihydroxyphenylalanine (L-dopa) than many other @PROTEIN$.	0
3713	TyrA had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (@COMPOUND$) than many other @PROTEIN$.	0
3714	@PROTEIN$ had a relatively higher affinity to @COMPOUND$ substrate L-dihydroxyphenylalanine (L-dopa) than many other tyrosinases.	0
3715	TyrA had a relatively higher affinity to diphenol substrate L-@COMPOUND$ (L-dopa) than many other @PROTEIN$.	0
3716	@PROTEIN$ had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (@COMPOUND$) than many other tyrosinases.	1
3717	@PROTEIN$ had a relatively higher affinity to diphenol substrate L-@COMPOUND$ (L-dopa) than many other tyrosinases.	1
3718	EDTA or glutathione notably inhibited the enzymatic activities of @PROTEIN$, whereas @COMPOUND$ and SDS activated them.	1
3719	These results suggest that @PROTEIN$ is the first reported distinct tyrosinase involved in @COMPOUND$ production in the genus Aeromonas.	1
3720	These results suggest that TyrA is the first reported distinct @PROTEIN$ involved in @COMPOUND$ production in the genus Aeromonas.	1
3721	@PROTEIN$ from goldfish white muscle: regulatory properties and redistribution under exposure to high environmental @COMPOUND$ level.	1
3722	Both sodium and potassium ions activated goldfish @PROTEIN$ at low concentrations, with maximal activation at about 80 mM of each @COMPOUND$ salt, whereas higher concentrations became inhibitory.	0
3723	Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did phosphate and @COMPOUND$ ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1
3724	Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did @COMPOUND$ and fluoride ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1
3725	Age-associated impairment of @PROTEIN$ phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, PTEN, and PP2A.	1
3726	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, @PROTEIN$, and PP2A.	1
3727	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through @PROTEIN$, PTEN, and PP2A.	1
3728	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, PTEN, and @PROTEIN$.	1
3729	Unfolding and inactivation of abalone (Haliotis diversicolor) @PROTEIN$ during denaturation by @COMPOUND$.	1
3730	Unfolding and inactivation of @PROTEIN$ from abalone (Haliotis diversicolor) during denaturation by @COMPOUND$ (GuHCl) of different concentrations has first been studied.	1
3731	NADH/NAD (+) ratio can be normalized by the activation or overexpression of nicotinamide nucleotide transhydrogenase (@PROTEIN$--&gt; @COMPOUND$+ NAD (+).	1
3732	NADH/NAD (+) ratio can be normalized by the activation or overexpression of @PROTEIN$ (NNT--&gt; @COMPOUND$+ NAD (+).	1
3733	@COMPOUND$/NAD (+) ratio can be normalized by the activation or overexpression of nicotinamide nucleotide transhydrogenase (@PROTEIN$--&gt; NADPH+ NAD (+).	1
3734	@COMPOUND$/NAD (+) ratio can be normalized by the activation or overexpression of @PROTEIN$ (NNT--&gt; NADPH+ NAD (+).	1
3735	An efficient electrocatalytic biosensor for sulfite detection was developed by co-immobilizing sulfite oxidase and @PROTEIN$ with polyaniline @COMPOUND$ in a layer-by-layer assembly.	0
3736	An efficient electrocatalytic biosensor for sulfite detection was developed by co-immobilizing @PROTEIN$ and cytochrome c with polyaniline @COMPOUND$ in a layer-by-layer assembly.	0
3737	The levels of @COMPOUND$ and @PROTEIN$ were lower in ginkgo groups but not significantly.	0
3738	These results indicate that cloned embryos have aberrant DNA methylation in the @COMPOUND$ sites of the PE region of @PROTEIN$, and this may contribute directly to abnormal expression of this gene in cloned embryos.	1
3739	Moreover, the dopaminergic and glutamatergic regulation of @PROTEIN$ gene activation by @COMPOUND$ was investigated.	1
3740	The acute @COMPOUND$-mediated activation of @PROTEIN$ gene was regulated by D1 but not D2 dopamine receptors.	1
3741	Activation of @PROTEIN$ gene may contribute to the @COMPOUND$-mediated synaptic and behavioral plasticity.	1
3742	@COMPOUND$, a new inhibitor of non-apoptotic death, rescued cells from death by @PROTEIN$, although the effect was also partial and temporary.	1
3743	van't Hoff analysis of @COMPOUND$-@PROTEIN$ equilibrium reveals a binding reaction that is enthalpy driven and entropy favored with TDeltaS degrees contributing 15% to the overall value of DeltaG degrees.	1
3744	eIFiso4G was shown to enhance the interaction of @PROTEIN$ with @COMPOUND$ cap analog by 2.4-fold.	1
3745	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, @PROTEIN$ and oxytocin transcripts was reduced.	1
3746	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of @PROTEIN$, HSD3B1, CYP19A1 and oxytocin transcripts was reduced.	1
3747	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, @PROTEIN$, CYP19A1 and oxytocin transcripts was reduced.	1
3748	In granulosa-lutein cells, STAR transcript abundance was not affected by @PROTEIN$, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, CYP19A1 and oxytocin transcripts was reduced.	1
3749	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, CYP19A1 and @PROTEIN$ transcripts was reduced.	1
3750	In both cell types, follistatin attenuated the suppressive effect of activin A and @PROTEIN$ on @COMPOUND$-induced P4 secretion but had no effect alone.	1
3751	@COMPOUND$ (1-ABT) is generally considered to be a nonselective mechanism-based inactivator of both human and non-human @PROTEIN$ (P450) enzymes.	1
3752	@COMPOUND$ is present in lipid deposits in the primate retina: potential implication in the induction of @PROTEIN$ and CNV formation.	1
3753	ETEC infection also caused a drastic inhibition of host @PROTEIN$ activity, as measured by @COMPOUND$ fluorescence.	0
3754	@COMPOUND$ is a nonnucleoside inhibitor of the hepatitis C virus (HCV) nonstructural protein 5B (@PROTEIN$) polymerase, and boceprevir is an inhibitor of the NS3 serine protease.	1
3755	Increased apoptosis of a human salivary gland (HSG) cell line occurred only in the presence of @COMPOUND$ (LPS-) and interferon (@PROTEIN$)-gamma-stimulated human monocytic THP-1 cells, which was reversed when caspase-1 in THP-1 cells was targeted by siRNA.	0
3756	A role for @COMPOUND$ and @PROTEIN$ combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.	0
3757	Effect of genetic polymorphisms of @PROTEIN$ and MDR1 on @COMPOUND$ concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.	0
3758	Effect of genetic polymorphisms of @PROTEIN$ and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with @COMPOUND$.	0
3759	Effect of genetic polymorphisms of CYP3A5 and @PROTEIN$ on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with @COMPOUND$.	0
3760	Effect of genetic polymorphisms of CYP3A5 and @PROTEIN$ on @COMPOUND$ concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.	0
3761	The aim of this study was to assess the influence of the cytochrome (CYP450)3A5 and multidrug resistance (@PROTEIN$) gene polymorphisms on @COMPOUND$ (CsA) trough concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.	0
3762	The aim of this study was to assess the influence of the cytochrome (CYP450)3A5 and multidrug resistance (@PROTEIN$) gene polymorphisms on cyclosporine A (CsA) trough concentration during the early stage after renal transplantation in Chinese patients co-treated with @COMPOUND$.	0
3763	The-417- and-593 bp promoter regions were sufficient for @PROTEIN$ gene activation by ethylene and @COMPOUND$ treatments, respectively.	1
3764	The-417- and-593 bp promoter regions were sufficient for @PROTEIN$ gene activation by @COMPOUND$ and methyl jasmonate treatments, respectively.	1
3765	Reversible two-step unfolding of @COMPOUND$-human @PROTEIN$ : a (1)H-NMR relaxometric and circular dichroism study.	1
3766	Human serum albumin (@PROTEIN$) participates in @COMPOUND$ scavenging, the bound heme turning out to be a reactivity center and a powerful spectroscopic probe.	1
3767	Human @PROTEIN$ (HSA) participates in @COMPOUND$ scavenging, the bound heme turning out to be a reactivity center and a powerful spectroscopic probe.	1
3768	Here, the reversible unfolding of @COMPOUND$-@PROTEIN$ has been investigated by (1)H-NMR relaxometry, circular dichroism, and absorption spectroscopy.	1
3769	The purified enzymes were a monomer with an apparent molecular mass of 32 kDa (Chi32) and 46 kDa (Chi46), respectively, and showed @PROTEIN$ activity bands with 0.01% @COMPOUND$ chitin as a substrate after SDS-PAGE.	0
3770	Possible relation of @COMPOUND$-induced @PROTEIN$ expression to the upregulation of VEGF and BDNF mRNA levels in rat C6 glioma cells.	1
3771	Possible relation of @COMPOUND$-induced HO-1 expression to the upregulation of @PROTEIN$ and BDNF mRNA levels in rat C6 glioma cells.	1
3772	Possible relation of @COMPOUND$-induced HO-1 expression to the upregulation of VEGF and @PROTEIN$ mRNA levels in rat C6 glioma cells.	1
3773	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding @PROTEIN$ (HO-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
3774	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (@PROTEIN$), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
3775	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (VEGF), and @PROTEIN$ (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
3776	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (@PROTEIN$), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
3777	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (@PROTEIN$) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
3778	Furthermore, we study the @PROTEIN$ activation after As(2)O(3) treatment and the HCC cells proliferation after combination of As(2)O(3) with PI3K inhibitor @COMPOUND$.	0
3779	@COMPOUND$ is a pesticide whose acute toxicity is due to inhibition of @PROTEIN$.	1
3780	@COMPOUND$-Epac2-mediated activation of @PROTEIN$ in developing male germ cells: RA-RhoGAP as a possible direct down-stream effector.	1
3781	@COMPOUND$-@PROTEIN$-mediated activation of Rap1 in developing male germ cells: RA-RhoGAP as a possible direct down-stream effector.	1
3782	Taken together, our results, obtained with endogenously expressed proteins, are consistent with a @COMPOUND$/Epac2/@PROTEIN$-mediated signaling that could exert its action, among others, through RA-RhoGAP to promote the progression of spermatogenesis.	1
3783	Taken together, our results, obtained with endogenously expressed proteins, are consistent with a @COMPOUND$/@PROTEIN$/Rap1-mediated signaling that could exert its action, among others, through RA-RhoGAP to promote the progression of spermatogenesis.	1
3784	Cholesterol promotes basal and @COMPOUND$-induced ATPase activity of P-@PROTEIN$ (P-gp).	1
3785	This study examines the structural basis for @PROTEIN$ binding of @COMPOUND$ and Cu-ATSM via competition with drugs having known albumin binding sites.	1
3786	This study examines the structural basis for @PROTEIN$ binding of Cu-PTSM and @COMPOUND$ via competition with drugs having known albumin binding sites.	1
3787	@COMPOUND$ from @PROTEIN$.	1
3788	At 8:1 warfarin: @PROTEIN$ @COMPOUND$ levels increased 300-500%.	1
3789	@COMPOUND$ was observed except at high ibuprofen: @PROTEIN$ ratios, where secondary ibuprofen binding to the IIA site may cause modest radiopharmaceutical displacement.	0
3790	0.05) in the overall @COMPOUND$-mediated @PROTEIN$ response.	1
3791	@COMPOUND$-stimulated @PROTEIN$ levels were not significantly different from controls.	1
3792	Atypical sialylated N-@COMPOUND$ structures are attached to neuronal @PROTEIN$.	1
3793	@COMPOUND$ linkages were identified for @PROTEIN$, Kv3.1, 3.3, 3.4, 1.1, 1.2 and 1.4, by evaluating their electrophoretic migration patterns in adult rat brain membranes digested with various glycosidases.	1
3794	No regional difference in @PROTEIN$ occupancy by the second-generation antipsychotic drug @COMPOUND$ in humans: a positron emission tomography study.	1
3795	In this study, regional distribution of @PROTEIN$ occupancy by @COMPOUND$ was determined in order to elucidate the limbic and cortical selectivity of second-generation antipsychotics.	1
3796	Striatal and extrastriatal @PROTEIN$ binding @COMPOUND$, respectively.	0
3797	@PROTEIN$, an intracellular sensor of bacteria-derived @COMPOUND$ (MDP) has been implicated as a key player in intestinal immune health and disease.	1
3798	@PROTEIN$ expression coupled with infusion of the IGF binding protein inhibitor @COMPOUND$ significantly prevented corticospinal motor neuron death 0.05), but did not promote corticospinal axon regeneration.	1
3799	We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to c-Src-dependent @COMPOUND$ phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor @PROTEIN$.	1
3800	We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to @PROTEIN$-dependent @COMPOUND$ phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor AP-2.	1
3801	Genotoxic effect of 2,4,6-@COMPOUND$ on @PROTEIN$ gene in zebrafish liver.	1
3802	Extensive neutrophil infiltration and chemoattractant factor interleukin 8 (@PROTEIN$) expression in IL-10 KO mice were observed after @COMPOUND$ administration.	1
3803	Extensive neutrophil infiltration and chemoattractant factor @PROTEIN$ (IL-8) expression in IL-10 KO mice were observed after @COMPOUND$ administration.	1
3804	In addition, increased signal transducer and activator of transcription factors (@PROTEIN$) 1 and STAT3 were observed in @COMPOUND$ treated IL-10 KO mice.	1
3805	In addition, increased signal transducer and activator of transcription factors (STAT) 1 and @PROTEIN$ were observed in @COMPOUND$ treated IL-10 KO mice.	1
3806	Interaction of @PROTEIN$ and @COMPOUND$ in endemic dilated cardiomyopathy.	1
3807	However, under the pressure of a death stimulus such as @COMPOUND$ treatment, L. infantum @PROTEIN$ is released from the single mitochondrion and translocates to the nucleus, where it is thought to participate in the process of DNA degradation that is associated with programmed cell death.	1
3808	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of superoxide dismutase (@PROTEIN$), catalase and glucose-6-phosphate dehydrogenase.	0
3809	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of superoxide dismutase (@PROTEIN$), catalase and glucose-6-phosphate dehydrogenase.	0
3810	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of @PROTEIN$ (SOD), catalase and glucose-6-phosphate dehydrogenase.	0
3811	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of @PROTEIN$ (SOD), catalase and glucose-6-phosphate dehydrogenase.	0
3812	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of superoxide dismutase (SOD), @PROTEIN$ and glucose-6-phosphate dehydrogenase.	0
3813	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of superoxide dismutase (SOD), @PROTEIN$ and glucose-6-phosphate dehydrogenase.	0
3814	However, these events were blocked by treatment with the antioxidant, @COMPOUND$ (NAC), as well as @PROTEIN$ overexpression.	0
3815	Changes in @COMPOUND$ consumption and the RQ ratio during sedentary and low-intensity exercise were not different between alpha(1)-@PROTEIN$-DN and WT.	0
3816	@PROTEIN$-mediated @COMPOUND$ efflux generates microparticles in addition to HDL through processes governed by membrane rigidity.	1
3817	Effects of DHT on COX-2 and @PROTEIN$ were attenuated by @COMPOUND$.	0
3818	Effects of @COMPOUND$ on COX-2 and @PROTEIN$ were attenuated by flutamide.	1
3819	Effects of DHT on @PROTEIN$ and iNOS were attenuated by @COMPOUND$.	0
3820	Effects of @COMPOUND$ on @PROTEIN$ and iNOS were attenuated by flutamide.	1
3821	In conclusion, activation of the NFkappaB-mediated COX-2/@PROTEIN$ pathway by the selective androgen receptor agonist, @COMPOUND$, results in a state of vascular inflammation.	1
3822	In conclusion, activation of the NFkappaB-mediated @PROTEIN$/iNOS pathway by the selective androgen receptor agonist, @COMPOUND$, results in a state of vascular inflammation.	1
3823	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-@COMPOUND$, and another had Evans blue (EB) injected for fluorescent microscopy for MMP-2, @PROTEIN$, tight junction proteins (TJPs), and in situ zymography.	0
3824	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-sucrose, and another had @COMPOUND$ (EB) injected for fluorescent microscopy for @PROTEIN$, MMP-9, tight junction proteins (TJPs), and in situ zymography.	0
3825	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-sucrose, and another had @COMPOUND$ (EB) injected for fluorescent microscopy for MMP-2, @PROTEIN$, tight junction proteins (TJPs), and in situ zymography.	0
3826	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-@COMPOUND$, and another had Evans blue (EB) injected for fluorescent microscopy for @PROTEIN$, MMP-9, tight junction proteins (TJPs), and in situ zymography.	0
3827	The electrons released from @COMPOUND$ by @PROTEIN$ were transferred to CTC in the reaction medium, and CTC reduction activity could be assessed spectrophotometrically and spectrofluorometrically.	1
3828	Effects of dissolved @COMPOUND$ tension and agitation rate on the production of heat-shock protein @PROTEIN$ 96 by MethA tumor cell suspension culture in stirred-tank bioreactors.	0
3829	Goldfish scales were incubated either with 20:3n-9 or with @COMPOUND$ at 15 degrees C for 6 and 18 h. Both osteoblastic and osteoclastic activities in the scale were assessed by measuring alkaline phosphatase (@PROTEIN$) and tartrate-resistant acid phosphatase, respectively.	0
3830	Goldfish scales were incubated either with 20:3n-9 or with @COMPOUND$ at 15 degrees C for 6 and 18 h. Both osteoblastic and osteoclastic activities in the scale were assessed by measuring @PROTEIN$ (ALP) and tartrate-resistant acid phosphatase, respectively.	0
3831	MC3T3-E1 cells (an osteoblast cell line derived from the mouse) were incubated with 20:3n-9 or @COMPOUND$ at 37 degrees C for 6 and 18 h. @PROTEIN$ activity in cell lysate was measured.	0
3832	Both kinases have been implicated in the phosphorylation of @COMPOUND$ 118 and serine 167 on @PROTEIN$, respectively.	1
3833	Expression of the @PROTEIN$-GFP fusion protein was observed exclusively upon @COMPOUND$ induction and was uniformly distributed throughout the intestinal epithelium.	1
3834	On hexanoamide the @PROTEIN$ exhibited a K(m) value of 5.5 mM compared to 0.07 mM for @COMPOUND$.	1
3835	On @COMPOUND$ the @PROTEIN$ exhibited a K(m) value of 5.5 mM compared to 0.07 mM for p-nitroacetanilide.	1
3836	@PROTEIN$ is an important neuronal calcium sensor (NCS) protein, which have been implicated in a wide range of @COMPOUND$+) signaling events in neurons and photoreceptors.	1
3837	Recoverin is an important neuronal calcium sensor (@PROTEIN$) protein, which have been implicated in a wide range of @COMPOUND$+) signaling events in neurons and photoreceptors.	1
3838	A decrease in @PROTEIN$ (7)R expression was observed in cultured OPCs after exposure to oxygen-@COMPOUND$ deprivation (OGD) for 2 h in vitro.	1
3839	The rate constant for the initial reaction between NO and the @PROTEIN$ (@COMPOUND$ is estimated to be (7.0+/-2.0)x10(6) M(-2) x s(-1) at 25 degrees C, which is approx.	1
3840	Acylcarnitines have been suggested to play a role in @PROTEIN$ resistance, as well as other @COMPOUND$ metabolites.	0
3841	These results suggest that @PROTEIN$ delivers @COMPOUND$ to mitochondria where regulatory oxysterols are generated.	1
3842	17beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) is a key enzyme of @COMPOUND$ biosynthesis, which might play an important role in follicular development of the ovary.	1
3843	@PROTEIN$ (HSD17B1) is a key enzyme of @COMPOUND$ biosynthesis, which might play an important role in follicular development of the ovary.	1
3844	@PROTEIN$ promoter hypermethylation correlates with a survival benefit from @COMPOUND$ in patients with recurrent anaplastic astrocytoma but not glioblastoma.	1
3845	To investigate the correlation between O(6)-methylguanine-DNA-methyltransferase (@PROTEIN$) promoter methylation and benefit from @COMPOUND$ in patients with recurrent high-grade glioma.	1
3846	@COMPOUND$ binding to human @PROTEIN$ : a study of protein conformation and binding affinity.	1
3847	Adenosine nucleotide translocase (@PROTEIN$) translocates ADP/@COMPOUND$ across the inner mitochondrial membrane.	1
3848	This review will focus on recent evidence that @COMPOUND$, @PROTEIN$ and neuropeptide Y act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	1
3849	This review will focus on recent evidence that @COMPOUND$, natriuretic peptides and @PROTEIN$ act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	1
3850	Glucocorticoid-activated GR repressed @PROTEIN$ gene induction by @COMPOUND$ (LPS).	1
3851	The data provide the first demonstration for the presence of @PROTEIN$ in primary cilia of renal epithelial cells, and a functional @COMPOUND$-signaling pathway, which targets ciliary channel function and may help control the sensory function of the primary cilium.	0
3852	The purpose of this research was to enhance intranasal drug targeting to the CNS by incorporating a vasoconstrictor (phenylephrine (PHE)) into nasal formulations containing therapeutic @PROTEIN$ (hypocretin-1 (HC) or the dipeptide L-Tyr-D-Arg (D-@COMPOUND$)).	0
